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AC	   Adenylate	  Cyclase	  
APC	   Anapahse	  Promoting	  Complex	  
Arpp19	   cAMP-­‐phosphoregulated	  protein19	  
ARS	   Autonomously	  replicating	  sequence	  
ATM	   Ataxia	  Telengiectasia	  
ATR	   ATM	  related	  
Bub	   Budding	  uninhibited	  by	  benzamidazole	  
C-­‐TAK	   Cdc25C-­‐associated	  protein	  kinase	  
CAK	   CDK	  activating	  kinase	  
CaM	  Kinase	  II	   Ca2+/calmodulin-­‐dependent	  protein	  kinase	  II	  
cAMP	   Cyclic	  Cyclic	  adenosine	  monophosphate	  
Cdc	   Cell	  division	  cycle	  
Cdh1	   Cdc20	  homolog	  1	  
CDK	   Cyclin	  dependent	  Kinase	  
Cdt1	   Cdc10-­‐dependent	  transcript	  1	  
Chk	  	   Checkpoint	  kinase	  
CHX	   Cycloheximide	  
Cip1	   CDK	  inhibitor	  protein	  1	  
CKI	   CDK	  inhibitors	  	  
CPE	   Cytoplasmic	  plyadenylation	  element	  
CPEB	   CPE	  binding	  protein	  
CRL4	   cullin	  ring	  E3	  ligases	  4	  
CSF	   Cytostatic	  factor	  
CT	   Cytoplasm	  Transfer	  
D-­‐box	   Destruction	  box	  
DDK	   Dbf4-­‐dependent	  kinase	  
DSB	   Double-­‐strand	  beark	  DNA	  
Emi2	   Early	  mitotic	  inhibitors	  
ENSA	   α-­‐Endosulfine	  
ERK	   Extracellular	  regulated	  kinase	  
Erp1	   Emi1-­‐releated	  protein	  1	  
FEN1	   Flap	  endonuclease	  1	  	  
GST	   Gultathion	  S	  trasferase	  
GVBD	   Germinal	  Vesicle	  Breakdown	  
Gwl	   Greatwall	  
IBMX	   3-­‐isobutyl-­‐1-­‐methylxanthine	  
IC	   Initiation	  complex	  
Mad	   Mitotic	  arrest	  defect	  
MAPK	   Mitogen	  Activated	  Protein	  Kinase	  
Mastl	   Microtubule	  associated	  serine/threonine	  kinase-­‐like	  
MCC	   Mitotic	  checkpoint	  complex	  
MCM	   Mini	  Chromsome	  maintenance	  proteins	  
MEK	   MAPK	  Erk	  kinase	  
MI	   Meiosis	  I	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MII	   Meiosis	  II	  
MPF	   M-­‐phase	  promoting	  Factor	  
MpP	   Maturation	  phosphorylated	  protein	  
Myt1	   Membrane-­‐associated	  tyrosine-­‐and	  threonine	  1	  
NEBD	   Nuclear	  Envelop	  BreakDown	  
Nek	   NIMA-­‐related	  espressed	  kinase	  
NES	   Nuclear	  localisation	  signal	  
NLS	   Nuclear	  localization	  signal	  
OA	   Okadaic	  acid	  
ORC	   Origin	  Recognition	  Complex	  
p90	  Rsk	   p90	  ribosomal	  S6	  kinase	  
PDE	   Phosphodiesterase	  
Pg	   Progesterone	  
PIP-­‐Box	   PCNA-­‐interacting	  protein	  box	  	  
PKA	   cAMP-­‐dependent	  protein	  kinase	  
PKA-­‐C	   Catalytic	  subunit	  of	  cAMP-­‐dependent	  protein	  kinase	  
PKA-­‐R	   Regulative	  subunit	  of	  cAMP-­‐dependent	  protein	  kinase	  
PKI	   PKA	  inhibitor	  
Plx1	   Polo	  like	  kinase	  1	  
PP1	   Protein	  Phosphatase	  1	  
PP2A	   Protein	  Phosphatase	  2A	  
pRB	   Retinoblastoma	  protein	  
Pre-­‐RC	   Pre	  Replicative	  Complex	  
Ringo	   Rapid	  inducer	  of	  G2/M	  in	  oocytes	  
SAC	   Spindle	  Assembly	  Checkpoint	  
SCF	   Skp,	  Cullin,	  F-­‐box	  containing	  complex	  
Sgo	   Shugoshin	  
ssDNA	   SIngle-­‐stranded	  DNA	  
UTR	   UnTranslated	  Region	  
xPR	   Xenopus	  Progesterone	  Receptor	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§ From	  monomeric	  Cdk1:	  the	  synthesis	  of	  Cyclins	  B	  
§ From	  the	  pre-­‐MPF:	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  concentration	  
D. Discussion	  
a. Arpp19,	   a	   tool	   to	   investigate	   the	   role	   of	   PKA	   during	  meiosis	  
resumption	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  phosphatases	  
1. Arpp19,	  PP1	  and	  the	  prophase	  arrest	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  anaphase	  transition	  
C. Cdc6	  in	  apoptosis	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The	  overall	  goal	  of	  my	  project	  was	  to	  unravel	  the	  mechanisms	  responsible	  for	  the	  differentiation	  of	  a	  
female	   diploid	   germ	   cell	   into	   a	   haploid	   fertilizable	   oocyte.	   Two	   critical	   features	   underlie	   the	  
differentiation	   of	   female	   germ	   cells,	   turning	   it	   into	   a	   fertilizable	   oocyte	   able	   to	   support	   sexual	  
reproduction.	  Firstly,	  the	  oocyte	  halts	  its	  meiotic	  progression	  in	  prophase	  of	  the	  1st	  meiotic	  division,	  
an	  arrest	   common	   to	  all	   species	   in	   the	  animal	   kingdom	  and	  necessary	   to	   support	   an	   intensive	   cell	  
growth	  due	  to	  the	  accumulation	  of	  nutrients	  and	  determinants	  required	  for	  the	  early	  development	  of	  
the	  future	  embryo.	  Secondly,	  the	  ploidy	  of	  the	  cell	  has	  to	  be	  reduced	  by	  half	  in	  order	  to	  generate	  a	  
haploid	   gamete.	   This	   process	   is	   ensured	   by	   the	   succession	   of	   the	   two	   meiotic	   divisions	   with	   no	  
intervening	  S-­‐phase	  and	  no	  DNA	  replication	  in-­‐between.	  	  
During	  my	  PhD,	  my	  scientific	  researches	  have	  been	  focused	  on	  these	  two	  specific	  subjects	  by	  using	  a	  
powerful	  model	  system	  well	  suited	  for	  the	  analysis	  of	  meiotic	  divisions,	  the	  Xenopus	  oocyte.	  Meiotic	  
divisions	  have	  evolved	  from	  the	  mitotic	  cell	  cycle,	  re-­‐using	  molecular	  engines	  of	  cell	  proliferation,	  but	  
placing	  them	  in	  a	  new	  context	  of	  regulatory	  pathways.	  Indeed,	  many	  actors	  of	  the	  meiotic	  divisions	  
are	   conserved	   and	   shared	   with	   the	   mitotic	   cell	   cycle.	   That	   is	   why	   I	   chose	   to	   describe	   in	   the	  
introductive	   part	   of	   this	   manuscript	   the	   control	   of	   the	   mitotic	   cell	   cycle.	   Then	   I	   highlight	   more	  
specifically	   the	  mechanisms	  that	  control	   the	  meiotic	  divisions.	  This	   introductive	  part	   is	   followed	  by	  
two	   chapters	   presenting	  my	   results.	   The	   first	   one	   is	   devoted	   to	   the	   small	   protein	   Arpp19	   and	   its	  
involvement	  in	  the	  prophase	  arrest.	  The	  second	  one	  focuses	  on	  the	  regulation	  of	  the	  Cdc6	  protein,	  
an	   essential	   replicative	   factor,	   and	   its	   role	   in	   controlling	   Cdk1	   activity	   as	   well	   as	   DNA	   replication	  
during	   the	   meiotic	   divisions.	   The	   manuscript	   ends	   with	   general	   perspectives	   of	   research	   avenues	  
open	  by	  my	  results.	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I	  -­‐	  Mitosis	  versus	  meiosis	  
In	   all	   living	  organisms,	   the	  universal	  way	   to	  propagate	   life	   is	   cell	   division	   that	   requires	   the	   faithful	  
duplication	   of	   the	   DNA	   (DNA	   replication)	   followed	   by	   the	   equal	   segregation	   of	   the	   genetic	  
information	   in	   two	   separate	   daughter	   cells	   (Cell	   division).	   In	   prokaryotes,	   which	   lack	   nucleus,	  
mitochondria	  and	  other	  membrane-­‐surrounded	  organelles,	  the	  cell	  division	  consists	  in	  a	  quick	  phase	  
of	  DNA	  synthesis	  followed	  by	  the	  fission	  of	  the	  cell	   in	  two	  daughter	  cells.	  Eukaryotic	  cells	  possess	  a	  
more	   complex	   structure	   than	   prokaryotes:	   the	   cytoplasm	   is	   partitioned	   in	   several	   specialized	  
organelles	  and	  the	  genetic	   information	   is	  encoded	  by	  more	  than	  one	  chromosome	  encapsulated	   in	  
the	  nucleus.	  Because	  these	  structures	  need	  to	  be	  shared	  between	  the	  two	  daughter	  cells,	  the	  cellular	  
division	   called	   Mitosis	   is	   part	   of	   a	   highly	   regulated	   system,	   the	   mitotic	   cell	   cycle.	   This	   cycle	  
orchestrates	   in	  time	  and	  space	  the	  replication	  of	  the	  DNA	  with	  the	  physical	  division	  of	  the	  cell	  and	  
supports	  the	  asexual	  reproduction	  of	  single-­‐cell	  organisms	  as	  well	  as	  the	  proliferation	  of	  somatic	  cells	  
in	  multicellular	  organisms.	  Eukaryotes	  have	  also	  evolved	  a	  second	  type	  of	  cell	  division	  called	  Meiosis.	  
In	  multicellular	   organisms,	   the	  meiotic	   division	   is	   specific	   of	   germ	   cells	   (sperms	   and	   oocytes)	   and	  
consists	   in	   the	   succession	   of	   two	   cellular	   divisions,	   the	   meiosis	   I	   and	   the	   meiosis	   II,	   with	   no	  
intervening	   S-­‐phase	   or	   DNA	   replication.	   This	   specialized	   division	   allows	   the	   formation	   of	   haploid	  
gametes	  that	  support	  the	  sexual	  reproduction.	  Following	  fertilization,	  the	  fusion	  of	  the	  oocyte	  with	  
the	  sperm	  reconstitutes	  a	  diploid	  genome	  to	  originate	  the	  next	  generation.	  	  
A. The	  mitotic	  cell	  cycle	  
a. Overview	  of	  the	  cell	  cycle	  
The	   mitotic	   cell	   cycle	   is	   divided	   in	   two	   main	   phases:	   the	   interphase,	   during	   which	   the	   DNA	   is	  
replicated	  and	  the	  M-­‐phase,	  during	  which	  the	  cell	  physically	  divides.	  Beside	  S-­‐phase,	  the	  interphase	  
also	   contains	   two	  Gap	   periods,	   G1	   and	  G2,	   occurring	   before	   and	   after	   the	   S-­‐phase	   (Fig.	   1).	   The	  G1	  
phase	   marks	   the	   irreversible	   commitment	   of	   the	   cell	   within	   the	   cell	   cycle,	   which	   is	   regulated	   by	  
extracellular	  mitogenic	  factors	  and	  the	  cellular	  size.	  During	  G2,	  the	  cell	  synthesizes	  and	  assembles	  all	  
the	   components	   and	   structures	   that	  will	   be	   necessary	   for	   the	  progression	   through	  M-­‐phase.	  After	  
fertilization,	   the	   embryonic	   cell	   cycles	   are	   characterized	   by	   a	   quick	   succession	   of	   S-­‐phases	   with	  
mitosis	  in	  the	  absence	  of	  G1	  and	  G2	  phases.	  This	  allows	  a	  very	  fast	  cell	  proliferation.	  G1	  and	  G2	  phases	  
appear	   at	   time	  of	   the	  mid-­‐blastula	   transition	   (MBT),	   also	   corresponding	   to	   the	   first	   transcriptional	  
expression	  of	  the	  embryonic	  genome.	  Hence	  cell	  cycles	  start	  to	  be	  connected	  with	  external	  stimuli.	  
Mitosis	   is	   the	   shortest	   phase	   of	   the	   cell	   cycle	   and	   is	   divided	   into	   five	   well-­‐characterized	   periods:	  
prophase,	  prometaphase,	  metaphase,	  anaphase	  and	  telophase.	   In	  prophase,	  chromosomes	  start	  to	  
condensate	  inside	  the	  nucleus	  and	  the	  centrosomes	  separate	  from	  each	  other,	  prefiguring	  the	  poles	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of	  the	  future	  mitotic	  spindle.	  In	  prometaphase,	  kinetochores	  are	  assembled	  on	  centromeres	  and	  get	  
attached	  to	  the	  spindle	  microtubules	  in	  order	  to	  pull	  the	  chromosomes	  toward	  the	  middle	  of	  the	  cell.	  
At	   this	  stage,	   the	  nuclear	  envelope	  breaks	  down.	  During	  metaphase,	   the	  chromosomes	  are	  aligned	  
halfway	  between	  the	  spindle	  poles	  on	  the	  metaphase	  plate.	   In	  anaphase,	  the	  sister	  chromatids	  are	  
split	   apart	   and	   migrate	   toward	   the	   opposite	   poles	   of	   the	   cell	   due	   to	   the	   shortening	   of	   the	  
kinetochore	  microtubules	  and	  to	  the	  elongation	  of	  the	  spindle,	  that	  increases	  the	  separation	  of	  the	  
chromosomes	   between	   the	   poles.	   During	   telophase,	   chromosomes	   reach	   the	   poles,	   the	   nucleus	  
starts	   to	   reassemble	   around	   each	   group	   of	   chromosomes	   and	   the	   DNA	   decondensates.	   The	  
telophase	  ends	  with	  the	  physical	  division	  of	  the	  two	  new-­‐born	  cells	  during	  the	  process	  of	  cytokinesis.	  
In	   adult	   organisms,	   most	   of	   the	   cells	   are	   not	   engaged	   within	   the	   cell	   cycle	   but	   are	   arrested	   in	   a	  
particular	  resting	  state	  called	  G0	  (Fig.	  1).	  The	  G0	  arrest	  can	  be	  temporary	  (quiescent	  cells)	  as	  for	  stem	  
cells,	  that	  are	  ready	  to	  re-­‐enter	  into	  the	  cell	  cycle	  in	  response	  to	  external	  stimuli,	  or	  irreversible	  such	  
as	  following	  the	  cellular	  differentiation	  or	  the	  entry	  into	  senescence.	  
b. Cell	  cycle	  engines	  
i. CDKs-­‐Cyclins	  
The	  core	  components	  of	  the	  molecular	  cell	  cycle	  engine	  are	  Cyclin-­‐dependent	  kinases	  (CDKs),	  which	  
belong	  to	  the	  CMGC	  (Cdk1,	  MAPK,	  Gsk,	  CK)	  group	  of	  kinases.	  This	  family	  comprises	  20	  members	  from	  
Cdk1	  to	  Cdk20	  that	  are	  involved	  in	  regulating	  transcription	  and	  cell	  cycle	  progression.	  CDKs	  are	  little	  
kinases	  of	  about	  250	  amino	  acids	  residues	  (around	  34-­‐40	  kDa)	  possessing	  a	  two-­‐lobed	  structure.	  The	  
amino	   terminal	   lobe,	   which	   is	   mainly	   composed	   of	   β-­‐sheets,	   contains	   a	   Glycine-­‐rich	   inhibitory	  
element	  (G-­‐loop)	  and	  a	  major	  helix	  (C	  helix)	  containing	  the	  PSTAIRE	  sequence	  of	  Cdk1.	  The	  carboxy	  
terminal	   lobe,	  which	   is	   rich	   in	  α-­‐helices,	   contains	   a	   flexible	   sequence	   that	   binds	   ATP	   (P-­‐loop),	   the	  
catalytic	   cleft	   and	   the	   activatory	   segment	   (T-­‐loop).	   As	   monomers,	   CDKs	   are	   inactive	   because	   the	  
catalytic	   cleft	   is	   closed	   by	   the	   T-­‐loop,	   preventing	   the	   access	   to	   the	   ATP	   and	   thus	   their	   enzymatic	  
activity.	  	  
The	   activation	   of	   CDKs	   requires	   their	   binding	   to	   activatory	   proteins,	   Cyclins	   (Jeffrey	   et	   al.	   1995).	  
Cyclins	  are	  a	  large	  family	  of	  approximately	  30	  members	  whose	  molecular	  weight	  varies	  from	  30	  to	  90	  
kDa	   (Malumbres	   2014).	   These	   proteins	   are	   structurally	   defined	   by	   the	   presence	   of	   a	   Cyclin-­‐box,	   a	  
large	  domain	  of	   100	   amino	  acids	   forming	   five	  α-­‐helixes	   and	  mediating	   their	   interaction	  with	  CDKs	  
(Kobayashi	  et	  al.	  1992).	  Upon	  phosphorylation	  at	  T161	  in	  the	  T-­‐loop	  and	  the	  association	  of	  Cyclins	  to	  
the	  C-­‐helix	  of	  CDKs,	  CDKs	  sustain	  a	  conformational	  change	  that	  takes	  the	  PSTAIRE	  sequence	  out	  from	  
the	  catalytic	  cleft.	  This	  process	  stabilizes	  the	  Cyclin-­‐CDK	  heterodimer	  and	  opens	  the	  catalytic	  cleft	  to	  
allow	  the	  binding	  of	  ATP	  within	  the	  P-­‐loop	  (Jeffrey	  et	  al.	  1995,	  Pavletich	  1999,	  Echalier	  et	  al.	  2014).	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While	   there	   is	  only	  one	  CDK,	   the	  homolog	  of	  Cdk1	   in	  yeasts	   (CDC28	   in	  S.	   cerevisiae	   and	  Cdc2	   in	  S.	  
pombe)	   (Nurse	   et	   al.	   1981,	   Stern	   et	   al.	   1996),	   several	   CDKs	   are	   involved	   in	   cell	   cycle	   control	  
metazoans	  (in	  mammals:	  Cdk1,	  Cdk2,	  Cdk4	  and	  Cdk6	  functioning	  as	  cell	  cycle	  engines)	   (Fig.	   1).	  The	  
same	   is	   true	   for	   Cyclins:	   in	   yeasts,	   two	   types	   of	   Cyclins,	   Clb	   (B	   type)	   and	   Cln,	   are	   present	   while	  
metazoans	   have	   A,	   B,	   C	   D	   and	   E	   type	   Cyclins.	   Various	   combinations	   between	   CDKs	   and	   Cyclins	  
generate	  complexes	  with	  different	  substrate	  specificities	  and	  therefore	  result	   in	  different	  cell	  cycle	  
events	   (Fig.	   1).	   G1-­‐phase	   Cyclin-­‐CDK	   complexes	   such	   as	   Cdk4/6-­‐Cyclin	   D	   are	   important	   for	   the	  
progression	   through	   G1	   and	   the	   commitment	   in	   S-­‐phase.	   S-­‐phase	   Cyclin-­‐CDK	   complexes	   such	   as	  
Cdk2-­‐Cyclin	   E	   and	   Cdk2-­‐Cyclin	   A	   are	   responsible	   for	   initiating	   and	   completing	  DNA	   replication.	  M-­‐
phase	   Cyclin-­‐CDK	   complexes	   such	   as	   Cdk1-­‐Cyclin	   A	   and	   Cdk1-­‐Cyclin	   B	   drive	   entry	   and	   progression	  
into	  mitosis	  (Fig.	  1).	  
ii. Regulation	  of	  CDKs-­‐Cyclins	  
The	   control	   of	   CDKs	   genes	   expression	   plays	   a	   minor	   role	   in	   the	   regulation	   of	   CDK	   activity.	   For	  
example,	  Cdk1	  and	  Cdk2	  are	  expressed	  at	  constant	  level	  all	  over	  the	  mitotic	  cell	  cycle.	  However,	  their	  
activity	  is	  tightly	  regulated	  by	  at	  least	  three	  mechanisms:	  Cyclins	  availability,	  stoichiometric	  inhibition	  
by	  CDK	  Inhibitors	  (CKIs)	  and	  phosphorylations	  (Fig.	  2).	  
1. Association	  to	  Cyclins	  
The	   association	   of	   Cyclins	   with	   CDKs	   is	   mandatory	   for	   CDK	   activity.	   Since	   Cyclin	   levels	   are	   tightly	  
regulated	  by	  transcriptional/translational	  mechanisms	  and	  by	  degradation,	  Cyclin	  levels	  constitute	  an	  
important	   regulatory	   element	   of	   CDK	   activities.	   Cyclins	   are	   targeted	   to	   the	   proteasome	   by	   two	  
ubiquitin	   ligases:	   SCF	   (Skp1-­‐Cullin-­‐F	  box	  protein	   complex)	   and	  APC	   (Anaphase	  Promoting	  Complex)	  
(Fig.	   2).	   The	   SCF	   recognizes	   Cyclins	   as	   substrates	   when	   they	   are	   phosphorylated	   at	   specific	   sites,	  
whereas	   Cyclin	   ubiquitination	   by	   the	   APC	   occurs	   following	   the	   binding	   of	   two	   specific	   APC	   co-­‐
activators:	  Cdc20,	  at	  the	  anaphase	  onset	  and	  Cdh1	  in	  late	  mitosis/G1	  transition.	  
2. Stoichiometric	  inhibition	  by	  CKIs	  
CKIs	  are	  subdivided	  into	  two	  classes	  based	  on	  their	  structure	  and	  CDK	  specificity.	  CKIs	  inactivate	  CDK	  
catalytic	   activity	   by	   forming	   trimers	   with	   CDK-­‐Cyclin	   complexes	   (Fig.	   2).	   Yeasts	   possess	   a	   single	  
specific	   inhibitor,	   Sic/Rum1,	  whereas	  higher	  eukaryotes	  utilize	  many	   inhibitors	   from	  the	   INK	   family
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(Inhibitor	   of	   CDKs	   comprising	   p15,	   p16,	   P18	   and	   p19)	   and	   the	   KIP/CIP	   family	   (p21,	   p27	   and	   p57)	  
(Sherr	  et	  al.	  1999).	  The	  INK	  family	  members	  primarily	  target	  Cdk4	  and	  Cdk6.	  Conversely,	  the	  KIP/CIP	  
family	  members	  are	  less	  specific	  and	  broadly	  interfere	  with	  the	  activities	  of	  CDK-­‐Cyclins	  D/E/A	  and	  B	  
complexes	  (Sherr	  et	  al.	  1999),	  thus	  providing	  an	  additional	  regulation	  level	  to	  CDK	  heterodimers.	  
3. Post-­‐translational	  modifications	  
A	   third	   level	   of	   CDK	   regulation	   is	   ensured	   by	   their	   phosphorylation	   within	   the	   T-­‐loop,	   a	   process	  
required	   for	   CDK	   activation,	   and	   within	   the	   G-­‐loop	   that	   restrains	   the	   activity	   of	   CDKs	   to	   avoid	  
unscheduled	  DNA	  replication	  or	  entry	  into	  M-­‐phase.	  
§ Activatory	  phosphorylation	  within	  the	  T-­‐loop	  
The	   full	   activation	  of	   CDKs	   requires	   their	   phosphorylation	  within	   the	   T-­‐loop,	   at	   T161	   for	   Cdk1	   and	  
T160	   for	   Cdk2	   (Krek	   et	   al.	   1992,	   Larochelle	   et	   al.	   2007,	   Malumbres	   2014)	   (Fig.	   2).	   This	  
phosphorylation	  is	  controlled	  by	  the	  CDK-­‐Activating	  Kinase	  (CAK),	  an	  heterodimer	  comprising	  Cdk7,	  
Cyclin	  H	  and	  Mat1	   (Fig.	   2).	  CAK	  activity	   remains	   constant	  along	   the	  cell	   cycle	   (Fesquet	   et	  al.	   1993,	  
Poon	  et	  al.	  1993,	  Solomon	  et	  al.	  1993).	  The	  activity	  of	  CDK-­‐Cyclin	  complexes	  is	  further	  restrained	  by	  
inhibitory	  phosphorylations.	  
§ Inhibitory	  phosphorylations	  within	  the	  G-­‐loop	  
The	  activation	  of	  CDKs	   is	  prevented	  by	  the	  phosphorylation	  at	   two	  residues	  within	  the	  G-­‐loop:	  T14	  
and	  Y15	  for	  Cdk1	  and	  Cdk2,	  which	  act	  by	  reducing	  the	  CDK	  affinity	  for	  their	  substrates	  (Malumbres	  
2014).	  These	  phosphorylations	  are	  catalysed	  by	   the	  Wee1/Myt1	  kinase	   family	  and	  removed	  by	   the	  
dual	  specificity	  phosphatases	  family,	  Cdc25.	  
– The	  Wee1/Myt1	  kinase	  family	  
In	   Metazoans,	   the	   Wee1/Myt1	   kinase	   family	   comprises	   Wee1	   and	   Myt1	   that	   phosphorylate	   and	  
inhibit	  Cdk1-­‐Cyclin	  B	  complexes	  in	  interphase.	  Both	  Wee1	  and	  Myt1	  catalyse	  the	  phosphorylation	  of	  
Cdk1	  at	  Y15	  but	  only	  Myt1	  would	  phosphorylate	  CDKs	  at	  T14	  (Parker	  et	  al.	  1992,	  Fattaey	  et	  al.	  1997).	  
In	   Xenopus	   and	   mammals,	   two	   isoforms	   of	   Wee1	   exists.	   The	   maternal	   or	   embryonic	   isoform	  
(unfortunately	   called	  Wee1A	   in	  Xenopus	   and	  Wee1B	   in	  mammals)	   is	   present	   in	   oocytes	   and	   early	  
embryos	  and	  controls	  the	  first	  embryonic	  cell	  division	  (Murakami	  et	  al.	  1998,	  Nakajo	  et	  al.	  2000,	  Han	  
et	  al.	  2005).	  The	  somatic	  form	  (Wee1B/Wee2	  in	  Xenopus	  and	  Wee1A	  in	  mammals)	  is	  expressed	  after	  
the	  MBT	  (Leise	  et	  al.	  2002,	  Okamoto	  et	  al.	  2002).	  Wee1	  is	  a	  nuclear	  protein	  mainly	  involved	  in	  mitotic	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cell	   cycles	   that	   prevents	   active	   Cdk1-­‐Cyclin	   B	   from	   accumulating	   in	   the	   nucleus	   during	   interphase	  
(Parker	  et	  al.	  1992,	  Heald	  et	  al.	  1993,	  Baldin	  et	  al.	  1995,	  Rothblum-­‐Oviatt	  et	  al.	  2001).	  While	  Cdk1	  is	  
only	  phosphorylated	  at	  Y15	   in	  yeast,	  Cdk1	  can	  be	  also	  phosphorylated	  at	  T14	   in	  higher	  eukaryotes.	  
The	   kinase	   responsible	   for	   the	   T14	   phosphorylation	   of	   Cdk1	   was	   first	   identified	   in	   membrane	  
fractions	   of	   Xenopus	   egg	   extracts	   and	   was	   called	   Myt1	   for	   Membrane-­‐associated	   tyrosine-­‐and	  
threonine	  specific	  Cdc2	  inhibitory	  kinase	  (Kornbluth	  et	  al.	  1994,	  Mueller	  et	  al.	  1995b).	  Myt1	  localizes	  
within	  the	  reticulum	  membranes	  (Mueller	  et	  al.	  1995b).	  Besides	  phosphorylating	  Cdk1	  at	  T14,	  Myt1	  
can	  also	  inhibit	  Cdk1	  activation	  by	  sequestering	  Cdk1	  in	  the	  intracellular	  membranes	  (Liu	  et	  al.	  1999,	  
Wells	  et	  al.	  1999).	  Myt1	  is	  conserved	  from	  C.	  elegans	  to	  human	  (Liu	  et	  al.	  1999,	  Cornwell	  et	  al.	  2002,	  
Okumura	   et	  al.	   2002,	   Jin	   et	  al.	   2005,	  Burrows	   et	  al.	  2006).	   In	  all	   these	  species,	  Myt1	   regulates	   the	  
G2/M	  transition	  during	  spermatogenesis	  and	  oogenesis,	  suggesting	  that	  Myt1	  specifically	  controls	  the	  
meiotic	  divisions	  of	  germ	  cells.	  
– The	  dual	  phosphatases	  Cdc25	  
The	   Cdc25	   phosphatase	   family	   comprises	   three	   isoforms,	   A,	   B	   and	   C,	   in	  mammals	  while	   only	   two	  
isoforms	  have	  been	  identified	  in	  Xenopus	   (A	  and	  C).	  These	  dual	  phosphatases	  dephosphorylate	  Y15	  
and	  T14	  residues	  of	  CDKs,	  hence	  activating	  the	  CDK-­‐Cyclin	  complexes.	   In	  Xenopus,	  Cdc25C,	  but	  not	  
Cdc25A,	   is	   essential	   for	   promoting	   mitosis.	   According	   the	   classical	   view,	   mammalian	   Cdc25A	  
regulates	  the	  G1/S	  transition	  while	  Cdc25B	  and	  Cdc25C	  were	  thought	  to	  control	  the	  G2/M	  transition	  
(Boutros	   et	   al.	   2007).	   However,	   more	   recent	   evidence	   suggests	   that	   all	   three	   isoforms	   can	  
dephosphorylate	  Cdk1-­‐Cyclin	   B	   complexes	   and	  play	   important	   roles	   during	   the	  G1/S	   and	   the	  G2/M	  
transitions	   (Boutros	   et	   al.	   2006,	   Karlsson-­‐Rosenthal	   et	   al.	   2006,	   Aressy	   et	   al.	   2008).	   Although	   an	  
undefined	  level	  of	  functional	  redundancy	  exists	  among	  the	  three	  mammalian	  Cdc25	  phosphatases,	  a	  
study	  using	  siRNA	  and	  microscopy	  in	  human	  cells	  showed	  that	  Cdc25A	  and	  Cdc25B	  cooperate	  for	  the	  
mitotic	  entry	  (Lindqvist	  et	  al.	  2005):	  Cdc25B	  activates	  Cdk1-­‐Cyclin	  B	  at	  centrosomes	  (Lindqvist	  et	  al.	  
2005)	  and	  the	  active	  Cdk1-­‐Cyclin	  B	  complexes	  are	  subsequently	  imported	  into	  the	  nucleus	  (Jackman	  
et	  al.	  2003);	  while	  Cdc25A	  was	  shown	  to	  be	  involved	  in	  chromatin	  condensation	  (Mailand	  et	  al.	  2002,	  
Lindqvist	  et	  al.	  2005).	  
c. Surveillance	  mechanisms	  
Importantly,	   the	   ordered	   execution	   of	   the	   cell	   cycle	   is	   coordinated	   by	   a	   series	   of	   surveillance	  
mechanisms	  termed	  checkpoints	   (Weinert	  et	  al.	  1988).	  These	  mechanisms	  are	  not	  required	  for	  cell	  
cycle	  events	  themselves	  but	  they	  ensure	  that	  each	  step	  of	  the	  cell	  cycle	  is	  completed	  correctly	  before	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the	  cell	  proceeds	  to	  the	  next	  phase.	  Hence,	  these	  processes	  reduce	  the	  occurrence	  of	  mistakes	  in	  the	  
genetic	   information	  and	  segregation,	  contributing	  to	  genome	  stability.	  Moreover,	   they	  connect	  the	  
cell	  cycle	  progression	  with	  the	  environment,	  thus	  allowing	  the	  cell	  to	  enter	  in	  the	  cell	  cycle	  only	  when	  
the	   external	   environment	   is	   favourable.	   	   Checkpoints	   are	   constitutive	   pathways	   that	   consist	   of	   at	  
least	   three	   components	   (Murray	   1992):	   a	   sensor	   that	   detects	   the	   problem;	   a	   signalling	   pathway	  
composed	  by	  mediators/transducers;	   and	   a	   response	   element	   in	   the	   cell	   cycle	  machinery	   (often	   a	  
regulator	   of	   the	   CDKs)	   able	   to	   halt	   cell	   cycle	   progression.	   Three	   key	   cell	   cycle	   transitions	   are	  
controlled	  during	  the	  cell	  cycle	  (Fig.	  1):	  the	  Start	  or	  Restriction	  point	  (G1/S	  transition)	  (See	  chapter:	  I-­‐	  
A.d.i.	   “The	  G1/S	   transition”),	   entry	   into	  mitosis	   (G2/M	   transition)	   (See	   chapter:	   I-­‐	   A.e.ii.	   “The	  G2/M	  
transition”)	   and	  exit	   from	  mitosis	   (M/G1	   transition)	   (See	   chapter:	   I-­‐	  A.e.iii.3.	   “Regulation	  of	  APC	  by	  
SAC”).	  The	  Start	  or	  restriction	  point	  monitors	  whether	  the	  cell	  can	  proceed	  through	  a	  new	  cell	  cycle	  
in	  G1,	  mostly	   by	   sensing	   the	  external	  medium.	   The	  entry	   into	  mitosis	   is	  mostly	   determined	  by	   the	  
completion	   of	   DNA	   replication,	  while	   exit	   from	  mitosis	   relies	   on	   the	   Spindle	   Assembly	   Checkpoint	  
(SAC)	  that	  monitors	  the	  quality	  of	  the	  chromosomes	  alignment	  on	  the	  metaphase	  plate,	  necessary	  to	  
ensure	  the	  correct	  segregation	  of	  DNA	  between	  the	  daughter	  cells.	  	  
Cells	   that	  meet	   the	   size	   and	  nutritional	   requirements	   can	   complete	   the	   cell	   cycle	   unless	   a	   specific	  
threat	  to	  genome	  integrity	  is	  perceived.	  One	  major	  threat	  is	  DNA	  damage,	  which	  is	  detected	  by	  the	  
presence	  of	  two	  DNA	  structures:	  Double-­‐Strand	  Breaks	  DNA	  (DSBs)	  and	  exposed	  single-­‐stranded	  DNA	  
(ssDNA)	   (Fig.	   3).	   These	   structures	   are	   generated	   during	   the	   physiological	   processes	   of	   DNA	  
replication	   and	   DNA	   recombination,	   but	   they	   can	   be	   the	   consequence	   of	   the	   exposure	   of	   cells	   to	  
external	   insults	   such	   as	   oxidative	   stresses,	   ionizing	   radiations,	   UV	   radiations	   or	   chemical	   agents.	  
These	   checkpoint	   mechanisms	   act	   throughout	   the	   cell	   cycle	   and	   arrest	   the	   cell	   cycle	   progression	  
mainly	   at	   G1/S	   or	   G2/M	   transitions	   to	   allow	   DNA	   repair.	   However,	   when	   DNA	   damages	   are	   too	  
extensive,	  the	  cell	  undergoes	  apoptosis	  or	  enters	  in	  senescence,	  a	  viable	  state	  characterised	  by	  the	  
definitive	  incapacity	  of	  the	  cell	  to	  divide.	  The	  sensors	  of	  these	  DNA	  damages	  include	  the	  proteins	  of	  
the	  PI3	  kinase	   family,	  ATM	  (Ataxia	   telangiectasia	  mutated)	  and	  ATR	   (Ataxia-­‐telangiectasia-­‐Related).	  
Once	  activated,	  these	  two	  proteins	  phosphorylate	  and	  activate	  mediators,	  Checkpoint	  kinases	  1	  and	  
2	  (Chk1	  and	  Chk2),	  that	  transduce	  the	  signal	  to	  the	  effectors	  which	  are	  part	  of	  the	  cell	  cycle	  engine,	  
such	  as	  Cdc25	  and	  Wee1.	  While	  ATR-­‐Chk1	  is	  traditionally	  involved	  in	  mediating	  DNA	  replication	  and	  
ssDNA	   checkpoints,	   ATM-­‐Chk2	   is	   rather	   implicated	   in	   the	   response	   to	   DSBs.	   However,	  
interconnection	  between	  these	  two	  networks	  exists	  (Fig.	  3).	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d. Control	  of	  S-­‐phase	  
i. The	  G1/S	  transition	  
The	   decision	   to	   enter	   S-­‐phase,	   which	   is	   under	   the	   control	   of	   the	   “restriction	   point”,	   represents	   a	  
irreversible	  commitment	   for	   the	  cell	   to	  enter	  and	  complete	  mitotic	  cell	   cycle.	  Once	   this	  decision	   is	  
taken,	   cells	   become	   refractory	   to	   extracellular	   signals,	   being	   sensible	   only	   to	   their	   internal	  
environment.	   The	   core	   component	   of	   this	   checkpoint	   is	   the	   retinoblastoma	   protein	   (pRB).	   In	   the	  
absence	   of	   extracellular	   mitogens,	   pRB	   is	   hypophosphorylated	   and	   associates	   with	   transcription	  
factors	   of	   the	   E2F	   family,	   to	   repress	   the	   expression	   of	   E2F-­‐target	   genes	   (Dyson	   1998)	   (Fig.	   4).	   In	  
response	  to	  mitogenic	  signals,	  GSK-­‐3β	  signalling	  is	   inhibited,	  G1-­‐Cyclin	  D	  is	  stabilized	  and	  associates	  
with	  Cdk4/6	  (Fig.	  4).	  The	  activation	  of	  these	  Cdk4/6-­‐Cyclins	  complexes	  leads	  to	  pRB	  phosphorylation	  
and	   causes	   its	   dissociation	   from	   E2F,	   which	   promotes	   the	   transcription	   of	   genes	   required	   for	   the	  
entry	  in	  S-­‐phase,	  such	  as	  S-­‐phase	  Cyclins	  (Fig.	  4).	  
ii. Molecular	  control	  of	  DNA	  replication	  
In	   Eukaryotes,	   genome	   sizes	   range	   between	   107	   bp	   in	   yeasts	   to	   1011	  bp	   in	  metazoan.	   The	   genetic	  
information	   is	   distributed	   across	   multiple	   chromosomes.	   Each	   of	   them	   contains	   many	   replicative	  
origins,	  ensuring	  a	  rapid	  duplication	  of	  the	  eukaryotic	  genomes.	  To	  allow	  that	  each	  chromosome	  is	  
entirely	   copied	   in	   a	   reasonable	   period	   of	   time	   and	   only	   once	   per	   cell	   cycle,	   the	   initiation	   of	   DNA	  
replication	  from	  multiple	  dispersed	  origins	  must	  be	  coordinated,	  and	  thus	  strictly	  controlled	  within	  
the	   cell	   cycle.	   This	   regulation	   was	   enlightened	   for	   the	   first	   time	   by	   performing	   cell	   fusion	  
experiments.	  When	  G1	  cells	  are	  fused	  with	  G2	  ones,	  unreplicated	  DNA	  of	  G1	  cells	  replicates,	  but	  the	  
nuclei	  of	  the	  G2	  cells	  do	  not	  support	  DNA	  replication	  until	  the	  hybrid	  cells	  have	  not	  passed	  through	  
mitosis	  (Rao	  et	  al.	  1970).	  This	  experiment	  suggests	  that	  G1	  DNA	  is	  differently	  “labelled”	  compared	  to	  
the	  G2	  one,	  and	  that	  the	  passage	  through	  mitosis	  is	  necessary	  to	  reset	  the	  competence	  to	  replicate	  
DNA.	   Nowadays,	   it	   is	   well	   known	   that	   DNA	   replication	   is	   organized	   into	   two	   sequential	   never-­‐
overlapping	  steps:	   the	  “licensing	   reaction”,	  which	  confers	   the	  competence	   to	   replicate	   (Blow	   et	  al.	  
2005),	  and	  the	  origin	  firing,	  during	  which	  DNA	  replication	  starts	  and	  origins	  loose	  the	  competence	  to	  
replicate.	   Licensing	   occurs	   during	   late	   M/G1	   and	   consists	   in	   the	   assembly	   of	   pre-­‐Replicative	  
Complexes	   (Pre-­‐RCs),	   ending	   with	   the	   loading	   of	   the	   replicative	   helicase	   Minichromosome	  
maintenance	   complex	   2-­‐7	   (MCM2-­‐7)	   at	   replicative	   origins.	   During	   the	   G1/S	   transition,	   the	   “origin	  
firing”	  converts	  pre-­‐RCs	   into	   initiation	  complexes	   (ICs),	  a	   step	   that	   requires	  S-­‐Cyclin/CDK	  and	  DDKs	  
(Cdc7-­‐Dbf4)	  activities	  as	  well	  as	  the	  binding	  of	  additional	  factors.	  This	  phase	  ends	  with	  the	  activation	  
of	  MCM	  helicases	  and	  the	  recruitment	  of	  the	  DNA	  polymerases.	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1. The	  licensing	  reaction	  
The	   recruitment	   of	  MCM2-­‐7	   to	   chromatin	   requires	   the	   stepwise	   formation	   of	   pre-­‐RCs	   in	   an	   ATP-­‐
dependent	  manner	  on	  replicative	  origins.	  This	  reaction	  starts	  during	  the	  M	  phase	  with	  the	  binding	  of	  
the	  Origin	  Recognition	  Complex	   (ORC)	   to	  DNA.	   In	  budding	  yeast,	   this	  binding	   requires	  a	   conserved	  
sequence	   of	   11-­‐bp	   or	   17-­‐bp,	   called	   Autonomously	   Replicating	   Sequence	   (ARS)	   (Stinchcomb	   et	   al.	  
1979),	  which	  marks	   the	   replication	   origin	   on	  DNA.	   In	  Metazoan,	  ORC	   binding	   is	   not	   targeted	   by	   a	  
clear	  consensus	  sequence	  (DePamphilis	  2005).	  In	  Eukaryotes,	  ORC	  is	  composed	  of	  six	  subunits	  (Orc1-­‐
6),	  among	  them	  Orc1	  that	  possesses	  a	  functional	  ATPase	  activity.	   In	  G1,	  ORC	  recruits	  Cdc6,	  another	  
AAA+	  ATPase,	  and	  Cdc10-­‐dependent	  transcript	  1	  (Cdt1)	  that	  direct	  the	  loading	  of	  Mcm2-­‐7	  complexes	  
onto	   the	   DNA.	   Loaded	   MCM2-­‐7	   consists	   in	   an	   inactive	   double	   hexamers	   that	   encircles	   double	  
stranded	  DNA	  (Evrin	  et	  al.	  2009,	  Remus	  et	  al.	  2009a,	  Remus	  et	  al.	  2009b)	  (Fig.	  5).	  
2. The	  firing	  of	  replicative	  origins	  
The	   inactivation	  of	   the	  APCCdh1,	  a	  ubiquitin	   ligase	  responsible	  on	  the	  degradation	  of	  Dbf4,	   together	  
with	   the	   progressive	   accumulation	   of	   S-­‐Cyclins	   lead	   to	   the	   activation	   of	   CDKs	   and	   Cdc7-­‐Dbf4,	   the	  
activities	   of	   both	   of	   them	   being	   required	   for	   the	   firing	   of	   the	   origins	   as	   well	   as	   the	   replication	  
initiation	   events	   (Siddiqui	   et	   al.	   2013)	   (Fig.	   6).	   The	   origin	   firing	   and	   replication	   occur	   continuously	  
during	   S-­‐phase	   (Rhind	   et	   al.	   2013).	   CDK	   activity	   promotes	   Cdc6	   phosphorylation	   and	   translocation	  
from	  the	  nucleus	  to	  the	  cytoplasm	  (Petersen	  et	  al.	  1999),	  thus	  blocking	  the	  possibility	  for	  fired	  origins	  
to	   be	   licensed	   again.	   Cdc7-­‐Dbf4	   phosphorylation	   of	   MCM2-­‐7	   complex	   promotes	   the	   stepwise	  
association	  of	  other	  factors,	  as	  the	  GINS	  complex,	  Cdc45,	  Sld2/3/7,	  whose	  phosphorylations	  by	  CDKs	  
are	  required	  for	  DNA	  replication	  in	  yeast	  (Siddiqui	  et	  al.	  2013).	  As	  a	  consequence,	  MCM2-­‐7	  helicases	  
are	  activated	  and	  the	  DNA	  polymerase	  is	  recruited	  on	  the	  DNA	  (Fig.	  6).	  
3. Elongation	  and	  termination	  of	  DNA	  replication	  
During	   the	   elongation	   step	   of	   DNA	   replication,	   the	   MCM	   helicases	   move	   through	   the	   DNA	   and	  
unwind	  it.	  The	  DNA	  polymerases	  then	  load	  onto	  the	  DNA	  and	  carry	  the	  individual	  nucleotides	  to	  the	  
site	  of	  replication	  by	  matching	  new	  nucleotides	  to	  their	  complementary	  bases	  on	  the	  parental	  DNA	  
strand.	   The	   leading	   strand,	   which	   runs	   in	   the	   3’	   to	   5’	   direction	   toward	   the	   fork,	   is	   continuously	  
replicated	   by	   DNA	   polymerases	   as	   these	   enzymes	   assemble	   nucleotides	   from	   5’	   to	   3’.	   As	   DNA	  
polymerase	   works,	   DNA	   helicase	   moves	   down	   the	   line	   to	   open	   continuously	   the	   replicative	   fork.	  
Once	   the	  polymerase	  encounters	   another	   replicative	   fork,	   the	  polymerase	   stops	  and	   is	  dissociated	  
from	  the	  leading	  strand.	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On	  the	  lagging	  strand,	  DNA	  polymerases	  move	  in	  the	  opposite	  direction	  toward	  the	  replication	  fork,	  
from	  5'	  to	  3'	  direction.	  Since	  DNA	  polymerases	  only	  possess	  a	  5'	  to	  3'	  activity,	  the	  polymerisation	  of	  
the	  lagging	  strand	  is	  discontinuous	  and	  starts	  with	  the	  action	  of	  a	  RNA	  polymerase,	  or	  Primase,	  which	  
synthesizes	  a	   short	  RNA	  polynucleotide	   (primer).	  Then,	   the	  DNA	  polymerase	  extends	   the	  3'	  end	  of	  
the	  primer	  generating	  short	  DNA	  fragments	  called	  Okazaki	  fragments	  (Fig.	  7).	  
At	  the	  end	  of	  Okazaki	  fragment	  synthesis,	  DNA	  polymerase	  runs	  into	  the	  previous	  Okazaki	  fragment	  
and	  displaces	   its	   5'	   end	   containing	   the	  RNA	  primer	   and	   a	   small	   segment	  of	  DNA.	   This	   generates	   a	  
RNA-­‐DNA	  single	  strand,	  which	   is	   removed	  by	   the	   flap	  endonuclease	  1	   (FEN1)	  and	  RNase	  H.	  Finally,	  
the	   gaps	   between	   Okazaki	   fragments	   and	   inside	   the	   leading	   strand	   due	   to	   different	   origins	   of	  
replication	  are	   filled	  by	   the	  DNA	  polymerase	  and	   linked	   together	  by	  a	  DNA	   ligase,	   reconstituting	  a	  
continuous	  DNA	  strand.	  
iii. Inhibition	  of	  DNA	  re-­‐replication	  
To	   ensure	   that	   DNA	   replication	   occurs	   only	   once	   per	   cell	   cycle,	   licensing	   and	   firing	   of	   origins	   are	  
temporally	  separated	  by	  the	  activity	  of	  CDKs	  that	  increases	  during	  S-­‐phase.	  CDKs	  further	  inhibit	  the	  
assembly	   of	   Pre-­‐RCs	   once	   the	   origin	   has	   fired	   in	   a	   way	   that	   it	   cannot	   be	   relicensed	   before	   the	  
completion	  of	  mitosis	  (Fig.	  8).	  	  
In	  S.	  cerevisiae,	  CDKs	  promote	  the	  ubiquitin-­‐dependent	  degradation	  of	  Cdc6	  by	  SCFCdc4	  (Drury	  et	  al.	  
1997,	  Elsasser	  et	  al.	  1999,	  Perkins	  et	  al.	  2001),	  the	  nuclear	  export	  of	  MCM-­‐Cdt1	  complexes	  (Labib	  et	  
al.	  1999,	  Nguyen	  et	  al.	  2000)	  and	  the	  inactivation	  of	  Orc2	  and	  Orc6	  (Nguyen	  et	  al.	  2001,	  Frigola	  et	  al.	  
2013).	   Since	   in	   S.	   cerevisiae	   many	   mechanisms	   to	   inhibit	   DNA	   re-­‐replication	   are	   overlapping,	   the	  
disruption	   of	   one	   mechanism	   is	   not	   sufficient	   to	   promote	   DNA	   re-­‐replication	   (Nguyen	   et	   al.	  
2000)(Fig.	  8).	  
In	  metazoans,	  ORC	  complex	   is	  dissembled	  During	  S-­‐phase	  because	  of	   the	  ubiquitination	  of	  Orc1	  by	  
SCFSkp2,	  which	   targets	  Orc1	   for	  degradation	   (Mendez	   et	  al.	   2002,	  Tatsumi	   et	  al.	   2003).	  Cdc6	   is	   also	  
phosphorylated	  and	  when	  overexpressed,	  this	  phosphorylation	  promotes	  its	  export	  from	  the	  nucleus	  
(Petersen	  et	  al.	  1999,	  Pelizon	  et	  al.	  2000),	  but	  a	  fraction	  of	  Cdc6	  remains	  associated	  to	  the	  chromatin	  
(Mendez	   et	   al.	   2000,	   Alexandrow	   et	   al.	   2004).	   Furthermore,	   two	   additional	  mechanisms	   targeting	  
Cdt1	   inhibit	   origin	   licensing	   outside	   G1	   in	  metazoans.	   The	   first	   one	   depends	   on	   Geminin,	  which	   is	  
present	  from	  S	  phase	  to	  M-­‐phase	  and	  binds	  Cdt1.	  The	  effect	  of	  Geminin	  binding	  to	  Cdt1	  depends	  on	  
the	   ratio	   between	   these	   two	   components	   in	   the	   complex:	   when	   Cdt1	   is	   in	   excess	   on	   Geminin,	  
Cdt1/Geminin	  complex	  can	  participate	  in	  the	  formation	  of	  Pre-­‐RC	  (Lutzmann	  et	  al.	  2006,	  Xouri	  et	  al.	  
2007).	  However,	  once	  DNA	   replication	   is	   started,	  more	  Geminin	   is	   recruited	  on	  chromatin	  and	   the	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increase	   of	   Geminin	   concentration	   inhibits	   the	   ability	   of	   Cdt1/Geminin	   complex	   to	   form	   Pre-­‐RC	  
(Lutzmann	  et	  al.	  2006).	  The	  second	  mechanism	  inhibiting	  Cdt1	  is	  its	  degradation,	  which	  depends	  on	  
the	  CRL4Cdt2	  ubiquitin	  ligase	  that	  recognize	  Cdt1	  PIP-­‐box	  (Arias	  et	  al.	  2006,	  Senga	  et	  al.	  2006)	  (Fig.	  8).	  
In	  Xenopus	  extracts	  and	  mammalian	  cells,	  the	  deregulation	  of	  Cdt1	  provokes	  re-­‐replication	  indicating	  
that	   the	  mechanisms	   targeting	   Cdc6	   and	  ORC	   are	   not	   sufficient	   to	   guarantee	   the	   inhibition	   of	   re-­‐
replication	   (Melixetian	   et	   al.	   2004a,	  Melixetian	   et	   al.	   2004b,	   Archambault	   et	   al.	   2005,	   Arias	   et	   al.	  
2005,	  Li	  et	  al.	  2005,	  Maiorano	  et	  al.	  2005).	  
In	   yeast,	   Xenopus	   extracts	   and	   human	   cells,	   the	   re-­‐replication	   process	   induces	   the	   activation	   of	  
checkpoints	  mechanisms	  with	  the	  appearance	  of	  damaged	  DNA	  (Melixetian	  et	  al.	  2004a,	  Melixetian	  
et	  al.	  2004b,	  Archambault	  et	  al.	  2005,	  Li	  et	  al.	  2005,	  Davidson	  et	  al.	  2006).	  The	  precise	  mechanism	  
generating	  these	  damages	  is	  elusive	  but	  may	  certainly	  involve	  fork	  stalling	  and	  collapse	  (Davidson	  et	  
al.	  2006,	  Neelsen	  et	  al.	  2013).	  
e. Control	  of	  M-­‐phase	  
The	   dramatic	   reorganisation	   of	   the	   cell	   during	  mitosis	  must	   be	   coordinated	   in	   time	   and	   space	   to	  
support	  three	  key	  events:	  the	  entry	  into	  mitosis,	  the	  sister	  chromatid	  segregation	  and	  the	  exit	  from	  
mitosis.	  
i. Discovery	  of	  Cdk1-­‐Cyclins	  
In	  a	  famous	  pioneer	  experiment,	  Masui	  and	  Markert	  showed	  that	  transferring	  the	  cytoplasm	  from	  a	  
MII-­‐arrested	   oocyte	   into	   a	   prophase-­‐arrested	   oocyte	   of	   Rana	   pipiens	   was	   able	   to	   induce	   meiosis	  
resumption	  in	  the	  recipient	  oocyte,	  without	  hormonal	  stimulation	  and	  independently	  of	  the	  nucleus	  
(Masui	  et	  al.	  1971).	  The	  cytoplasmic	  activity	  present	  in	  MII-­‐arrested	  oocytes	  was	  called	  “maturation-­‐
promoting	   factor”	   (MPF).	   The	   property	   of	   this	   activity	   to	   amplify	   itself	   was	   further	   demonstrated	  
after	  serial	  dilutions	  and	  by	  performing	  cytoplasmic	  transfer	  experiments	  in	  the	  presence	  of	  a	  protein	  
synthesis	   inhibitor,	   cycloheximide	   (CHX),	   which	   was	   unable	   to	   prevent	   meiosis	   resumption	   in	   the	  
recipient	  oocyte	  (Masui	  et	  al.	  1971,	  Wasserman	  et	  al.	  1975).	  These	  results	  demonstrated	  that	  a	  small	  
amount	   of	   active	   MPF	   present	   in	   the	   cytoplasm	   of	   the	   MII-­‐arrested	   oocyte	   was	   able	   to	   activate	  
cytoplasmic	   inactive-­‐MPF	   molecules	   present	   in	   prophase	   oocytes.	   This	   process	   was	   called	   “MPF	  
autoamplification”.	   In	  the	  following	  years,	   the	  activity	  of	  MPF	  was	  shown	  to	  be	  responsible	   for	  the	  
entry	  into	  mitosis	  in	  mammals	  (Sunkara	  et	  al.	  1979),	  yeast	  (Weintraub	  et	  al.	  1982),	  Xenopus	  (Gerhart	  
et	   al.	   1984)	   and	   finally	   in	   all	   eukaryotic	   species	   tested	   until	   now.	   Hence,	  MPF	   being	   the	   universal	  
factor	  promoting	  entry	  into	  M-­‐phase,	  it	  was	  re-­‐baptized	  “M-­‐phase	  promoting	  factor”.	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The	  molecular	  identification	  of	  MPF	  took	  17	  years	  after	  the	  discovery	  of	  its	  activity,	  and	  was	  solved	  
by	   the	   combination	   of	   biochemical	   and	   genetic	   approaches.	   In	   starfish	   oocytes,	   it	  was	   established	  
that	   an	   increase	   in	   protein	   phosphorylation	   was	   correlated	   with	   the	   oscillations	   of	   MPF	   activity	  
(Doree	  et	  al.	  1983),	  suggesting	  the	  involvement	  of	  a	  kinase	  during	  oocyte	  division.	  Moreover,	  it	  was	  
further	  discovered	  that	  protein	  synthesis	  and	  degradation	  were	  as	  necessary	  as	  the	  kinase	  burst	  for	  
the	  oscillations	  of	  MPF	  activity	  (Picard	  et	  al.	  1985).	  This	  behaviour	  of	  MPF	  activity	  was	  reminiscent	  of	  
a	  protein	  recently	  discovered	   in	  sea	  urchin	  embryo,	  whose	  degradation	  was	  necessary	  to	  exit	   from	  
M-­‐phase,	  the	  Cyclin	  (Evans	  et	  al.	  1983).	  Concomitantly,	  it	  was	  demonstrated	  that	  the	  gene	  cdc2	  was	  
essential	   for	   the	   G2/M	   transition	   in	   yeast	   (Nurse	   et	   al.	   1981).	   However,	   it	   was	   only	   following	   the	  
development	  of	  a	  functional	  test	  to	  easily	  assay	  MPF	  activity,	  that	  the	  molecular	  composition	  of	  MPF	  
was	  found.	  This	  assay	  was	  based	  on	  the	  use	  of	  Xenopus	  cell-­‐free	  extracts,	  generated	  from	  activated	  
laid	  MII-­‐arrested	  oocytes,	  supplied	  with	  sperm	  DNA.	  These	  extracts	  were	  blocked	  in	  interphase	  and	  
were	  able	  to	  mimic	  entry	  into	  mitosis	  following	  the	  addition	  of	  purified	  active	  MPF,	  as	  seen	  by	  DNA	  
condensation	  and	  the	  disassembly	  of	  the	  sperm	  nuclei	  (Lohka	  et	  al.	  1985).	  This	  functional	  assay	  was	  
therefore	   suitable	   to	   screen	   the	   presence	   of	   active	   MPF	   in	   candidate	   fractions	   purified	   from	   the	  
cytoplasm	  of	  MII-­‐oocytes	   using	   biochemical	   approaches	   such	   as	   ammonium	   sulphate	   precipitation	  
and	  chromatography.	  MPF	  was	  shown	  to	  be	  formed	  of	  two	  major	  proteins	  of	  32	  and	  45	  kDa:	  Cdk1	  
(the	   homolog	   of	   the	   Cdc2	   fission	   yeast	   gene),	   and	   its	   associated	   regulatory	   subunit,	   the	   Cyclin	   B	  
(Gautier	  et	  al.	  1988,	  Lohka	  et	  al.	  1988,	  Gautier	  et	  al.	  1990).	  
ii. The	  G2/M	  transition	  
1. The	  principal	  player:	  Cdk1-­‐Cyclin	  B	  
Since	   the	  expression	   level	  of	  Cdk1	   is	   constant	  during	   the	  cell	   cycle,	   the	   formation	  of	  Cdk1-­‐Cyclin	  B	  
complexes	   begins	   during	   interphase	   through	   the	   increase	   of	   Cyclin	   B	   synthesis.	   As	   Cyclin	   B	  
accumulates	   throughout	   G2,	   Cyclin	   B	   associates	  with	   free	   Cdk1	  molecules,	   concomitantly	  with	   the	  
phosphorylation	  of	  Cdk1	  at	  T161	  by	  CAK.	  However,	  these	  newly	  formed	  complexes	  are	  inactivated	  by	  
Wee1/Myt1	   that	   phosphorylate	   Cdk1	   at	   the	   inhibitory	   residues	   T14	   and	   Y15.	   The	   counteracting	  
phosphatase	  Cdc25	  is	  inactive	  during	  G2.	  Hence,	  cells	  do	  not	  enter	  into	  mitosis.	  The	  G2/M	  transition	  is	  
triggered	  by	  Cdc25	  activation,	  which	  promotes	  the	  dephosphorylation	  of	  Cdk1	  at	  T14	  and	  Y15.	  Cdk1	  
then	  reaches	  a	  threshold	  level	  of	  activity	  (Coudreuse	  et	  al.	  2010)	  and	  starts	  to	  phosphorylate	  Cdc25	  
and	  Wee1/Myt1,	   leading	   to	   Cdc25	   full	   activation	   and	  Wee1/Myt1	   complete	   inhibition,	   reinforcing	  
and	  maintaining	  Cdk1	  activity	  at	  a	  high	  level	  during	  the	  entire	  M-­‐phase	  (Fig.	  9).	  	  
The	   G2/M	   transition	   is	   tightly	   regulated	   by	   additional	   mechanisms	   that	   coordinate	   S-­‐phase	   with	  
mitosis	   and	   inhibit	   unscheduled	   M-­‐phase	   entry	   (Fig.	   9).	   These	   checkpoint	   pathways,	   which	   are	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activated	   before	   the	   completion	   of	   DNA	   replication	   or	   in	   the	   presence	   of	   DNA	   damages,	   shift	  
Wee1/Cdc25	  balance	  in	  favour	  of	  Wee1	  to	  prevent	  mitosis	  (reviewed	  in	  Langerak	  et	  al.	  2011).	  These	  
mechanisms	  directly	  regulate	  the	  activity	  and	  the	  intracellular	  localization	  of	  Wee1/Myt1	  and	  Cdc25.	  
§ Regulation	  of	  Wee1	  
The	  regulation	  of	  Wee1	  involves	  multiple	  mechanisms	  that	  target	  its	  expression	  level,	  its	  activity	  and	  
its	   localization.	  Wee1	   levels	   are	   regulated	   transcriptionally	   (Watanabe	   et	   al.	   1995),	   translationally	  
(Murakami	   et	   al.	   1998,	   Charlesworth	   et	   al.	   2000,	   Nakajo	   et	   al.	   2000)	   and	   by	   ubiquitination	   and	  
proteolysis	  (Michael	  et	  al.	  1998).	  The	  degradation	  of	  Wee1	  in	  M-­‐phase	  or	  late	  G2	  phase	  is	  triggered	  
by	  three	  SCF-­‐type	  ubiquitin	  ligases:	  SCFTome-­‐1,	  SCFβ-­‐TrCP1,	  and	  SCFβ-­‐TrCP2	  (Ayad	  et	  al.	  2003,	  Watanabe	  et	  
al.	  2004).	  Recognition	  of	  Xenopus	  embryonic	  Wee1	  by	  Tome-­‐1	  depends	  upon	  the	  phosphorylation	  at	  
S38	  (Ayad	  et	  al.	  2003),	  an	  SP	  site	  that	  is	  present	  in	  Xenopus	  embryonic	  Wee1A	  but	  not	  in	  human	  or	  
mouse	  embryonic	  Wee1B.	  Recognition	  of	  somatic	  Wee1A	  by	  β-­‐TrCPs	  relies	  on	   its	  phosphorylation	  
at	  two	  residues	  present	  in	  somatic	  Wee1	  (Wee1B/Wee	  in	  Xenopus	  and	  Wee1A	  in	  mammals)	  proteins	  
but	  not	  in	  embryonic	  isoforms:	  S53	  (a	  putative	  Plk1	  phosphorylation	  site)	  and	  S123	  (a	  putative	  Cdk1	  
phosphorylation	  site)	  (Watanabe	  et	  al.	  2004)	  (Fig.	  9).	  	  
In	   addition,	   Wee1	   activity	   is	   directly	   regulated	   by	   phosphorylation.	   During	   interphase,	   Xenopus	  
Wee1A	  autophosphorylates	  at	  T90,	  T103	  and	  T110,	  three	  poorly	  conserved	  residues	  in	  its	  N-­‐terminal	  
regulatory	   domain	   (Murakami	   et	   al.	   1999)	   (Fig.	   9).	   Mutation	   of	   these	   sites	   to	   phenylalanines	  
decreases	  Wee1A	  ability	  to	  inhibit	  Xenopus	  oocyte	  maturation	  without	  decreasing	  its	  in	  vitro	  kinase	  
activity	  on	  Cdk1-­‐Cyclin	  B	  (Murakami	  et	  al.	  1999).	  Therefore,	  this	  autophosphorylation	  may	  regulate	  
the	  interaction	  of	  Wee1A	  with	  some	  factors	  that	  modulate	  its	  activity	  or	  its	  intracellular	  localization.	  
During	  mitosis,	  the	  N-­‐terminal	  non-­‐catalytic	  domain	  of	  Wee1	  becomes	  hyperphosphorylated,	  causing	  
a	   shift	   in	   its	   electrophoretic	  migration,	   a	   process	   that	   is	   accompanied	  by	   a	  marked	  decrease	   in	   its	  
activity,	  which	  partially	  depends	  on	  Cdk1	  activity	  (Tang	  et	  al.	  1993,	  McGowan	  et	  al.	  1995,	  Mueller	  et	  
al.	  1995a)	  (Fig.	  9).	  However,	  the	  identity	  of	  the	  other	  kinases	  that	  phosphorylate	  the	  N-­‐terminal	  tail	  
of	   the	   protein	   is	   still	   controversial.	   Finally,	  Wee1	   is	   also	   regulated	   by	   its	   phosphorylation	   at	   S549	  
(S642	   in	  human),	  a	   conserved	   residue	   in	   the	  C-­‐terminal	   tail	  of	   the	  protein.	  The	  phosphorylation	  of	  
this	  site	  by	  Chk1	  and	  Akt	  allows	  the	  association	  of	  Wee1	  with	  different	  isoforms	  of	  14-­‐3-­‐3	  proteins,	  
producing	  opposite	  effects	  on	  the	  cell	  cycle	  (Lee	  et	  al.	  2001,	  Rothblum-­‐Oviatt	  et	  al.	  2001,	  Katayama	  
et	  al.	  2005).	  Akt	  phosphorylation	  at	  S642	  activates	  human	  Wee1	  binding	  to	  14-­‐3-­‐3θ,	  which	  decreases	  
Wee1	  activity	  and	  sequesters	  the	  protein	  in	  the	  cytoplasm,	  therefore	  inducing	  mitosis	  (Katayama	  et	  
al.	  2005).	  On	  the	  other	  hand,	  Chk1	  promotes	  Wee1	  binding	  to	  14-­‐3-­‐3β,	  increasing	  Wee1	  activity	  and	  
stability,	   and	   inhibiting	   the	   G2/M	   transition	   (Lee	   et	   al.	   2001,	   Rothblum-­‐Oviatt	   et	   al.	   2001).	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Phosphorylation	   is	   certainly	   an	   important	   way	   of	   negatively	   regulating	   Wee1	   function	   during	   M-­‐
phase,	   in	   particularly	   in	   systems	   like	   Xenopus	   embryos,	   where	   the	   overall	   abundance	   of	   Wee1A	  
varies	  little	  between	  interphase	  and	  M-­‐phase	  (Murakami	  et	  al.	  1998).	  
§ Regulation	  of	  Cdc25	  phosphatase	  
As	  for	  Wee1,	  the	  activity	  of	  Cdc25C	  is	  regulated	  by	  its	  phosphorylation	  that	  modulates	  its	  activity	  and	  
controls	  its	  intracellular	  localization,	  which	  depends	  on	  one	  nuclear	  localization	  signal	  (NLS)	  and	  two	  
nuclear	  export	  signals	  (NES).	  	  
In	   interphase,	   the	   phosphatase	   activity	   of	   Cdc25C	   is	   low	   (Kumagai	   et	   al.	   1992).	   The	   protein	   is	  
localized	  in	  the	  cytoplasm	  due	  to	  its	  phosphorylation	  at	  S216	  (S287	  in	  Xenopus),	  which	  promotes	  its	  
interaction	  with	  14.3.3	   (Furnari	   et	  al.	   1997,	  Peng	   et	  al.	   1997,	  Kumagai	   et	  al.	   1998a,	  Kumagai	   et	  al.	  
1998b,	  Zeng	  et	  al.	  1998,	  Furnari	  et	  al.	  1999,	  Kumagai	  et	  al.	  1999,	  Yang	  et	  al.	  1999,	  Graves	  et	  al.	  2001,	  
Lopez-­‐Girona	   et	   al.	   2001).	   Following	   DNA	   damage	   or	   DNA	   replication-­‐activated	   checkpoints,	   the	  
kinases	  Chk1	  and	  Chk2	  are	  activated	  and	  phosphorylate	  Cdc25	  at	  S287,	  sequestering	  Cdc25C	  within	  
the	  cytoplasm	  and	  arresting	  the	  cell	  cycle	  progression	  in	  G2	  in	  yeast,	  Xenopus	  and	  human	  (Furnari	  et	  
al.	  1997,	  Peng	  et	  al.	  1997,	  Sanchez	  et	  al.	  1997,	  Zeng	  et	  al.	  1998,	  Furnari	  et	  al.	  1999,	  Boutros	  et	  al.	  
2007)	   (Fig.	   9).	  Moreover,	   other	   kinases	   can	   phosphorylate	   Cdc25C	   at	   S287,	   among	   them	   are	   PKA	  
(Duckworth	  et	  al.	  2002),	  C-­‐TAK	  (Peng	  et	  al.	  1998)	  and	  CAM	  Kinase	  II	  (Hutchins	  et	  al.	  2003).	  Since	  the	  
activation	   of	   these	   kinases	   occurs	   independently	   of	   checkpoint	  mechanisms,	   this	   further	   suggests	  
that	  additional	  mechanisms	  restrain	  Cdc25C	  activation.	  
During	  the	  G2/M	  transition,	  Cdc25C	  must	  be	  dissociated	  from	  14-­‐3-­‐3	  proteins	  to	  be	  imported	  in	  the	  
nucleus	   and	   activated.	   The	   first	   step	   required	   for	   the	   activation	   of	   Cdc25C	   depends	   on	   its	  
phosphorylation	  at	  T138	   (T130	   in	  human),	  which	   is	  controlled	  by	   the	  balance	  of	  activities	  between	  
Cdk2	  and	  the	  phosphatase	  PP2A-­‐B56δ	  (Rosenblatt	  et	  al.	  1992,	  Izumi	  et	  al.	  1993,	  Rempel	  et	  al.	  1995,	  
Guadagno	  et	  al.	  1996,	  Margolis	  et	  al.	  2003,	  Margolis	  et	  al.	  2006a,	  Margolis	  et	  al.	  2006b)	  (Fig.	  9).	  Once	  
T138	   is	   phosphorylated,	   14.3.3	   is	   released	   from	   Cdc25C.	   This	   allows	   the	   binding	   of	   another	  
phosphatase,	  PP1,	  which	  in	  turn	  promotes	  the	  dephosphorylation	  of	  Cdc25C	  at	  the	  inhibitory	  residue	  
S287	  (Margolis	  et	  al.	  2003,	  Margolis	  et	  al.	  2006b)	  (Fig.	  9).	  	  
In	   mammals,	   it	   has	   been	   further	   proposed	   that	   the	   T130	   phosphorylation	   of	   Cdc25C	   creates	   a	  
docking	  site	  for	  the	  kinase	  Plk1	  that,	  in	  turn,	  phosphorylates	  Cdc25C	  at	  S198	  (Elia	  et	  al.	  2003a,	  Elia	  et	  
al.	   2003b).	   This	   residue	   being	   localized	   within	   the	   NES	   of	   Cdc25C,	   this	   phosphorylation	   would	  
promote	   the	   nuclear	   import	   of	   Cdc25C	   during	   the	  mitotic	   prophase,	   before	   the	   nuclear	   envelope	  
breakdowns	  (Toyoshima-­‐Morimoto	  et	  al.	  2001).	  Beside	  Cdk2	  and	  Plk1,	  the	  last	  kinase	  that	  efficiently	  
phosphorylates	   Cdc25C	   is	   Cdk1	   itself,	   thus	   creating	   a	   positive	   feedback	   loop	   that	   induces	   the	   full	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activation	  of	  Cdc25C	  (Izumi	  et	  al.	  1993).	  One	  site	  in	  particular,	  S285	  in	  Xenopus	   (S214	  in	  human),	   is	  
required	   for	   the	   full	   activation	  of	  Cdc25C	  and	   its	  mutation	   into	  alanine	  dramatically	  decreases	   the	  
ability	  of	  Cdc25C	  to	  promote	  M-­‐phase	  entry	  in	  human	  and	  Xenopus	  (Bulavin	  et	  al.	  2003a,	  Bulavin	  et	  
al.	  2003b,	  Margolis	  et	  al.	  2006b).	  This	  phosphorylation	  stimulates	  directly	  the	  activity	  of	  Cdc25C	  as	  
well	  as	  its	  interaction	  with	  PP1,	  thus	  keeping	  Cdc25C	  dephosphorylated	  at	  S287	  (Bulavin	  et	  al.	  2003a,	  
Bulavin	   et	   al.	   2003b,	   Margolis	   et	   al.	   2006b).	   This	   last	   feedback	   mechanism,	   between	   Cdk1	   and	  
Cdc25C,	  maintains	  the	  phosphatase	  activity	  of	  Cdc25C	  at	  a	  high	  level	  during	  M-­‐phase	  (Fig.	  9).	  
2. Role	  of	  protein	  phosphatases	  
M-­‐phase	   obviously	   depends	   on	   the	   activation	   of	   numerous	   kinases	   under	   the	   direct	   or	   indirect	  
control	  of	  Cdk1-­‐Cyclin	  B.	  It	  had	  been	  suspected	  that	  the	  opposite	  activities	  of	  phosphatases	  could	  be	  
regulated	  as	  well.	  This	  was	  indeed	  revealed	  by	  genetic	  screens	  in	  fission	  yeast	  and	  small	   interfering	  
RNA	   screens	   in	  Drosophila	   (Kinoshita	   et	   al.	   1990,	   Chen	   et	   al.	   2007).	   These	   two	   screens	   identified	  
PP2A	  and	  PP1	   as	  major	   actors	   for	  mitosis	   progression,	   particularly	   in	   anaphase	   and	  during	  mitotic	  
exit.	  Still,	  it	  is	  the	  use	  of	  Xenopus	  cycling	  extracts	  that	  clearly	  demonstrated	  the	  role	  of	  PP2A	  during	  
mitotic	   entry	   (Mochida	   et	   al.	   2009).	   PP2A	   phosphatase	   is	   a	   multimeric	   complex	   composed	   of	   a	  
catalytic	   subunit	   (C-­‐subunit),	   a	   non-­‐catalytic	   scaffolding	   subunit	   (A-­‐subunit)	   and	   a	   B-­‐subunit	   that	  
confers	   the	   substrate	   specificity.	   It	   was	   shown	   that	   the	   activity	   of	   one	   specific	   PP2A	   holoenzyme,	  
PP2A-­‐B55δ,	  is	  regulated	  in	  cycling	  extracts:	  being	  high	  in	  interphase	  and	  low	  during	  mitosis	  (Mochida	  
et	  al.	  2009).	   In	  addition,	   the	   immunodepletion	  of	  PP2A-­‐B55δ	   in	   interphase	  extracts	  accelerates	  the	  
entry	  into	  mitosis	  and	  arrests	  the	  extracts	  at	  this	  stage,	  whereas	  removing	  it	  during	  M-­‐phase	  strongly	  
delays	  the	  exit	  from	  mitosis	  (Mochida	  et	  al.	  2009).	  Furthermore,	  adding	  recombinant	  PP2A-­‐B55δ	   in	  
cycling	   extracts	   efficiently	   inhibits	   entry	   into	   M-­‐Phase	   (Mochida	   et	   al.	   2009).	   These	   results	  
demonstrate	  for	  the	  first	  time	  that	  the	  activation	  of	  Cdk1-­‐Cyclin	  B	  is	  not	  sufficient	  for	  M-­‐phase	  entry	  
and	   progression	   and	   that	   a	   member	   of	   the	   PP2A	   family,	   PP2A-­‐B55δ,	   needs	   to	   be	   simultaneously	  
inactivated.	  
This	   inhibition	  of	  PP2A-­‐B55δ	  depends	  on	  one	  specific	  kinase,	  Greatwall	   (Gwl),	  which	  was	   identified	  
by	  a	  screen	  aiming	  at	  finding	  new	  regulators	  of	  mitosis	  in	  Drosophila	  (Blake-­‐Hodek	  et	  al.	  2012).	  Gwl	  is	  
activated	   upon	   M-­‐phase	   entry	   by	   a	   Cdk1-­‐dependent	   phosphorylation	   at	   T193	   and	   T206	   and	   by	  
autophosphorylation	   at	   S833	   (Blake-­‐Hodek	   et	   al.	   2012,	   Lorca	   et	   al.	   2013)	   (Fig.	   10).	   When	   Gwl	   is	  
immunodepleted	  from	  Xenopus	  mitotic	  extracts,	  Cdk1	  is	  quickly	  inactivated	  in	  the	  presence	  or	  in	  the	  
absence	  of	  Wee1	  and	  Myt1	  kinases	  (Yu	  et	  al.	  2006,	  Vigneron	  et	  al.	  2009).	  These	  results	  indicate	  that	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Gwl	   is	   required	   to	  maintain	   a	  mitotic	   state	   even	   in	   the	   presence	   of	   active	   Cdk1	   and	   controls	   the	  
phosphorylation	  status	  of	  Cdk1	  substrates.	  Since	  the	  establishment	  of	  M-­‐phase,	  after	  Gwl	  depletion,	  
is	   rescued	   by	   either	   immunodepleting	   PP2A	   or	   inhibiting	   PP2A	   with	   okadaic	   acid	   (Vigneron	   et	   al.	  
2009),	   it	  was	  concluded	  that	  Gwl	  controls	  directly	  or	   indirectly	  PP2A	  activity.	  This	  process	   is	   indeed	  
mediated	  by	  a	  small	  protein	  of	  the	  α-­‐endosulfine	  family,	  ARPP19/ENSA,	  which	  was	  identified	  by	  mass	  
spectrometry,	  thanks	  to	  its	  ability	  to	  be	  phosphorylated	  by	  Gwl	  (Gharbi-­‐Ayachi	  et	  al.	  2010,	  Mochida	  
et	  al.	  2010).	  ARPP19/ENSA	  is	  phosphorylated	  by	  Gwl	  at	  a	  serine	  (S67	  in	  Xenopus)	  present	  in	  a	  specific	  
highly	  conserved	  motif	  (RGDS).	  The	  phosphorylation	  of	  ARPP19	  at	  S67	  by	  Gwl	  converts	  Arpp19	  into	  a	  
potent	  inhibitor	  of	  PP2A-­‐B55δ	  that	  acts	  by	  direct	  binding	  (Gharbi-­‐Ayachi	  et	  al.	  2010,	  Mochida	  et	  al.	  
2010)	   (Fig.	   10).	   Phosphorylated	   ARPP19/ENSA	   acts	   as	   a	   competitive	   substrate.	   It	   is	   slowly	  
dephosphorylated	  by	  PP2A-­‐B55δ,	   allowing	  PP2A	   to	  be	   reactivated	  at	   the	   time	  when	  Cdk1-­‐Cyclin	  B	  
and	  Gwl	  are	  inactivated	  (Williams	  et	  al.	  2014).	  This	  Gwl-­‐ARPP19	  module	  is	  conserved	  from	  yeast	  to	  
man,	  with	  differences.	  In	  human	  cells,	  as	  in	  Xenopus,	  Mastl	  (Gwl	  homologue)	  is	  necessary	  to	  to	  enter	  
mitosis	  and	  thereafter	  all	  over	  mitosis,	  and	  its	  complete	  depletion	  arrests	  the	  cells	  in	  G2	  (Burgess	  et	  
al.	  2010).	  In	  yeast,	  PP2A	  promotes	  M-­‐phase	  entry	  by	  antagonizing	  the	  inhibitory	  effect	  of	  Swe1,	  the	  
homolog	   of	   Wee1,	   on	   Cdk1.	   The	   pro-­‐mitosis	   role	   of	   Gwl/ARPP19	   module	   is	   conserved,	   because	  
Igo1/2	   (Arpp19	   homologs)	   contribute	   to	   localize	   and	   maintain	   high	   PP2A	   activity,	   which	   in	   this	  
system	  promotes	  mitotic	  entry	  (Juanes	  et	  al.	  2013).	  In	  addition	  to	  PP2A,	  PP1	  phosphatase	  has	  been	  
shown	  to	  play	  an	  important	  role	  in	  entry	  of	  M-­‐phase,	  although	  the	  control	  exerted	  by	  PP1	  is	  either	  
positive	  or	  negative	  according	  the	  model	  systems.	  Importantly,	  free	  monomeric	  PP1	  catalytic	  subunit	  
has	   a	   broad	   substrate	   specificity	   and	   for	   this	   reason	   it	   was	   initially	   considered	   as	   a	   not	   specific	  
housekeeping	   phosphatase.	   This	   view	   has	   changed	   by	   the	   discovery	   that	   PP1-­‐intercating	   proteins	  
(PIPs)	  are	  able	  to	  finely	  modulate	  PP1	  activity.	  Therefore,	  PP1	  interaction	  with	  different	  PIPs	  certainly	  
contributes	   to	   substrate	   specificity	   and	  determines	  how	  a	  particular	   PP1-­‐PIP	   complex	   is	   regulated.	  
Around	   180	   mammal	   proteins	   are	   known	   to	   interact	   with	   PP1,	   between	   them	   are	   present:	   PP1	  
substrates,	  proteins	  necessary	  for	  PP1	  intracellular	  localization	  and	  proteins	  modulating	  or	  inhibiting	  
its	  phosphatase	  activity	  (Reviewed	  in	  Bollen	  et	  al.	  2010).	  	  
During	   the	   G2/M	   transition,	   PP1	   is	   involved	   in	   the	   activation	   of	   Cdc25,	   promoting	   its	  
dephosphorylation	  at	  S287.	  During	  metaphase,	  PP1	   localized	  at	  the	  kinetochores	  dephosphorylates	  
Aurora	  B	  substrates,	  stabilizing	  microtubules	  attachment	  at	  the	  kinetochore	  and	  promoting	  Spindle	  
Assembly	  Checkpoint	   (SAC)	   silencing	   (Liu	   et	  al.	   2010,	  Meadows	   et	  al.	   2011)	   (See	  chapter	   I-­‐A.e.iii.3.	  
“Regulation	  of	  the	  APC	  by	  SAC”)	  (Fig.	  12).	  PP1	  involvement	  in	  these	  two	  processes	  suggests	  that	  the	  
phosphatase	   need	   to	   be	   activated	   for	   the	   entry	   and	   the	   execution	   of	  M-­‐phase.	   Alternatively,	   PP1	  
phosphatase	  counteracts	  the	  activity	  of	  NIMA-­‐related	  kinase	  2	  (Nek2),	  whose	  activation	  contributes	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to	  the	  separation	  of	  the	  duplicated	  centrosomes	  to	  create	  two	  independent	  microtubule	  organizing	  
centres	  prefiguring	  the	  two	  poles	  of	  the	  mitotic	  spindle	  (Ghosh	  et	  al.	  1998,	  Helps	  et	  al.	  2000,	  Meraldi	  
et	   al.	   2001).	   In	   addition,	   it	   was	   also	   been	   shown	   that	   Cdk1	   directly	   phosphorylates	   PP1	   at	   T320,	  
inhibiting	  its	  phosphatase	  activity	  (Dohadwala	  et	  al.	  1994,	  Kwon	  et	  al.	  1997).	  Finally,	  both	  PP2A	  and	  
PP1	   are	   required	   for	   mitotic	   exit,	   catalysing	   the	   dephosphorylation	   of	   the	   mitotic	   substrates	  
(Mochida	   et	   al.	   2009,	  Wu	   et	   al.	   2009,	   Schmitz	   et	   al.	   2010).	   These	   last	   results	   suggest	   that	   PP1	   is	  
inhibited	   during	  M-­‐phase,	   to	   prevent	   early	   dephosphorylation	   of	  mitotic	   substrates,	   and	   activated	  
only	  at	  anaphase	  onset.	  The	  high	  combinatory	  number	  of	  the	  PP1-­‐PIPs	  complexes	  could	  explain	  the	  
widely	   differentiated,	   and	   sometimes	   contradictory,	   roles	   of	   PP1	   during	   mitosis,	   suggesting	   that	  
probably	  some	  PP1-­‐PIP	  complexes	  need	  to	  be	  activated	  and	  others	  inhibited	  during	  the	  entry	  and	  the	  
execution	  of	  the	  M-­‐phase.	  Therefore,	  much	  work	  has	  still	   to	  be	  done	  to	  clarify	  the	  specific	  roles	  of	  
PP1	   in	   the	  cell	  division,	  each	  of	   them	  probably	  depending	  on	  specific	  subunit	  of	  PP1	  and	  of	  a	   tight	  
control	  of	  its	  intracellular	  localization.	  
iii. The	  exit	  from	  M-­‐phase	  
Once	  the	  cell	  has	  passed	  the	  metaphase,	  its	  progression	  through	  division	  is	  mainly	  regulated	  by	  the	  
APC/C	  degradation	  system,	  which	  targets	  two	  proteins:	  the	  securin,	  a	  specific	  inhibitor	  of	  a	  protease,	  
called	   separase,	   that	   is	   responsible	   for	   the	   cleavage	   of	   the	   cohesin	   rings	   that	   hold	   the	   sister	  
chromatids	   together	  and	   the	  Cyclin	  B,	   leading	   to	   the	   irreversible	   inactivation	  of	  Cdk1	   (Reviewed	   in	  
Harper	  et	  al.	  2002,	  Peters	  2002)	  (Fig.	  11).	  However,	  inactivating	  Cdk1	  is	  not	  sufficient	  for	  the	  return	  
in	  interphase	  and	  the	  activation	  of	  PP2A-­‐B55δ	  and	  PP1	  phosphatase	  is	  further	  required	  to	  hydrolyse	  
the	  phosphates	  incorporated	  within	  mitotic	  Cdk1	  substrates.	  
1. The	  ubiquitination	  of	  Cyclins	  
The	   degradation	   of	  mitotic	   Cyclins	   is	   mediated	   by	   two	   particular	  motifs	   within	   the	   N-­‐terminus	   of	  
Cyclin	  B:	   the	  Destruction	  Box	   (D-­‐Box),	  which	   is	  necessary	  and	   sufficient	   for	   the	  degradation	  of	   the	  
protein	  in	  Xenopus	  egg	  extracts	  and	  the	  KEN-­‐box	  (Evans	  et	  al.	  1983,	  Murray	  et	  al.	  1989,	  Glotzer	  et	  al.	  
1991).	  These	  sequences	  correspond	  to	  a	  two-­‐part	  degradation	  signal	  or	  degron,	  which	  consists	   in	  a	  
disordered	  region	  within	  the	  substrate	  where	  a	  polyubiquitin	  chains	  can	  be	  reversibly	  attached.	  This	  
reaction	   consists	   in	   the	   formation	   of	   an	   iso-­‐peptide	   binding	   between	   the	   ubiquitin	   and	   a	   lysine	  
residue	  on	  the	  target	  protein.	  Since	  ubiquitin	  contains	  some	  lysine	  residues	  (Lys	  63,	  Lys	  11,	  Lys	  48),	  
an	   ubiquitin	   chain	   can	  be	   polymerised.	   This	   polyubiquitination	   chain	   is	   attached	  by	   the	   sequential	  
	   40	  
	  
	   41	  
action	  of	  three	  enzymes:	  a	  ubiquitin	  activating	  enzyme	  (E1),	  a	  ubiquitin-­‐conjugating	  enzyme	  (E2)	  and	  
an	   ubiquitin-­‐ligase	   (E3).	   While	   the	   mono-­‐ubiquitination	   of	   a	   protein	   controls	   its	   activity,	   its	  
localization	  and	  its	  interaction	  with	  partners,	  a	  chain	  of	  at	  least	  4	  ubiquitins	  is	  required	  for	  the	  proper	  
recognition	   of	   the	   substrate	   by	   the	   proteasome.	   This	   process	   involves	   the	   19S	   subunit	   of	   the	  
proteasome	   that	   unfolds	   the	   protein	   and	   directs	   the	   substrate	   to	   the	   cavity	   of	   the	   20S	   subunit	  
responsible	  for	  the	  protein	  degradation.	  The	  activity	  of	  the	  proteasome	  is	  constant	  during	  cell	  cycle,	  
whereas	   the	   ubiquitination	   of	   the	   substrate	   that	   has	   to	   be	   degraded	   by	   the	   proteasome	   is	   highly	  
controlled,	  mainly	  by	  the	  E3	  regulation.	  
2. The	  Anaphase	  promoting	  Complex	  (APC)	  
During	  mitosis,	  the	  main	  ubiquitin	  ligase	  responsible	  for	  Cyclin	  B	  ubiquitination	  is	  the	  APC/C,	  which	  is	  
a	  cullin-­‐RING	  finger	  E3	  ubiquitin	  ligase	  composed	  of	  15-­‐17	  subunits	  depending	  on	  the	  species.	  These	  
subunits	   are	   organized	   in	   two	   sub-­‐complexes	   bridged	   together	   by	   APC1.	   The	   first	   sub-­‐complex	  
contains	   APC3	   and	   APC10	   that	   respectively	   bind	   two	   co-­‐activators,	   Cdc20	   (Fizzy)	   and	   Cdh1	   (Fizzy-­‐
related	  protein),	  which	  confer	  the	  substrate	  specificity	  acting	  as	  a	  Degron	  receptor.	  The	  second	  sub-­‐
complex	  contains	  the	  catalytic	  subunit,	  APC2,	  and	  the	  subunit	  able	  to	  contact	  E2,	  APC11.	  	  
During	   metaphase,	   the	   Cdk1-­‐dependent	   phosphorylation	   of	   several	   APC	   core	   subunits	   as	   well	   as	  
Cdh1	  promotes	   the	   recruitment	  of	  Cdc20	  and	   simultaneously	  prevents	  Cdh1	   from	   interacting	  with	  
APC10.	  APCCdc20	   is	   therefore	   the	  only	  complex	  active	  at	   the	  end	  of	  metaphase	  and	  coordinates	   the	  
inactivation	   of	   Cdk1	   and	   the	   separation	   of	   sister	   chromatids	   (Fig.	   11).	   Besides	   catalysing	   Cyclin	   B	  
degradation,	   the	   proteasome	   possesses	   also	   a	   “non	   proteolytic	   activity”	   able	   to	   dissociate	  
polyubiquitinated-­‐Cyclin	  B	  from	  Cdk1	  (Nishiyama	  et	  al.	  2000).	  This	  process	  also	  depends	  on	  APC	  and	  
contributes	   to	  Cdk1	   inactivation	   (Chesnel	  et	  al.	  2006).	  Altogether,	   these	  experiments	  enlighten	   the	  
importance	  of	  the	  APC/C	  as	  the	  main	  regulator	  of	  M/G1	  transition.	  
3. Regulation	  of	  the	  APC	  by	  SAC	  
In	   mitosis,	   APC/C	   is	   activated	   coincidently	   with	   the	   Nuclear	   Envelope	   Break	   Down	   (NEBD)	   in	  
metazoan	   cells	   (den	   Elzen	   et	   al.	   2001,	   Geley	   et	   al.	   2001,	  Wolthuis	   et	   al.	   2008).	   The	   activation	   of	  
APC/C	  is	  tightly	  regulated	  by	  the	  Spindle	  Assembly	  Checkpoint	  (SAC),	  which	  monitors	  the	  correct	  and	  
bipolar	   attachment	   of	   the	   kinetochores	   to	   the	   metaphase	   plate	   and	   prevents	   the	   APC/C	   from	  
recognizing	   its	  substrates	  unless	  this	  step	   is	  not	  correctly	  achieved	  (Hoyt	  et	  al.	  1991,	  Li	  et	  al.	  1991)	  
(Reviewed	   in	   Lara-­‐Gonzalez	   et	   al.	   2012).	   In	   prometaphase,	   the	   major	   SAC	   proteins	   Mad2,	  
BubR1/Mad3	  and	  Bub3	   form	   the	  Mitotic	  Checkpoint	  Complex	   (MCC)	  at	  kinetochores.	  Kinetochore-­‐
associated	  MCC	  binds	  and	  sequesters	  Cdc20	  at	  kinetochores,	  thus	  preventing	  APC	  activation	  and	  the	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consecutive	  proteolysis	  of	  the	  mitotic	  Cyclins	  and	  securin	  (Reviewed	  in	  Lara-­‐Gonzalez	  et	  al.	  2012).	  At	  
metaphase,	  when	   sister	   kinetochores	   are	   fully	   attached	   to	   kinetochore	  microtubules	   and	   correctly	  
bioriented,	  MCC	   is	   dissociated	   from	   the	   kinetochores,	   Cdc20	   is	   released	   and	   hence	   activates	   APC	  
(Musacchio	  et	  al.	  2007)	  (Fig.	  12).	  
	  
4. The	  metaphase	  to	  anaphase	  transition	  
Once	  SAC	  is	  turned	  off,	  the	  APC/C	  starts	  to	  degrade	  Cyclin	  B	  and	  securin,	  which	  are	  both	  inhibitors	  of	  
the	   separase	   (Stemmann	   et	   al.	   2001,	   Gorr	   et	   al.	   2005,	   Holland	   et	   al.	   2006)	   (Fig.	   11).	   Separase	   is	  
therefore	  activated	  and	  cleaves	  the	  Scc1	  subunit	  of	  the	  cohesin	  complex	  that	  holds	  together	  the	  two	  
sister	  chromatids.	  In	  animal	  cells,	  most	  of	  the	  cohesin	  complexes	  located	  on	  chromosome	  arms	  are	  
removed	   as	   a	   consequence	   of	   phosphorylation	   by	   the	   kinase	   Plk1	   (Hauf	   et	   al.	   2005)	   (Fig.	   11).	  
However,	   the	   complexes	   located	   at	   the	   centromeres	   are	   not	   released,	   being	   protected	   by	   the	  
Shugoshin	  protein	  that	  recruits	  the	  PP2A-­‐B56	  phosphatase	  and	  prevents	  the	  phosphorylation	  by	  Plk1	  
(Kitajima	   et	   al.	   2006,	   Riedel	   et	   al.	   2006,	   Tang	   et	   al.	   2006).	   These	   centromere-­‐located	   cohesin	  
complexes	  are	  eventually	  degraded	  by	  separase,	  allowing	  sister	  chromatids	  separation	  (Fig.	  11).	  After	  
anaphase,	   the	   cell	   exits	   from	  mitosis	   due	   to	   the	   degradation	   of	   Cyclin	   B	   that	   keeps	   Cdk1	   activity	  
below	  the	   level	  required	  to	  maintain	  the	  mitotic	  state.	  The	  cell	  executes	  cytokinesis	  and	  returns	  to	  
interphase	   by	   re-­‐shaping	   its	   intracellular	   structure.	   Part	   of	   this	   process	   relies	   on	   the	   APC/C	   that	  
degrades	  Plk1	  and	  Aurora	  kinases	  (Lindon	  et	  al.	  2004,	  Floyd	  et	  al.	  2008).	  Furthermore,	  PP1	  and	  PP2A	  
are	   required	   for	   controlling	   anaphase	   and	   mitosis	   exit	   (Kinoshita	   et	   al.	   1990,	   Chen	   et	   al.	   2007,	  
Wurzenberger	   et	   al.	   2012).	   The	  activity	  of	  PP1	   increases	   in	   anaphase	   (Wu	   et	   al.	   2009)	   and	   targets	  
multiple	   substrates	   that	   coordinate	  processes	   such	  as	   chromosomes	  decondensation	   (Vagnarelli	   et	  
al.	  2011)	  and	  nuclear	  envelope	  reassembly	  (Steen	  et	  al.	  2000).	  The	  drop	  in	  Cdk1-­‐Cyclin	  B	  allows	  the	  
inactivation	  of	  Greatwall,	  which	  leads	  to	  the	  dephosphorylation	  of	  ARPP19/ENSA	  at	  S67,	  reactivating	  
PP2A-­‐B55δ	   (Cundell	   et	   al.	   2013,	   Williams	   et	   al.	   2014).	   This	   specific	   PP2A	   isoform	   actively	  
dephosphorylates	  all	  the	  Cdk1	  substrates.	  As	  a	  consequence,	  the	  cell	  exits	  from	  mitosis	  and	  enters	  in	  
G1.	  The	  low	  level	  of	  Cdk1	  activity	  leads	  to	  the	  formation	  of	  APCCdh1	  that,	  in	  turn,	  degrades	  Cdc20,	  as	  
well	  as	  the	  Geminin,	  an	  inhibitor	  of	  Cdt1,	  allowing	  the	  cell	  to	  form	  the	  pre-­‐RCs.	  The	  cell	  will	  remain	  
arrested	  in	  G1	  until	  the	  conditions	  are	  favourable	  to	  be	  engaged	  in	  another	  cell	  cycle.	  
B. The	  meiotic	  division	  
Meiosis	   is	   a	  particular	  mode	  of	   cellular	  division	   that	  generates	  haploid	   cells	   from	  a	  mother	  diploid	  
cell.	   This	   process	   is	   required	   for	   sexual	   reproduction	   in	   eukaryotes.	   Sexual	   reproduction	   has	   the
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potentiality	   to	   generate	   diversity	   by	   mixing	   the	   genetic	   information	   coming	   from	   two	   individuals	  
thanks	  to	  the	  presence	  of	  three	  events:	  recombination	  (crossing	  over),	  chromosome	  segregation	  and	  
fertilization.	  The	  two	  first	  ones	  occur	  during	  meiosis.	  
The	  meiotic	  divisions	  consist	  in	  two	  cellular	  divisions	  (meiosis	  I	  and	  meiosis	  II)	  with	  no	  intervening	  S-­‐
phase,	  leading	  to	  the	  production	  of	  four	  haploid	  cells.	  Their	  fate	  depends	  on	  the	  specie	  and	  the	  sex	  
of	   the	   individual.	   In	   the	   animal	   kingdom,	   the	   4	   spermatozoa	   are	   viable	   whereas	   the	   female	  
progenitors	   undergo	   two	   asymmetrical	   divisions	   leading	   to	   the	   production	   of	   one	   oocyte	   and	   2	  
unviable	  cells,	  referred	  as	  polar	  bodies	  1	  and	  2	  (PB1	  and	  PB2).	  I	  will	  focus	  on	  female	  meiotic	  divisions	  
that	  are	  the	  paradigm	  used	  in	  my	  PhD	  work.	  
a. Characteristics	  of	  the	  female	  meiotic	  division	  
Meiotic	  divisions	  evolved	  from	  mitotic	  divisions.	  Hence	  many	  aspects	  of	  both	  processes	  are	  similar,	  
except	  those	  specific	  of	  meiosis	  that	  are	  critical	   for	  the	  accurate	  reduction	  of	  the	  parental	  genome	  
(Fig.	  13).	  
i. Two	  natural	  arrests	  during	  the	  meiotic	  cell	  division	  
Female	  meiotic	   divisions	   arrest	   naturally	   at	   two	   specific	   steps.	   These	   two	   arrests	   are	   physiological	  
and	  are	  therefore	  independent	  of	  any	  checkpoint	  mechanisms.	  
The	  first	  arrest	   is	  universal	   in	  all	  animal	  species	  and	  occurs	   in	  prophase	  of	  the	  first	  meiotic	  division	  
(prophase	   I)	   (See	   chapter	   I-­‐B.c.	   “the	   arrest	   in	   prophase”)	   This	   arrest	   lasts	   from	   months	   to	   years	  
depending	  on	  the	  species	  and	  is	  required	  for	  the	  accumulation	  of	  mRNAs	  and	  proteins	  necessary	  for	  
the	  development	  of	   the	   future	  embryo.	  Regarding	   the	  biochemistry	  of	   the	   cell	   cycle,	   this	   arrest	  at	  
prophase	  I	  is	  assimilated	  to	  a	  G2	  arrest,	  and	  its	  release	  is	  comparable	  to	  a	  G2/M	  transition	  since	  the	  
regulation	  of	  Cdk1	  operating	  during	  this	  period	  is	  similar	  to	  the	  ones	  described	  for	  mitosis.	  	  
The	  secondary	  arrest	  occurs	  during	  the	  second	  meiotic	  division	  and	  concerns	  laid	  oocytes.	  It	  provides	  
a	   time	  window	  for	  awaiting	   fertilization.	  This	  secondary	  arrest	  prevents	   the	  oocyte	   to	  undergo	  cell	  
divisions	   and	   development	   in	   the	   absence	   of	   fertilization,	   a	   process	   called	   parthenogenesis.	   It	  
corresponds	   to	   the	   stage	   at	  which	   the	   oocyte	   is	   fertilized.	   The	   step	   of	   this	   arrest	   depends	   on	   the	  
species	  and	  can	  occur	  either	  in	  metaphase	  of	  the	  first	  meiotic	  division	  or	  MI	  (some	  arthropods,	  some	  
molluscs),	   in	  metaphase	   of	   the	   second	  meiotic	   division	   or	  MII	   (all	   Vertebrates)	   (See	   chapter	   I-­‐B.f.	  
“The	   CSF	   arrest	   in	   vertebrates”),	   or	   at	   the	   pronucleus	   stage	   once	   the	   second	   meiotic	   division	   is	  
completed	   (a	   G1	   arrest)	   in	   many	   Invertebrates	   (for	   examples	   as	   model	   systems:	   sea	   urchins	   and	  
starfish).	  In	  some	  cases,	  the	  first	  arrest	  at	  prophase	  I	  corresponds	  also	  to	  the	  second	  arrest:	  it	  applies	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to	   species	   where	   fertilization	   occurs	   at	   prophase	   I	   (some	   sponges,	   some	   nematodes,	   some	  
crustacean)	  (Fig.	  13).	  
ii. Silencing	  of	  the	  genome	  
The	   transcriptional	   activities	   of	   the	   oocyte	   genome	   are	   strictly	   controlled	   during	   oogenesis.	  When	  
diploid	  germ	  cells,	  oogonia,	  enter	  prophase	  I	  of	  meiosis,	  the	  chromosomes	  get	  condensed,	  impairing	  
any	  transcriptional	  activity	  during	  the	  prophase	  period	  from	  leptotene	  to	  pachytene.	  The	  oocyte	  then	  
arrests	  at	  the	  diplotene	  stage	  of	  prophase	  I	  and	  some	  specific	  portions	  of	  the	  chromosomes	  undergo	  
decondensation,	  leading	  to	  the	  formation	  of	  uncondensed	  loops	  of	  chromatin,	  hence	  accounting	  for	  
the	  name	  of	  “lampbrush”	  chromosomes	  (Hill	  et	  al.	  1980).	  During	  the	  first	  part	  of	  the	  oocyte	  growth	  
period,	   the	   loops	   of	   the	   lampbrush	   chromosomes	   are	   transcribed	   at	   very	   high	   rates	   and	   their	  
products	   are	   accumulated	   in	   the	   oocyte	   as	   stores	   for	   the	   future	   embryo	   (Hill	   et	   al.	   1980).	   The	  
transcription	  is	  then	  shut	  off	  around	  the	  stages	  IV-­‐V	  of	  oogenesis	  in	  Xenopus.	  The	  loops	  disappear	  by	  
chromatin	  condensation	  and	   the	   transcription	  becomes	  undetectable.	  The	   full-­‐grown	  oocyte	   ready	  
for	  the	  prophase	  release	  and	  the	  ovulation	  is	  therefore	  transcriptionally	  silent	  (Fig.	  13).	  
While	  the	  mitotic	  cell	  cycle	  is	  tightly	  controlled	  by	  genome	  expression	  (transcription	  and	  translation),	  
the	  incubation	  of	  amphibian	  oocytes	  with	  α-­‐amanitin,	  an	  inhibitor	  of	  RNA	  Pol	  II	  and	  III,	  has	  no	  effect	  
on	  meiosis	  resumption	  (Wasserman	  et	  al.	  1974).	  Identical	  results	  were	  obtained	  with	  the	  replication	  
inhibitor,	  aphidicolin.	  Xenopus	  oocytes	  can	  be	  manually	  enucleated	  by	   just	  pricking	  the	  oocyte	   in	  a	  
hyperosmotic	   external	  medium.	   Under	   these	   conditions,	   the	   germinal	   vesicle	   is	   extruded	   and	   the	  
oocyte	  heals	  quickly.	  When	  enucleated	  oocytes	  are	  stimulated	  by	   the	  external	   stimuli	   inducing	   the	  
prophase	   release,	   they	   support	   the	   activation	   of	   MPF,	   showing	   that	   the	   transduction	   pathway	  
leading	  to	  meiosis	  resumption	  is	  independent	  of	  transcription,	  and	  also	  of	  every	  nuclear	  component	  
(Masui	  et	  al.	  1971).	  These	  results	  were	  not	  surprising,	  given	  the	  fact	  that	  the	  transcription	  is	  silent	  in	  
these	  cells.	  
On	  the	  other	  hand,	  the	  oocyte	  supports	  an	  active	  global	  protein	  synthesis	  activity,	  translating	  the	  so-­‐
called	   “maternal”	  mRNA	   stored	   in	   the	   cytoplasm,	  which	   is	   stimulated	  during	   the	  meiotic	  divisions.	  
The	   inhibition	   of	   protein	   translation	  with	   either	   Cycloheximide	   (CHX)	   or	   emetine	   totally	   abolishes	  
meiosis	  resumption	  in	  response	  to	  progesterone	  in	  Xenopus	  (Wasserman	  et	  al.	  1975).	  However,	  the	  
dependency	   of	   the	   completion	   of	  meiotic	   divisions	   towards	   protein	   synthesis	   depends	   on	   species	  
(See	   chapter:	   I-­‐B.d.iii.2.	   “The	   protein	   synthesis”).	   In	   all	   species	   studied	   so	   far	   (invertebrates	   and	  
vertebrates),	  one	  mechanism	  involved	  in	  the	  control	  of	  protein	  synthesis	  in	  the	  oocyte	  is	  the	  mRNAs	  
polyadenylation.	   This	   process	   is	   mediated	   through	   a	   3’UTR	   sequence	   called	   cytoplasmic	  
polyadenylation	   elements	   (CPE),	  which	   can	   be	   recognized	   by	   CPE	   binding	   proteins	   (CPEB).	   Several	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molecular	  pathways	  can	  modulate	  CPEB	  activation	  and	  consequentially	  the	  translation	  of	  mRNAs.	  In	  
addition,	  pathways	   such	  as	   the	  MAPK	  pathway	  or	  PKA	  activity	   can	  modulate	   the	  meiotic	  divisions,	  
but	   through	   non-­‐genomic	   effects.	   In	   conclusion,	   the	   meiotic	   divisions	   are	   independent	   of	  
transcription.	   They	   rely	   on	   post-­‐translational	   modifications	   and,	   in	   some	   species,	   on	   protein	  
translation	  (Fig.	  13).	  
iii. Recombination	  and	  post-­‐recombination	  events	  
The	  female	  diploid	  germ	  cells	  enter	  into	  meiosis	  and	  arrest	  in	  prophase	  I.	  Prophase	  I	  is	  highly	  specific	  
of	   meiosis	   and	   is	   classically	   divided	   into	   several	   stages:	   leptotene	   (chromosome	   condensation),	  
zygotene	  (pairing	  of	  homologous	  chromosomes),	  pachytene	  (chromosomal	  crossover),	  and	  diplotene	  
(division	  arrest).	  The	  meiotic	  recombination	  (crossing-­‐over)	  exchanges	  the	  genetic	  materials	  between	  
two	   homologous	   chromosomes.	   The	   crossing-­‐over,	   occurring	   during	   the	   pachytene	   stage	   of	  
prophase	  I,	  allows	  the	  independent	  segregation	  of	  loci	  present	  on	  the	  same	  chromosome,	  promoting	  
the	   formation	   of	   chromosomes	   composed	   by	   new	   combination	   of	   alleles.	   Importantly,	  
recombination	  also	  produces	   the	   formation	  of	   chiasma	   that	  are	  necessary	   for	  holding	  homologous	  
chromosomes	  together.	  This	  physical	  attachment	  persists	  until	  metaphase	   I	  and	   is	   fundamental	   for	  
chromosome	   segregation	  during	  meiosis	   I.	   The	  molecular	   recombination	  machinery	   itself	   is	   largely	  
shared	   by	   both	   the	   meiotic	   recombination	   and	   the	   homologous	   recombination	   repair	   during	   the	  
mitotic	  cell	  cycle	  (Bzymek	  et	  al.	  2010).	  However,	  in	  the	  case	  of	  meiosis,	  double-­‐strand	  breaks	  (DSBs)	  
are	  produced	  by	  a	  physiological	  cellular	  process,	  rather	  than	  resulting	  from	  accidental	  damages	  as	  in	  
the	   mitotic	   cell	   cycle	   (Fig.	   13).	   Furthermore,	   the	   sites	   of	   DSBs	   at	   meiotic	   recombination	   are	   not	  
random,	  but	  often	  clustered	  at	  hot	  spots	  (Lichten	  et	  al.	  1995).	  Of	  course,	  the	  recombination	  partners	  
are	  homologous	  chromosomes	  in	  meiosis	  whereas	  recombination	  occurs	  between	  sister	  chromatids	  
of	  a	  single	  chromosome	  during	  the	  mitotic	  cycle.	  
The	  post-­‐recombination	  events	  are	  also	  very	  different	  between	  mitosis	  and	  meiosis.	   In	  mitosis	   the	  
chiasma	   are	   resolved	   quickly.	   In	   contrast,	   in	  meiosis,	   they	   last	   until	   metaphase	   I	   that	   takes	   place	  
some	  weeks,	  or	  months	  or	  even	  years	  (human)	  later,	  depending	  on	  the	  length	  of	  the	  prophase	  arrest	  
that	  varies	  according	  to	  species.	  This	  prolonged	  arrest	  is	  linked	  to	  the	  so-­‐called	  maternal	  age	  effect	  in	  
humans	  (Hassold	  et	  al.	  2009),	  which	  corresponds	  to	  an	  increase	  in	  aneuploidy	  incidence	  as	  the	  age	  of	  
the	  mother	   increases.	   In	  mitosis,	   the	  cohesion	  between	  sister	   chromatids	   is	  established	   in	  S-­‐phase	  
and	  stays	  on	  chromosomes	  until	  mitosis	   (Uhlmann	  et	  al.	  1998).	  During	  meiosis,	   the	  gradual	   loss	  of	  
cohesins	  between	  sister	  chromatids	  and	  homologous	  chromosomes	  during	  the	  prolonged	  prophase	  
arrest	   increases	  the	  frequency	  of	  missegregation.	  This	  “cohesion	  fatigue”	  could	  be	  the	  cause	  of	  the	  
increased	  aneuploidy	  incidence	  correlated	  to	  the	  age	  of	  the	  mother.	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iv. The	  succession	  of	  two	  M-­‐phases	  with	  no	  intervening	  S-­‐phase	  
During	   the	  mitotic	   cell	   cycle,	   chromosomes	   replication	   and	   segregation	   alternate	   maintaining	   the	  
stability	  of	  the	  ploidy.	   In	  contrast,	  female	  meiosis	  consists	   in	  two	  cellular	  asymmetric	  divisions	  with	  
no	   intervening	   S-­‐phase,	   reducing	   the	   ploidy	   of	   the	   cell	   by	   half.	   The	   suppression	   of	   the	   S-­‐phase	   is	  
achieved	  by	  a	  special	  regulation	  of	  Cdk1	  activity	  during	  the	  MI-­‐MII	  transition,	  which	  is	  partially	  due	  to	  
a	  specific	  germ	  line	  kinase	  pathway:	  the	  Mos/MAPK	  pathway.	  As	  this	   issue	   is	  directly	  addressed	  by	  
my	  thesis	  project,	   it	   is	  described	  in	  more	  details	   in	  (Chapter	  I.B.e.iii.	  “The	  molecular	  control	  of	  DNA	  
replication”)	  (Fig.	  13).	  
v. The	  separation	  of	  homologous	  chromosomes	  
A	  major	  specific	  point	  of	  meiosis	  is	  the	  segregation	  of	  the	  homologous	  chromosomes	  during	  meiosis	  I	  
in	   contrast	   to	   the	   segregation	   of	   sister	   chromatids	   that	   occurs	   during	   mitosis.	   The	   meiosis	   I	   is	  
therefore	   reductional	  as	   it	  divides	  by	  half	   the	  cellular	  ploidy.	  The	  Meiosis	   II	   is	  equational	  and	  as	   in	  
mitosis,	   segregates	   sister	   chromatids	   in	   two	   daughter	   cells.	   The	   ability	   to	   segregate	   homologous	  
chromosomes	   relies	   on	   three	   mechanisms.	   The	   first	   one	   is	   the	   position	   of	   chromosomes	   on	   the	  
meiotic	  metaphase	  plate.	  Homologous	  chromosomes	  being	  paired	  together,	  they	  face	  each	  other	  on	  
the	  plate,	  instead	  to	  be	  aligned	  next	  to	  each	  other	  as	  in	  mitosis.	  The	  second	  one	  is	  the	  organization	  
of	   kinetochores.	   While	   sister	   kinetochores	   of	   one	   chromosome	   attach	   to	   the	   opposite	   poles	   in	  
mitosis,	  sister	  kinetochores	  of	  each	  homologous	  chromosome	  attach	  to	  one	  pole	  during	  metaphase	  I	  
(Fig.	   13).	   The	   third	   difference	   is	   the	   stepwise	   removal	   of	   cohesins	   from	   chromosomes.	  During	   the	  
mitotic	   cell	   cycle,	   cohesins	   connect	   sister	   chromatids	   together	   until	   the	   metaphase	   to	   anaphase	  
transition,	   when	   they	   are	   removed	   by	   phosphorylation	   and	   cleavage.	   In	   contrast,	   in	   meiosis	   I,	  
homologous	  chromosomes	  are	  connected	  both	  by	  chiasma	  and	  cohesins,	  while	  the	  sister	  chromatids	  
of	   each	   chromosomes	   are	   linked	   by	   centromeric	   cohesins.	   The	   issue	   of	   meiosis	   I	   is	   to	   separate	  
homologous	  chromosomes,	  but	  to	  preserve	  the	  attachment	  of	  sister	  chromatids	  of	  each	  of	  them.	  At	  
the	  onset	  of	  anaphase	   I,	   chiasma	  are	  resolved	  and	  the	  distal	  cohesins,	  which	  connect	   together	   the	  
homologous	   chromosomes,	   are	   phosphorylated,	   and	   then	   degraded.	   However,	   the	   centromeric	  
cohesins	   are	   protected	   from	   degradation,	   avoiding	   sister	   chromatids	   separation.	   This	   protecting	  
mechanism	   depends	   on	   the	   recruitment	   of	   Shugoshin	   (Sgo)	   and	   the	   PP2A	   phosphatase	   to	  
centromeres	   (Kitajima	   et	   al.	   2004,	   Kitajima	   et	   al.	   2006,	   Riedel	   et	   al.	   2006).	   Sgo/PP2A	   protects	  
centromeric	  cohesins	  by	  maintaining	  them	  under	  a	  dephosphorylated	  state.	  	  
Another	   key	   difference	   regards	   the	   spindle	   formation.	   Remarkably,	  meiotic	   spindles	   form	  without	  
centrosomes	  in	  the	  oocytes	  of	  most	  of	  animals,	  including	  human,	  mouse,	  Xenopus,	  Drosophila	  and	  C.	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elegans,	  conferring	  the	  typical	  barrel-­‐shaped	  morphology	  of	  oocyte	  meiotic	  spindles.	  This	  is	  specific	  
of	  oocytes,	  since	  spermatocytes	  still	  contain	  centrosomes	  that	  participate	  to	  spindle	  formation.	  How	  
centrosomes	   are	   eliminated	   during	   the	   early	   steps	   of	   the	   prophase	   oocyte	   growth	   is	   poorly	  
documented.	  Recent	  evidence	  suggests	   the	  existence	  of	  oocyte-­‐specific	  mechanisms	  compensating	  
for	  a	  lack	  of	  centrosomes	  (Goshima	  et	  al.	  2008).	  
A	   last	   meiotic	   specificity	   is	   the	   involvement	   of	   the	   SAC	   in	   the	   regulation	   of	   meiotic	   division	   that	  
depends	  on	  the	  species.	  A	  functional	  SAC	  is	  clearly	  operating	  in	  mouse	  oocytes	  undergoing	  meiosis,	  
since	  the	  complete	  disruption	  of	  meiosis	  I	  spindle	  using	  nocodazole,	  causes	  metaphase	  I	  arrest	  with	  
intact	  chromosome	  bivalents	  (Wassarman	  et	  al.	  1976a,	  Wassarman	  et	  al.	  1976b,	  Schultz	  et	  al.	  1977,	  
Eichenlaub-­‐Ritter	   et	   al.	   1989,	   Soewarto	   et	   al.	   1995,	   Brunet	   et	   al.	   1999,	   Homer	   et	   al.	   2005).	   Upon	  
nocodazole	   removal,	   the	   oocyte	   rebuilds	   a	   metaphase	   spindle	   and	   proceeds	   to	   anaphase	   and	  
cytokinesis	  by	  expelling	  the	  1st	  polar	  body.	  Moreover,	  deficiency	  in	  SAC	  proteins	  increases	  mouse	  egg	  
aneuploidies	   both	   in	   vivo	   and	   in	   vitro	   (Homer	   et	   al.	   2005,	   Leland	   et	   al.	   2009,	   Li	   et	   al.	   2009,	  
McGuinness	   et	   al.	   2009,	   Hached	   et	   al.	   2011).	   In	   contrast	   to	   mouse	   oocytes,	   the	   disruption	   of	  
microtubules	  with	  nocodazole	  does	  not	  cause	  any	  metaphase	  I	  arrest	  in	  Xenopus	  oocytes	  (Shao	  et	  al.	  
2013),	  suggesting	  that	  SAC	  does	  not	  monitor	  the	  MI	  spindle	  of	  Xenopus	  oocytes.	  
b. Oogenesis	  and	  meiotic	  maturation	  
In	   females,	   the	  meiotic	  maturation	   is	   the	   last	   step	   of	   oogenesis.	   This	   process	   corresponds	   to	   the	  
differentiation	  of	  a	  diploid	  germ	  cell	  progenitor	  in	  a	  mature	  fertilizable	  oocyte.	  During	  the	  embryonic	  
development,	   the	   primordial	   germ	   cells	   migrate	   to	   the	   embryonic	   gonads.	   These	   germ	   cells	  
proliferate	  by	  mitosis	  inside	  the	  gonad.	  After	  a	  last	  pre-­‐meiotic-­‐S-­‐phase,	  they	  enter	  into	  meiosis	  and	  
oocytes	  then	  become	  arrested	  at	  the	  diplotene	  stage	  of	  prophase	  of	  the	  first	  meiotic	  division	   in	  all	  
animal	   species.	  The	  mitotic	  proliferation	  period	  preceding	  entry	   into	  meiosis	   I	   is	   completed	  before	  
birth	   in	  mammals.	  Therefore	  the	  gonads	  of	  new-­‐born	  mammal	   females	  contain	  a	   fixed	  and	   limited	  
amount	  of	  oocytes	  with	  no	  capacity	  to	  self-­‐regenerate.	  In	  contrast,	  proliferation	  of	  germ	  cells	  occurs	  
all	  over	  the	  life-­‐span	  of	  most	  of	  the	  animals,	  except	  mammals.	  
i. The	  oocyte	  growth	  period	  
Depending	  on	  the	  species,	  the	  prophase	  I	  arrest	  lasts	  from	  months	  to	  years.	  During	  this	  long	  period,	  
the	   oocyte	   growths	   by	   accumulating	   all	   the	   mRNA	   and	   proteins	   required	   for	   the	   resumption	   of	  
meiosis	   and	   for	   the	   development	   of	   the	   future	   embryo.	   The	   growth	   is	   particularly	   spectacular	   in	  
oviparous	   species	   where	   the	   embryonic	   development	   entirely	   relies	   on	  maternal	   nutrient	   storage	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until	  the	  new	  organism	  is	  able	  to	  feed	  by	  itself.	  The	  oocyte	  growth	  in	  oviparous	  species	  does	  not	  only	  
depend	   on	   the	   intrinsic	   oocyte	   anabolic	   activities	   but	   also	   on	   the	   uptake	   of	   proteins,	   called	  
vitellogenesis,	   supplied	  by	   the	   female	   liver	   through	   the	  blood	   flow.	   In	  Xenopus,	   the	  oocyte	  growth	  
period	  (lasting	  2-­‐3	  years)	  has	  been	  divided	  in	  a	  first	  period	  relying	  on	  intrinsic	  oocyte	  synthesis,	  called	  
pre-­‐vitellogenesis,	  followed	  by	  a	  period	  of	  intense	  growth	  due	  to	  the	  vitellogenin	  uptake	  and	  called	  
vitellogenesis.	  Six	  stages	  have	  been	  described	  according	  to	  the	  diameter	  of	  the	  oocyte	  as	  well	  as	  the	  
external	   appearance	   of	   the	   growing	   oocyte	   (Dumont	   1972).	   During	   pre-­‐vitellogenesis,	   oocytes	   are	  
firstly	   colourless	   (Stage	   I)	   then	   become	   white	   and	   opaque	   (Stage	   II).	   Stage	   III	   corresponds	   to	   the	  
beginning	  of	  vitellogenesis	  with	  active	  uptake	  of	  the	  yolk	  and	  to	  the	  initiation	  of	  pigment	  synthesis.	  
The	  oocyte	   is	  almost	   fully	  dark.	  At	  the	  Stage	   IV,	   the	  animal	   (dark)	  and	  vegetal	   (white)	  hemispheres	  
are	  individualized	  due	  to	  a	  targeted	  localization	  of	  cellular	  pigmentation.	  As	  the	  oocyte	  reaches	  the	  
Stage	  V,	  the	  accumulation	  of	  the	  yolk	  starts	  to	  decrease	  and	  the	  cell	  almost	  reaches	  its	  maximal	  size.	  
The	   Stage	   VI,	   referred	   as	   post-­‐vitellogenic	   stage,	   is	   characterized	   by	   the	   presence	   of	   a	   white	  
equatorial	  band	  between	  the	  two	  hemispheres.	  The	  post-­‐vitellogenic	  oocyte	  is	  the	  biggest	  cell	  of	  the	  
whole	   organism,	   with	   a	   diameter	   comprised	   between	   1200	   and	   1300	   µm.	   At	   the	   end	   of	  
vitellogenesis,	   only	   the	   stage	   VI	   oocytes	   can	   resume	   meiosis	   and	   proceed	   through	   meiotic	  
maturation.	  
ii. Meiotic	  maturation	  
The	  meiotic	  maturation	  corresponds	  to	  the	  prophase	  release,	  which	   is	   initiated	  concomitantly	  with	  
ovulation.	  In	  Vertebrates,	  ovulation	  is	  launched	  by	  the	  Luteinizing	  Hormone	  (LH),	  and	  promotes	  the	  
release	   of	   the	   oocyte	   from	   its	   surrounding	   follicle	   cells	   and	   from	   the	   ovaries.	   In	  Xenopus,	   LH	   also	  
induces	   the	   synthesis	   of	   a	   steroid	   hormone,	   progesterone	   (Pg),	   by	   the	   follicle	   cells.	   Pg	   is	   released	  
from	  the	  follicle	  cells	  and	  acts	  on	  the	  oocyte	  both	  in	  a	  paracrine	  manner	  and	  through	  gap	  junctions	  
connecting	  the	  follicle	  cells	  and	  the	  oocyte.	  In	  Fish	  and	  amphibian,	  this	  steroid	  promotes	  the	  meiosis	  
resumption	  of	  the	  oocyte.	  
1. Morphological	  events	  
In	  Xenopus	  oocytes,	   the	   first	  meiotic	  division	  starts	  after	  a	   latent	  period	  ranging	   from	  2	   to	  6	  hours	  
after	   Pg	   stimulation	  with	   the	   nuclear	   envelope	   breakdown,	   also	   called	  GVBD	   for	   Germinal	   Vesicle	  
Break	  Down,	  which	   is	   visualized	  by	   the	   appearance	  of	   a	  white	   spot	   at	   the	   animal	   pole	  of	   the	   cell.	  
Soon	  after,	  a	  giant	  microtubular	  array	  (100	  µm)	  organizes	  at	  the	  base	  of	  the	  disrupting	  nucleus	  and	  
gathers	  the	  condensed	  bivalent	  chromosomes.	  This	  microtubular	  array	  migrates	  toward	  the	  animal	  
pole	  where	  it	  is	  reorganized	  into	  a	  short	  bipolar	  metaphase	  I	  spindle	  (10	  µm),	  oriented	  parallel	  to	  the	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oocyte	   surface.	  The	  spindle	   then	   rotates	  and	   the	   first	  polar	  body	   is	  extruded	  90	  minutes	   following	  
GVBD,	   marking	   the	   completion	   of	   meiosis	   I	   and	   reducing	   by	   half	   the	   cellular	   ploidy.	   Thereafter,	  
oocytes	   proceed	   immediately	   through	   the	   second	   meiotic	   division	   by	   organizing	   a	   metaphase	   II	  
spindle	  oriented	  parallel	  to	  the	  oocyte	  surface	  in	  the	  absence	  of	  nuclear	  envelope	  reformation.	  The	  
metaphase	   II	  spindle	  then	  rotates	  and	  become	  orthogonal	   to	  the	  oocyte	  cortex	  where	   it	  anchors	  3	  
hours	   after	   GVBD	   initiation	   (Gard	   1992).	   The	   oocyte	   arrests	   at	   that	   stage	   for	   several	   hours,	   until	  
fertilization.	  In	  the	  absence	  of	  fertilization,	  it	  dies	  by	  apoptosis	  (Du	  Pasquier	  et	  al.	  2011).	  
2. Profile	  of	  Cdk1	  activity	  
The	  succession	  of	  the	  two	  meiotic	  divisions	  depends	  on	  two	  successive	  waves	  of	  Cdk1	  activation	  (Fig.	  
14).	  The	  first	  activation	  of	  Cdk1	  promotes	  GVBD.	  After	  the	  metaphase	  I,	  MPF	  is	  inactivated	  due	  to	  the	  
ubiquitin-­‐dependent	   degradation	   of	   Cyclin	   B,	   allowing	   anaphase	   I	   and	   the	   exit	   from	   meiosis	   I.	  
However,	  Cdk1	   is	  not	   fully	   inactivated	  due	  to	  a	  concomitant	  degradation	  and	  synthesis	  of	  Cyclin	  B.	  
This	   residual	   level	   of	   active	   Cdk1	   prevents	   the	   decondensation	   of	   DNA	   and	   the	   reformation	   of	  
nucleus.	  Cdk1	  activity	  quickly	  raises	  again	  due	  to	  the	  arrest	  of	  Cyclin	  degradation	  and	  the	  synthesis	  of	  
new	  Cyclins	  B	  that	  induce	  entry	  into	  meiosis	  II	  signalled	  by	  the	  formation	  of	  a	  metaphase	  II	  spindle,	  
without	  prophase	  II.	  In	  vertebrates,	  the	  activity	  of	  MPF	  is	  then	  stabilized	  at	  a	  high	  level	  by	  a	  cytostatic	  
factor	  called	  CSF	  that	  ensures	  the	  arrest	  at	  metaphase	  II	  (Fig.	  14).	  	  
c. The	  arrest	  in	  prophase	  
In	  Vertebrates,	   the	  arrest	   at	  prophase	   I	   is	   controlled	  by	  a	  high	   intracellular	   concentration	  of	   cyclic	  
AMP	   (cAMP),	   which	   stimulates	   the	   activity	   of	   the	   cAMP-­‐dependent	   protein	   kinase	   A,	   PKA.	   This	  
regulation	  of	  the	  meiotic	  progression	  is	  reminiscent	  of	  the	  control	  exerted	  by	  cAMP	  during	  the	  G2/M	  
transition	  of	   some	  cell	   lines.	   In	  various	  cell	   lines,	   cAMP	   levels	   fluctuate	  during	   the	  cell	   cycle,	  being	  
high	  in	  interphase	  and	  low	  in	  mitosis	  (Burger	  et	  al.	  1972,	  Fernandez	  et	  al.	  1995).	  Moreover,	  the	  drop	  
in	  cAMP	  levels	  or	  the	  inhibition	  of	  PKA	  activity	  occurring	  in	  late	  G2	  are	  both	  required	  for	  the	  entry	  in	  
M-­‐phase	  (Stambrook	  et	  al.	  1976,	  Lamb	  et	  al.	  1991,	  Kurokawa	  et	  al.	  1998).	  While	  it	  is	  well	  established	  
that	   the	   cAMP-­‐PKA	   pathway	   keeps	   Cdk1	   inactive	   in	   prophase	   oocytes,	   the	   molecular	   connection	  
between	  PKA	  and	  MPF	  in	  oocytes	  as	  well	  as	  in	  somatic	  cells	  remains	  poorly	  documented.	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i. cAMP	  and	  PKA	  activity	  
In	  somatic	  cells,	  cAMP	  is	  a	  second	  messenger	  that	  regulates	  a	  plethora	  of	  cellular	  functions	  including	  
gene	  expression	  and	  proliferation.	   cAMP	   is	  produced	   from	  ATP	  by	   the	  enzymes	   from	  the	   family	  of	  
the	   adenylate	   cyclases	   (AC)	   and	   is	   degraded	   in	   5'-­‐AMP	  by	   the	  members	   of	   the	   phosphodiesterase	  
family	   (PDE).	   The	   direct	   target	   of	   cAMP	   is	   the	   cAMP-­‐dependent	   protein	   kinase	   A	   (PKA),	   an	  
heterodimer	  composed	  of	  two	  types	  of	  subunits:	  two	  catalytic	  subunits	  (PKA-­‐C)	  and	  two	  regulatory	  
subunits	   (PKA-­‐R).	   The	   PKA-­‐C	   subunits	   contain	   the	   active	   catalytic	   site,	   an	   ATP-­‐binding	   site	   and	   a	  
binding	   domain	   for	   PKA-­‐R	   subunits.	   The	   PKA-­‐R	   subunits	   bind	   to	   each	   other	   in	   an	   anti-­‐parallel	  
orientation	  to	  form	  a	  homodimer.	  Each	  monomer	  possesses	  additional	  domains:	  one	  for	  the	  binding	  
of	   cAMP,	   the	   second	   one	   for	   the	   interaction	  with	   a	   PKA-­‐C	   subunit,	   the	   third	   one	   being	   an	   "auto-­‐
inhibitory"	  domain,	  which	  serves	  as	  a	  substrate	  or	  pseudosubstrate	  for	  PKA-­‐C.	  When	  the	  intracellular	  
concentration	  of	   cAMP	   is	   low,	   PKA-­‐R	  dimer	  binds	   to	  PKA-­‐C	   and	  PKA	   is	   inactive.	  When	   the	   level	   of	  
cAMP	  increases,	  cAMP	  binds	  to	  PKA-­‐R	  dimer	  and	  releases	  it	  from	  the	  PKA-­‐C	  subunits,	  leading	  to	  the	  
activation	  of	  PKA.	  
In	  mammal	  prophase-­‐arrested	  oocytes,	  the	  source	  of	  cAMP	  results	  from	  the	  influx	  of	  cAMP	  through	  
gap	  junctions	  connecting	  follicular	  cells	  to	  the	  oocyte,	  but	  also	  from	  the	  endogenous	  production	  of	  
cAMP	   within	   the	   oocyte	   induced	   by	   the	   adenylate	   cyclase	   activation	   through	   G-­‐protein	   coupled	  
receptor,	  GPCR3	   (Reviewed	   in	  Mehlmann	   2005).	  Moreover,	   in	   rodent	   oocytes,	   the	   influx	   of	   cGMP	  
from	   follicular	   cells	   to	   the	  oocyte	  prevents	   the	  activation	  of	   the	  PDE3,	  ensuring	  a	  high	   cAMP	   level	  
(Norris	  et	  al.	  2009).	  In	  Xenopus	  oocyte,	  the	  adenylate	  cyclase	  activity	  maintains	  high	  levels	  of	  cAMP	  
(Mulner	   et	   al.	   1979b,	   Finidori-­‐lepicard	   et	   al.	   1981,	   Sadler	   et	   al.	   1981a)	   that	   in	   turn	   activate	   PKA	  
(Maller	   et	   al.	   1977,	  Wang	   et	   al.	   2004).	  Any	   treatment	   that	   increases	   either	   the	   intracellular	   cAMP	  
levels	  or	  the	  activity	  of	  PKA	  totally	  abolishes	  Cdk1	  activation	  upon	  hormonal	  stimulation	  (Ozon	  et	  al.	  
1978,	  Huchon	  et	  al.	  1979,	  Ozon	  et	  al.	  1979a,	  Ozon	  et	  al.	  1979b).	  Reversely,	  inhibiting	  the	  PKA	  activity	  
is	  sufficient	  for	  triggering	  meiosis	  resumption	  independently	  of	  the	  hormonal	  stimulation	  (Maller	  et	  
al.	  1977)	  (Huchon	  et	  al.	  1981c,	  Rime	  et	  al.	  1992b,	  Daar	  et	  al.	  1993)	  (Fig.	  16).	  The	  cAMP-­‐PKA	  pathway	  
is	   already	   functional	   in	   stage	   IV	   oocytes	   since	   progesterone,	   although	   not	   able	   to	   promote	   Cdk1	  
activation	   and	   GVBD,	   leads	   to	   the	   inhibition	   of	   adenylate	   cyclase,	   either	   measured	   in	   vitro	  with	  
purified	  adenylate	  cyclase	  from	  stage	  IV	  oocytes	  or	  assayed	  in	  vivo	  by	  a	  drop	  in	  cAMP	  level	  (Mulner	  
et	  al.	  1983,	  Sadler	  et	  al.	  1983a).	  Thus,	  cAMP	  and	  PKA	  are	  key	  actors	  for	  the	  oocyte	  arrest	  at	  prophase	  
by	  keeping	  Cdk1	  inactive.	  Importantly,	  the	  effects	  exerted	  by	  PKA	  on	  meiotic	  division	  progression	  are	  
independent	  of	  transcription	  on	  the	  contrary	  to	  somatic	  cells.	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ii. Statute	  of	  Cdk1	  and	  its	  direct	  regulators	  
In	  prophase	  oocytes,	  Cdk1	  is	  kept	  inactive	  by	  two	  mechanisms	  depending	  on	  the	  species:	  either	  the	  
absence	  of	  its	  activatory	  partner,	  the	  Cyclin	  B,	  and	  or	  its	  inhibitory	  phosphorylations	  at	  T14	  and	  Y15.	  
In	  some	  fishes,	  like	  Goldfish,	  Cyclin	  B	  is	  not	  expressed	  in	  prophase.	  The	  activation	  of	  Cdk1	  then	  relies	  
on	   Cyclin	   B	   synthesis	   that	   associates	  with	  monomeric	   Cdk1	   that	   becomes	   phosphorylated	   at	   T161	  
upon	  Cyclin	  binding	  (Tanaka	  et	  al.	  1995,	  Yamashita	  et	  al.	  1995).	   In	  mouse,	  the	  activation	  of	  Cdk1	  is	  
initiated	   through	   the	   dephosphorylation	   at	   Y15	   of	   the	   stockpile	   of	   pre-­‐MPF.	   This	   activity	   level	  
promotes	  GVBD	  but	  is	  not	  high	  enough	  to	  sustain	  the	  formation	  of	  the	  metaphase	  I	  spindle.	  Cyclin	  B	  
must	   be	   synthesized	   to	   elevate	   the	   level	   of	   Cdk1	   activity	   and	   to	   proceed	   through	   the	   meiosis	   I	  
(Hampl	   et	   al.	   1995b,	   Winston	   1997,	   Polanski	   et	   al.	   1998).	   In	   Xenopus,	   both	   mechanisms	   are	  
functional	  as	  suggested	  by	  the	  presence	  of	  two	  different	  inactive	  pools	  of	  Cdk1:	  a	  monomeric	  form	  of	  
Cdk1,	  which	   is	   ready	   to	  be	  activated	  because	  a	  part	  of	   it	   is	  already	  phosphorylated	  at	  T161,	  and	  a	  
dimeric	   form	  of	  Cdk1	  associated	  with	   the	  Cyclin	  B	   that	   forms	   the	  pre-­‐MPF	   (Kobayashi	   et	   al.	   1991,	  
Hochegger	  et	  al.	  2001,	  De	  Smedt	  et	  al.	  2002)	  (Fig.	  15).	  In	  pre-­‐MPF	  complexes,	  Cdk1	  is	  phosphorylated	  
at	  T161,	  T14	  and	  Y15,	  these	  two	  last	  phosphorylations	  maintaining	  it	  in	  an	  inactive	  state	  (Gautier	  et	  
al.	  1989,	  Mueller	  et	  al.	  1995b,	  De	  Smedt	  et	  al.	  2002).	  The	  pre-­‐MPF	  is	  constantly	  formed	  in	  prophase	  
due	  to	  a	  slow	  synthesis	  of	  Cyclin	  B	  that	  associates	  with	  monomeric	  Cdk1	  present	  in	  large	  excess,	  and	  
are	  immediately	  phosphorylated	  by	  Myt1	  (Rime	  et	  al.	  1995,	  Gaffre	  et	  al.	  2011).	  
1. Wee1	  and	  Myt1	  
In	  Xenopus	  prophase-­‐arrested	  oocytes,	  Wee1	  is	  expressed	  from	  stage	  I	  to	  stage	  IV	  during	  the	  growth	  
period	   and	   is	   responsible	   for	   the	   inactivation	   of	   Cdk1	   inside	   pre-­‐MPF	   complexes	   that	   accumulate	  
during	   this	   period	   (Nakajo	   et	   al.	   2000).	   From	   stage	   IV	   to	   VI,	  Wee1	   is	   no	   longer	   expressed	   at	   the	  
protein	  level	  and	  it	  reappears	  during	  late	  meiotic	  maturation,	  when	  the	  oocyte	  enters	  in	  the	  second	  
meiotic	  division	  (Murakami	  et	  al.	  1998,	  Charlesworth	  et	  al.	  2000,	  Nakajo	  et	  al.	  2000).	  In	  contrast,	  the	  
kinase	  Myt1	   is	  constantly	  expressed	  starting	  from	  stage	   IV,	  where	   its	  activity	  takes	  over	  the	  one	  of	  
Wee1,	  and	  during	  the	  whole	  meiotic	  maturation.	  In	  prophase	  oocytes,	  Myt1	  is	  hypophosphorylated	  
and	  active	  (Palmer	  et	  al.	  1998,	  Gaffre	  et	  al.	  2011).	  In	  stage	  VI	  resting	  oocytes,	  the	  slow	  rate	  of	  Cyclins	  
B2	  and	  B5	  synthesis	   induces	   the	   formation	  of	  Cdk1-­‐Cyclin	  B	  complexes	   that	  are	   inactivated	  by	  Y15	  
phosphorylation	   (Rime	   et	   al.	   1995)(Gaffre	   et	   al.	   2011).	  Myt1	   inhibition	   with	   either	   PD0166285	   or	  
blocking	   antibodies	   induces	  meiosis	   resumption	   in	   the	   absence	   of	   progesterone	   (Ruiz	   et	   al.	   2008,	  
Gaffre	   et	   al.	   2011).	   Conversely,	   the	   overexpression	   of	  Myt1	   delays	   Cdk1	   activation	   in	   response	   to	  
progesterone	   in	   a	   dose-­‐dependent	  manner	   (Gaffre	   et	   al.	   2011).	   Therefore,	   the	   activity	   of	  Myt1	   is
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required	   in	   prophase	   to	   inhibit	   by	   phosphorylation	   the	   newly	   Cdk1-­‐Cyclin	   B	   complexes	   that	   are	  
permanently	  formed	  during	  this	  long-­‐lasting	  arrest	  (Fig.	  15).	  	  
On	  the	  contrary	  to	  Xenopus	  oocytes,	  the	  kinase	  Wee1	  is	  present	  in	  mice	  prophase-­‐arrested	  oocytes	  
and	   its	  activity	   is	  enhanced	  following	   its	  phosphorylation	  by	  PKA	  at	  S16	  (Han	  et	  al.	  2005).	  Whether	  
PKA	  can	  regulate	  Myt1	  activity	  during	  prophase	  arrest	  in	  Xenopus	  oocytes	  is	  unknown	  and	  deserves	  
to	  be	  investigated.	  
2. Cdc25	  
Two	   genes	   encoding	   the	   phosphatase	   Cdc25	   have	   been	   identified	   from	   a	   Xenopus	   oocytes	   cDNA	  
library	   (Izumi	   et	   al.	   1992,	   Kumagai	   et	   al.	   1992,	   Okazaki	   et	   al.	   1996).	   One	   of	   them	   is	   clearly	  
homologous	  to	  human	  Cdc25A	  while	  the	  other	  one	  is	  closer	  from	  human	  Cdc25B.	  This	  latter	  form	  is	  
thought	  to	  be	  the	  physiological	  regulator	  of	  Cdk1	  during	  oocyte	  meiotic	  maturation	  and	  despite	   its	  
closer	   similarities	   with	   human	   Cdc25B,	   has	   been	   called	   Cdc25C	   in	   Xenopus	   (Izumi	   et	   al.	   1992,	  
Kumagai	  et	  al.	  1992,	  Okazaki	  et	  al.	  1996).	  In	  Xenopus	  oocyte,	  Cdc25C	  is	  expressed	  at	  the	  protein	  level	  
under	   an	   inactive	   form	   during	   the	  whole	   growth	   period	   (Dunphy	   et	   al.	   1991,	   Gautier	   et	   al.	   1991,	  
Jessus	   et	   al.	   1992,	  Nakajo	   et	   al.	   1999,	  Nakajo	   et	   al.	   2000,	  Oe	   et	   al.	   2001).	  As	   in	   somatic	   cells,	   the	  
mechanism	  responsible	  for	  keeping	  Cdc25C	  inactive	   in	  prophase	  depends	  on	   its	  phosphorylation	  at	  
S287	   (Duckworth	  et	  al.	  2002)	   (Fig.	   15).	  While	  Chk1	  and	  Chk2	  were	  at	   first	  proposed	  as	   the	  kinases	  
responsible	  for	  the	  S287	  phosphorylation	  of	  Cdc25C,	  as	  in	  mitotic	  cells	  (Nakajo	  et	  al.	  1999,	  Oe	  et	  al.	  
2001),	  it	  was	  then	  proposed	  that	  this	  phosphorylation	  is	  under	  the	  control	  of	  PKA	  (Duckworth	  et	  al.	  
2002).	   The	   injection	   of	   PKI	   promotes	   the	   dephosphorylation	   at	   S287	   of	   Cdc25C	   and	   leads	   to	   its	  
dissociation	   from	   14-­‐3-­‐3	   proteins	   (Duckworth	   et	   al.	   2002).	   Cdc25C	   dephosphorylation	  was	   further	  
observed	   in	  response	  to	  progesterone	  and	  was	   impeded	  following	  the	   incubation	  of	  oocytes	   in	  the	  
presence	   of	   IBMX,	   a	   phosphodiesterase	   inhibitor	   (Duckworth	   et	   al.	   2002).	   Furthermore,	  
overexpressing	   PKA-­‐C	   totally	   impairs	   the	   ability	   of	   overexpressed	   Cdc25C	   in	   promoting	   meiosis	  
resumption	  whereas	   the	   expression	   of	   a	   non	   phosphorylatable	   form	   of	   Cdc25C,	   the	   S287A-­‐Cdc25	  
mutant,	   is	   able	   to	   bypass	   the	   lock	   exerted	   by	   PKA.	   Altogether,	   these	   results	   strongly	   suggest	   that	  
Cdc25C	   is	   a	   physiological	   substrate	   of	   PKA	   in	   prophase	   oocytes	   and	   that	   the	   PKA-­‐dependent	  
phosphorylation	  at	   S287	  prevents	   its	   activation	  during	   the	  prophase	  arrest	   (Fig.	   15).	   In	   agreement	  
with	  these	  results,	  Xenopus	  WT-­‐Cdc25C	  is	  a	  weak	  inducer	  of	  meiosis	  resumption	  compared	  to	  S287A-­‐
Cdc25	  mutant	   (Nakajo	   et	   al.	   1999,	   Duckworth	   et	   al.	   2002).	   In	   contrast,	   overexpressing	   human	   or	  
Xenopus	   Cdc25A	   activates	   Cdk1	   independently	   of	   progesterone	   stimulation	   (Rime	   et	   al.	   1994,	  
Okazaki	   et	   al.	   1996,	   Duckworth	   et	   al.	   2002).	   The	   difference	   in	   the	   ability	   to	   promote	   meiosis	  
resumption	  between	  these	  two	  isoforms	  of	  Cdc25,	  A	  and	  C,	  can	  be	  explained	  by	  the	  absence	  of	  the	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S287	  within	  Cdc25A,	  which	   therefore	   cannot	  be	  phosphorylated	  and	   inhibited	  by	  PKA	   in	  prophase	  
(Okazaki	  et	  al.	  1996).	  The	  negative	  effect	  of	  S287	  phosphorylation	  on	  Cdc25C	  activity	  is	  attributed	  to	  
its	  interaction	  with	  14.3.3	  proteins	  and	  its	  nuclear	  import	  inhibition.	  However	  the	  precise	  role	  of	  this	  
regulation	   has	   to	   be	   further	   investigated	   in	   the	   oocyte	   context	   where	   the	   regulation	   of	   nuclear	  
localization	  of	  the	  main	  actors	  does	  not	  appear	  to	  be	  instrumental	  for	  controlling	  meiotic	  divisions.	  
Especially,	   the	   activation	   of	   Cdk1	   does	   not	   require	   the	   nucleus,	   as	   it	   occurs	   in	   response	   to	   Pg	   in	  
enucleated	  Xenopus	  oocytes.	  Opposite	  to	  S287,	  the	  phosphorylation	  of	  many	  other	  S	  and	  T	  residues	  
inside	  Cdc25C	  is	  required	  to	  activate	  its	  phosphatase	  activity.	  Those	  residues	  are	  not	  phosphorylated	  
in	  prophase	  oocytes,	  leading	  to	  an	  inactive	  hypo-­‐phosphorylated	  form	  of	  Cdc25.	  
	  
In	  summary,	  the	  arrest	  at	  prophase	  I	  is	  regulated	  by	  a	  high	  level	  of	  PKA	  activity	  that	  indirectly	  keeps	  
Cdk1	  inactive.	  Pre-­‐MPF	  molecules	  are	  kept	  inactive	  by	  phosphorylation	  at	  T14	  and	  Y15	  by	  high	  Myt1	  
activity	  which	  overrides	  Cdc25	  phosphatase	  activity	  (Fig.	  15).	  
	  
d. Mechanisms	  controlling	  the	  release	  from	  the	  prophase	  arrest	  
i. The	  competence	  to	  resume	  meiosis	  
The	  competence	  to	  resume	  meiosis	   is	  acquired	  during	  the	  very	  last	  steps	  of	  vitellogenesis.	  Stage	  IV	  
oocytes	   are	   unable	   to	   mature	   in	   response	   to	   progesterone	   despite	   progesterone	   ability	   to	  
downregulate	  cAMP-­‐PKA	  signalling	  pathway	  (Mulner	  et	  al.	  1983,	  Sadler	  et	  al.	  1983a).	  Furthermore,	  
the	   injection	   of	   Cyclin	   B2,	   Cdc25	   or	   Okadaic	   acid,	   at	   a	   concentration	   sufficient	   to	   trigger	   meiotic	  
maturation	   in	   stage	   VI	   oocytes,	   are	   all	   unable	   to	   promote	   Cdk1	   activation	   in	   stage	   IV	   oocytes	  
(Reynhout	   et	   al.	   1975,	   Sadler	   et	   al.	   1983a,	   Rime	   et	   al.	   1995).	   However,	   injecting	   active	   MPF	   by	  
cytoplasm	  transfer	  in	  stage	  IV	  oocytes	  induces	  GVBD,	  but	  with	  only	  a	  low	  Cdk1	  activity,	  which	  is	  not	  
able	  to	  promote	  the	  formation	  of	  a	  metaphase	  I	  spindle	  (Rime	  et	  al.	  1991).	  At	  GVBD	  inactive	  pre-­‐MPF	  
not	   dephosphorylated	   at	   Y15	   is	   still	   present,	   suggesting	   that	   only	   the	   transferred	  molecules	   have	  
been	   activeted	   but	   did	   not	   activate	   the	   endogenous	   pre-­‐MPF	   stockpile	   of	   the	   oocyte	   (Rime	   et	   al.	  
1991).	   Therefore,	   in	   stage	   IV	  oocytes,	   the	   cAMP-­‐PKA	  pathway	  downregulation	   is	  not	   connected	   to	  
the	  activation	  of	  MPF	  and	  the	  inability	  of	  stage	  IV	  oocytes	  to	  resume	  meiosis	  is	  due	  to	  a	  defect	  within	  
the	  MPF	   autoamplification,	   a	   preocess	   necessary	   to	   dephosphorylate	   completely	   Cdk1	   at	   T14	   and	  
Y15.	  Plx1	   is	  not	  expressed	   in	  stage	   IV	  oocytes	  and	   its	  ectopic	  expression	  was	  shown	  to	   restore	   the	  
MPF	   autoamplification	   loop	   in	   these	   small	   oocytes	   as	   long	   as	   PP2A	   is	   inhibited	   by	   OA	   injection	  
(Karaiskou	   et	   al.	   2004).	   This	   suggests	   that	   the	   pathway	   induced	   by	   Pg	   and	   inhibiting	   PP2A	  
phosphatase,	  a	  requirement	  for	  MPF	  autoamplification,	  is	  not	  active	  in	  these	  small	  growing	  oocytes.	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The	  incompetency	  to	  resume	  meiosis	  is	  therefore	  due	  to	  a	  defect	  in	  the	  pathway	  leading	  to	  Cdk1	  full	  
activation	  as	  well	  as	  the	  inability	  to	  regulate	  PP2A,	  both	  of	  them	  being	  possibly	  connected.	  
ii. Hormones	  and	  Receptors	  
The	  release	  of	  the	  oocyte	  into	  the	  oviduct	  (or	  ovulation)	  is	  promoted	  by	  the	  pituitary	  gonadotropin	  
LH	  (luteinizing	  Hormone)	  that	  concomitantly	  induces	  the	  secretion	  of	  steroid	  hormones	  responsible	  
for	   meiosis	   resumption	   from	   the	   follicular	   cells	   surrounding	   the	   oocyte.	   In	   Xenopus	   oocytes,	  
progesterone	   is	   the	   physiological	  mediator	   of	  meiotic	  maturation	   (Haccard	   et	   al.	   2012)	   but	  many	  
different	  C19	  and	  C21	  steroids	  are	  able	  to	  induce	  meiotic	  maturation	  in	  vitro	  on	  defolliculated	  oocytes,	  
such	  as	  testosterone,	  pregnenolone	  and	  many	  others,	  whatever	  they	  are	  physiological	  hormones	  or	  
metabolic	  intermediates	  or	  antagonists	  of	  natural	  hormones	  or	  synthetic	  compounds	  (Baulieu	  et	  al.	  
1978).	  	  
The	  canonical	  way	  by	  which	  progesterone	  acts	  on	  cells,	  depends	  on	  Progesterone	  Receptors	  (PR)	  that	  
are	  found	  in	  the	  cytoplasm	  and	  the	  nucleus	  of	  target	  cells.	  Classically,	  unliganded	  PRs	  reside	  mainly	  
in	   the	  cytoplasmic	   compartment	  as	   inactive	  proteins.	  Upon	   ligand	  binding,	  PR	  are	  phosphorylated,	  
dimerize	  and	   translocate	   to	   the	  nucleus	  where	   they	  act	  as	   specific	   transcription	   factors.	  They	  bind	  
their	   target	   genes	  at	   specific	  palindromic	  progesterone-­‐response	  elements	   (PREs)	   located	   in	   active	  
chromatin	  (reviewed	  in	  Abdel-­‐Hafiz	  et	  al.	  2014).	  Then	  PRs	  activate	  or	  repress	  transcription	  depending	  
on	   the	   promoter	   being	   regulated	   and	   on	   the	   cofactors	   that	   are	   recruited	   to	   this	   promoter.	   This	  
classical	  model	  has	  been	  recently	  come	  into	  question	  with	  data	  showing	  that	  PR	  can	  be	  localized	  into	  
the	  nucleus	  independently	  of	  the	  hormone,	  that	  the	  dimerization	  is	  not	  required	  for	  the	  PR-­‐mediated	  
transcription	   and	   that	   PR	   can	   act	   through	   cell	   membranes	   and	   cytoplasmic	   signalling	   pathways,	  
independently	   of	   transcription	   (Boonyaratanakornkit	   et	   al.	   2008,	   Jacobsen	   et	   al.	   2012).	   Beside	   the	  
binding	   to	   the	   ligand,	   PRs	   are	   also	   controlled	   by	   post-­‐translational	   modifications	   including	  
sumoylation,	  phosphorylation,	  ubiquitination	  and	  acetylation	  that	  modify	  the	  stability,	  the	  hormone	  
sensitivity	  and	  the	  nuclear	   localization	  of	  both	  ligand	  and	  unliganded	  receptors	  (reviewed	  in	  Abdel-­‐
Hafiz	  et	  al.	  2014).	  These	  modifications	  are	   initiated	  by	  signalling	  pathways	  activated	  at	   the	   level	  of	  
cell	  membranes	  and,	  in	  turn,	  PRs	  modify	  the	  cell	  signalling	  through	  non-­‐genomic	  mechanisms.	  These	  
non-­‐genomic	   effects	   are	   mainly	   driven	   by	   a	   small	   fraction	   of	   classical	   cytoplasmic	   liganded	   PRs	  
associated	  with	   tyrosine	  kinases	  and	  other	  modules,	  but	  also	  by	  cell	   surface	  membrane	  PRs	   (mPR)	  
(reviewed	   in	   Abdel-­‐Hafiz	   et	   al.	   2014).	   The	  mPRs	   posses	   seven	   transmembrane	   domains	   and	   some	  
conserved	   cysteines	   for	   disulfide	   bounding	   (Zhu	   et	   al.	   2003,	   Thomas	   et	   al.	   2004).	   These	   receptors	  
bind	  progesterone	  outside	  of	  the	  cell	  and	  activate	  a	  G-­‐protein	  coupled	  pathways	  inside	  the	  cell	  (Zhu	  
et	  al.	  2003,	  Thomas	  et	  al.	  2007).	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In	  Xenopus	   oocytes,	   the	  molecular	   identity	   of	   the	   PR	   remains	   a	  mystery	   since	   half	   a	   century.	   This	  
receptor	  has	  particular	   features	  compared	  to	  classical	  PRs.	  The	  fact	   that	  multiple	  different	  steroids	  
induce	  meiosis	  resumption	  suggests	  either	  the	  presence	  of	  original	  steroids	  receptors	  with	  a	  very	  low	  
specificity	   or	   the	   presence	   of	   more	   than	   one	   receptor.	   Moreover,	   progesterone	   acts	   at	   µM	  
concentration	  (the	  concentration	  effectively	  measured	  in	  the	  Xenopus	  ovary,	  (Haccard	  et	  al.	  2012)),	  
as	   well	   as	   the	   other	   steroids,	   meaning	  more	   than	   103	   order	   of	  magnitude	   higher	   than	   the	   active	  
concentrations	  of	  these	  hormones	  in	  the	  blood.	  This	  implies	  the	  presence	  of	  an	  original	  low	  affinity	  
receptor.	   As	   already	   mentioned,	   the	   mechanism	   induced	   by	   progesterone	   is	   independent	   of	  
transcription,	  meaning	  that,	  even	  so	  the	  classical	  PR	  would	  be	   involved,	   it	  would	  act	  with	  different	  
targets	   than	   in	   somatic	   cells.	   	   Moreover,	   the	   mechanism	   induced	   by	   progesterone	   in	   Xenopus	  
oocytes	   relies	   on	   membranes	   (Maller	   2001).	   While	   the	   injection	   of	   a	   lipidic	   solution	   containing	  
progesterone	   induces	  meiosis	   resumption	   (Tso	   et	   al.	   1982),	   injecting	   progesterone	   in	   an	   aqueous	  
solution	  does	  not	  trigger	  meiosis	  resumption	  (Jacobelli	  et	  al.	  1974).	  Moreover,	  when	  progesterone	  is	  
coupled	  to	  sepharose	  beads	  or	  to	  high	  molecular	  weight	  polymers	  that	  cannot	  enter	  within	  the	  cell,	  
progesterone	   is	   able	   to	   promote	   meiosis	   resumption	   (Ishikawa	   et	   al.	   1977,	   Godeau	   et	   al.	   1978).	  
Altogether,	  these	  results	  suggest	  that	  progesterone	  and	  other	  steroids	  have	  to	  reach	  a	  target	  that	  is	  
present	   either	   in	   the	   plasma	   membrane	   or	   in	   intracellular	   membranes	   connected	   to	   the	   plasma	  
membrane.	  
Several	  mRNAs	  encoding	  various	  steroid	  receptors	  are	  stored	  in	  oocytes.	  Among	  them,	  two	  canonical	  
nuclear	   progesterone	   receptors	   (nPR),	   xPR-­‐1	   and	   xPR-­‐2,	   have	  been	   cloned	   in	   addition	   to	  one	  mPR	  
(Tian	   et	   al.	   2000,	   Bagowski	   et	   al.	   2001,	   Liu	   et	   al.	   2005b).	   The	   knock-­‐down	   of	   Xenopus	   xPR1	   with	  
antisense	  oligonucleotides	  strongly	  delays	  meiosis	  resumption	  in	  response	  to	  progesterone	  but	  does	  
not	  abolish	  this	  process	  (Tian	  et	  al.	  2000).	  This	  work	  has	  been	  a	  subject	  of	  controversy.	  There	  was	  no	  
evidence	   showing	   that	   antisense	  oligonucleotides	   really	  deplete	  endogenous	   xPR	  protein	   from	   the	  
oocyte.	  Very	  recently,	  it	  has	  been	  shown	  that	  the	  knock-­‐out	  of	  the	  classical	  progesterone	  receptor	  in	  
zebrafish	   impairs	   ovulation	   but	   does	   not	   affect	   oocyte	  meiosis	   resumption	   induced	   by	   the	   steroid	  
(Zhu	  et	  al.	  2015).	  Finally,	  since	  progesterone	  can	  trigger	  Cdk1	  activation	  in	  enucleated	  oocytes,	  nPR	  is	  
unlikely	   to	   be	   the	   receptor	  mediating	   the	   non-­‐genomic	   effects	   of	   progesterone,	   unless	   it	   reaches	  
original	   targets	   specific	   of	   the	   oocyte.	   All	   data	   actually	   converge	   to	   exclude	   a	   role	   of	   the	   classical	  
nuclear	  progesterone	  receptors	  in	  triggering	  meiotic	  maturation.	  
mPR	  is	  a	  seven	  transmembrane	  receptor	  that	  was	  firstly	   identified	  in	  zebrafish	  and	  goldfish	   (Zhu	  et	  
al.	  2003,	  Tokumoto	  et	  al.	  2006).	  Xenopus	  oocytes	  also	  express	  mPR	  and	  this	  receptor	  efficiently	  binds	  
progesterone	   with	   the	   expected	   affinity	   for	   meiotic	   maturation	   (Josefsberg	   Ben-­‐Yehoshua	   et	   al.	  
2007).	  These	  features	  render	  this	  receptor	  family	  member	  a	  very	  attractive	  candidate	  for	  mediating	  
progesterone	  effects	  on	  oocyte	  meiotic	  maturation.	  However,	  mPR	  does	  not	  bind	  testosterone	  and	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therefore	  does	  not	  fulfil	  the	  criteria	  of	  low	  specificity.	  A	  possibility	  is	  that	  mPR	  plays	  a	  physiological	  
role	   in	   initiating	   the	   signalling	   pathway	   induced	   by	   progesterone	   but	   that	   other	   receptors	   with	  
different	  specificities	  are	  also	  involved.	  Another	  provocative	  hypothesis	  is	  that	  the	  oocyte	  would	  not	  
express	   any	   steroid	   receptors	   and	   that	   active	   steroids,	   corresponding	   generally	   to	   the	   more	  
hydrophobic	  molecules	  among	  steroids,	  enter	   the	  plasma	  membrane,	  modify	   the	   lipidic	   layers	  and	  
lead	   to	   the	   clustering	   of	   membrane	   proteins,	   such	   as	   G-­‐proteins,	   inducing	   a	   signalling	   pathway	  
through	  this	  local	  molecular	  re-­‐organization	  of	  the	  membrane.	  
It	  has	  to	  noted	  that	  insulin	  and	  IGF-­‐1	  are	  able	  to	  trigger	  in	  vitro	  oocyte	  meiotic	  maturation	  (El-­‐Etr	  et	  
al.	   1979,	  Maller	   et	   al.	   1981).	   In	   this	   case,	   it	   is	   well	   established	   that	   both	   factors	   act	   through	   the	  
classical	  receptor	  of	  IGF-­‐1	  that	  is	  expressed	  in	  the	  plasma	  membrane	  of	  the	  oocyte	  (Zhu	  et	  al.	  1998).	  
Surprisingly	  however,	   it	   is	  also	  clear	   that	  once	   the	   receptor	  of	   IGF-­‐1	   is	  activated,	   it	   reproduces	   the	  
early	  events	  induced	  by	  progesterone,	  i.e.	  a	  drop	  in	  cAMP	  due	  to	  the	  inhibition	  of	  adenylate	  cyclase,	  
and	   a	   decrease	   in	   PKA	   activity,	   and	   then	   all	   the	   subsequent	   events	   leading	   to	   MPF	   activation.	  
Whether	   IGF-­‐1	   is	  physiologically	   involved	   in	  oocyte	  meiosis	  resumption	   is	  not	  known,	  although	   it	   is	  
noteworthy	  that	  elevated	  levels	  of	  IGF-­‐1	  are	  present	  in	  the	  Xenopus	  ovary.	  
iii. The	  limiting	  steps	  for	  meiosis	  resumption	  
Two	  limiting	  steps	  are	  necessary	  for	  meiosis	  resumption	  in	  full-­‐grown	  oocytes:	  the	  downregulation	  of	  
PKA	   activity	   in	   Vertebrates	   and,	   depending	   on	   the	   species,	   the	   synthesis	   of	   new	   proteins	   from	  
maternal	  mRNA	  (Fig.	  15).	  
1. The	   decrease	   of	   cAMP	   levels	   and	   the	   downregulation	   of	  
PKA	  
The	  first	  intracellular	  events	  occurring	  within	  10	  minutes	  upon	  progesterone	  stimulation	  in	  Xenopus	  
oocytes	  are	  the	  inhibition	  of	  the	  adenylate	  cyclase	  activity,	  the	  decrease	  of	  about	  20%	  of	  the	  cAMP	  
intracellular	   concentration	   and	   the	   consequential	   downregulation	   of	   PKA	   activity	   (Mulner	   et	   al.	  
1979a,	  Sadler	   et	  al.	   1981b,	  Sadler	   et	  al.	   1983b,	  Wang	   et	  al.	   2004)	   (Fig.	   16).	   These	  events	  are	  both	  
necessary	  and	  sufficient	  for	  Cdk1	  activation.	  The	  incubation	  of	  oocytes	  with	  inhibitors	  of	  PDEs,	  such	  
as	   IBMX	   (3-­‐isobutyl-­‐1-­‐methylxanthine)	   or	   Cholera	   toxin,	   which	   maintain	   a	   high	   level	   of	   cAMP	   in	  
oocytes,	   totally	   abolishes	   the	   ability	   of	   progesterone	   to	   trigger	  meiosis	   resumption	   (Huchon	   et	   al.	  
1979,	  Maller	  et	  al.	  1980,	  Thibier	  et	  al.	  1982)	  (Fig.	  16).	  Moreover,	  the	  inhibition	  of	  PKA,	  by	   injecting	  
either	   recombinant	   PKA-­‐R	   or	   an	   inhibitor	   of	   PKA,	   PKI,	   induces	   Cdk1	   activation	   independently	   of	  
progesterone	   whereas	   the	   injection	   of	   PKA-­‐C	   prevents	   progesterone-­‐induced	   Cdk1	   activation	  
(Huchon	   et	   al.	   1981c)	   (Maller	   et	   al.	   1977)	   (Fig.	   16).	   This	   implies	   that	   some	   substrates	   of	   PKA	   are	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phosphorylated	   in	   prophase	   and	   must	   be	   dephosphorylated	   to	   promote	   Cdk1	   activation.	   The	  
identification	   of	   these	   PKA	   substrates	   in	   oocytes	   has	   been	   a	   challenge	   for	  many	   years.	   Cdc25C	   is	  
clearly	  a	  PKA	  substrate	  in	  the	  oocyte	  (Duckworth	  et	  al.	  2002).	  However,	  it	  does	  not	  correspond	  to	  the	  
protein	   whose	   dephosphorylation	   is	   mandatory	   for	   Cdk1	   activation.	   Indeed,	   the	   timing	   of	   Cdc25	  
dephosphorylation	  at	  the	  PKA	  site,	  S287,	  does	  not	  fit	   in	  the	  window	  of	  PKA	  inactivation	  that	  occurs	  
within	  one	  hour	  following	  progesterone	  addition.	  Cdc25C	  is	  dephosphorylated	  at	  S287	  at	  the	  time	  of	  
MPF	  activation,	  just	  before	  GVBD,	  in	  a	  protein	  synthesis-­‐dependent	  manner	  (Duckworth	  et	  al.	  2002),	  
strongly	   suggesting	   that	   this	   dephosphorylation	   takes	   place	   downstream	  of	   Cdk1	   activation	   and	   is	  
not	  a	  direct	  consequence	  of	  PKA	  inactivation.	  In	  the	  early	  80s,	  biochemical	  attempts	  have	  led	  to	  the	  
proposal	  that	  the	  PKA	  substrate	  in	  the	  Xenopus	  oocyte	  could	  be	  a	  20	  kDa	  acid-­‐	  and	  thermo-­‐resistant	  
protein	  (Boyer	  et	  al.	  1986)	  whose	  molecular	  identity	  had	  not	  been	  elucidated	  at	  that	  time.	  Therefore,	  
the	  identification	  of	  the	  PKA	  substrate	  whose	  dephosphorylation	  is	  required	  for	  Cdk1	  activation	  and	  
meiosis	  resumption	  in	  Vertebrates	  remains	  an	  opened	  question.	  
2. The	  protein	  synthesis	  
In	   prophase-­‐arrested	   oocytes,	   transcription	   is	   dormant	   and	   the	   synthesis	   of	   new	   proteins	   is	   only	  
regulated	  at	  a	  translational	  level,	  from	  maternal	  mRNA.	  The	  requirement	  for	  protein	  synthesis	  during	  
meiosis	  resumption	  varies	  according	  to	  species.	  
In	  species	  where	  prophase	  oocytes	  do	  not	  contain	  pre-­‐MPF,	  such	  as	  some	  fishes,	  meiosis	  resumption	  
relies	   entirely	   on	   Cyclins	   B	   synthesis	   (Katsu	   et	   al.	   1993).	   In	   mouse,	   the	   activation	   of	   Cdc25	   is	  
independent	  of	  protein	  synthesis	  and	  sufficient	  for	  the	  dephosphorylation	  and	  the	  activation	  of	  pre-­‐
MPF	   leading	   to	  GVBD	   (Polanski	   et	  al.	   1998,	   Ledan	   et	  al.	   2001).	  However,	   the	   level	  of	  Cdk1	  activity	  
thus	   generated	   is	   not	   high	   enough	   to	   organize	   the	   first	  meiotic	   spindle	   and	   GVBD	   is	   immediately	  
followed	  by	  a	  massive	  synthesis	  of	  Cyclin	  B,	  which	  binds	  monomeric	  Cdk1	  and	   increases	   its	  activity	  
(Hampl	   et	   al.	   1995a,	  Winston	   1997,	   Polanski	   et	   al.	   1998,	  Hoffmann	   et	   al.	   2006).	   In	  Xenopus,	   as	   in	  
most	  mammals	   (except	  small	   rodents),	  although	  a	  high	   level	  of	  pre-­‐MPF	   is	  stored	   in	  the	  cytoplasm	  
and	  able	  to	  be	  activated	  by	  Cdk1	  dephosphorylation	  at	  Y15	  and	  T14,	  the	  synthesis	  of	  new	  proteins	  is	  
necessary	   for	   Cdk1	   activation.	   Oocytes	   stimulated	   by	   progesterone	   are	   unable	   to	   mature	   when	  
protein	  synthesis	  is	  prevented	  by	  Cycloheximide	  (CHX)	  (Wasserman	  et	  al.	  1975)	  (Fig.	  16).	  In	  contrast,	  
all	  components	  able	  to	  directly	  activate	  Cdk1	  activity	  or	  the	  autoamplification	  loop,	  as	  Cyclins,	  Cdc25,	  
or	  okadaic	  acid,	  act	  independently	  of	  protein	  synthesis	  (Rime	  et	  al.	  1990,	  Gautier	  et	  al.	  1991,	  Lee	  et	  
al.	   1992,	  Nebreda	   et	   al.	   1995),	   confirming	   that	   protein	   synthesis	   is	   required	  prior	   Cdk1	   activation.	  
Interestingly,	  the	  inhibition	  of	  PKA	  induced	  by	  PKI	  injection	  is	  unable	  to	  activate	  Cdk1	  in	  the	  presence	  
of	  CHX	  (Huchon	  et	  al.	  1981c).	  This	  suggests	  that	  the	  protein	  synthesis	  step	   is	   initiated	  downstream	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PKA	  inhibition	  (Fig.	  15).	  The	  molecular	  links	  between	  these	  two	  limiting	  steps	  in	  meiosis	  resumption	  
have	  not	  yet	  been	  uncovered.	  However,	  three	  classes	  of	  proteins	  are	  known	  to	  be	  synthesized	  from	  
maternal	  mRNA	   in	  response	  to	  progesterone	  and	  may	  be	  necessary	   for	  Cdk1	  activation	   in	  oocytes:	  
the	  Cyclins	  A	  and	  B,	  the	  kinase	  Mos	  and	  the	  protein	  Ringo/Speedy.	  
§ The	  Cyclins	  
– Cyclin	  A	  
In	  Xenopus	   oocytes,	   Cyclin	   A	   accumulates	   at	   a	   low	   level	   starting	   at	  GVBD	   (Kobayashi	   et	   al.	   1991).	  
While	  purified	  Cyclin	  A	  is	  able	  on	  its	  own	  to	  induce	  meiosis	  resumption	  by	  interacting	  with	  free	  Cdk1	  
(Swenson	   et	   al.	   1986),	   the	   injection	   of	   antisense	   directed	   against	   Cyclin	   A1	   mRNA	   did	   not	   block	  
meiosis	   resumption	   in	   response	   to	  progesterone	   (Minshull	   et	  al.	   1991).	  Hence,	  Cyclin	  A1	   synthesis	  
might	   not	   represent	   a	   requirement	   for	   MPF	   activation	   although	   it	   certainly	   participates	   to	   the	  
activation	  of	  Cdk1.	  Its	  involvement	  in	  this	  process	  needs	  to	  be	  clarified.	  
– Cyclins	  B	  
In	  Xenopus	  oocytes,	  four	  subtypes	  of	  Cyclin	  B	  have	  been	  identified:	  B1,	  B2,	  B4	  and	  B5	  (Hochegger	  et	  
al.	  2001).	  Cyclins	  B2	  and	  B5	  are	  present	  in	  prophase-­‐arrested	  oocytes	  and	  associate	  with	  monomeric	  
Cdk1	   to	   form	   the	   pre-­‐MPF.	   Cyclins	   B1	   and	   B4	   are	   not	   expressed	   in	   prophase,	   or	   sometimes	  
depending	  on	  the	  female	  individuals,	  at	  a	  low	  level.	  B1-­‐	  and	  B4-­‐Cyclins	  are	  synthesized	  in	  response	  to	  
progesterone	  (Kobayashi	  et	  al.	  1991,	  Hochegger	  et	  al.	  2001),	  independently	  of	  Cdk1	  activity	  because	  
those	  proteins	  appear	  upon	  hormonal	  stimulation	   in	  prophase	  oocytes	   injected	  with	  p21Cip1,	  a	  CDK	  
inhibitor	  known	  to	  prevent	  Cdk1	  activation	  and	  GVBD	  in	  Xenopus	  oocytes	  (Frank-­‐Vaillant	  et	  al.	  1999).	  
Cyclin	  B1	  also	  accumulates	  following	  PKI	  injection	  in	  p21Cip1-­‐injected	  oocytes,	  arguing	  that	  Cyclin	  B1	  
accumulation	   is	  under	  the	  control	  of	  PKA	  downregulation	  during	  meiosis	  resumption.	  Whether	  this	  
accumulation	   results	   from	   an	   increase	   rate	   of	   synthesis	   or	   a	   stabilization	   of	   the	   protein	   remains	  
unknown	   in	  Xenopus	  oocytes.	  Translation	   is	  clearly	   required	  as	  antisense	  oligonucleotides	   targeted	  
against	   Cyclins	   B	   prevent	   Cyclin	   B1	   accumulation.	   However	   in	  mouse	   oocyte,	   the	   inhibition	   of	   the	  
APCCdh1	  is	  necessary	  for	  stabilizing	  Cyclin	  B1	  and	  for	  meiosis	  resumption	  (Reis	  et	  al.	  2006).	  	  
The	   potential	   importance	   of	   Cyclin	   B	   during	  meiosis	   resumption	  was	   initially	   revealed	   by	   injecting	  
recombinant	  Cyclin	  B.	  When	  a	  sufficient	  amount	  of	  Cyclin	  B,	  able	  to	  overcome	  the	  activity	  of	  Myt1,	  is	  
injected	   in	   prophase	   oocytes,	   Cdk1	   is	   activated	   independently	   of	   progesterone	   and	   of	   protein	  
synthesis	   (Nebreda	   et	   al.	   1995).	   Exogenous	   Cyclin	   B	   binds	   to	   free	   T161-­‐phosphorylated	   Cdk1	   and	  
triggers	  the	  full	  activation	  of	  Cdk1.	  Although,	  Cyclin	  B	  synthesis	  is	  sufficient	  for	  Cdk1	  activation,	  this	  
process	   is	   not	   however	   necessary	   for	   meiosis	   resumption	   since	   the	   injection	   of	   antisense	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oligonucleotides	   directed	   against	   the	   four	   Cyclin	   B	   isoforms	   does	   not	   block	  meiosis	   resumption	   in	  
response	  to	  progesterone	  (Hochegger	  et	  al.	  2001,	  Haccard	  et	  al.	  2006).	  	  
§ The	  kinase	  Mos	  
The	   protein	   Mos	   is	   a	   serine/threonine	   kinase	   specifically	   expressed	   in	   female	   germ	   cells.	   Mos	   is	  
responsible	   for	   the	   activation	   of	   MAPKK	   (MEK)	   that	   in	   turn	   activates	   MAPK	   then	   p90Rsk	  
independently	  of	  PKA	  activity	  and	  protein	  synthesis	  (Nebreda	  et	  al.	  1993,	  Posada	  et	  al.	  1993,	  Shibuya	  
et	  al.	  1993,	  Dupre	  et	  al.	  2011).	  This	  pathway	  is	  referred	  as	  the	  Mos/MAPK	  pathway.	  Mos	  mRNAs	  are	  
present	   at	   a	   very	   low	   level	   in	   brain	   and	   testis	   and	   are	   very	   abundant	   in	   ovaries,	   particularly	   in	  
oocytes.	  During	  oogenesis,	  Mos	  transcripts	  are	  already	  present	  at	  high	  concentration	  as	  early	  as	   in	  
Stage	  I	  oocytes	  but	  the	  protein	  is	  never	  expressed	  during	  the	  growth	  period	  or	  in	  prophase-­‐arrested	  
full-­‐grown	  oocytes	  (Sagata	  et	  al.	  1988).	  
The	  translation	  of	  Mos	  mRNA	  is	  initiated	  in	  response	  to	  progesterone	  stimulation	  just	  before	  GVBD	  
(Sagata	  et	  al.	  1988).	  However,	  the	  accumulation	  of	  Mos,	  as	  well	  as	  the	  activation	  of	  MAPK,	  are	  only	  
detected	   at	   GVBD	   when	   Cdk1	   is	   activated.	   The	   involvement	   of	   the	   Mos/MAPK	   pathway	   in	   the	  
activation	  of	  Cdk1	  in	  Xenopus	  oocyte	  is	  supported	  by	  several	  lines	  of	  evidence.	  Firstly,	  the	  injection	  of	  
recombinant	   Mos	   or	   its	   direct	   targets	   such	   as	   active	   thiophosphorylated	   MAPK	   or	   active	   p90Rsk	  
induced	   GVBD	   and	   activates	   Cdk1	   independently	   of	   progesterone	   stimulation	   (Yew	   et	   al.	   1992,	  
Haccard	  et	  al.	  1995,	  Gross	  et	  al.	  2001	  and	  reviewed	  in	  Dupre	  et	  al.	  2011).	  Secondly,	  the	  Mos-­‐induced	  
Cdk1	  activation	  was	  shown	  to	  be	  independent	  of	  protein	  synthesis,	  provided	  that	  low	  concentrations	  
of	  progesterone,	  unable	  to	  trigger	  meiosis	  resumption	  by	   itself,	   is	  added	  (Yew	  et	  al.	  1992).	  Thirdly,	  
inhibiting	  Mos	   synthesis	  with	   antisense	   oligonucleotides	   directed	   against	   its	  mRNA	  abolishes	   Cdk1	  
activation	   in	   response	   to	  progesterone	   (Sagata	   et	   al.	   1988).	  Altogether,	   these	   results	   indicate	   that	  
the	  Mos/MAPK	  pathway	  is	  necessary	  and	  sufficient	  for	  Cdk1	  activation	  in	  response	  to	  progesterone.	  
These	   findings	   generated	   however	   controversy.	   In	   other	   species	   such	   as	   Mouse,	   Starfish	   and	  
Goldfish,	  neither	  Mos	  synthesis	  nor	  MAPK	  activation	  are	  required	  for	  meiosis	  resumption	  (Hashimoto	  
et	   al.	   1994b,	  Verlhac	   et	   al.	   1996a,	   Sadler	   et	   al.	   1998,	   Kajiura-­‐Kobayashi	   et	   al.	   2000).	   Furthermore,	  
Mos	  does	  not	  accumulate	  and	  MAPK	  is	  not	  activated	  when	  Cdk1	  activation	  is	  prevented	  by	  injecting	  
the	  CDK	   inhibitor,	  p21Cip1	   (Frank-­‐Vaillant	   et	  al.	   1999),	   strongly	   suggesting	   that	   the	  activation	  of	   the	  
Mos/MAPK	  pathway	  relies	  on	  the	  activation	  of	  Cdk1.	  Finally,	  the	  inhibition	  of	  MAPK	  activation	  either	  
by	   the	   pharmacological	   inhibitor	   of	   MEK	   activity,	   U0126,	   or	   by	   Geldanamycin,	   which	   acts	   on	   the	  
chaperone	   protein	   HSP90,	   delays	   GVBD	   in	   response	   to	   progesterone	   and	   totally	   impedes	   Cdk1	  
activation	   following	   Mos	   injection	   in	   Xenopus	   oocytes	   (Fisher	   et	   al.	   1999,	   Gross	   et	   al.	   2000).	  
Moreover,	   injecting	   specific	   morpholino	   antisense	   oligonucleotides	   directed	   against	   Mos	   mRNA	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prevents	   both	  Mos	   synthesis	   and	  MAPK	   activation	   but	   does	   not	   block	   Cdk1	   activation	   and	   GVBD,	  
although	  both	   events	   are	   delayed	   (Dupre	   et	   al.	   2002).	   Therefore,	   in	  Xenopus	   as	   in	   all	   species,	   the	  
Mos/MAPK	  pathway	  is	  dispensable	  for	  meiosis	  resumption	  and	  the	  1st	  acyivation	  of	  Cdk1.	  
§ Ringo/Speedy	  
The	  Speedy/Ringo	  protein	  was	   first	   identified	   in	  1999	   in	   two	   independent	  screens	  using	  a	  Xenopus	  
oocyte	  cDNA	  library.	  The	  first	  one	  was	  aimed	  at	  identifying	  new	  mRNAs	  whose	  translation	  was	  able	  
to	   stimulate	   meiosis	   resumption	   in	   this	   species.	   The	   second	   one	   was	   designed	   to	   find	   proteins	  
conferring	  radio-­‐resistance	  in	  yeast	  and	  thus	  promoting	  their	  release	  from	  G2	  when	  irradiated	  (Ferby	  
et	  al.	  1999a,	  Lenormand	  et	  al.	  1999).	  Ringo	  is	  expressed	  in	  response	  to	  progesterone	  during	  meiotic	  
maturation	  and	  must	  be	  downregulated	  after	  GVBD	  to	  ensure	  the	  proper	  progression	  of	  the	  oocyte	  
in	   Meiosis	   II	   (Terret	   et	   al.	   2001,	   Gutierrez	   et	   al.	   2006).	   When	   overexpressed	   in	   prophase,	  
Ringo/Speedy	  binds	  and	  activates	  free	  monomeric	  Cdk1	  independently	  of	  protein	  synthesis;	  leading	  
to	   meiosis	   resumption	   (Ferby	   et	   al.	   1999a,	   Lenormand	   et	   al.	   1999).	   Reversely,	   the	   injection	   of	  
antisense	  oligonucleotides	  directed	  against	   its	  mRNA	  delays	  Cdk1	  activation	  but	  does	  not	  block	  the	  
process	  (Ferby	  et	  al.	  1999a,	  Lenormand	  et	  al.	  1999).	  	  
	  
Therefore,	   injecting	   any	   of	   these	   proteins	   (Cyclins,	   Mos	   and	   Ringo)	   induces	   Cdk1	   activation	  
independently	   of	   progesterone	   stimulation	   and	   of	   protein	   synthesis,	  whereas	   the	   ablation	   of	   only	  
one	  of	  these	  proteins	  using	  pharmacological	  inhibitors	  or	  antisense	  oligonucleotides	  does	  not	  impair	  
meiosis	  resumption.	  These	  results	  strongly	  support	  the	  view	  that	  these	  pathways	  act	  redundantly	  to	  
activate	  Cdk1.	  Accordingly,	  it	  was	  shown	  that	  neither	  progesterone	  nor	  PKI	  triggered	  GVBD	  and	  Cdk1	  
activation	   when	   the	   synthesis	   of	   Cyclin	   B	   together	   with	   Mos	   was	   prevented	   using	   a	   cocktail	   of	  
specific	   antisense	   oligonucleotides	   directed	   against	   both	   mRNA	   (Haccard	   et	   al.	   2006).	   The	  
replenishment	  of	  one	  of	  these	  two	  pathways,	  by	   injecting	  either	  recombinant	  Cyclin	  B	  or	  Mos,	  was	  
able	   to	   rescue	   Cdk1	   activation	   induced	   by	   progesterone	   or	   PKI	   (Haccard	   et	   al.	   2006).	   Therefore,	  
progesterone	   launches	  more	  than	  one	  signalling	  pathway,	  each	  able	  to	  trigger	  meiosis	  resumption.	  
The	  activation	  of	  at	  least	  one	  of	  these	  pathways,	  controlled	  either	  by	  Cyclin	  B	  or	  by	  Mos,	  is	  sufficient	  
for	  the	  entry	  in	  MI.	  Moreover,	  since	  inhibiting	  both	  the	  synthesis	  of	  Cyclin	  B	  and	  Mos	  is	  sufficient	  for	  
preventing	   Cdk1	   activation,	   this	   further	   suggests	   that	   Speedy/Ringo	   could	   not	   play	   a	   critical	  
physiological	   role	  on	   its	  own	   to	   support	   a	   key	   transduction	  pathway	   induced	  by	  progesterone	  and	  
leading	  to	  Cdk1	  activation	  (Haccard	  et	  al.	  2006).	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3. PP1	  
The	  activation	  of	  the	  phosphatase	  PP1	  was	  shown	  to	  be	  required	  for	  meiosis	  resumption	  of	  Xenopus	  
oocytes	  (Huchon	  et	  al.	  1981b,	  Foulkes	  et	  al.	  1982).	  The	  injection	  of	  specific	  proteic	  PP1	  inhibitors,	  the	  
Inhibitor	   1	   or	   the	   Inhibitor	   2,	   prevents	   meiosis	   resumption	   induced	   either	   by	   progesterone	   or	  
following	  the	  injection	  of	  PKI	  (Huchon	  et	  al.	  1981b,	  Foulkes	  et	  al.	  1982).	  Since	  injected	  Inhibitor	  1	  is	  
unable	  to	  abolish	  meiosis	  resumption	  following	  the	  transfer	  of	  cytoplasm	  from	  a	  MII-­‐arrested	  oocyte	  
(Huchon	   et	   al.	   1981b),	   PP1	   activation	   is	   unlikely	   to	   be	   required	  within	   the	  MPF	   autoamplification	  
loop.	   In	  addition,	   the	   injection	  of	   Inhibitor	  1	  three	  hours	  after	  hormonal	   treatment	  does	  not	  affect	  
meiotic	  maturation.	  Therefore,	  the	  activation	  of	  PP1	  is	  required	  at	  a	  quite	  early	  step	  of	  the	  signalling	  
pathway	   induced	   by	   progesterone,	   downstream	   PKA	   inhibition.	   The	   mechanisms	   controlling	   PP1	  
activation	   as	  well	   as	   the	  molecular	   cascade	   connecting	   PP1	   to	   Cdk1	   activation	   have	   not	   been	   yet	  
elucidated.	   Interestingly,	  PP1	   is	   involved	   in	  regulating	  the	  dephosphorylation	  of	  Cdc25C	  at	  S287,	  at	  
least	  in	  Xenopus	  egg	  extracts	  (Margolis	  et	  al.	  2003,	  Margolis	  et	  al.	  2006b).	  It	  would	  be	  interesting	  to	  
determine	  whether	  the	  activation	  of	  PP1	  could	  trigger	  a	  partial	  activation	  of	  Cdc25C,	  thus	  helping	  to	  
switch	  the	  balance	  of	  activities	  between	  Myt1	  and	  Cdc25C.	  
iv. The	  two-­‐steps	  mechanism	  of	  Cdk1	  activation	  
From	   all	   the	   experiments	   described	   above,	   a	   model	   involving	   a	   two-­‐steps	   mechanism	   for	   Cdk1	  
activation	  has	  been	  proposed	  in	  Xenopus	  oocyte.	  During	  the	  first	  step,	  progesterone	  induces	  a	  drop	  
of	   cAMP	   level,	   the	   subsequent	   downregulation	   of	   PKA	   activity	   and	   the	   synthesis	   of	   new	   proteins	  
from	   maternal	   mRNA.	   This	   first	   part	   of	   the	   signalling	   pathway	   takes	   from	   2	   to	   6	   hours	   to	   be	  
implemented,	  depending	  on	   the	   female	  and	  generates	  a	   starter	  amount	  of	  active	  Cdk1.	  This	   small	  
amount	  of	  active	  Cdk1	  then	   launches	  the	  second	  step	  necessary	  for	  the	  full	  activation	  of	  Cdk1,	  the	  
MPF	  autoamplification	  loop,	  which	  acts	  as	  an	  OFF-­‐ON	  switch	  and	  drives	  irreversibly	  the	  oocyte	  in	  M-­‐
phase.	  The	  MPF	  autoamplification	  relies	  on	  phosphorylation/dephosphorylation	  events	  and	  converts	  
the	   stockpile	   of	   inactive	   pre-­‐MPF	   into	   active	  MPF.	   The	   transfer	   of	   cytoplasm	   from	   a	  MII-­‐arrested	  
oocyte	   into	   a	   prophase-­‐arrested	   oocyte	   mimics	   the	   autoamplification	   loop,	   as	   it	   allows	   a	   small	  
amount	  of	  ectopic	  active	  MPF	  from	  the	  donor	  cell	  to	  launch	  the	  loop	  converting	  pre-­‐MPF	  into	  MPF	  in	  
the	  recipient	  oocyte.	  Cytoplasmic	  transfer	  or	  injection	  of	  okadaic	  acid,	  a	  strong	  inhibitor	  of	  PP1	  and	  
PP2A	   phosphatases,	   induce	  GVBD	   in	   the	   absence	   of	   protein	   synthesis	   (CHX)	   or	   in	   the	   presence	   of	  
elevated	   levels	  of	  cAMP	  (IBMX)	   (Wasserman	   et	  al.	  1975,	  Rime	   et	  al.	  1990,	  Dupre	   et	  al.	  2013).	  This	  
means	  that	  the	  MPF	  autoamplification	   loop	   is	   independent	  of	  cAMP	  level,	  PKA	  activity	  and	  protein	  
synthesis.	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This	  model	   involving	   a	   biphasic	   activation	   of	   Cdk1	   is	   however	   difficult	   to	   study	   and	   remains	   to	   be	  
formally	   proved.	   Indeed,	   the	   induction	   of	   GVBD	   in	   response	   to	   progesterone	   is	   not	   totally	  
synchronous	   over	   time	   in	  Xenopus	   oocytes	   and	   at	   the	   time	   of	   GVBD50	   (when	   50%	   of	   the	   oocytes	  
exhibit	  GVBD),	  some	  oocytes	  have	  already	  reached	  GVBD	  whereas	  some	  others	  are	  still	  defective	  for	  
Cdk1	  activity.	  Secondly,	  there	  is	  no	  morphological	  criterion	  to	  detect	  the	  1st	  activation	  of	  Cdk1.	  The	  
only	  morphological	  change	  detectable	  is	  the	  appearance	  of	  the	  spot	  that	  characterizes	  GVBD,	  which	  
is	   induced	   by	   the	   full	   activation	   of	   Cdk1	   and	   the	   establishment	   of	   the	  MPF	   automplification	   loop.	  
Indeed,	  Cdk1	  activation	  is	  initiated	  before	  the	  appearance	  of	  the	  spot.	  Finally,	  the	  transition	  between	  
the	  1st	  activation	  of	  Cdk1	  and	  the	  MPF	  autoamplification	  loop	  is	  very	  fast	  and	  seems	  to	  occur	  without	  
distinguishable	  intermediate	  step.	  
One	  strategy	  to	  address	  the	  role	  of	  one	  particular	  protein	  within	  the	  mechanism	  of	  Cdk1	  activation	  
has	  been	  to	  analyse	  whether	  the	  candidate	  protein	  can	  induce	  meiosis	  resumption	  independently	  or	  
not	   of	   PKA	   activity	   and/or	   protein	   synthesis.	   However,	   although	   some	   proteins	   involved	   in	   Cdk1	  
activation	  such	  as	  Mos,	  Cyclin	  B	  and	  Cdc25C	  can	  trigger	  meiosis	  resumption	  in	  the	  presence	  of	  CHX	  
(Gautier	  et	  al.	  1991,	  Roy	  et	  al.	  1991,	  Lee	  et	  al.	  1992,	  Huchon	  et	  al.	  1993b,	  Rime	  et	  al.	  1994),	  these	  
actors	  are	  all	  unable	  to	  promote	  meiosis	  resumption	   in	  the	  presence	  of	  a	  high	   level	  of	  PKA	  activity	  
(Rime	  et	  al.	  1992a,	  Matten	  et	  al.	  1994,	  Rime	  et	  al.	  1994,	  Dupre	  et	  al.	  2013).	  This	  suggests	  that	  the	  
activity	  of	  PKA	  locks	  Cdk1	  activation	  at	  two	  points	  of	  meiosis	  resumption,	  once	  in	  the	  early	  signalling	  
pathway,	  as	  already	  described,	  and	  the	  second	  time	  within	  the	  MPF	  autoamplification	  loop	  (Fig.	  16	  
and	  24).	  
1. Formation	  of	  the	  starter	  amount	  of	  active	  Cdk1	  
In	  response	  to	  progesterone,	  the	  starter	  amount	  of	  active	  Cdk1	  can	  be	  formed	  by	  two	  non-­‐exclusive	  
means:	  (i)	  the	  association	  of	  newly	  synthesized	  Cyclin	  B	  with	  the	  monomeric	  form	  of	  Cdk1	  and	  (ii)	  the	  
conversion	   of	   a	   small	   amount	   of	   pre-­‐MPF	   into	   active	   MPF	   by	   switching	   the	   balance	   of	   activities	  
between	   Cdc25C	   and	  Myt1	   (Fig.	   17).	   This	   latter	   mechanism	   therefore	   implies	   that	   the	   activity	   of	  
Cdc25C	   and/or	   of	   Myt1	   must	   be	   at	   least	   partially	   regulated	   upon	   progesterone	   stimulation	   and	  
independently	  of	  Cdk1	  activity.	  
§ From	  monomeric	  Cdk1:	  the	  synthesis	  of	  Cyclins	  B	  
Progesterone	   stimulates	   the	   basal	   synthesis	   rate	   of	   Cyclin	   B1,	   and	   probably	   B4,	   independently	   of	  
MPF	  activation	  (Frank-­‐Vaillant	  et	  al.	  1999,	  Hochegger	  et	  al.	  2001).	  These	  newly	  synthesized	  Cyclin	  B	  
molecules	  then	  associate	  with	  monomeric	  Cdk1.	  A	  part	  of	  Cdk1	  is	  already	  phosphorylated	  at	  T161	  by	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CAK	  in	  prophase	  (De	  Smedt	  et	  al.	  2002)	  (Fig.	  17).	  In	  agreement	  with	  this	  hypothesis,	  the	  injection	  of	  a	  
dominant	  negative	  form	  of	  Cdk1,	  the	  mutant	  K33R-­‐Cdk1,	  which	  binds	  to	  Cyclin	  B1	  and	  B2	  in	  Xenopus,	  
prevents	  meiosis	  resumption	  in	  response	  to	  progesterone	  (Nebreda	  et	  al.	  1995).	  This	  mutated	  form	  
of	   Cdk1	   locks	   the	   activation	   of	   Cdk1	   induced	   by	   Cyclin	   A.	   Importantly,	   it	   has	   no	   effect	   on	  
Cdk1activation	  induced	  by	  the	  addition	  of	  okadaic	  acid	  in	  extracts	  produced	  from	  prophase	  oocytes,	  
a	  process	  known	  to	  promote	  MPF	  autoamplification	  independently	  of	  protein	  synthesis	  (Nebreda	  et	  
al.	  1995).	  This	  result	  indicates	  that	  the	  K33R	  mutant	  of	  Cdk1	  acts	  as	  a	  dominant	  negative	  form	  over	  
endogenous	   Cdk1	   by	   sequestering	   newly	   synthesized	   proteins,	   namely	   Cyclins,	  which	   are	   required	  
for	   meiotic	   maturation.	   However,	   K33R-­‐Cdk1	   is	   unable	   to	   inhibit	   meiosis	   resumption	   when	   this	  
process	  is	  initiated	  by	  launching	  the	  MPF	  autoamplification	  loop,	  suggesting	  that	  Cyclin	  B	  synthesis	  is	  
unlikely	  required	  for	  the	  second	  step	  of	  Cdk1	  auto-­‐amplification.	  
One	  hypothesis	  explaining	  the	  initial	  activation	  of	  Cdk1	  is	  that	  newly	  synthesized	  Cyclin	  B	  or	  injected	  
Cyclins	  associate	  with	  free	  T161-­‐phosphorylated	  Cdk1	  and	  directly	  generate	  newly	  active	  Cdk1-­‐Cyclin	  
B	  complexes	  that	  escape	  Myt1	  inhibition.	  The	  increasing	  quantity	  of	  these	  Cdk1-­‐Cyclin	  B	  complexes	  
could	  titrate	  the	  activity	  of	  Myt1	  thus	  leading	  to	  a	  sufficient	  amount	  of	  active	  Cdk1-­‐Cyclin	  B	  able	  to	  
partly	   inhibit	  Myt1	  activity	  (Gaffre	  et	  al.	  2011).	  Accordingly,	  although	  Myt1	  inhibition	  occurs	  before	  
GVBD	  and	  Cdc25C	  activation,	  this	  process	  is	  no	  longer	  observed	  when	  oocytes	  are	  previously	  injected	  
with	  Cyclin	  B	  antisense	  oligonucleotides	  (Gaffre	  et	  al.	  2011).	  These	  results	  strongly	  argue	  that	  Myt1	  
inhibition	   depends	   on	   the	   newly	   formed	   active	   Cdk1-­‐Cyclin	   B	   complexes	   and,	   thus,	   contributes	   to	  
launch	  the	  MPF	  autoamplification	  loop.	  Another	  hypothesis	  would	  be	  a	  role	  for	  Ringo/speedy.	  Since	  
overexpressed	  Ringo	  was	  shown	  to	  bind	  Cdk1	  and	  Myt1	  together,	  Ringo	  could	  help	  in	  inhibiting	  Myt1	  
either	  directly	  or	  by	  forming	  active	  Cdk1-­‐Ringo	  complexes	  (Ferby	  et	  al.	  1999b,	  Ruiz	  et	  al.	  2008).	  
§ From	  the	  pre-­‐MPF	  :	  the	  synthesis	  of	  Mos,	  Myt1	  and	  
Cdc25	  
Recombinant	  Mos	   is	  a	  much	   less	  efficient	   inducer	  of	  meiotic	  maturation	  compared	  to	  recombinant	  
Cyclin	  B.	   Its	  ability	  to	  activate	  Cdk1	   independently	  of	  protein	  synthesis	  relies	  on	  the	  amount	  of	  the	  
injected	  recombinant	  protein	  and	  on	  the	  presence	  of	  sub-­‐liminal	  amounts	  of	  progesterone	  (Yew	  et	  
al.	  1992).	  Moreover,	  Mos-­‐induced	  Cdk1	  activation	  totally	  depends	  on	  the	  activation	  of	  MAPK	  (Gross	  
et	   al.	   2000),	   and	   induces	   GVBD	   in	   the	   presence	   of	   antisense	   oligonucleotides	   against	   Cyclin	   B,	  
meaning	   in	   the	   absence	   of	   Cyclin	   B	   synthesis	   and	   in	   the	   absence	   of	   newly	   formed	   Cdk1-­‐Cyclin	   B	  
complexes	   (Haccard	   et	   al.	   2006).	   Altogether,	   these	   results	   strongly	   argue	   that	   the	   effect	   of	   the	  
Mos/MAPK	  pathway	  in	  triggering	  meiosis	  resumption	  is	  mediated	  through	  the	  activation	  of	  the	  pre-­‐
MPF	  (Fig.	  17).	  This	  function	  can	  be	  exerted	  either	  by	  inhibiting	  Myt1	  or	  by	  activating	  Cdc25.	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Myt1	  was	  shown	  to	  be	  hyperphosphorylated	  and	  inhibited	  in	  response	  to	  progesterone	  before	  GVBD	  
and	  before	   the	   activation	  of	   Cdc25	   (Gaffre	   et	   al.	   2011).	   The	  Mos/MAPK	  pathway	   is	   able	   to	   inhibit	  
Myt1	  through	  Mos,	  active	  MAPK	  and	  p90Rsk	  (Palmer	  et	  al.	  1998,	  Peter	  et	  al.	  2002,	  Gaffre	  et	  al.	  2011).	  
Accordingly,	   recombinant	   Mos	   leads	   to	   Myt1	   partial	   phosphorylation	   in	   p21Cip1-­‐injected	   oocytes	  
despite	   the	   lack	   of	   Cdk1-­‐Cyclin	   B	   activity	   (Gaffre	   et	   al.	   2011),	   suggesting	   that	   this	   pathway	   is	  
sufficient	   to	   partially	   inhibit	   Myt1.	   However,	   the	   full	   phosphorylation	   of	   Myt1	   in	   response	   to	  
progesterone	   is	   still	   observed	   in	  Mos	  morpholinos-­‐injected	   oocytes	   further	   treated	  with	  U0126	   to	  
specifically	  block	  the	  MAPK-­‐independent	  activation	  of	  p90Rsk	  (Dupre	  et	  al.	  2002,	  Gaffre	  et	  al.	  2011).	  
The	  Mos/MAPK	  pathway	  may	   therefore	   enhance	  Myt1	   inhibition	   in	   response	   to	   progesterone	   but	  
would	   not	   be	   necessary,	   since	  Myt1	   complete	   phosphorylation	   is	   occurring	   also	   in	   its	   absence.	   As	  
Cdk1	   contained	   in	   pre-­‐MPF	   molecules	   is	   already	   phosphorylated	   at	   Y15	   and	   T14	   and	   that	   these	  
phosphorylations	   are	   not	   subjected	   to	   any	   turn-­‐over,	   the	   key	   reaction	   to	   activate	   pre-­‐MPF	   is	   the	  
dephosphorylation	  of	   both	   inhibitory	   residues	  of	   Cdk1,	   i.e.	   the	   activation	  of	   Cdc25.	   Therefore,	   the	  
precocious	  activation	  of	  Cdc25C	  could	  also	  generate	   few	  active	  MPF	  molecules	   from	  the	  huge	  pre-­‐
MPF	  store.	  The	  Mos/MAPK	  pathway	  has	  been	  shown	  to	  enhance	  Cdc25C	  activity	  by	  phosphorylation	  
(Wang	   et	   al.	   2010).	   Whether	   this	   mechanism	   is	   functional	   and	   sufficient	   to	   trigger	   meiosis	  
resumption	  is	  unknown.	  
Importantly	  also,	  the	  stability	  of	  the	  Mos	  protein	  depends	  on	  its	  Cdk1-­‐phosphorylation	  (Castro	  et	  al.	  
2001b).	  Mos	  accumulates	  at	  detectable	  levels	  around	  the	  time	  of	  GVBD,	  where	  it	  activates	  the	  MAPK	  
pathway.	  This	   is	  consistent	  with	  the	  presence	  of	  active	  Cdk1,	  able	  to	  stabilize	  Mos.	  Moreover,	  Mos	  
protein	   cannot	   accumulate	   in	   response	   to	   progesterone	   in	   oocytes	   where	   Cdk1	   activation	   is	  
prevented	  by	  p21Cip1	  protein	  (Wang	  et	  al.	  2010).	  These	  results	  imply	  that	  Mos	  is	  rather	  dependent	  on	  
Cdk1	  than	  the	  opposite.	  Therefore,	  the	  Mos/MAPK	  pathway	  is	  more	   likely	   involved	  within	  the	  MPF	  
automplification	  loop	  rather	  than	  in	  firing	  the	  system	  by	  the	  production	  of	  a	  starter	  amount	  of	  Cdk1	  
activity.	  
2. The	  MPF	  autoamplification	  loop	  
Once	  the	  starter	  amount	  of	  active	  Cdk1	   is	  generated,	   it	  activates	  by	  phosphorylation	  many	  parallel	  
pathways	  that	  quickly	  converge	  to	  convert	  the	  pre-­‐MPF	  into	  active	  MPF.	  More	  MPF	  is	  produced	  from	  
pre-­‐MPF,	  more	  the	  parallel	  pathways	  are	  recruited,	  and	   faster	   is	   the	  pre-­‐MPF	  converted	   into	  MPF.	  
This	   MPF	   autoamplification	   reinforces	   the	   activity	   of	   Cdk1	   and	   inhibits	   the	   Cdk1-­‐counteracting	  
phosphatases	   as	   in	   mitosis,	   allowing	   the	   phosphorylation	   of	   mitotic	   substrates.	   This	   positive	  
feedback	  loop	  is	  controlled	  by	  multiple	  kinases:	  Cdk1	  itself	  but	  also	  the	  Mos/MAPK	  pathway	  and	  the	  
kinase	  Plx1;	  and	  by	  two	  main	  phosphatases,	  PP1	  and	  PP2A.	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§ Role	  of	  Cdk1	  on	  its	  regulators:	  the	  core	  part	  
When	   injected	   in	   prophase,	   human	   Cdc25A	   induces	   meiosis	   resumption	   independently	   of	  
progesterone	  and	  protein	  synthesis	   (Rime	  et	  al.	  1994).	  Cdc25	   interacts	  with	  active	  Cdk1-­‐Cyclin	  B	   in	  
vivo	   through	  a	  small	   region	  within	   the	  Cyclin	  B	  called	  P-­‐Box	   (Jessus	  et	  al.	  1992,	  Zheng	  et	  al.	  1993).	  
Moreover,	  Cdk1-­‐Cyclin	  B	  directly	  phosphorylates	  Xenopus	  Cdc25C	  at	  T48,	  T67,	  T138,	  S205	  and	  S285	  
and	  activates	  Cdc25C	   in	  vitro	  and	   in	  vivo	   (Hoffmann	  et	  al.	  1993,	   Izumi	  et	  al.	  1993,	  Strausfeld	  et	  al.	  
1994)	  (Fig.	  18).	  As	  mentioned	  above,	  Cdc25C	  is	  a	  weak	  inducer	  of	  meiosis	  resumption	  in	  Xenopus	  due	  
to	   its	   PKA-­‐dependent	   phosphorylation	   at	   S287	   (Duckworth	   et	   al.	   2002).	  However,	  when	  Cdc25C	   is	  
firstly	   in	  vitro	  thiophosphorylated	  by	  Cdk1-­‐Cyclin	  B	  then	  injected	  in	  prophase	  oocytes,	   it	  becomes	  a	  
potent	   inducer	   of	   Cdk1	   activation	   (Hoffmann	   et	   al.	   1993),	   indicating	   that	   the	   Cdk1-­‐dependent	  
phosphorylation	  of	  Cdc25C	  is	  dominant	  over	  the	  PKA-­‐dependent	  phosphorylation	  at	  S287.	  	  
In	  addition	  to	  Cdc25,	  Myt1	  is	  hyperphosphorylated	  during	  meiosis	  resumption	  (Mueller	  et	  al.	  1995b,	  
Liu	  et	  al.	  1999,	  Wells	  et	  al.	  1999).	  The	  phosphorylation	  of	  Myt1	  by	  Cdk1-­‐Cyclin	  B	  complexes	  does	  not	  
really	  affect	  its	  activity	   in	  vitro	  (Mueller	  et	  al.	  1995b,	  Booher	  et	  al.	  1997).	  However,	  the	  injection	  of	  
Cyclin	   B	   in	   the	   presence	   of	   CHX	   induces	   the	   full	   phosphorylation	   of	   Myt1	   (Gaffre	   et	   al.	   2011),	  
supporting	   the	   view	   that	   the	   full	   inhibition	   of	  Myt1	   is	   predominantly	   under	   the	   control	   of	   active	  
Cdk1-­‐Cyclin	  B.	  	  
Hence,	   it	   is	   clear	   that	   the	  direct	  phosphorylation	  of	  Myt1,	  which	   inhibits	   its	  activity,	  and	  of	  Cdc25,	  
which	   activates	   this	   phosphatase,	   by	  Cdk1-­‐Cyclin	  B	   constitutes	   the	  minimal	   core	  of	   the	  MPF	  auto-­‐
amplification	  loop	  (Fig.	  18).	  
§ Cdc25	  regulation	  by	  Plx1	  	  
In	  Xenopus	  egg	  extracts	  depleted	  of	  Cdk1	  and	  Cdk2	  and	  treated	  with	  microcystine,	  a	  PP1	  and	  PP2A	  
phosphatase	  inhibitor,	  Cdc25C	  remains	  phosphorylated	  at	  the	  time	  of	  M-­‐phase	  entry,	  indicating	  that	  
a	  kinase	  distinct	   from	  CDK	  contributes	   to	  Cdc25	  phosphorylation	   (Izumi	   et	  al.	   1995).	  Based	  on	   this	  
observation,	   this	   kinase	   was	   isolated	   and	   identified	   as	   Xenopus	   Plx1,	   the	   homolog	   of	   Plk1	   in	  
mammals,	   as	   the	   kinase	   phosphorylating	   Cdc25C	   independently	   of	   Cdk1	   in	   vitro	   (Kumagai	   et	   al.	  
1996).	   During	   meiotic	   maturation,	   Plx1	   is	   phosphorylated	   and	   activated	   concomitantly	   with	   both	  
Cdc25	  and	  Cdk1	  (Qian	  et	  al.	  1998).	  The	  injection	  of	  p21Cip1	  abolishes	  Plx1	  phosphorylation	  in	  response	  
to	   progesterone	   (Karaiskou	   et	   al.	   1998),	   showing	   that	   Plx1	   activation	   depends	   on	   active	   Cdk1.	  
Accordingly,	   active	   Cdk1-­‐Cyclin	   B	   complexes	   phosphorylate	   directly	   Plx1	   at	   S340,	   a	   process	  
responsible	   for	   its	   electrophoretic	   retardation	   in	   M-­‐phase	   (Kelm	   et	   al.	   2002)	   (Fig.	   19).	   Plx1	   is	  
therefore	   implicated	  within	   the	  MPF	   autoamplification,	   i.e.	   activated	   by	   Cdk1	   and	   contributing	   to	  
Cdk1	  activation.	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The	   role	   of	   Plx1	   within	   the	   MPF	   autoamplification	   loop	   is	   to	   facilitate	   Cdc25C	   activation,	   hence	  
contributing	  indirectly	  to	  Cdk1	  activation.	  The	  overexpression	  of	  a	  constitutive	  form	  of	  Plx1	  induces	  
meiotic	   maturation	   independently	   of	   progesterone	   addition	   whereas	   its	   inhibition	   using	   specific	  
antibodies	   delays,	   but	   does	   not	   block,	   meiosis	   resumption	   induced	   by	   either	   progesterone	   or	  
recombinant	   Cdc25C	   (Qian	   et	   al.	   1998).	   Plx1	   is	   therefore	   sufficient	   but	   not	   necessary	   for	   the	  
activation	  of	  Cdk1,	  suggesting	  that	  other	  kinases	  are	  implicated	  in	  the	  process	  of	  Cdc25C	  activation.	  
Plx	   family	  comprises	  three	  members,	  Plx1,	  Plx2	  and	  Plx3,	  opening	  the	  possibility	  that	  Plx2	  and	  Plx3	  
could	  participate	  to	  the	  autoamplification	  loop.	  Plx2	  and	  Plx3	  are	  expressed	  in	  Xenopus	  oocytes	  and	  
are	   concomitantly	   activated	   with	   Plx1	   and	   Cdk1	   (Duncan	   et	   al.	   2001).	   As	   for	   Plx1,	   their	  
overexpression	   stimulates	   progesterone-­‐induced	   oocyte	   maturation	   whereas	   overexpressing	  
catalytically	   inactive	  kinases	  delays	  meiosis	   resumption	   (Duncan	   et	  al.	   2001).	  This	   suggests	   that,	  at	  
least	   in	  oocytes,	   these	   three	  Plx	   isoforms	  may	  be	   regulated	  similarly	  and	  have	  certainly	   redundant	  
functions.	  
The	   role	   of	   Plx1	   in	   regulating	   Cdc25C	   was	   deciphered	   in	   two	   types	   of	   extracts	   prepared	   from	  
prophase-­‐arrested	  oocytes,	  either	  “diluted”	  or	  “undiluted”.	  The	  “undiluted”	  extracts	  do	  not	  contain	  
any	   membrane	   but	   support	   protein	   synthesis	   and	   the	   addition	   of	   PKI	   activates	   Cdk1	   (Qian	   et	   al.	  
2001).	   Immunodepleting	  Plx1	  from	  these	  extracts	  prevents	  the	  activation	  of	  both	  Cdc25C	  and	  Cdk1	  
suggesting	  that	  Plx1	  contributes	  to	  Cdk1	  activation	  (Qian	  et	  al.	  2001).	  In	  diluted	  extracts,	  the	  addition	  
of	   Cdc25A	   produces	   a	   linear	   activation	   of	   Cdk1	   that	   can	   be	   visualized	   by	   the	   progressive	  
dephosphorylation	   of	   Cdk1	   at	   Y15	   in	   parallel	   with	   the	   progressive	   phosphorylation	   of	   Cdc25	  
(Karaiskou	  et	  al.	  1999).	  This	  slow	  increase	  of	  both	  Cdk1	  and	  Cdc25	  activities	  results	  from	  the	  direct	  
dephosphorylation	   of	   Cdk1	   by	   Cdc25,	   in	   a	   simple	   two-­‐components	   system,	   that	   is	   independent	   of	  
Plx1.	  This	  linear	  activation	  of	  Cdk1	  does	  not	  represent	  the	  OFF-­‐ON	  switch	  occurring	  in	  vivo.	  This	  latter	  
phenomenon	  is	  however	  reproduced	   in	  vitro	   in	  “diluted”	  extracts	  after	  the	  addition	  of	  okadaic	  acid	  
to	   inhibit	   PP2A/PP1	   activity	   (Karaiskou	   et	   al.	   1998).	  Okadaic	   acid	   leads	   to	   the	   abrupt	   activation	   of	  
Cdk1,	  consequential	   to	  Cdc25	  hyperphosphorylation	  and	  the	  full	  dephosphorylation	  of	  Cdk1	  at	  Y15	  
(Karaiskou	   et	   al.	   1999).	   The	   depletion	   of	   Plx1	   from	   these	   extracts	   abolishes	   this	   fast	   activation	   of	  
Cdk1	  in	  response	  to	  okadaic	  acid	  (Karaiskou	  et	  al.	  1999),	  supporting	  the	  role	  of	  Plx1	  within	  the	  MPF	  
autoamplification	  loop	  by	  activating	  Cdc25C	  (Fig.	  19).	  
	  
§ The	  Mos/MAPK	  pathway	  
At	   the	   time	  of	  GVBD,	   the	  Cdk1-­‐dependent	  phosphorylation	  of	  Mos	  at	  S3	  stabilizes	   the	  protein	  and	  
allows	   its	   accumulation	   (Castro	   et	   al.	   2001b).	   The	   Mos/MAPK	   pathway	   reinforces	   the	   MPF	  
autoamplification	   loop,	  as	  discussed	  before.	   Indeed,	   inhibiting	  the	  Mos/MAPK	  pathway	  with	  U0126	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leads	  only	  to	  a	  partial	  activation	  of	  Cdk1	  in	  oocytes	  stimulated	  by	  progesterone	  (Gross	  et	  al.	  2000).	  
As	   described	   before,	   the	  Mos-­‐MAPK	   pathway	   has	   the	   double	   potential	   to	   act	   on	   both	   Cdc25	   and	  
Myt1	  (Fig.	  19).	  
– Effects	  on	  Cdc25	  
In	  mitotic	  Xenopus	  extracts,	  MAPK	  phosphorylates	  Cdc25C	  at	  T48,	  T138	  and	  S205	   independently	  of	  
Cdk1	   and	   Plx1,	   but	   without	   producing	   the	   characteristic	   shift	   in	   its	   electrophoretic	   migration	  
detected	   in	   M-­‐phase	   (Wang	   et	   al.	   2007)	   (Fig.	   19).	   This	   shows	   that,	   even	   though	   MAPK	  
phosphorylates	  Cdc25,	  it	  is	  not	  the	  only	  kinase	  involved	  in	  this	  process.	  To	  measure	  the	  phosphatase	  
activity	  of	  Cdc25	  before	  and	  after	  phosphorylation,	  its	  ability	  to	  convert	  pre-­‐MPF	  in	  MPF	  was	  assayed	  
using	  an	  in	  vitro	  H1	  kinase	  assay.	  Purified	  pre-­‐MPF	  is	  not	  active	  and	  therefore	  cannot	  phosphorylate	  
H1	  in	  an	  in	  vitro	  kinase	  assay.	  The	  addition	  of	  Cdc25	  promotes	  the	  conversion	  of	  pre-­‐MPF	  into	  MPF,	  
promoting	   H1	   phosphorylation.	   It	   was	   shown	   that	   in	   order	   to	   reach	   the	   same	   level	   of	   phosphate	  
incorporation	  within	  H1,	  a	  lower	  concentration	  of	  Cdc25	  was	  required	  if	  the	  protein	  was	  previously	  in	  
vitro	  phosphorylated	  by	  MAPK.	  These	  results	  showed	  that	  the	  MAPK-­‐dependent	  phosphorylation	  of	  
Cdc25	  increases	  Cdc25	  ability	  to	  convert	  pre-­‐MPF	  in	  MPF.	  More	  recently,	  it	  was	  also	  shown	  that	  the	  
kinase	  p90Rsk2	  is	  also	  able	  to	  directly	  phosphorylate	  Cdc25	  (Wang	  et	  al.	  2010).	  
– Effect	  on	  Myt1	  
In	  addition	  to	  Cdc25,	  p90Rsk	   interacts,	  phosphorylates	  and	   inhibits	  Myt1	  (Palmer	  et	  al.	  1998).	  Using	  
again	  the	  in	  vitro	  H1	  kinase	  assay	  to	  measure	  Cdk1	  activation,	  it	  was	  shown	  that	  active	  Myt1	  kinase,	  
immunopurified	   from	  prophase-­‐arrested	  oocytes,	   is	  able	   to	   inhibit	  Cdk1-­‐Cyclin	  B	  activity.	  However,	  
when	  Myt1	  is	  previously	  incubated	  with	  active	  p90rsk,	   its	  inhibitory	  activity	  towards	  Cdk1-­‐Cyclin	  B	  is	  
reduced	  (Palmer	  et	  al.	  1998).	  p90rsk	  phosphorylates	  Myt1	  at	  5	  different	  sites	  (T453,	  S472,	  S475,	  S492	  
and	  S504),	  which	  are	  different	   from	  the	  ones	   targeted	  by	  Cdk1	   (Ruiz	   et	  al.	  2010)(Fig.	   19).	  Using	   in	  
vitro	   H1	   kinase	   assay,	   it	  was	   shown	   that	  wild	   type	  Myt1,	   as	  well	   as	   the	  mutant	  Myt1-­‐5A	   (without	  
MAPK	  phosphorylation	  sites)	  and	  the	  mutant	  Myt1-­‐3A	   (without	  Cdk1	  phosphorylation	  sites)	  are	  all	  
able	   to	   efficiently	   inhibit	   Cdk1	   activity	   (Ruiz	   et	   al.	   2010).	   However,	   if	   wild	   type	  Myt	   is	   previously	  
incubated	  with	  either	  Cdk1-­‐RINGO	  or	  p90Rsk,	  its	  ability	  to	  block	  H1	  activity	  in	  this	  in	  vitro	  kinase	  assay	  
is	   reduced	   (Ruiz	   et	   al.	   2010).	   Therefore	   both	  Cdk1	   and	  Mos/MAPK/p90Rsk	   are	   able	   to	   inhibit	  Myt1	  
activity.	   Interestingly,	  Cdk1-­‐RINGO	  is	  able	  to	   inhibit	  Myt1-­‐5A,	  and	  conversely	  p90Rsk	   is	  able	  to	  block	  
Myt1-­‐3A	   (Ruiz	   et	   al.	   2010).	   These	   results	   show	   that	   either	   Mos/MAPK/p90Rsk	   or	   Cdk1-­‐RINGO	  
activities	  phosphorylate	  distinct	  sites	  on	  Myt1	  and	  have	  the	  potential	  to	  inhibit	  Myt1.	  On	  the	  other	  
hand,	  none	  of	  these	  two	  convergent	  redundant	  pathways	  is	  necessary	  for	  the	  inhibition	  of	  Myt1.	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§ Greatwall	  and	  PP2A-­‐B55δ 	  
As	  in	  mitosis,	  the	  phosphatase	  activities	  counteracting	  Cdk1	  activity	  needs	  to	  be	  inhibited	  to	  resume	  
meiosis.	  This	  shut	  off	  is	  required	  to	  allow	  the	  phosphorylation	  of	  regulators	  of	  Cdk1	  activity	  (as	  Plx1,	  
Cdc25,	  Myt1,	  MAPK,	  etc)	  as	  well	  as	  substrates	  of	  Cdk1	  necessary	  for	  the	  mechanistic	  events	  of	  cell	  
division	  (as	  lamins,	  condensins,	  histones,	  MAPs,	  etc).	  
The	   inhibition	   of	   PP2A/PP1	   by	   injecting	   okadaic	   acid	   is	   sufficient	   to	   induce	  meiotic	  maturation	   in	  
Xenopus	   oocytes,	   independently	   of	   progesterone,	   of	   PKA	   downregulation	   and	   of	   protein	   synthesis	  
(Rime	   et	   al.	   1990).	   In	   prophase	   diluted	   extracts,	   the	   addition	   of	   OA	   also	   leads	   to	   Cdk1	   activation	  
(Karaiskou	  et	  al.	  1998,	  Karaiskou	  et	  al.	  1999).	  This	  indicates	  that	  PP2A	  inhibition	  is	  mandatory	  for	  the	  
MPF	   autoamplification	   to	   run.	   Since	   PP2A	   activity	   counteracts	   the	   Cdk1-­‐dependent	  
phosphorylations,	   its	   inhibition	   is	   necessary	   to	   stabilize	   the	   Cdk1-­‐dependent	   phosphorylations	   of	  
Cdc25C	  and	  Myt1,	  which	  represents	  the	  core	  part	  of	  the	  MPF	  autoamplification	  loop,	  and	  probably	  
Cdk1	  phosphorylation	  of	  other	  players	  of	  the	  loop,	  as	  Plx1	  and	  members	  of	  the	  Mos/MAPK	  pathway.	  
In	  addition,	  Cdk1	  phosphorylates	  a	  lot	  of	  mitotic	  substrates	  to	  orchestrate	  M-­‐phase	  progression	  and	  
these	  phosphorylation	  events	  are	  only	  stable	  if	  the	  activity	  of	  PP2A	  is	  inhibited	  (Castilho	  et	  al.	  2009,	  
Mochida	  et	  al.	  2009,	  Vigneron	  et	  al.	  2009,	  Burgess	  et	  al.	  2010,	  Goldberg	  2010).	  
As	  in	  mitosis,	  the	  kinase	  responsible	  for	  the	  inhibition	  of	  PP2A	  is	  Greatwall	  (Gwl)	  (Castilho	  et	  al.	  2009,	  
Vigneron	  et	  al.	  2009,	  Burgess	  et	  al.	  2010,	  Goldberg	  2010).	  The	  search	  of	  the	  substrate	  of	  Gwl	  led	  to	  
the	   identification	   of	   Arpp19,	   a	   small	   protein	   of	   the	   endosulfine	   family	   (Gharbi-­‐Ayachi	   et	   al.	   2010,	  
Mochida	  et	  al.	  2010).	  Arpp19	  is	  phosphorylated	  at	  S67	  by	  Gwl,	  which	   is	  necessary	  and	  sufficient	  to	  
convert	  Arpp19	  in	  a	  powerful	  inhibitor	  of	  a	  specific	  isoform	  of	  PP2A,	  PP2A-­‐B55δ	  (Gharbi-­‐Ayachi	  et	  al.	  
2010,	  Mochida	   et	   al.	   2010)	   (See	   chapter:	   I-­‐A.e.ii.2.	   “role	   of	   proteins	   phosphatase”)	   (Fig.	   10).	   The	  
endosulfine	   family	   comprises	   two	   classes	   of	   proteins,	   which	   are	   encoded	   by	   different	   genes:	   the	  
endosulfines	  (α	  and	  β)	  and	  the	  cAMP-­‐phosphoregulated	  proteins	  (Arpp).	  
In	  Xenopus	  oocytes,	  the	  injection	  of	  a	  purified	  active	  form	  of	  Gwl	  or	  of	  an	  active	  mutant	  of	  Gwl,	  the	  
K71M-­‐Gwl,	  promotes	  Cdk1	  activation	  independently	  of	  progesterone	  (Yamamoto	  et	  al.	  2011,	  Dupre	  
et	  al.	  2013).	  Gwl	  activates	  Cdk1	  through	  the	  phosphorylation	  of	  Arpp19	  at	  S67	  since	  the	  injection	  of	  a	  
non-­‐phosphorylatable	   form	   of	   Arpp19	   at	   S67	   (Arpp19-­‐S67A)	   abolishes	   Cdk1	   activation	   induced	   by	  
K71M-­‐Gwl	   (Dupre	   et	   al.	   2013).	   The	   Arpp19-­‐S67A	   mutant	   is	   able	   to	   block	   meiosis	   resumption	   in	  
response	   to	   progesterone	   but	   also	   in	   response	   to	   the	   transfer	   of	   cytoplasm	   from	   a	   MII-­‐arrested	  
oocytes	   (Dupre	   et	   al.	   2013).	   This	   demonstrates	   that	   the	  Gwl/Arpp19/PP2A	  module	   plays	   a	   critical	  
role	  in	  the	  MPF	  automplification	  loop.	  Importantly,	  Cdk1	  activity	  is	  required	  for	  the	  activation	  of	  the	  
Gwl-­‐ARPP19	  pathway	  (Dupre	  et	  al.	  2013).	  This	  reinforces	  the	  view	  that	  Gwl/Arpp19/PP2A	  is	  not	  part	  
of	   the	   first	   step	   of	   Cdk1	   activation,	   where	   the	   starter	   amount	   of	   Cdk1	   activity	   is	   generated	   from	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scratch,	   but	   is	   embarked	   into	   the	  MPF	   autoamplification	   loop	   that	   is	   launched	   by	   the	   first	   active	  
molecules	  of	  Cdk1.	  Once	  Gwl	   is	  activated,	  Arpp19	   interacts	  with	  PP2A-­‐B55δ	  and	   inhibits	   its	  activity	  
(Dupre	   et	   al.	   2013).	   This	   result	   was	   further	   confirmed	   using	   a	   S67-­‐thiophosphorylated	   form	   of	  
ARPP19.	  When	  injected	  in	  prophase,	  this	  phosphorylated	  form	  of	  Arpp19	  interacts	  with	  PP2A-­‐B55δ	  
independently	  of	  protein	  synthesis,	  of	  Cdk1	  activation	  and	  of	  PKA	  downregulation	  and	  promotes	  the	  
activation	  of	  Cdk1	  independently	  of	  PKA	  activity	  (Dupre	  et	  al.	  2013)	  
The	   role	   of	   Gwl-­‐ARPP19	   is	   conserved	   among	   species	   but	   seems	   to	   be	   differentially	   regulated.	   In	  
Drosophila,	  oocytes	  depleted	   for	  endo	   (the	  unique	  member	  of	   the	  ARPP19/Endosulfine	   family)	  are	  
unable	  to	  progress	  through	  meiosis	  because	  of	  a	  low	  level	  of	  Cdk1	  substrate	  phosphorylation,	  even	  
in	   the	   presence	   of	   high	   Cdk1	   activity	   (Von	   Stetina	   et	   al.	   2008).	   In	   mouse,	   siRNA	   for	   both	  
Endosulfine/Arpp19	  abolishes	  meiosis	  resumption	  (Matthews	  et	  al.	  2014),	  whereas	  the	  depletion	  of	  
Gwl	  only	  affects	  the	  progression	  in	  meiosis	  after	  meiosis	  I	  (Adhikari	  et	  al.	  2014).	  These	  observations	  
suggest	  that	  another	  parallel	  pathway	  is	  activated	  in	  order	  to	  inhibit	  PP2A-­‐B55δ	  activity	  in	  these	  cells,	  
which	   depends	   on	   Arpp19	   but	   not	   on	   Gwl.	   An	   explanation	   about	   this	   unknown	   pathway	   was	  
provided	  by	  studies	  in	  starfish	  oocytes.	  In	  the	  oocytes	  of	  this	  species,	  Gwl	  is	  nuclear	  while	  Arpp19	  is	  
cytoplasmic	   (Hara	   et	   al.	   2012).	  When	   Gwl	   is	   removed	   by	   enucleating	   the	   oocytes	   or	   inhibited	   by	  
injecting	   blocking	   antibodies,	   Cdk1	   is	   still	   activated	   (Hara	   et	   al.	   2012).	   However,	   the	   depletion	   of	  
Arpp19	  abolishes	  Cdk1	  activation,	   in	   the	  presence	  or	   in	   the	  absence	  of	  Gwl	   (Okumura	  et	  al.	  2014).	  
This	  effect	  is	  due	  to	  the	  phosphorylation	  of	  Arpp19	  by	  Cdk1,	  at	  S69,	  a	  site	  distinct	  from	  the	  residue	  
targeted	  by	  Gwl	  (S106	  in	  starfish).	  This	  phosphorylation	  by	  Cdk1	  allows	  Arpp19	  to	  bind	  and	  to	  inhibit	  
PP2A	  with	   a	   lower	   efficiency	   compared	   to	   ARPP19	   phosphorylated	   by	  Gwl	   (Okumura	   et	   al.	   2014).	  
Whether	  this	  mechanism	  is	  conserved	  in	  Xenopus	  oocytes	  or	  in	  other	  systems	  is	  not	  known.	  
e. The	  MI-­‐MII	  transition	  
In	  Xenopus	  oocytes,	  the	  metaphase	  I	  spindle	  organizes	  30	  minutes	  after	  GVBD.	  After	  anaphase	  I	  and	  
then	   the	  extrusion	  of	   the	  1st	   polar	  body,	   the	  metaphase	   II	   spindle	  organizes	   at	   the	   cortex	   and	   the	  
oocyte	  arrests	  at	  this	  stage.	  This	  MI-­‐MII	  transition	  lasts	  120	  minutes	  starting	  from	  GVBD	  until	  the	  MII	  
arrest.	  It	  is	  characterized	  by	  the	  decrease	  of	  50%-­‐70%	  of	  Cdk1	  activity	  that	  occurs	  during	  anaphase	  I.	  
However,	  this	  drop	  in	  Cdk1	  activity	  does	  not	  reach	  the	  basic	  levels	  assayed	  in	  prophase.	  Thereafter,	  
the	   re-­‐increase	   of	   Cdk1	   activity,	   allows	   the	   formation	   of	   the	   metaphase	   II	   spindle.	   During	   this	  
transition,	  Cdk1	  activity	  is	  proportional	  to	  the	  concentration	  of	  Cyclin	  B,	  which	  is	  positively	  regulated	  
by	  MAPK	  (See	  chapter:	   I-­‐B.e.ii.	  “Function	  of	  the	  Mos/MAPK	  pathway”)	  and	  negatively	  controlled	  by	  
APCFizzy	  (Cdc20).	  When	  the	  1st	  meiotic	  division	  is	  completed,	  the	  nuclear	  envelope	  does	  not	  assemble,	  
chromosomes	  remain	  condensed	  and	  DNA	  replication	  is	  prohibited	  (Huchon	  et	  al.	  1981a,	  Gerhart	  et	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al.	  1984,	  Gard	  1992,	  Furuno	  et	  al.	  1994).	  All	  these	  events	  depends	  on	  the	  activity	  of	  Cdk1	  and	  by	  the	  
Mos/MAPK	  pathway.	  
The	  transition	  from	  metaphase	  I	  to	  anaphase	  I	  as	  well	  as	  the	  extrusion	  of	  the	  1st	  polar	  body	  rely	  on	  
the	   degradation	   of	   Cyclin	   B	   that	   leads	   to	   the	   decrease	   of	   Cdk1	   activity.	   After	  metaphase	   I,	   all	   the	  
isoforms	   of	   Cyclins	   (B1,	   B2,	   B4	   and	   B5)	   are	   ubiquitinated	   by	   APCCdc20	   (APCFizzy	   in	   Xenopus)	   and	  
degraded	  by	  the	  proteasome	  (Glotzer	  et	  al.	  1991,	  Kobayashi	  et	  al.	  1991,	  Hochegger	  et	  al.	  2001,	  Taieb	  
et	  al.	  2001).	  The	  activation	  of	  APCCdc20,	  which	  correlates	  with	  the	  phosphorylation	  status	  of	  Cdc27,	  a	  
subunit	   of	   APC	   (King	   et	   al.	   1995),	   is	   absolutely	   required	   in	   Xenopus	   extracts	   to	   produce	   cyclical	  
oscillation	  of	  Cdk1	  activity	  (Lorca	  et	  al.	  1998).	  Surprisingly,	  both	  the	  APCcdc20	  activation	  and	  the	  Cyclin	  
B	  degradation,	  were	  shown	  to	  be	  dispensable	  for	  the	  entry	  in	  MII.	  The	  injection	  of	  antisense	  against	  
Cdc20	   completely	   blocks	   the	   degradation	   of	   Cyclin	   B,	   as	   well	   as	   the	   Cdk1	   partial	   inactivation	  
characteristic	   of	   the	   MI-­‐MII	   transition	   (Taieb	   et	   al.	   2001).	   Similar	   results	   were	   obtained	   by	  
inactivating	  the	  APC	  by	  injecting	  blocking-­‐antibodies	  against	  Cdc20	  or	  Cdc27	  or	  by	  injecting	  Mad2,	  an	  
APC	  inhibitor	  (Peter	  et	  al.	  2001).	  In	  all	  cases,	  oocytes	  extrude	  the	  1st	  polar	  body,	  reaccumulate	  Cyclin	  
E	  and	  are	  able	  to	  enter	  in	  MII	  as	  seen	  by	  the	  assembly	  of	  a	  MII	  spindle	  (Peter	  et	  al.	  2001,	  Taieb	  et	  al.	  
2001).	   These	   results	   suggest	   that	   the	   activation	   of	   APCCdc20	   is	   not	   required	   for	   the	   segregation	   of	  
homologous	  chromosome	  as	  it	  is	  for	  the	  segregation	  of	  sister	  chromatids.	  However,	  the	  injection	  of	  
undegradable	  Cyclin	  B	  at	  GVBD	  was	  shown	  to	  prevent	  anaphase	  I,	  leading	  to	  abnormal	  spindles	  not	  
anchored	   to	   the	   cortex	   and	   failing	   to	   segregate	   chromosomes	   (Huchon	   et	   al.	   1993a).	   this	   result	  
suggests	   that	   the	  absence	  of	  Cyclin	  B	  degradation	  and	   thus	  of	  Cdk1	  activity	  drop	  prevents	   the	  exit	  
from	   the	   1st	   meiotic	   division.	   In	   a	   similar	   way,	   the	   expression	   of	   the	   APC	   inhibitor	   Erp1	   arrests	  
oocytes	   in	  MI,	  without	   the	  extrusion	  of	   the	  1st	   polar	  body,	  demonstrating	   the	   requirement	  of	  APC	  
activation	   for	   the	  MI-­‐MII	   transition	   (Ohe	   et	   al.	   2007,	   Tung	   et	   al.	   2007).	  One	   explanation	   for	   these	  
discrepancies	  would	  be	  the	  incomplete	  inhibition	  of	  APC	  by	  antisense	  against	  Cdc20	  and	  by	  blocking	  
antibody	  against	  Cdc27,	  which	  would	  leave	  a	  population	  of	  APC	  active	  to	  promote	  the	  degradation	  of	  
securine	  and	  a	  local	  inhibition	  of	  Cdk1.	  Another	  hypothesis	  could	  be	  the	  involvement	  of	  Cdh1	  during	  
the	  MI-­‐MII	  transition,	  a	  role	  that	  has	  not	  yet	  been	  investigated	  in	  Xenopus.	  
	  
i. The	  role	  of	  Cdk1	  
The	  activation	  of	   the	  APC	  during	   this	   transition	   is	   under	   the	   control	   of	   Cdk1	   since	   the	   injection	  of	  
p21Cip1	   at	  GVBD	   completely	   blocks	   Cdc27	   phosphorylation	   and	   delays	   Cyclin	   B	   degradation	   (Frank-­‐
Vaillant	  et	  al.	  2001).	  Therefore,	  Cdk1	  is	  positively	  regulating	  its	  own	  inactivation	  by	  controlling	  Cyclin	  
B	  degradation,	  as	   it	   is	   in	  mitosis	  (Fig.	  20).	  While	  the	  APC	  has	  to	  be	  activated	  to	  exit	  from	  MI,	   it	  has	  
also	   to	   be	   inactivated	   to	   enable	   the	   oocyte	   to	   enter	   in	   MII.	   The	   simplest	   explanation	   for	   APC
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inactivation	  would	   be	   the	   loss	   of	   Cdk1	  positive	   activity	   caused	  by	   the	  APC-­‐induced	  degradation	  of	  
Cyclin	  B.	  However,	  it	  was	  shown	  that	  APC	  inactivation	  requires	  the	  translation	  of	  a	  small	  amount	  of	  
Erp1,	   an	  APC	   inhibitor	   responsible	  on	   the	  CSF	   arrest	   in	  MII	   (Ohe	   et	   al.	   2007)	   (see	   chapter:	   I-­‐B.f.iv.	  
“Erp1/Emi2”).	   Erp1	   starts	   to	   accumulate	   around	   1	   hour	   after	   GVBD	   at	   the	   time	   of	   Cyclin	   B	   re-­‐
accumulation.	   The	   knock-­‐down	   of	   Erp1	   blocks	   totally	   Cyclin	   B	   re-­‐accumulation	   as	   well	   as	   Cdk1	  
reactivation	  leading	  to	  DNA	  replication	  (Ohe	  et	  al.	  2007).	  The	  translational	  regulation	  of	  Erp1	  is	  based	  
on	   the	   polyadenylation	   of	   its	   mRNA	   that	   depends	   on	   Cdk1	   activity	   and	   not	   on	   the	   Mos/MAPK	  
pathway	   (Tung	   et	  al.	  2007)	   (Fig.	   20).	  All	   these	  data	   suggest	   that	  Cdk1	  activity	  orchestrates	   its	  own	  
inhibition	   by	   activating	   APC,	   but	   also	   facilitates	   its	   own	   reactivation,	   promoting	   the	   translation	   of	  
Erp1	  in	  order	  to	  inhibit	  the	  APC	  (Fig.	  20).	  
ii. Function	  of	  the	  Mos/MAPK	  pathway	  
The	  accumulation	  of	  Cyclin	  B	  required	  to	  enter	  MII	  is	  independent	  of	  Cdk1	  activity,	  as	  the	  injection	  of	  
p21Cip1	  at	  GVBD	  does	  not	   impair	  Cyclin	  B	  accumulation	   (Frank-­‐Vaillant	   et	  al.	  2001).	   In	  contrast,	   the	  
Mos/MAPK	   module	   plays	   an	   essential	   role	   in	   regulating	   this	   critical	   period	   of	   meiosis.	   The	  
requirement	  of	  the	  Mos/MAPK	  pathway	  for	  the	  MI-­‐MII	  transition	  was	  demonstrated	  using	  different	  
approaches:	   the	   injection	   of	   “classical”	   antisense	   oligonucleotides	   against	   Mos	   mRNA	   or	   of	   Mos	  
neutralizing	   antibodies	   at	   GVBD	   (Furuno	   et	   al.	   1994),	   the	   injection	   of	  Mos-­‐Morpholinos	   antisense	  
oligonucleotides	   (Dupre	   et	   al.	   2002)	   and	   the	   pharmacological	   inhibition	   of	  MAPK	   activation	   using	  
U0126,	  a	  MEK	  inhibitor	  (Gross	  et	  al.	  2000).	  Under	  all	  these	  conditions,	  Cyclin	  B	  is	  degraded	  and	  Cdk1	  
is	  thus	  inactivated,	  oocytes	  exit	  from	  meiosis	  I	  but	  do	  not	  enter	  into	  meiosis	  II.	  They	  are	  driven	  in	  a	  
pseudo	   interphasic	   state	   with	   the	   reformation	   of	   nuclei.	   However,	   while	   U0126-­‐treated	   oocytes	  
remain	  arrested	  at	  this	  interphasic	  state,	  the	  Mos-­‐morpholino	  injected	  oocytes	  slowly	  reaccumulate	  
Cyclins	  B	  and	  reactivate	  Cdk1.	  Thereafter,	  the	  activity	  of	  Cdk1	  oscillates,	  mimicking	  the	  Cdk1	  pattern	  
in	  embryonic	  cell	  divisions	  (Dupre	  et	  al.	  2002).	  	  
The	  different	  effects	  caused	  by	  the	  inhibition	  of	  the	  Mos/MAPK	  pathway	  over	  Cdk1	  reactivation	  can	  
be	   explained	  by	   several	   reasons.	   The	   first	   one	   is	   that	   50	  µM	  of	  U0126,	   the	   concentration	  used	   to	  
prevent	  MAPK	  activation	  in	  oocytes,	  inhibits	  other	  kinases	  that	  MEK	  that	  could	  account	  for	  the	  total	  
block	  in	  interphase,	  as	  suggested	  in	  Dupre	  et	  al.	  (2002).	  A	  second	  hypothesis	  is	  that	  the	  Mos	  kinase,	  
that	   is	   impaired	  by	  morpholino	  but	  not	  by	  U0126,	   has	  other	   targets	   than	  MEK	   that	   can	   act	   in	   the	  
presence	   of	   U0126	   but	   not	   in	   the	   presence	   of	   morpholino	   antisense,	   although	   this	   hypothesis	   is	  
highly	  improbable.	  Another	  hypothesis	  relies	  on	  the	  activity	  of	  p90Rsk	  activity,	  the	  fourth	  kinase	  of	  the	  
Mos/MEK/MAPK/p90Rsk	  cascade.	  While	  p90Rsk	  remains	  partially	  activated	  in	  Mos	  morpholino-­‐injected	  
oocytes	   (Dupre	   et	   al.	   2002),	   its	   activity	   is	   totally	   abolished	   in	   U0126-­‐treated	   oocytes	   (Gross	   et	   al.	  
	   81	  
2000).	   Moreover,	   the	   overexpression	   of	   a	   constitutively	   active	   form	   of	   p90Rsk	   in	   U0126-­‐treated	  
oocytes	   rescues	   the	   reaccumulation	   of	   Cyclin	   B,	   the	   hyperphosphorylation	   of	   Cdc27	   and	   the	  
formation	   of	  metaphase	   II	   spindles	   in	   the	   absence	   of	   detectable	  MAP	   kinase	   activity	   (Gross	   et	   al.	  
2000).	  These	  results	  reveal	  a	  prominent	  role	  of	  p90Rsk	  that	  could	  be	  preserved	  in	  the	  presence	  of	  Mos	  
morpholino	   antisense	   but	   not	   with	   U0126.	   The	   effect	   of	   the	   Mos/MAPK	   module	   on	   Cyclin	   B	  
accumulation	  can	  be	  exerted	  by	   increasing	   the	  synthesis	  of	  new	  Cyclin	  B	  or/and	  by	  decreasing	   the	  
degradation	   of	   the	   protein	   (Fig.	   20).	   When	   Cyclin	   B	   degradation	   is	   blocked	   with	   antisense	   oligos	  
against	   Cdc20	   mRNA,	   the	   inhibition	   of	   the	   Mos/MAPK	   pathway	   by	   U0126	   still	   decreases	   the	  
accumulation	   of	   Cyclin	   B	   (Taieb	   et	   al.	   2001),	   showing	   that	   the	   Mos/MAPK	   pathway	   is	   able	   to	  
positively	  regulate	  Cyclin	  B	  synthesis.	  Moreover,	  the	  inhibition	  of	  the	  Mos/MAPK	  module	  by	  U0126	  
accelerates	   the	  degradation	  of	   radiolabeled	  Cyclin	  B	   injected	  at	  GVBD	   (Gross	   et	  al.	   2000),	   showing	  
that	  the	  Mos/MAPK	  pathway	  is	  also	  downregulating	  Cyclin	  B	  degradation.	  
Therefore,	   the	  Mos/MEK/MAPK/p90Rsk	   cascade	  plays	   a	   critical	   role	  during	   the	  MI-­‐MII	   transition	  by	  
reducing	  the	  rate	  of	  Cyclin	  B	  degradation	  and	  increasing	  its	  synthesis.	  These	  two	  concomitant	  effects	  
then	   contribute	   to	   attenuate	   Cdk1	   inactivation	   between	   the	   two	   divisions	   and	   to	   promote	   its	   re-­‐
activation	  responsible	  for	  MII	  entry	  (Fig.	  20).	  
iii. The	  molecular	  control	  of	  DNA	  replication	  
An	  important	  feature	  of	  the	  meiotic	  divisions	   is	  that	  oocytes	  must	  not	  replicate	  their	  genomic	  DNA	  
between	   these	   two	   divisions.	   This	   process	   is	   essential	   for	   the	   success	   of	   reproduction	   and	   the	  
embryonic	  development	  as	  it	  reduces	  by	  half	  the	  ploidy	  of	  the	  oocyte	  and	  leads	  to	  the	  formation	  of	  a	  
haploid	  gamete.	  However,	  the	  unfertilized	  oocyte	  has	  to	  be	  competent	  for	  DNA	  replication	  in	  order	  
to	   support	   the	   embryonic	   cell	   cycles	   following	   fertilization.	   Indeed,	   the	   embryonic	   genome	   is	   not	  
expressed	  during	   the	   first	   13	   cell	   cycles	   that	   follow	   fertilization	   and	   these	   embryonic	   divisions	   are	  
entirely	  ensured	  by	  the	  molecular	  machineries	  stored	  by	  the	  oocyte	  before	   fertilization.	  Therefore,	  
oocytes	   must	   synchronize	   the	   acquisition	   of	   the	   competence	   to	   replicate	   DNA	   with	   some	  
mechanisms	  preventing	  the	  usage	  of	  this	  competence	  before	  fertilization.	  	  
	  
1. The	  competence	  to	  replicate	  DNA	  
Prophase-­‐arrested	   oocytes	   are	   unable	   to	   replicate	   their	   DNA.	   This	   competence	   is	   acquired	   during	  
meiotic	  maturation	  (Furuno	  et	  al.	  1994,	  Lemaitre	  et	  al.	  2002,	  Whitmire	  et	  al.	  2002).	  This	  process	  can	  
be	   investigated	  by	   inhibiting	  protein	  synthesis	  at	  different	  time	  after	  GVBD.	  The	  addition	  of	  CHX	  at	  
GVBD	  promotes	  the	  formation	  of	  interphasic	  nuclei	  that	  are	  unable	  to	  replicate	  (Furuno	  et	  al.	  1994).	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Hence,	  oocytes	  at	  that	  stage	  are	  still	  incompetent	  to	  replicate.	  However,	  when	  CHX	  is	  added	  later,	  45	  
minutes	   after	   GVBD,	   oocytes	   form	   nuclei	   that	   replicate	   DNA	   (Furuno	   et	   al.	   1994).	   This	   pioneer	  
experiment	  demonstrates	   that	   the	   competence	   to	   replicate	  DNA	   is	  established	  by	   the	   synthesis	  of	  
some	  proteins	  during	  the	  45	  minutes	  that	   follow	  GVBD,	  hence	  at	   the	  period	  of	   the	  metaphase	   I	   to	  
anaphase	  I	  transition.	  However,	  DNA	  replication	  does	  not	  take	  place	  under	  physiological	  conditions,	  
meaning	   that	   this	   competence	   is	  not	   functional	  because	  a	  mechanism	   inhibiting	  DNA	  replication	   is	  
also	  settled	  in	  a	  protein-­‐synthesis	  dependent	  manner	  during	  the	  MI-­‐MII	  transition.	  	  
All	  the	  proteins	  of	  the	  pre-­‐RC	  are	  present	  at	  the	  protein	  level	  in	  prophase-­‐arrested	  oocytes,	  with	  the	  
exception	   of	   Cdc6	   (Lemaitre	   et	   al.	   2002,	   Whitmire	   et	   al.	   2002).	   This	   protein	   is	   synthesized	   from	  
maternal	   mRNA	   during	   meiotic	   maturation	   and	   starts	   to	   accumulate	   45	   minutes	   after	   GVBD	  
(Lemaitre	  et	  al.	  2002,	  Whitmire	  et	  al.	  2002).	  Importantly,	  the	  injection	  of	  recombinant	  Cdc6	  induces	  
DNA	   replication	   in	  oocytes	   treated	  with	  CHX	  at	  GVBD,	  while	   inhibiting	   its	   synthesis	  with	   antisense	  
oligonucleotides	   prevents	   DNA	   replication	   in	   oocytes	   incubated	   with	   CHX	   45	  minutes	   after	   GVBD	  
(Lemaitre	   et	   al.	   2002).	  Hence,	   Cdc6	   corresponds	   to	   the	  protein	  whose	   synthesis	   starts	   45	  minutes	  
after	  GVBD	  and	  that	  is	  required	  for	  the	  oocyte	  to	  be	  competent	  to	  replicate	  DNA.	  Interestingly,	  this	  
mechanism	  regulating	  the	  competence	  to	  replicate	  DNA	  is	  conserved	  in	  other	  species	  (Lemaitre	  et	  al.	  
2004)(Fig.	  21).	  
2. The	  inhibition	  of	  DNA	  replication	  
Several	   non-­‐exclusive	   mechanisms	   can	   inhibit	   DNA	   replication	   during	   meiotic	   maturation.	   In	  
prophase,	  pre-­‐RCs	  cannot	  be	  formed	  because	  Cdc6	  is	  missing	  but	  also	  because	  other	  proteins	  such	  as	  
ORC	  proteins	  are	  localized	  within	  the	  cytoplasm	  or	  are	  only	  partly	  nuclear	  (Lemaitre	  et	  al.	  2002).	  The	  
localization	   of	   the	   pre-­‐RCs	   components	   could	   therefore	   account	   for	   the	   inability	   of	   the	   oocyte	   to	  
support	  DNA	  replication.	  However,	  the	  obvious	  mechanism	  that	  prevent	  DNA	  replication	  in	  prophase	  
is	  the	  absence	  of	  Cdc6.	  Because	  this	  factor	  is	  missing,	  MCMs	  cannot	  bind	  on	  chromatin	  in	  prophase	  
extracts,	   even	   though	   the	   nucleus/cytoplasm	   organization	   is	   lost	   and	   allows	   a	   direct	   access	   to	  
chromatin	  (Whitmire	  et	  al.	  2002).	  The	  absence	  of	  Cdc6	  is	  a	  key	  mechanism	  to	  avoidthe	  assembly	  of	  
pre-­‐RCs	  onto	  chromatin	  in	  prophase	  but	  also	  during	  the	  first	  period	  of	  meiotic	  resumption,	  until	  right	  
after	   GVBD.	   Around	   45	  minutes	   after	   GVBD,	   Cdc6	   starts	   to	   accumulate	   and	   a	  minimal	   amount	   of	  
Cdc6	   is	   sufficient	   for	   the	   formation	   of	   the	   pre-­‐RCs.	   This	   period	   is	   critical	   for	   the	   oocyte	   as	   the	  
accumulation	  of	  Cdc6	  starts	  at	  a	  period	  where	  the	  activity	  of	  Cdk1	  decreases.	  This	  period	  is	  therefore	  
favourable	   for	   DNA	   replication	   but	   two	   activities	   prevent	   the	   occurrence	   of	   DNA	   replication	   after	  
meiosis	  I:	  Cdk1	  and	  the	  Mos/MAPK	  pathway	  (Fig.	  21).	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§ Cdk1	  
The	  role	  of	  Cdk1	  activity	  in	  inhibiting	  DNA	  replication	  during	  MI-­‐MII	  transition	  was	  first	  enlightened	  
by	   injecting	   at	   GVBD	   the	   dominant	   negative	   form	   of	   Cdk1	   (Cdk1-­‐K33R),	   which	   induces	   DNA	  
replication	  in	  Xenopus	  oocytes	  (Furuno	  et	  al.	  1994).	  Furthermore,	  when	  Cdk1	  reactivation	  is	  inhibited	  
by	  injecting	  Wee1	  in	  Metaphase	  I,	  Cdk1	  is	  inactivated	  by	  Y15	  phosphorylation	  and	  oocytes	  enter	  into	  
a	   replicative	   state	   (Nakajo	   et	   al.	   2000).	   This	   suggests	   that	   the	   “threshold”	   level	   of	   Cdk1	   activity	  
preserved	  during	   the	  MI-­‐MII	   transition	   is	   sufficient	   to	   inhibit	  DNA	  replication	  at	   this	  critical	  period.	  
This	  hypothesis	  was	  confirmed	  using	  “meiotic	  extracts”	  (M-­‐M	  extracts)	  (Iwabuchi	  et	  al.	  2000).	  These	  
extracts	  are	  generated	   from	  MI	  oocytes	  and	   recapitulate	  all	   the	  molecular	  events	  occurring	  during	  
the	  MI-­‐MII	   transition	   (Iwabuchi	   et	   al.	   2000).	   The	   addition	   of	   CHX	   in	   these	   extracts	   promotes	   the	  
degradation	  of	  Cyclin	  B,	  the	  full	  inactivation	  of	  Cdk1	  and	  DNA	  is	  replicated	  (Iwabuchi	  et	  al.	  2000).	  The	  
level	   of	   Cdk1	   activity	   during	   the	  MI-­‐MII	   transition	   is	   directly	   proportional	   to	   the	   concentration	   of	  
Cyclin	  B.	  Hence,	   adding	  a	  non-­‐destructible	  Cyclin	  B	   reactivates	  Cdk1	   in	   a	  dose-­‐dependent	  manner.	  
Using	   this	   approach,	   it	   was	   shown	   that	   the	  minimal	   level	   of	   Cdk1	   activity	   necessary	   to	   block	   the	  
formation	  of	  nuclei	  and	  DNA	  replication	  is	  similar	  to	  the	  one	  measured	  in	  vivo	  (Iwabuchi	  et	  al.	  2000).	  
Altogether,	   these	   results	   indicate	   that	   as	   in	   somatic	   cells,	   Cdk1	   is	   a	   potent	   inhibitor	   of	   DNA	  
replication	  in	  oocyte	  and,	  more	  importantly,	  that	  the	  residual	  activity	  of	  Cdk1	  preserved	  between	  the	  
two	  meiotic	  divisions	  contributes	  to	  the	  inhibition	  of	  DNA	  replication	  during	  the	  MI-­‐MII	  transition.	  
§ The	  Mos/MAPK	  pathway	  
Strikingly,	   inhibiting	   the	  Mos/MAPK	  pathway	   also	   leads	   to	   the	   reformation	  of	   nuclei	   that	   replicate	  
DNA	   after	   meiosis	   I	   (Furuno	   et	   al.	   1994,	   Gross	   et	   al.	   2000,	   Dupre	   et	   al.	   2002).	   Whether	   the	  
mechanism	   induced	  by	   the	  Mos/MAPK	  pathway	   to	   inhibit	  DNA	   replication	   is	   direct	  or	   is	  mediated	  
through	  Cdk1	  has	  not	  been	  yet	  determined.	  As	  mentioned	  above,	  these	  two	  activities	  rely	  on	  each	  
other	   during	   the	   MI-­‐MII	   transition.	   Inhibiting	   one	   leads	   to	   the	   inactivation	   of	   the	   other	   one,	  
rendering	   difficult	   to	   determine	   their	   respective	   roles.	   Since	   the	   Mos/MAPK	   pathway	   positively	  
regulates	  the	  accumulation	  of	  Cyclin	  B	  by	  acting	  at	  the	  level	  of	  both	  its	  synthesis	  and	  its	  degradation,	  
the	   inhibitory	   action	  of	   the	  Mos/MAPK	  pathway	   towards	  DNA	   replication	   can	   rely	   on	   its	   ability	   to	  
maintain	  and	  reactivate	  Cdk1	  during	  the	  MI-­‐MII	  transition.	  Accordingly,	  injecting	  recombinant	  Mos	  is	  
not	  sufficient	  to	  abolish	  DNA	  replication	  in	  oocytes	  treated	  with	  CHX	  45	  minutes	  after	  GVBD	  (Furuno	  
et	  al.	  1994),	  suggesting	  that	  the	  synthesis	  of	  another	  protein	  than	  Mos	  is	  required	  for	  the	  inhibition	  
of	  DNA	  replication.	  This	  newly	  synthetized	  protein	  could	  correspond	  to	  Cyclin	  B	   (Gross	  et	  al.	  2000,	  
Taieb	  et	  al.	  2001).	  To	  investigate	  the	  role	  of	  the	  Mos/MAPK	  pathway	  in	  preventing	  DNA	  replication	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independently	   of	   Cdk1-­‐Cyclin	   B,	   Cdk1	   activity	   must	   be	   specifically	   inhibited	   at	   GVBD	   in	   oocytes	  
wherein	   the	   MAPK	   is	   kept	   active.	   This	   could	   be	   achieved	   by	   injecting	   Cyclin	   B	   antisense	  
oligonucleotides	   in	  prophase	  oocytes,	   then	  to	   induce	  meiotic	  maturation	  with	  progesterone	  and	  to	  
inject	  recombinant	  Mos	  at	  GVBD.	  Another	  strategy	  will	  be	  to	  co-­‐inject	  the	  dominant	  negative	  mutant	  
Cdk1-­‐K33R	  together	  with	  Mos	  at	  GVBD.	  
Interestingly,	  in	  starfish	  oocytes,	  oocytes	  do	  not	  arrest	  at	  MII,	  but	  in	  G1,	  after	  the	  completion	  of	  the	  
second	  meiotic	  division,	  and	  the	  Mos/MAPK/p90Rsk	  pathway	  is	  responsible	  for	  this	  arrest	  (Mori	  et	  al.	  
2006).	  During	  the	  G1	  arrest	  that	  precedes	  fertilization,	  pre-­‐RCs	  are	  already	  formed	  onto	  the	  DNA	  of	  
the	  female	  pro-­‐nucleus	  but	  DNA	  replication	  is	  inhibited	  (Tachibana	  et	  al.	  2010).	  In	  this	  model	  system,	  
the	  activity	  of	  p90Rsk	  activity	  is	  both	  necessary	  and	  sufficient	  to	  prevent	  origin	  firing	  by	  blocking	  the	  
loading	  of	   the	  protein	  Cdc45	  on	   the	   chromatin.	  Under	   this	   condition,	  DNA	  polymerases	   cannot	  be	  
recruited	  and	  as	  a	  consequence,	  replicative	  forks	  are	  not	  activated.	  The	   inhibition	  of	  p90Rsk	  using	  a	  
blocking	  antibody	  induces	  the	  loading	  of	  Cdc45,	  the	  firing	  of	  replicative	  forks	  and	  DNA	  replication,	  in	  
the	   absence	   of	   fertilization	   (Tachibana	   et	   al.	   2010).	   Conversely,	   Cdc45	   cannot	   be	   loaded	   onto	  
chromatin	   in	   fertilized	   oocytes	   previously	   injected	   with	   a	   constitutively	   active	   form	   of	   p90Rsk	  
(Tachibana	  et	  al.	  2010).	  The	  ability	  of	  p90Rsk	  to	  inhibit	  DNA	  replication	  is	  independent	  of	  Cdk1	  activity	  
as	  these	  oocytes	  are	  arrested	  in	  G1	  with	  no	  active	  MPF.	  Similar	  results	  were	  further	  obtained	  in	  sea	  
urchin	  oocytes,	  which	  are	  also	  arrested	  at	  the	  pronucleus	  stage	  at	  the	  end	  of	  meiotic	  maturation.	  In	  
this	  species,	   it	  was	  further	  shown	  that	  the	  inhibition	  of	  the	  Mos/MAPK	  pathway	  by	  U0126,	  and	  the	  
concomitant	  inhibition	  of	  ATM/ATR	  kinases	  using	  Caffeine	  promotes	  DNA	  replication	  independently	  
of	  fertilization	  (Aze	  et	  al.	  2010).	  These	  data	  suggest	  that	  S-­‐phase	  is	  inhibited	  in	  those	  oocytes	  by	  the	  
synergic	  action	  of	  the	  Mos/MAPK	  pathway	  and	  the	  checkpoint	  kinases	  ATM/ATR.	  Whether	  p90Rsk	   is	  
the	  end	  product	  of	   the	  Mos/MAPK	   cascade	   that	   plays	   a	   specific	   role	   in	   inhibiting	  DNA	   replication,	  
independently	  of	  Cdk1,	  in	  Xenopus	  oocytes	  deserves	  further	  investigation.	  However,	  Cdc45	  is	  clearly	  
the	  limiting	  step	  targeted	  by	  p90Rsk	  in	  Echinoderms,	  whereas	  this	  protein	  does	  not	  appear	  to	  be	  a	  key	  
limiting	  factor	  in	  Xenopus.	  	  
f. The	  CSF	  arrest	  	  
i. Discovery	  of	  CSF	  
The	  pathway	  responsible	  for	  the	  second	  arrest	  can	  be	  divided	  into	  two	  parts:	  an	  upstream	  part	  very	  
well	   conserved	   through	   evolution	   and	   a	   downstream	   part	   composed	   of	   effectors	   responsible	   for	  
arresting	  the	  oocytes	  at	  different	  steps	  according	  the	  species	  and	  that	  vary	  between	  species.	  CSF	  was	  
first	  described	  in	  Amphibians	  by	  Masui	  and	  Markert	   in	  1971	  by	  injecting	  the	  cytoplasm	  from	  a	  MII-­‐
arrested	  oocyte	  in	  one	  of	  the	  two	  blastomeres	  of	  a	  two-­‐cell	  embryo	  (Masui	  et	  al.	  1971).	  The	  division	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of	  the	  injected	  blastomere	  is	  arrested	  at	  metaphase	  while	  the	  uninjected	  one	  continues	  to	  divide.	  As	  
a	  control,	  the	  injection	  of	  the	  cytoplasm	  from	  a	  prophase	  oocyte	  is	  unable	  to	  arrest	  the	  cell	  division	  
of	   the	   injected	   blastomere.	   This	   cytostatic	   activity	  was	   called	   CSF.	   As	   for	  MPF,	   researchers	   began	  
investigations	   to	   identify	   the	  molecular	   identity	   of	   CSF.	   Four	   properties	   have	   to	   be	   satisfied	   for	   a	  
protein	   to	   be	   part	   of	   the	   CSF:	   (1)	   it	   is	   inactive	   in	   prophase-­‐arrested	   oocytes,	   (2)	   it	   appears	   during	  
meiotic	  maturation,	  (3)	  it	  is	  inactivated	  after	  fertilization	  or	  following	  the	  parthenogenetic	  activation	  
of	   the	  oocyte	  and	   (4)	   its	   injection	   in	  a	  blastomere	  of	  a	   two	  cell-­‐embryo	  must	  promote	  an	  arrest	   in	  
metaphase	   (Masui	   et	  al.	   1971).	  CSF	   is	   conserved	  among	  vertebrates	  and	   it	   is	  now	  well	  established	  
that	  CSF	  is	  tightly	  linked	  to	  the	  Mos/MAPK	  pathway.	  	  
ii. The	  Mos/MAPK	  pathway	  
The	  first	  protein	  identified	  as	  a	  CSF	  component	  was	  Mos.	  Mos	  satisfies	  all	  the	  CSF	  criteria:	  it	  is	  absent	  
in	  prophase,	  accumulates	  in	  response	  to	  progesterone,	  is	  activated	  at	  the	  time	  of	  GVBD	  and	  is	  stable	  
until	   fertilization	   that	   provokes	   its	   proteasome-­‐dependent	   degradation	   (Sagata	   et	   al.	   1988,	  
Watanabe	  et	  al.	  1989,	  Lorca	  et	  al.	  1991,	  Castro	  et	  al.	  2001a).	  Moreover,	   the	   injection	  of	  Mos	  or	  of	  
any	  of	  its	  targets,	  MEK,	  MAPK	  or	  p90Rsk,	  under	  constitutively	  active	  forms,	  in	  a	  blastomere	  of	  a	  two-­‐
cell	  embryo	  arrests	  the	  injected	  blastomere	  in	  metaphase	  (Sagata	  et	  al.	  1989,	  Haccard	  et	  al.	  1993).	  
Finally,	  cytoplasm	  from	  Xenopus	  MII	  oocytes	  that	  are	  depleted	  in	  Mos	  loses	   its	  CSF	  activity,	   i.e.	  the	  
ability	   to	   arrest	   blastomeres	   in	   metaphase	   (Sagata	   et	   al.	   1989).	   The	   demonstration	   of	   the	  
physiological	  involvement	  of	  the	  Mos/MAPK	  pathway	  during	  the	  MII	  arrest	  came	  from	  the	  analysis	  of	  
knock-­‐out	  Mos	  mouse	  oocytes.	  In	  this	  species,	  oocytes	  without	  Mos	  proceed	  through	  a	  third	  meiotic	  
division	   without	   arresting	   in	   metaphase	   II,	   and	   in	   some	   cases,	   keep	   dividing,	   giving	   raise	   to	   an	  
abnormal	  embryonic	  body	  that	  eventually	  dies	  (Colledge	  et	  al.	  1994,	  Hashimoto	  et	  al.	  1994b,	  Verlhac	  
et	  al.	  1996b,	  Verlhac	  et	  al.	  2000).	  The	  role	  of	  the	  Mos/MAPK	  pathway	  in	  the	  second	  meiotic	  arrest	  is	  
well	   conserved	   among	   sea	   urchin,	   starfish,	   ascidians,	   nematodes,	   jellyfish,	   Drosophila,	   fishes,	  
Xenopus	   and	  mouse	   oocytes,	   despite	   the	   arrest	   of	   oocytes	   at	   various	   steps	   of	  meiotic	  maturation	  
(prophase,	  MI,	  MII,	  G1)	  according	  the	  species	   (Tachibana	  et	  al.	  1997,	  Dupre	  et	  al.	  2002,	  Mori	  et	  al.	  
2006,	  Amiel	   et	  al.	   2009,	  Aze	   et	  al.	   2010).	   Importantly,	   immunodepleting	  p90Rsk	  or	  MAPK	  or	  adding	  
U0126	  is	  not	  sufficient	  to	  release	  Xenopus	  CSF	  extracts	  from	  M-­‐phase	  and	  overexpressing	  Mos	  in	  MII-­‐
arrested	   oocytes	   does	   not	   prevent	   the	   activation	   of	   oocyte	   induced	   by	   Ca2+	   (Bhatt	   et	   al.	   1999,	  
Reimann	   et	   al.	   2002).	   In	   Xenopus,	   the	   Mos/MAPK	   pathway	   is	   therefore	   necessary	   for	   the	  
establishment	  of	   the	  arrest	   in	  metaphase	   II	  but	   is	  not	  required	  for	   its	  maintenance.	   In	  vertebrates,	  
since	  oocytes	  injected	  with	  Mos	  reach	  GVBD	  and	  proceed	  through	  meiosis	  II	  without	  arresting	  in	  MI,	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this	   further	   indicates	   that	   a	   protein,	   produced	   during	   the	   MI-­‐MII	   transition,	   cooperates	   with	   the	  
Mos/MAPK	  pathway	  to	  establish	  the	  arrest	  at	  MII.	  
iii. Role	  of	  APC	  
Based	   on	   the	   ubiquitin-­‐dependent	   degradation	   of	   Cyclin	   B	   that	   is	   necessary	   to	   inactivate	   Cdk1	   in	  
somatic	  cells,	  it	  was	  assumed	  that	  APC/C	  could	  be	  a	  primary	  target	  of	  CSF	  to	  maintain	  a	  high	  level	  of	  
Cyclin	  B	  in	  MII.	  Consistently	  with	  this	  idea,	  the	  overexpression	  of	  proteins	  implicated	  in	  the	  SAC,	  such	  
as	   Mad2,	   Bub1	   and	   Mps1,	   block	   the	   Ca2+-­‐induced	   release	   of	   M-­‐phase	   in	   Xenopus	   CSF	   extracts	  
(Schwab	  et	  al.	  2001,	  Tunquist	  et	  al.	  2003,	  Grimison	  et	  al.	  2006).	  However,	  when	  the	  same	  proteins	  
are	  depleted	  from	  eggs,	  neither	  the	  inhibition	  of	  APC/C	  nor	  the	  maintenance	  of	  CSF	  arrest	  is	  affected	  
(Abrieu	  et	  al.	  2001,	  Sharp-­‐Baker	  et	  al.	  2001,	  Tunquist	  et	  al.	  2003).	  This	  is	  in	  agreement	  with	  the	  fact	  
that	  Xenopus	  oocytes	  are	  defective	  for	  the	  SAC	  (Shao	  et	  al.	  2013)	  and	  CSF-­‐arrested	  oocytes	  contain	  
an	   intact	  metaphase	   plate	   that	   is	   not	   expected	   to	   trigger	   SAC	   activation	   (Masui	   et	   al.	   1971).	   This	  
result	  strongly	  suggests	  that	  SAC	  proteins	  are	  not	  active	  players	  contributing	  to	  the	  CSF	  activity	  and	  
that	  the	  oocyte	  is	  equipped	  with	  a	  CSF-­‐specific	  inhibitor	  of	  APC/C.	  In	  2002,	  Emi1	  was	  proposed	  to	  be	  
this	  CSF-­‐specific	  inhibitor	  (Reimann	  et	  al.	  2002).	  Recombinant	  Emi1	  is	  able	  to	  induce	  a	  mitotic	  arrest	  
when	   injected	   into	  a	  blastomere	  of	   a	   two	   cell-­‐embryo	  and	   its	   immunodepletion	   from	  CSF	  extracts	  
leads	  to	  APC/C	  activation	  and	  Cyclin	  B	  degradation	  (Reimann	  et	  al.	  2002).	  However,	  the	  physiological	  
relevance	  of	   Emi1	  as	  CSF	  was	   rapidly	   challenged.	   Emi1	   is	   stable	   in	  prophase	  and	  both	  ectopic	   and	  
endogenous	  Emi1	  are	  highly	  unstable	  proteins	  during	  meiotic	  maturation	   (Margottin-­‐Goguet	   et	   al.	  
2003,	  Tung	  et	  al.	  2005).	  Moreover,	  the	  arrest	  in	  MII	  promoted	  by	  injected	  Emi1	  is	  not	  released	  upon	  
oocytes	  activation	  (Ohsumi	  et	  al.	  2004).	  	  
Another	   intriguing	   issue	   is	  that	  the	   incubation	  of	  MII-­‐arrested	  oocytes	  with	  CHX	  promotes	  a	  partial	  
degradation	   of	   the	   Cyclin	   B	   and	   a	   decrease	   of	   Cdk1	   activity	   up	   to	   50%	   of	   its	   initial	   level,	   without	  
provoking	  the	  release	  from	  the	  MII	  arrest	  (Thibier	  et	  al.	  1997).	  While	  there	  is	  no	  overall	  variation	  in	  
the	  concentration	  of	  Cyclin	  B	  during	  the	  MII	  arrest,	  a	  fraction	  of	  Cyclin	  B	  is	  however	  under	  turnover	  
while	  the	  other	  one	  is	  stabilized.	  Hence,	  the	  CSF	  arrest	  is	  a	  dynamic	  process	  wherein	  the	  expression	  
level	  of	  Cyclin	  B	  could	  be	  regulated	  by	  two	  mechanisms:	  APC/C	  and	  the	  Mos/MAPK	  pathway.	  Both	  
actors	  were	  reconciled	  by	  the	  finding	  of	  Erp1/Emi2.	  
iv. Erp1/Emi2	  
Upon	  fertilization,	  the	  activity	  of	  the	  kinase	  CaMKII	  is	  increased	  by	  the	  peak	  of	  Ca2+	  and	  results	  within	  
less	  than	  5	  minutes	  in	  the	  activation	  of	  APC/C	  and	  the	  degradation	  of	  Cyclin	  B	  (Lorca	  et	  al.	  1993).	  In	  
contrast,	  the	  Mos/MAPK	  pathway	  remains	  active	  for	  at	  least	  30	  minutes	  following	  egg	  activation	  or	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fertilization	   (Castro	   et	   al.	   2001a).	   Therefore,	   fertilization	   bypasses	   the	   protection	   ensured	   by	   the	  
Mos/MAPK	  module	  to	  trigger	  Cyclin	  B	  degradation	  through	  an	  unknown	  mechanism.	  This	  bypass	  can	  
be	  achieved	  by	  the	  inactivation	  of	  an	  unknown	  effector	  of	  the	  Mos/MAPK	  pathway.	  The	  intermediate	  
protein	   was	   identified	   in	   a	   yeast	   two-­‐hybrid	   screen	   seeking	   proteins	   interacting	   with	   catalytically	  
inactive	   Plx1	   and	   was	   called	   Erp1/Emi2	   (Liu	   et	   al.	   2005a,	   Schmidt	   et	   al.	   2005).	   Erp1/Emi2	   is	   an	  
inhibitor	  of	  APCCdc20	  that	  acts	  by	  direct	  binding	  (Shoji	  et	  al.	  2006,	  Wu	  et	  al.	  2007b).	   In	  CSF	  extracts,	  
Erp1/Emi2	  is	  fully	  degraded	  within	  5	  minutes	  after	  Ca2+	  addition	  and	  its	  immunodepletion	  promotes	  
the	  release	  from	  the	  metaphase	  arrest	  in	  the	  absence	  of	  Ca2+	  (Schmidt	  et	  al.	  2005).	  The	  mechanism	  
responsible	   for	   its	   degradation	   was	   further	   elucidated.	   Following	   oocyte	   activation,	   Erp1/Emi2	   is	  
phosphorylated	   by	   CaMKII,	   which	   provides	   a	   Plx1	   docking	   site	   necessary	   for	   its	   degradation	   by	  
SCFβTrCP	  E3	  ubiquitin	  ligase	  (Liu	  et	  al.	  2005a,	  Rauh	  et	  al.	  2005,	  Schmidt	  et	  al.	  2005,	  Hansen	  et	  al.	  2006).	  
The	   inhibition	  of	  APC/C	   is	   then	   relieved	  and	  promotes	   the	  exit	   from	  MII.	  Altogether,	   these	   results	  
strongly	  suggest	  that	  Erp1/Emi2	  is	  the	  long	  though	  CSF-­‐specific	  inhibitor	  of	  APC/C	  that	  is	  responsible	  
for	  mediating	   the	  arrest	   in	  MII.	  Although	  the	  endogenous	  expression	  of	  Xenopus	  Erp1/Emi2	  during	  
the	   prophase	   arrest	   as	   well	   as	   during	   meiosis	   resumption	   is	   still	   under	   debate,	   Erp1/Emi2	   is	   not	  
present	   at	   a	   sufficient	   level	   in	   MI	   to	   prevent	   Cyclin	   B	   degradation	   since	   its	   injection	   at	   GVBD	   is	  
sufficient	  to	  arrest	  the	  oocyte	   in	  MI	  (Ohe	  et	  al.	  2007).	  Clearly,	  the	  protein	   is	  accumulated	  at	  a	  high	  
level	  when	  the	  oocytes	  enter	  in	  MII	  (Schmidt	  et	  al.	  2005,	  Ohe	  et	  al.	  2007).	  Importantly,	  Erp1/Emi2	  is	  
required	   for	   the	  CSF	  activity	  of	   the	  Mos/MAPK	  pathway	  (Inoue	  et	  al.	  2007,	  Nishiyama	  et	  al.	  2007).	  
Recombinant	  Erp1/Emi2	  injected	  at	  GVBD	  loses	  its	  ability	  to	  arrest	  oocytes	  at	  MI	  in	  the	  presence	  of	  
U0126	  (Inoue	  et	  al.	  2007).	  Moreover,	  injected	  Mos	  is	  no	  longer	  capable	  of	  arresting	  blastomers	  at	  M-­‐
phase	  when	  Erp1/Emi2	  expression	   is	   suppressed	  by	  morpholino	   antisense	   (Inoue	   et	   al.	   2007).	   The	  
link	   between	   Erp1/Emi2	   and	   the	   Mos/MAPK	   module	   is	   mediated	   by	   p90Rsk	   that	   directly	  
phosphorylates	  Erp1,	  increasing	  its	  stability	  and	  its	  ability	  to	  interact	  and	  inhibit	  APC/C	  (Inoue	  et	  al.	  
2007,	  Nishiyama	  et	  al.	  2007)	  (Fig.	  22).	  	  Strikingly,	  Cdk1	  also	  phosphorylates	  Erp1/Emi2	  at	  two	  distinct	  
residues,	   T545	   and	   T551,	   decreasing	   Erp1/Emi2	   interaction	  with	   APC/C	   (Wu	   et	   al.	   2007b)	   .	   These	  
Cdk1-­‐dependent	  phosphorylations	  of	  Erp1/Emi2	  are	  antagonized	  by	  the	  activity	  of	  PP2A.	  This	  process	  
may	   be	   used	   by	   the	   oocyte	   to	   finely	   tune	   the	   level	   of	   Cyclin	   B	   accumulation	   to	   ensure	   that	   the	  
process	   of	   fertilization	   and	   the	   following	   embryonic	   cell	   cycles	   are	   not	   impaired.	   Interestingly,	   the	  
p90Rsk-­‐dependent	   phosphorylation	   of	   Erp1/Emi2	   promotes	   the	   recruitment	   of	   PP2A	   to	   the	   protein	  
(Wu	   et	   al.	   2007a,	   Wu	   et	   al.	   2007b).	   The	   binding	   of	   PP2A	   to	   Erp1/Emi2	   then	   induces	   its	  
dephosphorylation	  at	  T545	  and	  T551,	  enhancing	  its	  binding	  to	  APC/C	  and	  thus	  its	  inhibition	  (Fig.	  22).	  
Collectively,	  these	  important	  findings	  show	  that	  the	  Mos/MAPK	  pathway	  promotes	  the	  arrest	  in	  MII	  
by	   regulating	   Erp1/Emi2	   through	   p90Rsk-­‐dependent	   phosphorylation,	   which	   promotes	   APC/C
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inhibition,	  the	  stability	  of	  Cyclin	  B	  and	  therefore	  the	  MII	  arrest.	  Exit	  from	  this	  arrest	   is	  provoked	  by	  
the	  degradation	  of	  Erp1/Emi2	  due	  to	   the	  CAMKII	   that	   is	  activated	  by	   the	  Ca2+	   surge,	  bypassing	   the	  
effects	  of	  the	  p90Rsk	  phosphorylation.	  
This	  long	  story	  shows	  that	  it	  was	  illusory	  to	  search	  for	  one	  protein	  as	  the	  CSF	  factor,	  since	  CSF	  is	  not	  a	  
single	   factor	   but	   rather	   a	   dynamic	   process	   involving	  many	   enzymatic	   actors.	   It	   also	   addresses	   the	  
question	  of	  the	  control	  of	  meiotic	  arrests	   in	   invertebrates	  oocytes.	   In	  these	  species	  the	  Mos/MAPK	  
module	  is	  clearly	  involved,	  but	  obviously	  with	  other	  targets	  than	  Erp1/Emi2	  and	  APC/C	  as	  their	  arrest	  
occur	  at	  other	  phases	  than	  M-­‐phase.	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II	  –	  Arpp19	  and	  the	  arrest	  in	  prophase	  I	  
The	  first	  part	  of	  my	  Ph.D.	  project	  regards	  the	  underlying	  mechanisms	  responsible	  for	  arresting	  the	  oocyte	  
in	   prophase	   of	   the	   1st	   meiotic	   division.	   This	   arrest	   is	   conserved	   in	   all	   animal	   species,	   lasts	   for	   an	  
extraordinary	  long	  period	  used	  by	  the	  oocytes	  to	  accumulate	  nutrients	  and	  determinants	  essential	  for	  the	  
embryonic	  development.	  This	  arrest	   is	  commonly	  assimilated	  to	  a	  G2	  arrest	  and	   is	   released	  by	  external	  
stimuli,	  progesterone	  in	  Xenopus,	  which	  initiates	  a	  signalling	  pathway	  whose	  ultimate	  goal	  is	  to	  activate	  
MPF.	   Remarkably,	   while	   the	   molecular	   mechanisms	   controlling	   the	   activation	   of	   MPF	   are	   well	  
understood,	  little	  is	  known	  about	  the	  mechanisms	  ensuring	  for	  the	  remarkably	  durable	  prophase	  I	  arrest	  
(2-­‐3	  years	   in	  Xenopus	  but	  up	  to	  40	  years	   in	  human).	   In	  a	  similar	  manner,	   little	   is	  known	  on	  how	  these	  
mechanisms	   are	   either	   unlocked	   or	   circumvented	   by	   external	   stimuli	   to	   induce	   re-­‐entry	   into	   meiotic	  
divisions.	  	  
In	  all	  vertebrates,	  the	  maintenance	  of	  prophase	  arrest	  requires	  that	  cAMP	  and	  the	  activity	  of	  the	  cAMP-­‐
dependent	   protein	   kinase	   (PKA)	   be	  maintained	   at	   high	   levels	   in	   the	   oocyte.	   This	   conclusion	   has	   been	  
supported	  by	  many	  studies	  and	  led	  to	  the	  conclusion	  that	  a	  phosphoprotein,	  a	  specific	  PKA	  substrate,	  is	  
responsible	  for	  the	  prolonged	  prophase	  arrest	  of	  the	  oocyte.	  Thus,	  PKA	  plays	  an	  important	  role	  in	  keeping	  
Cdk1	  inactive	  during	  the	  prophase	  I	  arrest	  of	  meiosis	  in	  vertebrates.	  However,	  the	  crucial	  questions	  of	  the	  
identity	  of	  the	  essential	  substrate	  of	  PKA	  and	  its	  molecular	  roles	  have	  not	  been	  solved.	  The	  study	  of	  this	  
physiological	  process	  should	  lead	  to	  great	  advances	  in	  our	  knowledge	  of	  hormonal	  regulation,	  cell	  cycle	  
regulation	  and	  signal	  transduction.	  
A. The	  endosulfine	  family	  
The	  endosulfine	  family	  comprises	  two	  main	  members	  encoded	  by	  different	  genes:	  the	  endosulfines	  
(α	  and	  β)	  and	  the	  cAMP-­‐phosphoregulated	  proteins	  including	  Arpp16,	  Arpp19	  and	  Arpp21,	  base	  on	  
their	  N-­‐terminus	  end.	  Endosulfine	  was	  identified	  as	  an	  endogenous	  ligand	  of	  sulfonylurea	  receptor	  K+	  
channels	  in	  the	  pancreas	  (Virsolvy-­‐Vergine	  et	  al.	  1992),	  whereas	  Arpp	  members	  were	  first	  identified	  
in	   the	   nervous	   system	   as	   in	   vitro	   substrates	   for	   PKA	   (Walaas	   et	   al.	   1983).	  While	   Arpp16	   is	  mainly	  
expressed	  in	  brain	  and	  is	  conserved	  in	  birds	  and	  mammals,	  Arpp19	  is	  ubiquitously	  expressed	  in	  every	  
tissue	  and	   is	   conserved	   in	  all	  eukaryotes	   from	  yeast	   to	  human	   (Girault	   et	  al.	  1990).	   Little	   is	  known	  
about	   the	   structure	   of	   these	   little	   proteins.	   ENSA	   behaves	   as	   an	   unfolded	   protein	   in	   solution	   and	  
forms	   a	   4	  α-­‐helixe-­‐structure,	   when	   incubated	   with	   lipid	   mimetics	   (Boettcher	   et	   al.	   2008).	   These	  
proteins	  are	  heat	  stable	  and	  acid	  resistant	  and	  are	  thought	  to	  be	  monomeric.	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a. Phosphorylation	  of	  endosulfines	  
Four	   distinct	   sites	   of	   phosphorylation	   have	   been	   identified	   in	   these	   proteins	   (Fig.	   23).	   The	   best	  
conserved	  motif,	  FDSGDY,	  is	  present	  in	  all	  the	  proteins	  of	  the	  endosulfine	  family	  and	  is	  targeted	  by	  
the	  kinase	  Gwl	  (Gharbi-­‐Ayachi	  et	  al.	  2010,	  Mochida	  et	  al.	  2010)(Labandera	  et	  al.	  2015).	  Cdk1	  targets	  
two	  sites:	  preferentially	  S28	  but	  also	  T99	   in	  vitro,	  and	  also	   in	  Xenopus	  CSF	  extracts	   (Mochida	  et	  al.	  
2010)(Mochida	  2013).	  The	   last	  site,	  S109	   in	  Xenopus	   (S107	   in	  human),	   is	  phosphorylated	  by	  PKA	   in	  
vitro	   and	   in	   Xenopus	   extracts	   (Mochida	   et	   al.	   2010)(Mochida	   2013).	   In	   CSF	   extracts	   derived	   from	  
oocytes	  arrested	  at	  metaphase	  II,	  both	  Gwl	  and	  Cdk1	  sites	  of	  Arpp19	  are	  phosphorylated	  (Mochida	  
2013).	   Following	   the	   addition	   of	   Ca2+,	   CSF	   extracts	   exit	   from	   the	   CSF	   arrest	   and	   S67	   of	   Arpp19	   is	  
quickly	  dephosphorylated	  in	  a	  OA-­‐dependent	  manner	  whereas	  the	  Cdk1-­‐dependent	  phosphorylation	  
of	  Arpp19	  remains	  stable	  for	  up	  to	  30	  minutes	  before	  vanishing	  (Mochida	  2013).	  Interestingly,	  in	  CSF	  
extracts,	  the	  phosphorylation	  of	  Arpp19	  at	  S109	  has	  never	  been	  observed	  neither	  during	  arrest	  in	  M-­‐
phase	   nor	   following	   the	   return	   in	   interphase.	   However,	   this	   phosphorylation	   can	   be	   induced	   by	  
adding	  cAMP	  analogues	  (Mochida	  2013).	  	  
The	  phosphorylation	  at	  S67	  of	  Arpp19	  by	  Gwl	  converts	  Arpp19	  in	  an	  inhibitor	  of	  PP2A-­‐B55δ	  (Gharbi-­‐
Ayachi	  et	  al.	  2010,	  Mochida	  et	  al.	  2010),	  and	  this	  process	  has	  been	  well	  characterized	  in	  many	  animal	  
models	  both	  in	  mitosis	  and	  in	  meiosis	  (See	  chapters:	  I-­‐A.e.ii.2.	  “Role	  of	  protein	  phosphatase”	  and	  I-­‐
B.d.iv.2.	   “Greatwall	   and	   PP2A”).	   On	   the	   contrary	   little	   is	   known	   on	   the	   function	   of	   Arpp19	  
phosphorylation	  by	  Cdk1.	  Recently,	   this	   function	  was	   investigated	   in	   starfish	  oocytes	  where	   it	  was	  
shown	  that	  Cdk1	  phosphorylation	  was	  promoting	  Arpp19	  ability	  to	  inhibit	  PP2A	  independentently	  of	  
Gwl	   (Okumura	   et	   al.	   2014)	   (See	   chapter:	   I-­‐B.d.iv.2.	   “Greatwall	   and	   PP2A”).	   Finally,	   it	   has	   been	  
proposed	   that	   the	   S107	   phosphorylation	   alters	   the	   secondary	   structure	   of	   human	   ENSA,	   since	   the	  
phospho-­‐mimetic	  mutant	  protein,	  S107E-­‐ENSA,	  become	  unable	  to	  form	  the	  forth	  α-­‐helixes	  following	  
its	   incubation	   with	   lipid	   mimetics	   (Boettcher	   et	   al.	   2008).	   The	   PKA	   site	   is	   very	   well	   conserved	   in	  
vertebrates,	  while	  it	  tends	  to	  be	  lost	  in	  lower	  eukaryotes.	  
B. Working	  hypothesis	  
Interestingly,	  the	  injection	  of	  50	  pmol	  of	  ATP-­‐γ-­‐S	  in	  prophase	  arrested	  oocytes	  was	  shown	  to	  inhibit	  
progesterone-­‐induced	  meiotic	  maturation	  (Belle	  et	  al.	  1984).	  The	  proteins	  phosphorylated	  by	  using	  
ATP-­‐γ-­‐S	   as	   a	   phosphate	   donor	   are	   resistant	   to	   phosphatases	   and	   hence	   are	   stabilized	   under	   a	  
phosphorylated	   state.	   It	   was	   then	   hypothesized	   that	   ATP-­‐γ-­‐S	   stabilizes	   the	   PKA-­‐dependent	  
phosphorylation	  of	  maturation	  phosphorylated	  proteins	  (MpP),	  whose	  dephosphorylation	  is	  required	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for	  meiosis	  resumption.	  In	  order	  to	  identify	  these	  PKA	  substrates,	  oocytes	  were	  injected	  with	  PKA-­‐C	  
together	  with	  radiolabeled	  γ32-­‐ATP.	  Under	  this	  condition,	  the	  phosphorylation	   level	  of	  two	  proteins	  
of	   32	   kDa	   and	   20	   kDa	  was	   increased	   compare	   to	   oocytes	   injected	  with	   only	   γ32-­‐ATP	   (Boyer	   et	   al.	  
1986).	   It	   was	   further	   showed	   that	   the	   20	   kDa	   protein,	   but	   not	   the	   32kDa	   one,	   was	   the	   only	   one	  
incorporating	  γ-­‐S35-­‐ATP	  in	  prophase	  arrested	  oocytes	  (Boyer	  et	  al.	  1986).	  These	  results	  suggest	  that	  
the	  thiophosphorylation	  by	  PKA	  of	  the	  20	  kDa	  protein	  could	  be	  responsible	  for	  arresting	  oocytes	   in	  
prophase	  following	  the	  injection	  of	  γ-­‐S-­‐ATP.	  In	  good	  agreement	  with	  this	  hypothesis,	  the	  addition	  of	  
progesterone	  leads	  to	  the	  early	  dephosphorylation	  of	  the	  20	  kDa	  protein	  in	  oocytes	  injected	  with	  γ32-­‐
ATP	  (Boyer	  et	  al.	  1986).	  Finally,	  a	  causal	  relationship	  between	  these	  two	  putative	  PKA	  substrates,	  the	  
20	   kDa	   and	   the	   32	   kDa	   proteins,	  was	   enlightened	   by	   injecting	   first	   γ-­‐S-­‐ATP	   and	   then	   γ32-­‐ATP.	   The	  
general	  pattern	  of	  γ32-­‐ATP	  incorporation	  was	  then	  compared	  between	  oocytes	  pre-­‐injected	  with	  ATP-­‐
γ-­‐S	  or	  not	  (Boyer	  et	  al.	  1986).	  While	  the	  20	  kDa	  protein	  slightly	  incorporated	  32P,	  the	  32kDa	  protein,	  
which	   cannot	   incorporate	   ATP-­‐γ-­‐S,	   was	   much	   more	   phosphorylated	   than	   in	   control	   oocytes.	   This	  
experiment	   indicates	   that	   the	   irreversible	   phosphorylation	   of	   the	   20	   kDa	   protein	   increases	   the	  
phosphorylation	  of	   the	  32kDa	  protein.	  The	  20	  kDa	  protein	  could	  exert	   this	   function	  by	  activating	  a	  
kinase	  or	  by	   inhibiting	  a	  phosphatase.	  While,	  the	  20	  kDa	  protein	  was	  partially	  purified	  based	  on	   its	  
acid	  stability	  and	  heat	  resistance	  (Boyer	  et	  al.	  1986),	  its	  molecular	  identity	  was	  never	  solved.	  	  
Since	  the	  biochemical	  properties	  of	  Arpp19	  are	  very	  closed	  to	  the	  20	  kDa	  MpP	  and	  given	  that	  Arpp19	  
is	  a	  substrate	  of	  PKA,	  we	  then	  wondered	  whether	  the	  20	  kDa	  MpP	  could	  be	  Arpp19.	  At	  first	  glance,	  
this	   hypothesis	   looks	   provocative,	   since	   Arpp19	   is	   known	   to	   be	   a	   positive	   regulator	   of	   M-­‐phase	  
through	   its	   Gwl-­‐phosphorylation	   at	   S67.	   How	   could	   it	   be	   responsible	   for	   a	   G2	   arrest	   while	   it	   is	  
essential	   to	   promote	  M-­‐phase?	   Interestingly,	   depending	   on	   the	   amount	   of	   injected	   protein,	   wild-­‐
type-­‐Arpp19	   (WT-­‐Arpp19)	   is	   able	   to	   produce	   opposite	   effects	   on	   meiosis	   resumption	   induced	   by	  
progesterone.	  At	  low	  concentration,	  WT-­‐Arpp19	  is	  able	  to	  stimulate	  Cdk1	  activation.	  This	  enhancing	  
effect	   of	   the	   low	   dose	   of	   WT-­‐Arpp19	   was	   proposed	   to	   be	   mediated	   by	   its	   S67	   phosphorylation	  
through	   the	   Cdk1-­‐dependent	   activation	   of	   Gwl	   (Dupre	   et	   al.	   2013).	   In	   contrast,	   injected	   at	   high	  
concentration,	   WT-­‐Arpp19	   is	   able	   to	   abolish	   Cdk1	   activation	   in	   response	   to	   progesterone.	   We	  
therefore	  attempted	  to	  test	  the	  hypothesis	  that	  Arpp19	  could	  be	  the	  20	  kDa	  MpP	  protein	  described	  
about	  30	  years	  ago	  (Boyer	  et	  al.	  1986).	  We	  performed	  the	  same	  purification	  protocol	  to	  isolate	  the	  
20	   kDa	   MpP	   and	   submitted	   the	   heat	   and	   acid-­‐stable	   fractions	   of	   oocytes	   from	   prophase	   and	  
metaphase	  II	  to	  western	  blot	  with	  an	  anti-­‐Arpp19	  antibody.	  Arpp19	  was	  strongly	  detected	  at	  20	  kDa	  
in	  these	  fractions.	  From	  these	  results,	  we	  decided	  to	  investigate	  whether	  Arpp19	  is	  the	  long	  searched	  
substrate	  of	  PKA	  responsible	  for	  the	  prophase	  arrest.	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C. Results:	   the	   phosphorylation	   of	   Arpp19	   by	   the	   protein	  
kinase	  A	  prevents	  Cdk1	  activation	  in	  Xenopus	  oocytes	  
To	  analyse	  the	  role	  of	  Arpp19	  phosphorylation	  at	  S109	  during	  meiosis	  resumption,	  we	  generated	  an	  
Arpp19	  phospho-­‐mimetic	  mutant	  by	  mutating	  the	  S109	   into	  an	  aspartic	  acid	  (S109D-­‐Arpp19)	  and	  a	  
non	  phosphorylatable	  form	  of	  Arpp19	  by	  mutating	  the	  S109	  into	  an	  alanine	  (S109A-­‐Arpp19).	  	  
a. Effects	   of	   S109A-­‐	   and	   S109D-­‐Arpp19	   mutants	   on	   meiosis	  
resumption	  induced	  by	  progesterone	  or	  PKI	  
These	   two	   mutant	   proteins	   were	   injected	   in	   prophase	   oocytes	   and	   their	   effects	   on	   meiosis	  
resumption	   were	   ascertained	   by	   western	   blotting	   several	   markers	   of	   Cdk1	   activation:	   Gwl,	   Mos,	  
phosphorylated	   MAPK,	   Cyclin	   B2,	   Cdc27.	   As	   controls,	   we	   further	   used	   recombinant	   WT-­‐Arpp19,	  
known	   to	   either	   block	   or	   facilitate	   meiosis	   resumption	   in	   response	   to	   progesterone,	   as	   well	   as	  
recombinant	  S67A-­‐Arpp19,	  which	  cannot	  be	  phosphorylated	  at	  S67	  and	  prevents	  both	  progesterone	  
and	  PKI	   ability	   to	   induce	  meiosis	   resumption	   (Dupre	   et	   al.	   2013).	  While	   the	  S109A-­‐Arpp19	  mutant	  
had	   no	   effect	   on	   GVBD	   induction	   and	   Cdk1	   activation	   in	   response	   to	   progesterone,	   the	   S109D-­‐
Arpp19	  abolished	  meiosis	  resumption	  upon	  progesterone	  addition.	  Injected	  at	  a	  same	  concentration,	  
WT-­‐Arpp19	   delayed	  GVBD	   induction	  whereas	   the	   S109A-­‐Arpp19	  mutants	   has	   little	   effect	   on	   Cdk1	  
activation	   following	   hormonal	   stimulation,	   suggesting	   that	   S109	   phosphorylation	   mediates	   the	  
inhibitory	  effect	  of	  WT-­‐Arpp19.	  Noteworthy,	  S109A-­‐Arpp19	  was	  unable	  to	  activate	  Cdk1	  on	  its	  own.	  
These	   results	   indicate	   that	   the	   activation	   of	   Cdk1	   and	  meiosis	   resumption	   are	   inhibited	  when	   the	  
phosphorylation	  of	  Arpp19	  at	  S109	  is	  maintained.	  
b. S109D-­‐Arpp19	  blocks	  the	  initial	  activation	  of	  Cdk1	  but	  not	  the	  
MPF	  autoamplification	  loop	  
If	   the	   S109D-­‐Arpp19	   plays	   the	   role	   of	   the	   early	   substrate	   of	   PKA,	   the	   injection	   of	   this	   mutant	   is	  
expected	  to	  block	  the	  first	  Cdk1	  activation	   induced	  by	  PKI.	   In	  contrast,	   the	  same	  mutant	  should	  be	  
unable	   to	   block	   the	   second	   step,	   the	   MPF	   auto-­‐amplification,	   induced	   by	   the	   injection	   of	   either	  
okadaic	  acid,	  S67-­‐thio-­‐phosphorylated-­‐Arpp19,	  constitutively	  active	  K71M-­‐Gwl	  or	  cytoplasm	  transfer.	  
Indeed,	  these	  approaches	  launch	  the	  MPF	  autoamplification	  loop	  independently	  of	  PKA	  activity,	  with	  
the	   exception	   of	   K71M-­‐Gwl	   that	   is	   unable	   to	   induce	  meiosis	   resumption	   in	   the	   presence	   of	   IBMX	  
(Dupre	  et	  al.	  2013).	  
Meiosis	   resumption	   was	   triggered	   by	   injecting	   PKI	   in	   oocytes	   previously	   injected	   with	   either	  WT-­‐
Arpp19	   or	   S109D-­‐Arpp19.	   While	   Cdk1	   was	   activated	   in	   oocytes	   injected	   with	   WT-­‐Arpp19,	   Cdk1	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activation	   in	   the	  presence	  of	   the	  S109D-­‐Arpp19	  mutant	  never	  occurs.	  On	  the	  other	  hand,	   injecting	  
S109D-­‐Arpp19	  did	  not	   inhibit	  the	  MPF	  autoamplification	  triggered	  by	  okadaic	  acid,	  K71M-­‐Gwl,	  S67-­‐
thio-­‐phosphorylated-­‐Arpp19	   or	   cytoplasm	   transfer.	   Therefore,	   keeping	   Arpp19	   phosphorylated	   at	  
S109	   prevents	   the	   initial	   activation	   of	   Cdk1	   but	   is	   unable	   to	   block	   meiosis	   resumption	   directly	  
induced	  by	   the	  MPF	  autoamplification	   loop.	  These	   results	  argue	   for	  Arpp19	  being	   the	   substrate	  of	  
PKA	  whose	  dephosphorylation	  is	  needed	  for	  the	  initial	  activation	  of	  Cdk1	  
c. Endogenous	   Arpp19	   is	   phosphorylated	   by	   PKA	   in	   prophase	  
and	   is	   dephosphorylated	   within	   one	   hour	   following	  
progesterone	  addition	  
All	   the	   previous	   data	   were	   obtained	   using	   recombinant	   proteins	   injected	   into	   oocytes.	   We	   then	  
addressed	  the	  question	  of	  the	  endogenous	  Arpp19	  as	  the	  early	  substrate	  of	  PKA.	  If	  this	  hypothesis	  is	  
correct,	  Arpp19	  must	  be	  phosphorylated	  by	  PKA	  in	  prophase	  and	  should	  be	  dephosphorylated	  within	  
one	   hour	   after	   progesterone	   addition	   in	   a	   CHX-­‐independent	   manner.	   Using	   a	   specific	   antibody	  
directed	   against	   the	   S109-­‐phosphorylated	   form	   of	   Arpp19,	   we	   discovered	   that	   Arpp19	   is	   indeed	  
phosphorylated	   at	   S109	   in	   prophase-­‐arrested	   oocytes.	  We	   further	  monitored	   the	   phosphorylation	  
statute	   of	   injected	  WT-­‐Arpp19	   at	   S109.	   As	   expected,	   the	   protein	   was	   phosphorylated	   at	   S109	   in	  
prophase.	  To	  ascertain	  that	  this	  S109	  phosphorylation	  was	  dependent	  on	  PKA	  activity,	  oocytes	  were	  
injected	  with	  WT-­‐Arpp19	   then	   injected	  with	   PKI.	   Following	   the	   injection	   of	   PKI,	   both	   endogenous	  
Arpp19	   and	   recombinant	   WT-­‐Arpp19	   were	   quickly	   and	   fully	   dephosphorylated	   at	   S109	   within	   30	  
minutes.	  This	  demonstrates	   that	  Arpp19	   is	  phosphorylated	  at	  S109	   in	  a	  PKA-­‐dependent	  manner	   in	  
prophase-­‐arrested	  oocytes.	  
We	   then	   analysed	   the	   dephosphorylation	   at	   S109	   of	   endogenous	   and	   recombinant	   Arpp19	   in	  
response	  to	  progesterone.	  Upon	  hormonal	  stimulation,	  both	  proteins	  were	  dephosphorylated	  within	  
one	   hour	   independently	   of	   protein	   synthesis.	   Importantly,	   the	   S109	   dephosphorylation	   of	  
endogenous	  Arpp19	  was	  partial,	  about	  50%	  of	  the	  Arpp19	  proteins	  remaining	  phosphorylated	  at	  that	  
site.	   Thereafter,	   Arpp19	  was	   fully	   rephosphorylated	   at	   S109	   around	  GVBD.	   This	   rephosphorylation	  
was	  still	  observed	  in	  oocytes	  injected	  with	  PKI,	  showing	  that	  a	  kinase	  distinct	  from	  PKA	  is	  responsible	  
for	   the	   phosphorylation	   of	   Arpp19	   at	   S109	   at	   GVBD.	   Therefore,	   endogenous	   Arpp19	   behaves	   as	  
injected	  WT-­‐Arpp19	  and	  fulfils	  the	  criteria	  for	  being	  the	  prophase-­‐specific	  PKA	  substrate.	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d. The	  extent	  of	  WT-­‐Arpp19	  dephosphorylation	  at	  S109	  depends	  
on	  progesterone	  concentration	  
In	   Xenopus,	   PKI	   as	   progesterone	   induce	   GVBD	   in	   a	   dose-­‐dependent	   manner	   (Maller	   et	   al.	   1977,	  
Huchon	  et	  al.	  1981c,	  Rime	  et	  al.	  1992b).	  This	  suggests	   that	   the	  extent	  of	   the	  dephosphorylation	  of	  
the	   PKA	   substrate	   should	   vary	   as	   a	   function	   of	   progesterone	   concentration.	   Since	   WT-­‐Arpp19	   is	  
phosphorylated	  by	  PKA	  in	  prophase-­‐arrested	  oocytes,	  more	  WT-­‐Arpp19	  protein	  is	  injected,	  higher	  is	  
the	   level	   of	   S109	   phosphorylation.	   This	   could	   explain	  why	  WT-­‐Arpp19	   prevents	   Cdk1	   activation	   in	  
response	  to	  progesterone	  in	  a	  dose-­‐dependent	  manner.	  	  
To	  address	  this	  question,	  prophase	  oocytes	  were	   injected	  with	  either	  WT-­‐Arpp19	  or	  S109D-­‐Arpp19	  
(600	  ng	  per	  oocyte,	  a	  concentration	  of	  WT-­‐Arpp19	  that	  blocks	  meiosis	  resumption)	  then	   incubated	  
with	   the	   usual	   concentration	   of	   progesterone	   (1	   μM).	   This	   high	   amount	   of	  WT-­‐Arpp19	   prevented	  
both	  GVBD	  induction	  and	  Cdk1	  activation.	  The	  concentration	  of	  progesterone	  was	  then	  raised	  to	  10	  
μM	   for	   both	  WT-­‐	   or	   S109D-­‐Arpp19	   injected	   oocytes.	   Under	   this	   condition,	   both	   GVBD	   and	   Cdk1	  
activation	   were	   induced	   in	   oocytes	   injected	   with	   600	   ng	   of	   WT-­‐Arpp19.	   In	   contrast,	   10	   μM	  
progesterone	  remained	  unable	  to	  promote	  meiosis	  resumption	  in	  S109D-­‐Arpp19	  injected	  oocytes.	  In	  
agreement	  with	  these	  results,	  WT-­‐Arpp19	  was	  weakly	  dephosphorylated	  at	  S109	  in	  response	  to	  1	  μM	  
progesterone	   whereas	   the	   extent	   of	   its	   dephosphorylation	   at	   S109	   was	   significantly	   increased	   in	  
response	   to	  10	  μM	  progesterone.	  Therefore,	   the	  extent	  of	  S109	  dephosphorylation	   is	   regulated	  by	  
the	   concentration	   of	   progesterone	   and	   accounts	   for	   the	   negative	   effect	   of	   Arpp19	   on	   meiosis	  
resumption.	   Noteworthy,	   this	   provides	   the	   first	   clue	   to	   understand	   the	   variability	   of	   the	   oocyte	  
response	  to	  the	  concentrations	  of	  progesterone	  depending	  on	  the	  females.	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D. Discussion	  
Altogether,	   our	   results	   demonstrate	   that	   Arpp19	   phosphorylation	   at	   S109	   by	   PKA	   is	   essential	   for	  
maintaining	   the	   oocyte	   arrested	   in	   prophase.	   This	   represents	   a	   breakthrough	   that	   opens	   new	  
avenues	  for	  understanding	  the	  control	  of	  meiotic	  divisions,	  and	  more	  broadly	  cell	  cycle	  regulation.	  
a. Arpp19,	   a	   tool	   to	   investigate	   the	   role	   of	   PKA	   during	  meiosis	  
resumption	  
A	  signalling	  pathway	  is	  often	  considered	  as	  a	  chain	  of	  “events”	  (including	  the	  expression/degradation	  
of	  a	  protein,	  the	  activation/inhibition	  of	  an	  enzyme,	  the	  change	  of	  localization	  or	  of	  interactors	  for	  a	  
particular	  factor)	  that	  are	  ordered	  to	  provoke	  a	  final	  effect.	  The	  order	  of	  these	  events	  in	  a	  signalling	  
pathway	   can	   be	   deciphered	   by	   artificially	  manipulating	   them	  and	  by	   performing	   epistatic	   analysis.	  
For	   example,	   two	   events	   (1	   and	   2)	   positively	   regulate	   the	   signalling	   pathway:	   the	   “event	   1”	   is	  
activated	  while	  the	  “event	  2”	  inhibited,	  if	  the	  final	  effect	  is	  still	  observed	  it	  means	  that	  the	  “event	  1”	  
acts	  downstream	  the	  “event	  2”.	  Reversely,	  if	  the	  final	  effect	  is	  blocked,	  it	  can	  be	  concluded	  that	  the	  
“event	  1”	  is	  upstream	  the	  “event	  2”.	  	  
The	   signalling	   pathway	   induced	   by	   progesterone	   and	   leading	   to	   GVBD	   could	   be	   schematized	   as	   a	  
linear	  pathway:	  the	  hormonal	  stimulation	  promotes	  the	  decrease	  of	  cAMP	  levels	  that	  downregulates	  
PKA,	  which	  in	  turn	  leads	  to	  protein	  synthesis	  and	  the	  generation	  of	  a	  starter	  amount	  of	  active	  Cdk1.	  
This	  starter	  amount	  of	  active	  Cdk1	  then	  triggers	  the	  MPF	  autoamplification	  loop,	  which	  catalyses	  the	  
conversion	  of	   the	  pre-­‐MPF	   into	  active	  MPF	  and	   is	  necessary	   for	  GVBD	   (the	   final	  event	   that	   is	  easy	  
visualized).	  However,	  this	  basic	  view	  of	  meiosis	  resumption	  as	  a	  linear	  pathway	  has	  been	  challenged	  
these	   last	   years.	   Firstly,	   Cyclin	   B	   and	   Mos	   synthesis	   can	   trigger	   independently	   of	   each	   other	   the	  
activation	  of	  Cdk1,	  suggesting	   that	  at	   least	   two	  parallel	  pathways	  are	  acting	   redundantly	   to	   induce	  
GVBD.	  Secondly,	  the	  injection	  of	  Cyclin	  B	  induces	  GVBD	  when	  protein	  synthesis	  is	  blocked	  with	  CHX	  
(Huchon	  et	  al.	  1993b),	  but	  loses	  this	  ability	  when	  PKA	  activity	  is	  maintained	  at	  a	  high	  level,	  with	  IBMX	  
(Rime	  et	  al.	  1992a).	  These	  results	  strongly	  suggest	  that	  PKA	  locks	  meiosis	  resumption	  by	  acting	  both	  
upstream	  and	  downstream	  protein	  synthesis.	  As	  a	  consequence,	  any	  treatments	  used	  to	  keep	  high	  
PKA	  activity	  will	  systematically	  lock	  the	  signalling	  pathway	  at	  two	  different	  steps,	  making	  impossible	  
to	   perform	   a	   correct	   epistasis	   analysis	   (See	   chapter:	   I-­‐B.d.iv.	   “the	   two-­‐steps	   mechanism	   of	   Cdk1	  
activation”)	  (Fig.	  24).	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Our	  work	  demonstrates	  that	  the	  phospho-­‐mimetic	  mutant	  of	  Arpp19,	  the	  S109D,	  blocks	  the	  ability	  of	  
progesterone	  and	  PKI	   in	  triggering	  GVBD	  whereas	   it	  has	  no	  effect	  on	  GVBD	  induction	  following	  the	  
injection	  of	  okadaic	  acid	  or	   the	   cytoplasmic	   transfer	   from	  a	  MII-­‐arrested	  oocyte.	  Altogether,	   these	  
results	  strongly	  argue	  for	  Arpp19	  being	  the	  PKA	  substrate	  which	  blocks	  the	  early	  signalling	  pathway	  
triggered	  by	  progesterone.	  Therefore,	   the	   injection	  of	  PKI	   together	  with	   the	  S109D-­‐Arpp19	  mutant	  
could	  be	  used	  as	  a	   tool	   to	  maintain	   the	  early	  PKA	   lock	  and	  suppress	   the	  second	  PKA	   lock	   that	   lays	  
downstream	  protein	  synthesis	  (Fig.	  25).	  Under	  this	  condition,	  the	  injection	  of	  Cyclin	  B	  might	  be	  able	  
to	   induce	   GVBD.	   This	   approach	   would	   be	   a	   convenient	   way	   to	   test	   the	   involvement	   of	   events	  
occurring	  during	  the	  window	  separating	  S109	  dephosphorylation	  of	  Arpp19	  from	  protein	  synthesis:	  
any	  event	  occurring	  within	  this	  window	  should	  be	  able	  to	  induce	  GVBD	  in	  oocytes	  previously	  injected	  
with	  both	  PKI	  and	  S109D-­‐Arpp19,	  but	  not	  in	  oocytes	  incubated	  with	  CHX.	  
It	   is	  well	   established	   that	   PKA	   locks	   Cdk1	   activation	   at	   several	   steps,	   but	   once	   Cdk1	   is	   completely	  
activated	  in	  the	  automplification	  loop	  it	  become	  insensible	  to	  the	  PKA	  lock.	  Is	  MPF	  automplification	  
loop	  dominant	  over	  PKA	  activity	  only	  because	  it	  is	  occurring	  downstream	  PKA	  locks?	  or	  it	  is	  because	  
once	   it	   is	   able	   to	   actively	   downregulate	   or	   keep	   inhibited	   PKA	   activity?	   To	   answer	   that	   question	  
Arpp19	  phosphorylation	  at	  S109	  can	  be	  further	  used	  as	  a	  tool	  to	  track	  the	  activity	  of	  PKA	  during	  the	  
MPF	   automplification	   loop.	   Arpp19	   is	   rephosphorylated	   at	   S109	   at	   GVBD,	   independently	   of	   PKA	  
activity	   and	   in	   a	   protein	   synthesis	   dependent	   manner.	   To	   address	   this	   question	   the	   injection	   of	  
okadaic	   acid	   will	   lunch	   the	   automaplification	   loop	   indepdendently	   of	   protein	   syntheisis.	   The	  
phosphorylation	   status	   of	   WT-­‐Arpp19	   injected	   at	   GVBD	   and	   of	   endogenous	   Arpp19	   at	   S109	   will	  
indicated	  if	  the	  MPF	  automplification	  loop	  inhibits	  PKA	  activity	  independent	  of	  hormonal	  stimulation.	  	  
b. The	   underlying	   mechanisms	   controlled	   by	   S109	  
phosphorylated	  Arpp19	  during	  the	  prophase	  arrest	  
	  
i. The	  active	  form	  of	  Arpp19:	  S109p-­‐Arpp19	  versus	  S109-­‐Arpp19	  
Does	  Arpp19	  phosphorylated	  at	  S109	  block	  a	  step	  required	  for	  Cdk1	  activation	  (hypothesis	  1)?	  Does	  
the	   phosphorylation	   at	   S109	   exclude	   Arpp19	   from	   playing	   its	   role	   in	   the	   early	   steps	   of	   meiosis	  
resumption	  (hypothesis	  2)?	  In	  other	  words,	  does	  S109	  phosphorylation	  of	  Arpp19	  render	  the	  protein	  
inhibitory	  towards	  Cdk1	  activation	  (hypothesis	  1),	  or	  does	  it	  prevent	  Arpp19	  to	  play	  a	  positive	  role	  in	  
meiosis	   resumption	   (hypothesis	   2)?	   Are	   both	   mechanisms	   involved	   in	   controlling	   meiosis	  
resumption?	  (Fig.	  26).	  These	  issues	  are	  difficult	  to	  answer	  because	  endogenous	  Arpp19	  is	  expressed	  
at	   the	   protein	   level	   and	   very	   stable	   all	   over	   meiotic	   maturation	   and	   its	   expression	   cannot	   be
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suppressed	  with	   antisense	   oligonucleotides.	   Secondly,	   as	  mentioned	   above,	   PKA	   activity	   blocks	   at	  
two	  distinct	  steps	  during	  meiotic	  resumption.	  	  
S109D-­‐Arpp19	   blocks	   Cdk1	   activation	   in	   response	   to	   progesterone	   or	   following	   PKI	   injection.	   This	  
result	   supports	   the	   idea	   that	   the	   S109	   phosphorylation	   blocks	   a	   step	   required	   within	   the	   initial	  
activation	   of	   Cdk1	   (Hypothesis	   1).	   Under	   this	   condition,	   S109	   of	   endogenous	   Arpp19	   should	   be	  
dephosphorylated,	  unless	  S109D-­‐Arpp19	  locks	  its	  own	  phosphatase	  (see	  Chapter	  II.D.b.iv.1.	  “Arpp19,	  
PP1	   and	   the	   prophase	   arrest”).	   However,	   since	   we	   do	   not	   know	   the	   phosphorylation	   status	   of	  
endogenous	  Arpp19,	  the	  second	  hypothesis	  cannot	  be	  formally	  excluded.	  In	  addition,	  the	  injection	  of	  
S109A-­‐Arpp19	   is	   unable	   on	   its	   own	   to	   induce	  meiosis	   resumption	   independently	   of	   Progesterone.	  
This	   result	   demonstrates	   that	   the	   sole	   dephosphorylation	   of	   Arpp19	   at	   S109	   is	   not	   sufficient	   to	  
activate	   Cdk1	   and	   thus	   exclude	   the	   hypothesis	   II.	   However,	   since	   PKA	   still	   locks	   Cdk1	   activation	  
downstream	   protein	   synthesis,	   thus	   could	   explain	   the	   inability	   of	   S109A-­‐Arpp19	   to	   induce	  
maturation.	  In	  order	  to	  maintain	  only	  the	  early	  PKA	  lock,	  PKI	  with	  S109D-­‐Arpp19	  should	  be	  injected.	  
These	   oocytes,	   which	   are	   still	   blocked	   in	   prophase,	   can	   be	   further	   injected	   with	   increasing	  
concentration	   of	   S109A-­‐Arpp19	   to	   see	   whether	   GVBD	   induction	   is	   restored.	   This	   experiment	   was	  
performed	   and	   injectioning	   	   S109A-­‐Arrp19	   cannot	   bypass	   the	   inhibitory	   effect	   exerted	   by	   S109D-­‐
Arpp19.	   These	   results	   strongly	   support	   that	   S109D-­‐Arpp19	   is	   actively	   blocking	   a	   step	   required	   for	  
Cdk1	  activation.	  Hence,	  the	  phosphorylated	  form	  of	  Arpp19	  at	  S109	  is	  the	  active	  form	  of	  the	  protein	  
inhibiting	  meiosis	  resumption	  and	  the	  dephosphorylated	  form	  of	  Arpp19	  at	  S109	  probably	  does	  not	  
regulate	  Cdk1	  activation	  (Hypothesis	  1).	  
ii. Interplay	  between	  the	  phosphorylations	  of	  Arpp19	  at	  S109	  and	  at	  
S67	  
In	  Xenopus	  oocyte,	  the	  Gwl-­‐dependent	  phosphorylation	  of	  Arpp19	  at	  S67	  converts	  this	  protein	  into	  a	  
potent	  inhibitor	  of	  PP2A-­‐B55δ,	  a	  key	  event	  required	  for	  the	  activation	  of	  the	  MPF	  autoamplification	  
loop	  (Dupre	  et	  al.	  2013).	  Overexpressing	  a	  mutant	  of	  Arpp19	  that	  cannot	  be	  phosphorylated	  at	  S67,	  
the	   S67A-­‐Arpp19	   mutant,	   blocks	   Cdk1	   activation	   in	   response	   to	   progesterone	   or	   following	   PKI	  
injection	  (Dupre	  et	  al.	  2013).	  This	  mutant	  acts	  as	  a	  dominant	  negative	  over	  Gwl	  and	  was	  shown	  to	  
prevent	  the	  S67	  phosphorylation	  of	  endogenous	  Arpp19;	  indicating	  that,	  PP2A-­‐B55δ	  is	  unlikely	  to	  be	  
inhibited	   under	   this	   condition.	   On	   the	   other	   hand,	   injecting	   a	   form	   of	   Arpp19,	   previously	   in	   vitro	  
thiophosphorylated	   by	   Gwl	   at	   S67,	   S67*-­‐Arpp19,	   binds	   efficiently	   PP2A	   and	   activates	   Cdk1	  
independently	   of	   progesterone	   and	   of	   PKA	   downregulation	   (Dupre	   et	   al.	   2013).	   Altogether,	   these	  
results	  clearly	  demonstrate	  that	  the	  inhibition	  of	  PP2A-­‐B55δ	  by	  S67-­‐phosphorylated	  Arpp19	  is	  both	  
necessary	   and	   sufficient	   for	   meiosis	   resumption.	   Therefore,	   S109-­‐phosphorylated	   Arpp19	   could	  
impede	  Cdk1	  activation	  by	  preventing	  its	  own	  ability	  to	  inhibit	  PP2A.	  This	  negative	  effect	  of	  S109p-­‐
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Arpp19	   can	   be	   exerted	   in	   two	   ways:	   the	   inhibition	   of	   Arpp19	   phosphorylation	   at	   the	   Gwl-­‐site	   or	  
blocking	  the	  binding	  to	  PP2A	  (Fig.	  27).	  
S67*-­‐Arpp19	  as	  well	  as	  K71M-­‐Gwl	  are	  able	  to	  trigger	  meiosis	  resumption	  in	  the	  presence	  of	  S109D-­‐
Arpp19	  (Dupre	  et	  al.	  2013).	  This	  result	   indicates	  that	  the	  constitutive	  phosphorylation	  of	  Arpp19	  at	  
S67	   is	   dominant	   “in	   trans”	   over	   the	   negative	   effect	   induced	  by	   S109D.	  Moreover,	   injected	   S109D-­‐
Arpp19	   is	   phosphorylated	   at	   S67	   at	   GVBD	   following	   the	   injection	   of	   okadaic	   acid	   or	   cytoplasm	  
transfer	  (Dupre	  et	  al.	  2013).	  This	  experiment	  suggests	  that	  S109	  phosphorylation	  of	  Arpp19	  does	  not	  
affect	  Gwl	  ability	  to	  phosphorylate	  Arpp19	  at	  S67;	  at	  least	  when	  Gwl	  is	  fully	  activated.	  Since	  Gwl	  and	  
S67-­‐phosphorylated	  Arpp19	  are	  involved	  within	  the	  MPF	  autoamplification	  loop,	  these	  results	  are	  in	  
good	  agreement	  with	  the	  dominance	  of	  the	  MPF	  autoamplification	  loop	  over	  the	  PKA	  lock.	  However,	  
okadaic	  acid	  and	  cytoplasmic	  transfer	  do	  not	  recapitulate	  the	  two-­‐step	  mechanism	  required	  for	  Cdk1	  
activation	   in	  response	  to	  progesterone.	  Therefore,	  we	  cannot	  rule	  out	  the	  possibility	  that	  the	  S109	  
phosphorylation	  of	  Arpp19	  decreases	  the	  affinity	  of	  Gwl	  for	  Arpp19	  and/or	  delays	  the	  kinetic	  of	  S67-­‐
phosphorylation	  in	  a	  physiological	  situation,	  such	  as	  in	  response	  to	  progesterone.	  	  
To	  gain	  some	  insights	  regarding	  this	  mechanism,	  the	  kinetic	  of	  S67	  phosphorylation	  could	  be	  in	  vitro	  
analysed	   using	   active	   wild	   type	   Gwl,	   immunoprecipitated	   from	   MII-­‐arrested	   oocytes	   (K71M-­‐Gwl	  
cannot	  be	  used	  due	  to	  its	  altered	  substrate	  specificity),	  in	  the	  presence	  of	  either	  WT-­‐Arpp19,	  S109D-­‐
Arpp19	  or	   S109A-­‐Arpp19.	  Moreover,	   it	  would	  be	  possible	   to	  perform	  a	   time	   course	  experiment	   in	  
progesterone-­‐stimulated	  oocytes	  previously	  injected	  with	  a	  physiological	  concentration	  of	  either	  WT-­‐
Arpp19	  or	  S109A-­‐Arpp19	  to	  follow	  S67	  phosphorylation.	   In	  these	  oocytes,	  recombinant	  Arpp19	  will	  
compete	   with	   endogenous	   Arpp19	   for	   Gwl	   phosphorylation.	   Therefore,	   the	   level	   S67	  
phosphorylation	  of	  endogenous	  and	  recombinant	  protein	  can	  be	  analyse	  in	  the	  same	  oocytes.	  If	  the	  
S109	   phosphorylation	   somehow	   delays	   the	   S67	   phosphorylation,	   the	   S109A-­‐Arpp19,	   but	   not	  WT-­‐
Arpp19,	   will	   be	   phosphorylated	   at	   S67	   in	   advance	   compared	   to	   endogenous	   Arpp19.	   Altogether,	  
these	   experiments	   will	   give	   us	   a	   hint	   regarding	   a	   direct	   relation	   between	   S109	   and	   S67	  
phosphorylation	  status	  exists	  (Fig.	  27).	  	  
Recently,	   it	  was	   shown	   in	   starfish	   oocytes	   that	   the	   Cdk1-­‐dependent	   phosphorylation	   of	   Arpp19	   at	  
S69	   during	   meiotic	   maturation	   was	   able	   to	   inhibit	   PP2A	   (Okumura	   et	   al.	   2014).	   Importantly,	   this	  
inhibition	  of	  PP2A-­‐B55δ	  is	  independent	  of	  the	  Gwl	  dependent	  phosphorylation	  of	  Arpp19	  (Okumura	  
et	  al.	  2014).	  Xenopus	  Arpp19	  possesses	  two	  potential	  sites	  of	  phosphorylation	  for	  Cdk1,	  S28	  and	  S99,	  
with	  S28	  being	  more	  efficiently	  phosphorylated	  in	  vitro	  by	  Cdk1	  (Mochida	  et	  al.	  2010).	  Whether	  Cdk1	  
phosphorylates	   Arpp19	   and	   has	   a	   function	   in	   Cdk1	   autoamplification	   during	   Xenopus	   meiotic	  
maturation	  is	  unknown.	  If	  so,	  it	  will	  be	  important	  to	  determine	  whether	  a	  crosstalk	  exits	  between	  the	  
S109	   and	   S28	   phosphorylations	   of	   Arpp19	   by	   performing	   similar	   experiments	   than	   the	   ones	  
described	  for	  Gwl.	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A	  second	  hypothesis	  is	  that	  S109	  phosphorylation	  of	  Arpp19	  prevents	  directly	  the	  ability	  of	  Arpp19	  to	  
interact	  with	  PP2A	  (Fig.	  27).	  To	  answer	  this	  question,	  Cdk1	  activation	  as	  well	  as	  the	  binding	  of	  Arpp19	  
to	   PP2A	   should	   be	   analysed	   in	   oocytes	   injected	   with	   either	   S67*-­‐Arpp19,	   S109D-­‐S67*-­‐Arpp19	   or	  
S109A-­‐S67*-­‐	   Arpp19.	   If	   S109D-­‐S67*-­‐Arpp19	   is	   unable	   to	   activate	   Cdk1	   and	   to	   bind	   PP2A,	   the	  
phosphorylation	  of	  Arpp19	  at	  S109	  certainly	  blocks	  the	  functionality	  of	  the	  Gwl-­‐site	  in	  cis	  (within	  the	  
same	  protein)	  (Fig.	  27).	  	  
Finally,	  it	  will	  be	  possible	  to	  measure	  PP2A	  phosphatase	  activity	  in	  vitro	  in	  the	  presence	  of	  a	  different	  
single	   and	   double	   Arpp19	   mutants,	   as	   it	   is	   described	   in	   Mochida	   (2013).	   If	   S109D-­‐S67*-­‐Arpp19	  
produces	   a	   weaker	   inhibition	   of	   PP2A	   compared	   to	   S67*-­‐Arpp19,	   it	   will	   suggest	   that	   the	  
phosphorylation	  of	  the	  PKA-­‐site	  could	  attenuate	  the	  ability	  of	  Arpp19	  in	  inhibiting	  PP2A	  in	  vitro.	  
Noteworthy,	  Arpp19	  dephosphorylation	  at	  S109	  occurs	  much	  earlier	  than	  the	  phosphorylation	  at	  S67	  
by	   Gwl.	   Moreover,	   while	   the	   S67	   phosphorylation	   of	   endogenous	   Arpp19	   relies	   on	   both	   protein	  
synthesis	  and	  Cdk1	  activation,	   the	  S109	  dephosphorylation	  of	  Arpp19	   is	   independent	  of	   these	   two	  
events.	  It	  would	  be	  then	  surprising	  that	  in	  the	  oocyte,	  the	  PKA-­‐dependent	  phosphorylation	  of	  Arpp19	  
can	   directly	   regulate	   its	   own	  Gwl-­‐dependent	   phosphorylation	   or	   the	   binding	   to	   PP2A,	   since	   these	  
events	  are	  temporarily	  distinct	  (several	  hours	  of	  gap)	  and	  under	  distinct	  regulations.	  	  
iii. PKA,	  ArpP19	  and	  protein	  synthesis	  
In	   the	  absence	  of	  nutrient,	  yeast	  cell	  enter	   in	  quiescence	  state	   (G0)	  by	  downregulating	  PKA	  activity	  
and	  activating	  Rim15	  (Gwl	  homolog).	  Rim1	  then	  phosphorylates	  Igo1	  and	  Igo2	  (Arpp19	  homologues)	  
that	   inhibit	   the	   action	   of	   factors	   implicated	   in	   mRNA	   deccaping	   (Luo	   et	   al.	   2011).	   In	   this	   system,	  
Arpp19	  homologues	  can	  positively	  control	  mRNA	  stability	  and	  therefore	  protein	  synthesis.	  	  
Since	   protein	   synthesis	   is	   a	   required	   step	   for	   Cdk1	   activation	   in	   Xenopus	   oocytes	   and	   occurs	  
downstream	   PKA	   inactivation,	   the	   phosphorylated	   form	   of	   Arpp19	   at	   S109	   may	   inhibit	   meiosis	  
resumption	   in	   response	   to	  progesterone	  or	   following	  PKI	   injection	  by	   repressing	   the	   translation	  of	  
specific	  proteins.	  A	  good	  marker	  of	  protein	  synthesis	  is	  the	  Cyclin	  B1	  whose	  accumulation	  occurs	  in	  
response	  to	  progesterone	  or	  PKI	  injection	  in	  a	  Cdk1-­‐independent	  manner	  (Frank-­‐Vaillant	  et	  al.	  1999).	  
In	   all	   our	   experiments,	   the	   accumulation	   of	   Cyclin	   B1	   was	   never	   prevented	   in	   response	   to	  
progesterone	   or	   following	   PKI	   injection	   in	   oocytes	   previously	   injected	   with	   S109D-­‐Arpp19	  
(unpublished	   results).	   Therefore,	   PKA	   inhibition	   of	   protein	   synthesis	   is	   unlikely	   to	   be	   mediated	  
through	  the	  phosphorylation	  of	  Arpp19	  at	  S109	  (Fig.	  28).	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iv. Arpp19,	  an	  inhibitor	  of	  PP1	  and	  PP2A	  phosphatases	  
1. Arpp19,	  PP1	  and	  the	  prophase	  arrest	  
The	  investigation	  of	  PP1	  activity	  during	  meiotic	  maturation	  in	  Xenopus	  oocytes	  is	  difficult	  because	  of	  
several	   reasons.	  Three	  different	  catalytic	  subunits	  of	  PP1	   (PP1C	  α,	  β	  and	  γ)	  are	  present	   in	  Xenopus	  
oocytes	   and	   their	   regulation	   remains	   elusive	   during	   meiotic	   maturation	   (McCoy	   et	   al.	   2013).	  
Moreover,	   there	   is	   no	   specific	   chemical-­‐inhibitors	   discriminating	   between	   PP1	   and	   PP2A	  
phosphatases.	  For	  example,	  OA	  is	  known	  to	  inhibit	  both	  PP2A	  and	  PP1	  activity,	  having	  lower	  IC50	  for	  
PP2A.	   Finally,	   there	   is	   no	   identified	   specific	   substrate	   for	   PP1	   in	   oocytes	   beside	   Cdc25,	   which	   is	  
dephosphorylated	   at	   S287	   by	   PP1.	   However,	   S287	   dephosphorylation	   of	   Cdc25	   requires	   the	   prior	  
activation	  of	  Cdk1,	   in	  order	   to	   release	  Cdc25	   from	  14-­‐3-­‐3	  binding,	  an	  event	   that	   is	   required	   for	   its	  
dephosphorylation	   in	   mitosis	   (Margolis	   et	   al.	   2006b).	   Therefore,	   Cdc25	   is	   not	   a	   good	   marker	   to	  
investigate	  PP1	  activation	  during	  meiotic	  resumption	  in	  ovo.	  	  
In	  1981,	  the	  injection	  of	  a	  specific	  inhibitor	  of	  PP1,	  the	  inhibitor-­‐1	  (I-­‐1)	  was	  shsown	  to	  inhibit	  meiosis	  
resumption	  induced	  by	  progesterone	  or	  following	  PKI	   injection	  (Huchon	  et	  al.	  1981b).	  However,	   I-­‐1	  
can	  no	  longer	  impede	  Cdk1	  activation	  when	  injected	  3	  hours	  after	  the	  addition	  of	  progesterone	  and	  
is	  unable	  to	  block	  meiosis	  resumption	  triggered	  by	  cytoplasmic	  transfer	  (Huchon	  et	  al.	  1981b).	  These	  
results	  suggest	  that	  the	  activation	  of	  PP1	  is	  required	  downstream	  PKA	  inhibition	  as	  an	  early	  step	  to	  
activate	   Cdk1.	   Interestingly,	   the	   20kDa	   MpP,	   whose	   dephosphorylation	   is	   required	   for	   meiotic	  
maturation,	  was	  hypothesized	  to	  be	  an	  inhibitor	  of	  protein	  PP1	  (Boyer	  et	  al.	  1986).	  Since	  we	  believe	  
that	  this	  20	  kDa	  MpP	  corresponds	  to	  Arpp19	  (Dupre	  et	  al.	  2014),	  it	  will	  be	  interesting	  to	  investigate	  
whether	  endogenous	  S109p-­‐Arpp19	  and	  S109D-­‐Arpp19	  act	  as	  an	  inhibitor	  of	  PP1.	  	  
The	  identity	  of	  the	  phosphatase	  removing	  phosphates	  incorporated	  at	  S109	  of	  Arpp19	  is	  unknown.	  It	  
is	  possible	  to	  speculate	  that	  S109p-­‐Arpp19	  could	  be	  at	  the	  same	  time	  an	  inhibitor	  and	  a	  substrate	  of	  
PP1,	  as	  already	  described	  for	  S67p-­‐Arpp19	  and	  PP2A	  inhibition	  (Williams	  et	  al.	  2014).	  Since	  Arpp19	  is	  
partially	  dephosphorylated	  at	  S109	  following	  progesterone	  addition	  and	  is	  rephosphorylated	  at	  S109	  
at	   GVBD,	   this	   suggests	   that	   PP1	   activation	   could	   be	   only	   transitory	   during	   meiosis	   resumption.	  
According	  to	  that	  view,	  S109D-­‐Arpp19	  or	  Arpp19	  thiophosphorylated	  by	  PKA	  in	  vitro	  (S109*-­‐Arpp19),	  
which	   cannot	  be	  dephosphorylated	   at	   S109,	   should	   act	   as	   a	   pseudo-­‐substrates	   for	   PP1,	   exerting	   a	  
dominant	   negative	   effect	   (Fig.	   29).	   If	   this	   hypothesis	   is	   correct,	   the	   co-­‐injection	   of	   S109D-­‐Arpp19	  
together	  with	  PKI	  is	  expected	  to	  block	  the	  S109	  dephosphorylation	  of	  endogenous	  Arpp19,	  showing	  
that	   S109D-­‐Arpp19	   blocks	   the	   phosphatase	   activity	   responsible	   for	   its	   own	   dephosphorylation.	   To	  
prove	  that	  this	  phosphatase	  is	  PP1,	  injecting	  PKI	  together	  with	  okadaic	  acid	  is	  expected	  to	  slow	  down	  
S109	   dephosphorylation	   of	  WT-­‐Arpp19	   compared	   to	   PKI-­‐injected	   oocytes.	   Furthermore,	   a	   specific	  
inhibitor	  of	  PP1	  can	  be	  injected	  such	  as	  I-­‐1,	  previously	   in	  vitro	  thiophosphorylated	  at	  T35	  by	  PKA	  to	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maintain	   its	   inhibitory	  ability	  toward	  PP1	  (Huchon	  et	  al.	  1981b).	  Finally,	   if	  S109D-­‐Arpp19	  acts	  as	  an	  
inhibitor	  of	  PP1,	  it	  should	  behave	  like	  I-­‐1	  and	  must	  lose	  its	  inhibitory	  effect	  over	  meiosis	  resumption	  
when	  injected	  3	  hours	  after	  progesterone	  addition	  (Huchon	  et	  al.	  1981b).	  	  
An	   in	  ovo	  approach	  to	  monitor	  endogenous	  PP1	  activation	  could	  be	  set	  up	  using	  a	  fragment	  of	  PP1	  
that	  comprises	  the	  T320	  residue	  (Lewis	  et	  al.	  2013).	  This	  residue	  is	  known	  to	  be	  phosphorylated	  by	  
Cdk1,	  leading	  to	  PP1	  inhibition,	  and	  to	  be	  dephosphorylated	  by	  PP1	  itself,	  at	  the	  time	  of	  its	  activation	  
(Dohadwala	  et	  al.	  1994,	  Wu	  et	  al.	  2009).	  This	  peptide	   is	  efficiently	   in	  vitro	  phosphorylated	  by	  Cdk1	  
(Lewis	   et	   al.	   2013)	   and	   could	   be	   injected	   in	   oocytes	   to	  monitor	   the	   activity	   of	   PP1	   during	  meiotic	  
maturation.	  If	  PP1	  is	  activated	  in	  response	  to	  progesterone	  or	  following	  PKI	  injection,	  this	  peptide	  is	  
expected	  to	  be	  dephosphorylated	  before	  the	  activation	  of	  Cdk1	  and	  in	  oocytes	  injected	  with	  p21Cip1.	  
For	  all	   these	  conditions,	   it	  will	  be	  therefore	   interesting	  to	  determine	  whether	  the	  prior	   injection	  of	  
S109D-­‐Arpp19	   blocks	   its	   dephosphorylation.	   Designing	   an	   in	   vitro	   dephosphorylation	   assay	   to	  
monitor	  PP1	  activity	  can	  further	  complement	  these	  in	  ovo	  experiments.	  The	  peptide	  could	  be	  in	  vitro	  
phosphorylated	   by	   Cdk1	   then	   added	   to	   immunopurified	   PP1	   from	   oocytes	   collected	   at	   different	  
times.	   The	   same	   assay	   could	   be	   performed	   in	   the	   presence	   of	   WT-­‐Arpp19	   or	   S109D-­‐Arpp19	   to	  
determine	  whether	  these	  proteins	  can	  modulate	  PP1	  activity.	  
In	  summary,	  the	  regulation	  of	  PP1	  by	  S109-­‐phosphorylated	  Arpp19	  and	  the	  possibility	  of	  a	  feedback	  
loop	  between	  these	  both	  players	  certainly	  deserves	  investigation.	  It	  leaves	  still	  open	  the	  question	  of	  
the	   crucial	   downstream	   targets	   of	   PP1	   that	   lead	   to	   Cdk1	   activation.	   In	   Boyer	   et	   al.	   (1986),	   it	   was	  
shown	  that	  the	  constitutive	  phosphorylation	  of	  the	  20	  kDa	  was	  increasing	  the	  phosphorylation	  of	  the	  
32	   kDa	  protein.	   Therefore,	  we	   can	   speculated	   that	   S109p-­‐Arrp19	   (the	  20	   kDa	  protein)	   could	  block	  
PP1	  which	  activation	  is	  required	  to	  dephosphorylated	  the	  still	  not	  identified	  protein	  of	  32	  kDa.	  
2. Role	  of	  Arpp19	  rephosphorylation	  at	  S109	  at	  GVBD	  
Another	   important	   issue	   that	  must	   be	   addressed	   regards	   the	   role	   of	   Arpp19	   rephosphorylation	   at	  
S109	  at	  the	  time	  of	  GVBD.	  Interestingly,	  okadaic	  acid	  triggers	  meiosis	  resumption	  in	  the	  presence	  of	  
CHX	   (Rime	   et	   al.	   1990)	   but	   S67*-­‐Arpp19	   cannot	   induce	   Cdk1	   activation	   in	   the	   absence	   of	   protein	  
synthesis	   (Dupre	   et	   al.	   2013).	   Therefore,	   S67*-­‐Arpp19	   does	   not	   phenocopy	   okadaic	   acid	   although	  
both	  of	  them	  were	  supposed	  to	  target	  the	  same	  enzyme,	  PP2A.	  A	  major	  difference	  between	  okadaic	  
acid	  and	  S67*-­‐Arpp19	  is	  that	  the	  former	  inhibits	  PP1	  and	  all	  PP2A	  holoenzymes	  whereas	  the	  latter	  is	  
only	  an	  inhibitor	  of	  PP2A-­‐B55δ.	  This	  observation	  suggests	  that	  the	  inhibition	  of	  another	  phosphatase	  
in	  addition	  to	  PP2A-­‐B55δ	  is	  necessary	  for	  GVBD	  and	  for	  the	  MPF	  autoamplification	  loop.	  	  
In	   mouse	   oocytes,	   the	   injection	   of	   blocking	   antibodies	   against	   PP1	   is	   able	   to	   stimulate	   GVBD	   in	  
roscovitine-­‐treated	  oocytes	  (Swain	  et	  al.	  2003).	  Moreover,	  in	  this	  model,	  Gwl	  is	  dispensable	  until	  MI	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suggesting	   that	   the	   inhibition	   of	   PP2A-­‐B55δ	   is	   not	   necessary	   for	   GVBD	   occurrence	   during	  meiosis	  
resumption	   (Adhikari	   et	   al.	   2014).	   From	   these	   results,	   it	   has	   been	   proposed	   that	   during	   meiosis	  
resumption	  in	  mice	  PP1,	  and	  not	  PP2A-­‐B55δ,	  is	  the	  phosphatase	  counteracting	  Cdk1	  phosphorylation	  
during	  meiosis	   resumption	   in	  mice	   and	   its	   inhibition	   allow	   the	   nuclear	   breakdown	   (Adhikari	   et	   al.	  
2013).	   During	   mitosis,	   it	   is	   well	   established	   that	   Cdk1	   phosphorylates	   PP1	   at	   T320	   efficiently	  
inhibiting	   its	   activity	   (Dohadwala	   et	   al.	   1994).	   However,	   this	   pathway	   can	   be	   activated	   only	  
downstream	   the	   first	   activation	   of	   Cdk1.	   According	   to	   our	   hypothesis,	   Arpp19	   phosphorylated	   at	  
S109	   can	   behave	   as	   a	   PP1	   inhibitor.	   Actually,	  we	   have	   shown	   that	   Arpp19	   is	   rephosphorylated	   at	  
S109	  independently	  of	  PKA	  activity	  at	  GVBD	  time,	  but	  in	  a	  protein	  synthesis-­‐dependent	  manner.	  The	  
re-­‐phosphorylation	   at	   S109	   could	   be	   important	   to	   inhibit	   PP1	   and	   to	   induce	   GVBD	   (Fig.	   30).	   To	  
investigate	   that	   hypothesis,	   it	  will	   be	   important	   to	  monitor	   the	   phosphorylation	   status	   at	   S109	   of	  
endogenous	  and	  recombinant	  Arpp19	  protein,	  in	  CHX-­‐treated	  oocytes	  injected	  with	  S67*-­‐Arpp19.	  If	  
S67*-­‐Arpp19	  is	  not	  phosphorylated	  at	  S109	  at	  GVDB	  equivalent	  time,	  it	  could	  explain	  the	  inability	  of	  
that	  protein	  to	  induce	  GVBD	  in	  CHX-­‐treated	  oocytes:	  the	  CHX	  impairs	  Arpp19	  re-­‐phosphorylation	  at	  
S109	   blocking	   its	   ability	   to	   inhibit	   PP1.	   If	   this	   model	   is	   true,	   the	   ability	   to	  mature	   in	   CHX-­‐treated	  
oocytes	  injected	  with	  S67*-­‐Arpp19	  should	  be	  rescued	  by	  injecting	  S109D-­‐Arpp19,	  or	  I-­‐1.	  Moreover,	  it	  
will	   be	   important	   to	   identify	   the	   pathway	   responsible	   for	   Arpp19	   re-­‐phosphorylation	   at	   S109,	  
knowing	   that	   this	  pathway	   required	  protein	  synthesis.	  The	  sequence	  surrounding	   the	  S109	   residue	  
corresponds	   to	   a	   minimal	   consensus	   site	   for	   p90Rsk	   phosphorylation	   (RxxS).	   Recombinant	   Mos	  
indirectly	   activates	   MAPK	   and	   p90Rsk	   independently	   of	   protein	   synthesis.	   In	   CHX-­‐treated	   oocytes,	  
p90Rsk	  cannot	  be	  activated	  in	  response	  to	  progesterone	  because	  of	  the	  inhibition	  of	  Mos	  synthesis.	  If	  
p90Rsk	  is	  the	  kinase	  responsible	  for	  the	  Arpp19	  rephosphorylation	  at	  S109,	  the	  injection	  of	  Mos	  would	  
therefore	   restore	   the	   phosphorylation	   at	   S109	   as	   well	   as	   the	   inhibition	   of	   PP1.	   Notably,	   Cdk1	  
activation	  is	  restored	  in	  CHX-­‐treated	  oocytes	  when	  S67*-­‐Arpp19	  is	  injected	  together	  with	  Mos.	  
Importantly,	  this	  model	  is	  based	  on	  the	  hypothesis	  that	  S67*-­‐Arpp19	  is	  dephosphorylated	  at	  S109	  in	  
CHX	   treated	   oocytes.	   However,	   the	   activity	   of	   PKA	   in	   this	   experiment	   should	   be	   able	   to	  maintain	  
S109	  phosphorylation	  as	  progesterone	  was	  not	  added,	  unless	  if	  injection	  of	  S67*-­‐Arpp19	  is	  not	  able	  
to	  downregulated	  the	  ability	  of	  PKA	  to	  phosphorylate	  Arpp19	  at	  S109.	  	  
3. A	  new	  model	  for	  meiosis	  resumption	  	  
Based	  on	  those	  ideas,	  the	  following	  model	  for	  controlling	  meiosis	  resumption	  can	  be	  proposed	  (Fig.	  
31).	  The	  high	  activity	  of	  PKA	  maintains	  the	  phosphorylation	  of	  Arpp19	  at	  S109.	  S109p-­‐Arpp19	  then
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inhibits	  PP1	  by	  being	  a	  substrate	  in	  excess	  (Fig.	  29).	  Upon	  progesterone	  addition,	  the	  activity	  of	  PKA	  
drops	  and	  a	  fraction	  of	  Arpp19	  is	  dephosphorylated	  at	  S109.	  As	  a	  consequence,	  PP1	  is	  activated	  (Fig.	  
29).	  The	  identity	  of	  its	  targets	  and	  their	  links	  with	  Cdk1	  activation	  are	  still	  pending.	  Just	  before	  GVBD,	  
the	   p90Rsk-­‐dependent	   phosphorylation	   of	   Arpp19	   at	   S109	   as	   well	   as	   the	   initial	   activation	   of	   Cdk1,	  
which	   phosphorylates	   PP1	   at	   T320,	   allows	   for	   the	   full	   inhibition	   of	   PP1.	   Concomitantly,	   the	   Gwl-­‐
dependent	   phosphorylation	   of	   Arpp19	   at	   S67	   directly	   inhibits	   PP2A-­‐B55δ.	   This	   double	  
phosphorylation	  of	  Arpp19	  at	  both	  S109	  and	  S67	  provokes	  therefore	  the	  inhibition	  of	  both	  PP1	  and	  
PP2A-­‐B55δ	  in	  order	  to	  fully	  activate	  Cdk1	  through	  the	  MPF	  autoamplification	  loop.	  The	  oocytes	  then	  
can	  undergo	  GVBD.	  Accordingly,	  Arpp19	  acts	  as	  an	  inhibitor	  and	  a	  substrate	  of	  phosphatases	  whose	  
selectivity	   is	  controlled	  by	   its	  phosphorylation	  status	  at	  S109	  and	  S67,	  as	  already	  described	  for	  S67	  
and	  PP2A	  inhibition	  (Williams	  et	  al.	  2014)	  (Fig.	  29-­‐30).	  
4. Role	   of	  Arpp19	   rephosphorylation	   at	   S109	  during	  MI-­‐MII	  
transition	  
Even	  though	  the	  rephosphorylation	  of	  Arpp19	  at	  S109	  would	  not	  be	  necessary	  for	   inhibiting	  PP1	  at	  
GVBD,	  this	  protein	  could	  play	  a	  role	  during	  the	  MI-­‐MII	  transition.	  	  
In	  mitosis,	  the	  activity	  of	  PP1	  increases	  in	  anaphase	  (Wu	  et	  al.	  2009)	  and	  targets	  multiple	  substrates	  
that	  coordinate	  processes	  such	  as	  chromosomes	  decondensation	  (Vagnarelli	  et	  al.	  2011)	  and	  nuclear	  
envelope	  reassembly	  (Steen	  et	  al.	  2000).	  These	  events	  are	  not	  occurring	  during	  the	  MI-­‐MII	  transition	  
(Huchon	   et	   al.	   1981a,	   Gerhart	   et	   al.	   1984,	   Gard	   1992,	   Furuno	   et	   al.	   1994),	   suggesting	   that	   PP1	   is	  
inhibited	  during	  this	  phase.	  However,	  the	  activity	  of	  Cdk1	  decreases	  during	  Anaphase	  I,	  as	  probably	  
the	  level	  of	  the	  inhibitory	  phosphorylation	  at	  T320	  of	  PP1.	  Whether	  the	  residual	  activity	  is	  sufficient	  
to	   keep	   PP1	   inhibited	   is	   unknown.	   We	   can	   propose	   that	   S109p-­‐Arpp19,	   presumably	   maintained	  
under	   its	   phosphorylated	   status	   by	   the	  Mos/MAPK	   cascade,	   could	   help	   inhibiting	   PP1	   during	   that	  
transition	  (Fig.	  32).	  When	  the	  Mos/MAPK	  activity	  is	  inhibited	  with	  morpholino	  against	  Mos	  or	  U0126,	  
oocytes	   exit	   from	   meiosis	   I	   and	   do	   not	   enter	   into	   meiosis	   II	   but	   they	   are	   driven	   in	   a	   pseudo	  
interphasic	   state	   accompanied	   with	   the	   reformation	   of	   nuclei	   and	   DNA	   replication	   (Furuno	   et	   al.	  
1994,	   Gross	   et	   al.	   2000,	   Dupre	   et	   al.	   2002).	   It	  will	   be	   interesting	   to	   see	   if	   the	   injection	   of	   S109D-­‐
Arpp19	   at	   GVBD	   is	   able	   to	   block	   nuclei	   reformation	   and,	   therefore,	   DNA	   replication	   in	   oocytes	  
maturing	  without	  the	  Mos/MAPK	  pathway.	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v. The	  phosphorylation	  at	  S109	  controls	  the	   localization	  of	  Arpp19:	  
the	  14.3.3	  hypothesis	  
The	   localization	   of	   the	   actors	   regulating	   Cdk1	   activation	   in	   the	   oocyte	   could	   affect	   meiosis	  
resumption,	   even	   though	   enucleated	   Xenopus	   oocytes	   are	   able	   to	   resume	   meiosis	   (Masui	   et	   al.	  
1971).	   This	   assumption	   comes	   from	   experiments	   showing	   that	   the	   activation	   of	   Cdk1	   proceed	  
differently	   in	   the	   absence	   of	   the	   nucleus,	   Cdk1	   being	   slowly	   activated	   and	   reaching	   a	   plateau	  
indicative	  of	  a	  defect	  within	  the	  MPF	  autoamplification	  loop	  (Iwashita	  et	  al.	  1998).	  	  
It	  will	  be	  interesting	  to	  study	  the	  localization	  of	  endogenous	  Arpp19	  in	  prophase	  as	  well	  as	  in	  oocytes	  
collected	   30	   minutes	   after	   PKI	   injection	   to	   determine	   whether	   Arpp19	   is	   present	   or	   not	   in	   the	  
nucleus.	  Since	  Arpp19	  is	  totally	  dephosphorylated	  at	  S109	  upon	  PKI	  injection	  at	  that	  time,	  this	  would	  
suggest	  whether	  Arpp19	  localization	  can	  be	  regulated	  by	  its	  PKA-­‐dependent	  phosphorylation.	  Then,	  
the	   localization	   of	   S109A-­‐Arpp19	   is	   expected	   to	   be	   abnormal	   in	   prophase	   oocytes	   while	   S109D-­‐
Arpp19	  localization	  should	  not	  be	  altered	  following	  PKI	  injection.	  	  
In	   somatic	   cell	   lines,	   PKA	   is	   known	   to	   regulate	   Cdc25	   localization	   by	   phosphorylating	   S287,	  which	  
blocks	  its	  nuclear	  import	  by	  promoting	  its	  interaction	  with	  14-­‐3-­‐3	  proteins.	  Interestingly,	  the	  S109	  of	  
Arpp19	  lays	  within	  a	  minimal	  consensus	  site	  for	  the	  binding	  of	  14-­‐3-­‐3	  (R106xxpS109).	  The	  R106	  residue	  
within	  S109D-­‐Arpp19	  could	  be	  mutated	  into	  an	  alanine	  in	  order	  to	  prevent	  the	  interaction	  between	  
Arpp19	  and	  14.3.3,	  without	  affecting	  S109	  phosphorylation.	   If	  this	  mutation	  abolishes	  the	  ability	  of	  
the	   S109D	   in	   inhibiting	   Cdk1	   activation,	   this	   will	   suggest	   that	   the	   inhibitory	   effect	   of	   Arpp19	  
conferred	   by	   its	   phosphorylation	   at	   S109	   is	   probably	  mediated	   by	   its	   binding	   to	   14-­‐3-­‐3.	   Then,	   the	  
localization	   of	   S109D-­‐R106A-­‐Arpp19	   should	   be	   similar	   to	   S109A-­‐Arpp19	   in	   prophase-­‐arrested	  
oocytes.	   The	   interaction	   between	   Arpp19	   and	   14-­‐3-­‐3	   could	   be	   further	   studied	   by	   performing	   GST	  
pull-­‐down	   experiments	   and	   confirmed	   in	   vivo	   by	   immunoprecipitating	   endogenous	   Arpp19	   from	  
prophase-­‐arrested	   oocytes	   injected	   or	   not	   with	   PKI.	   This	   model	   would	   explain	   how	   Arpp19	   is	  
regulated	  in	  prophase	  by	  its	  phosphorylation	  at	  S109,	  without	  however	  answering	  the	  question	  of	  its	  
early	  function	  in	  the	  induction	  of	  Cdk1	  activation.	  
vi. Finding	  Arpp19	  interactome	  
The	  identification	  of	  Arpp19	  interactors	  would	  provide	  precious	  clues	  on	  the	  mechanisms	  regulated	  
by	  S109-­‐phosphorylated	  Arpp19.	  The	  immunoprecipitation	  of	  endogenous	  Arpp19	  or	  GST	  pull	  down	  
experiments	  of	  recombinant	  Arpp19	  proteins	  can	  be	  performed	  from	  prophase-­‐arrested	  oocytes	  or	  
at	  a	  given	  time	  following	  either	  progesterone	  addition	  or	  PKI	  injection.	  These	  experiments	  could	  be	  
analysed	  using	  a	  candidate	  driven	  approach	  (by	  western	  blot)	  or	  in	  an	  unbiased	  manner	  using	  mass	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spectrometry.	  Another	  possibility	   is	   to	   fractionate	  extracts	   from	  prophase	  oocytes,	   injected	  or	  not	  
with	   PKI,	   using	   size-­‐excluding	   chromatography	   (Gel	   Filtration).	   This	   biochemical	   approach	   will	  
ascertain	  whether	  Arpp19	   is	   eluted	  with	  other	   proteins	   and	  will	   give	   a	   good	  estimation	   about	   the	  
molecular	  weight	  of	   the	  complexes	  containing	  Arpp19.	  The	  pre-­‐incubation	  of	  extracts	  with	  Arpp19	  
antibodies	   can	   be	   used	   for	   identifying	  Arpp19	   interacting	   protein:	   the	   antibodies	  will	   bind	  Arpp19	  
complex	   increasing	   its	  molecular	  weight	   and	  modifying	   the	   elution	   profile	   of	   both	   Arpp19	   and	   its	  
interactors.	  	  
c. S109p-­‐Arpp19	  function	  during	  the	  mitotic	  cell	  cycle	  
The	  role	  of	  S67p-­‐Arpp19	  as	  an	  inhibitor	  of	  PP2A-­‐B55δ	  is	  well	  conserved	  between	  the	  meiotic	  division	  
and	  the	  mitotic	  cell	  cycle.	  However,	  nothing	  is	  known	  regarding	  the	  function	  of	  S109	  phosphorylation	  
during	  the	  somatic	  cell	  cycle.	  	  
i. Regulation	  of	  the	  G2/M	  transition	  by	  PKA	  
PKA	  activity	  fluctuates	  in	  synchronized	  mammalian	  cells	  being	  high	  in	  interphase	  and	  low	  in	  M-­‐phase	  
(Burger	   et	   al.	   1972).	  Moreover,	   keeping	   a	   high	   level	   of	   cAMP	   blocks	   the	   G2/M	   transition	   and	   this	  
inhibition	  can	  be	  reversed	  by	  overexpressing	  PKI	  (Stambrook	  et	  al.	  1976,	  Lamb	  et	  al.	  1991,	  Kurokawa	  
et	   al.	   1998).	   If	   Arpp19	   is	   the	   substrate	   of	   PKA	  mediating	   these	   effects,	   the	  mutant	   S109D-­‐Arpp19	  
should	  phenocopy	   the	   inhibition	  of	  M-­‐phase	  entry	   caused	  by	  high	  cAMP	   levels.	   In	   the	  presence	  of	  
S109D-­‐Arpp19,	   G2/M	   arrest	   should	   be	   resistant	   to	   PKI	   overexpression.	   These	   experiments	   would	  
show	  that	  the	  PKA-­‐dependent	  phosphorylation	  of	  Arpp19	  at	  S109	   is	  sufficient	   for	  arresting	  the	  cell	  
cycle.	   If	   cells,	   in	   which	   endogenous	   Arpp19	   is	   knocked	   down	   and	   substituted	   with	   S109A-­‐Arpp19	  
(expressed	  at	  a	  physiological	   level),	  are	   treated	  with	  high	  cAMP	   level	   they	  should	  not	  arrest	  at	   the	  
G2/M	   transition.	   This	  will	   prove	   that	   S109	  phosphorylation	   is	  necessary	   for	  mediating	   the	  negative	  
effect	  of	  high	  PKA	  activity	  on	  the	  G2/M	  transition.	  However,	  PKA	  activity	  could	  control	  other	  actors	  
than	  Arpp19	  involved	  in	  the	  machinery	  of	  the	  cell	  cycle	  such	  as	  Cdc25	  and	  Wee1.	  
ii. Checkpoint	  recovery	  
In	   somatic	   cells,	   Cdc25	  phosphorylation	   at	   S287	   is	  mainly	   controlled	  by	  Chk1	   and	  Chk2,	  which	   are	  
activated	   in	   response	   to	   DNA	   damages.	   Since	   PKA	   and	   the	   Chk	   kinases	   share	   a	   similar	   minimum	  
consensus	  site	  of	  phosphorylation	  (R/KxxS/T),	  it	  will	  be	  interesting	  to	  determine	  whether	  Arpp19	  can	  
be	  further	  phosphorylated	  by	  Chk1	  and	  Chk2	  and	  involved	  in	  a	  checkpoint-­‐related	  mechanism	  during	  
the	  G2/M	  transition.	  Checkpoint	  arrest	  and	  recovery	  are	  easily	  and	  well	  studied	   in	  Xenopus	   cycling	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extracts	   supplied	  with	   biotin-­‐labelled	   double-­‐stranded	   oligonucleotides	   (DS-­‐oligo).	   These	   DS-­‐oligos	  
promote	  the	  activation	  of	  ATM	  and	  ATR	  that	  in	  turn	  activate	  Chk1	  and	  Chk2	  leading	  to	  the	  arrest	  of	  
the	  cell	  cycle	  at	  the	  G2/M	  transition	  (Peng	  et	  al.	  2010).	  Under	  this	  condition,	  PP2A	  activity	  is	  required	  
to	  inactivate	  Plx1,	  a	  kinase	  necessary	  for	  the	  checkpoint	  recovery	  (Clemenson	  et	  al.	  2009,	  Peng	  et	  al.	  
2011,	  Wang	  et	  al.	  2015).	  Recently,	  Gwl	  was	  also	  found	  to	  be	  important	  for	  the	  checkpoint	  recovery	  
that	   starts	   60	   to	   90	   minutes	   after	   the	   removal	   of	   DS-­‐oligos	   (Peng	   et	   al.	   2011).	   The	   checkpoint	  
recovery	  decreases	  the	  phosphorylation	  level	  of	  Chk1	  and	  allows	  the	  extracts	  to	  enter	  into	  M-­‐phase.	  
The	   addition	   of	   Gwl	   facilitates	   Chk1	   dephosphorylation	   and	  M-­‐phase	   entry	   whereas	   its	   depletion	  
postpones	  these	  events	  (Peng	  et	  al.	  2010).	  Interestingly,	  during	  checkpoint	  recovery,	  Plx1	  was	  found	  
to	  interact	  directly	  and	  to	  phosphorylate	  Gwl,	  leading	  to	  its	  activation	  (Peng	  et	  al.	  2011).	  Moreover,	  
Gwl	  can	  facilitate	  Plx1	  activation	  in	  an	  indirect	  manner	  (Peng	  et	  al.	  2011).	  Possibly,	  the	  hypothetical	  
phosphorylation	   of	   Arpp19	   at	   S109	   by	   Chk1	   can	   be	   important	   to	   keep	   Arpp19	   inactive,	   meaning	  
unable	  to	  bind	  PP2A	  and	  to	   inhibit	   its	  activity.	  This	  would	  prevent	  the	  activation	  of	  a	  pathway	  that	  
otherwise	   would	   inhibit	   PP2A,	   contribute	   to	   Plk1	   activation	   and	   thus	   reinforce/provoke	   the	  
checkpoint	  recovery	  (Fig.	  33).	  Moreover,	  this	  situation	  would	  be	  critical	  for	  somatic	  cells	  as	  inhibiting	  
PP2A-­‐B55δ	  is	  sufficient	  to	  promote	  M-­‐phase	  entry.	  The	  idea	  that	  Gwl	  function	  during	  the	  checkpoint	  
recovery	  depends	  on	  its	  ability	  to	  phosphorylate	  Arpp19	  at	  S67	  deserves	  to	  be	  investigated.	  Xenopus	  
cycling	  extracts	  would	  therefore	  be	  a	  suitable	  approach	  to	  examine	  the	  involvement	  of	  Arpp19	  in	  the	  
checkpoint	  maintenance	  through	  its	  S109	  phosphorylation,	  and	   in	  the	  checkpoint	  recovery	  through	  
its	   S67	   phosphorylation.	   The	   inactivation	   of	   Arpp19	   (as	   an	   inhibitor	   of	   PP2A-­‐B55δ)	   would	   confer	  
strength	  and	  robustness	  to	  the	  arrest.	  Indeed,	  the	  arrest	  would	  be	  secured	  by	  a	  high	  activity	  of	  PP2A-­‐
B55δ	  and	  by	  the	  low	  activity	  of	  Cdk1,	  caused	  by	  its	  phosphorylation	  at	  Y15	  following	  the	  inactivation	  
of	  Cdc25.	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III	   -­‐	   The	   timely	   accumulation	   of	   Cdc6	   is	   necessary	   to	   ensure	   two	  
meiotic	   divisions	   in	   the	   absence	   of	   DNA	   replication	   in	   Xenopus	  
oocytes	  
	  
Initially	  discovered	  as	  a	  major	  actor	  within	  the	  initiation	  of	  DNA	  replication,	  Cdc6	  is	  now	  implicated	  in	  
a	   plethora	   of	   mechanisms	   that	   regulate	   the	   progression	   of	   the	   mitotic	   cell	   cycle:	   re-­‐replication	  
control,	  synchronisation	  of	  S-­‐phase	  with	  mitosis	  and	  exit	  from	  M-­‐phase.	  All	  these	  functions	  of	  Cdc6	  
have	   been	   unravelled	   in	   different	   model	   organisms	   in	   which	   Cdc6	   was	   either	   overexpressed	   or	  
depleted.	  During	  the	  cell	  cycle,	  these	  different	  functions	  of	  Cdc6	  are	  tightly	  regulated	  by	  its	  level	  of	  
expression	  and/or	   its	   intracellular	   localization.	  An	  additional	   level	  of	  complexity	   is	  reached	  because	  
these	  regulations	  have	  diverse	  effects	  depending	  on	  the	  phase	  of	  the	  cell	  cycle	  and	  on	  the	  organism.	  
For	   example,	   the	   CDKs-­‐dependent	   phosphorylations	   of	   Cdc6	   can	   either	   stabilize	   the	   protein	   or	  
promote	  its	  degradation	  by	  acting	  differently	  on	  APCCdh1	  or	  SCF	  degradation	  systems.	  Similarly,	  Cdc6	  
is	  fully	  degraded	  in	  yeast	  after	  S-­‐phase	  initiation	  until	  entry	  into	  G1	  whereas	  in	  mammalian	  cells,	  Cdc6	  
is	   not	   completely	   eliminated	   in	   S-­‐	   and	   G2-­‐phases	   and	   the	   downregulation	   of	   its	   function	   mainly	  
involves	  the	  inhibition	  of	  its	  nuclear	  import	  and	  not	  its	  degradation.	  	  
During	   meiosis,	   little	   is	   known	   regarding	   the	   function	   and	   the	   regulation	   of	   Cdc6	   beside	   its	  
requirement	  for	  the	  competence	  to	  replicate	  DNA	  in	  Xenopus	  oocyte.	  Cdc6	  is	  the	  only	  missing	  factor	  
of	   the	   replicative	  machinery	  and	   its	  accumulation	  during	  meiotic	  maturation	  confers	   to	   the	  oocyte	  
the	   competence	   to	   replicate	   DNA.	   During	   meiosis,	   the	   oocyte	   physiologically	   undergoes	   two	  
consecutive	  M-­‐phases	  without	  an	  intervening	  S-­‐phase.	  An	  important	  issue	  for	  the	  oocyte	  is	  to	  avoid	  
DNA	  replication	  to	  take	  place	  when	  the	  oocyte	  exits	  from	  the	  1st	  meiotic	  division,	  given	  the	  fact	  that	  
it	  has	  a	  replication	  machinery	  ready	  to	  be	  used,	  as	  it	  should	  be	  during	  a	  regular	  cell	  cycle.	  Since	  Cdc6	  
is	   involved	   in	   the	   coordination	   of	   S-­‐phase	  with	  mitosis	   and	   also	   regulates	  M-­‐phase	   progression	   in	  
somatic	  cells,	  we	  wondered	  whether	  the	  regulation	  of	  Cdc6	  was	  important	  for	  the	  meiotic	  divisions.	  
A. Regulation	  of	  the	  level	  of	  Cdc6	  expression	  
In	  all	  eukaryotes,	  the	  level	  of	  Cdc6	  protein	  results	  from	  a	  tight	  balance	  between	  the	  transcription	  and	  
the	   translation	   but	   also	   from	   the	   degradation	   of	   Cdc6	   through	   different	   mechanisms	   involving	  
ubiquitin	  ligases	  such	  as	  SCF	  or	  APC/C,	  whose	  regulation	  depends	  on	  the	  model	  organism	  and	  on	  the	  
phase	  of	  the	  cell	  cycle.	  
In	  S.	  cerevisiae	  and	  S.	  pombe,	  Cdc6	  accumulates	  in	  late	  M-­‐phase	  and	  G1.	  In	  these	  two	  organisms,	  CDK	  
activities	  are	  able	  to	  promote	  Cdc6	  degradation	  throughout	  the	  cell	  cycle.	  Therefore,	  at	  the	  onset	  of	  
S-­‐phase,	  S-­‐Cyclins	  associated	  with	  CDK	  (Cdc28	  in	  cerevisiae	  and	  Cdc2	  in	  pombe)	  phosphorylate	  Cdc6	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and	  promote	  its	  proteasome-­‐dependent	  degradation	  by	  allowing	  SCFCdc4	  to	  interact	  through	  a	  F-­‐box	  
motif	  within	  Cdc6	  (Drury	  et	  al.	  1997,	  Perkins	  et	  al.	  2001).	  This	  mechanism	  is	  important	  to	  prevent	  re-­‐
replication.	   While	   Cdc6	   overexpression	   is	   sufficient	   to	   induce	   DNA	   re-­‐replication	   in	   S.	   pombe,	  
redundant	  mechanisms	  are	  effective	  to	  prevent	  re-­‐replication	  in	  S.	  cerevisiae	  and	  deregulating	  Cdc6	  
expression	   is	   not	   sufficient	   to	   induce	   this	   process	   in	   this	   species	   (Nguyen	   et	   al.	   2001).	   During	  M-­‐
phase,	  mitotic	  Cyclins	  bind	  to	  a	  site	  overlapping	  the	  Cdc6	  F-­‐box	  binding	  motif	  (Mimura	  et	  al.	  2004).	  
This	  interaction	  stabilizes	  Cdc6	  by	  preventing	  its	  recognition	  by	  SCFCdc4	  and	  simultaneously	  inhibits	  its	  
ability	   to	   associate	   with	   components	   of	   the	   pre-­‐RCs	   (Mimura	   et	   al.	   2004).	   In	   late	   M-­‐phase,	   the	  
degradation	  of	  mitotic	  Cyclins	  inactivates	  Cdk1	  and	  releases	  Cdc6	  that	  thereafter	  forms	  the	  pre-­‐RCs	  
(Fig.	  34).	  
In	  higher	  eukaryotes,	  the	  stability	  of	  Cdc6	  is	  regulated	  by	  degradation	  mechanisms	  depending	  on	  two	  
ubiquitin	  ligases:	  APCCdh1,	  which	  recognizes	  the	  D-­‐	  and	  KEN-­‐	  boxes	  within	  Cdc6	  (Petersen	  et	  al.	  2000),	  
and	  CRL4Cdt2	  recognizing	   a	   PIP-­‐like	  motif	   in	   the	   N-­‐terminus	   of	   the	   protein	   (Clijsters	   et	   al.	   2014).	   In	  
quiescent	  cells	  (G0)	  and	  during	  early	  G1,	  Cdc6	  is	  ubiquitinated	  by	  APCCdh1	  and	  degraded.	  In	  late	  G1,	  the	  
activation	  of	  Cdk2-­‐Cyclin	  E	  stabilizes	  Cdc6	  and	  prevents	  its	  association	  with	  APC.	  Cdc6	  is	  thus	  allowed	  
to	   form	   the	   pre-­‐RC.	   At	   the	   onset	   of	   S-­‐phase,	   Cdc6	   is	   phosphorylated	   by	   Cdk2-­‐Cyclin	   A,	   and	   is	  
relocalized	  into	  the	  cytoplasm	  then	  degraded	  by	  CRL4Cdt2	  (Petersen	  et	  al.	  1999,	  Clijsters	  et	  al.	  2014).	  
However,	   it	  was	  shown	  that	  a	  pool	  of	  Cdc6	  remains	  stably	  bound	  to	  the	  chromatin	  throughout	  the	  
cell	  cycle	  (Mendez	  et	  al.	  2000,	  Alexandrow	  et	  al.	  2004),	  accounting	  for	   its	  function	   in	  mitosis.	   In	  G2	  
and	   M-­‐phases,	   soluble	   Cdc6	   can	   re-­‐accumulate,	   because	   Cdk1-­‐Cyclin	   A/B	   inhibits	   CRL4Cdt2	  
ubiquitination	   system	   (Rizzardi	   et	   al.	   2015).	   However,	   Cdc6	   remains	   in	   the	   cytoplasm	   due	   to	   its	  
phosphorylation	  by	  Cdk1-­‐Cyclin	  B	  (Clijsters	  et	  al.	  2014)	  (Fig.	  35).	  	  
B. Cdc6	  and	  the	  mitotic	  cell	  cycle	  
a. Coordination	  of	  S-­‐phase	  with	  mitosis	  
i. Role	  of	  Cdc6	  in	  Yeast	  
In	  yeast,	  Cdc6-­‐null	  cells	  fail	  to	  replicate	  DNA	  and	  get	  arrested	  in	  G1	  as	  seen	  by	  FACS	  analysis	  and	  the	  
accumulation	  of	   cells	  with	  1N	  DNA	  content	   (Kelly	   et	  al.	   1993,	  Piatti	   et	  al.	   1995).	  This	  phenotype	   is	  
typical	  of	  mutants	  with	  DNA	  replication	  defects.	  Surprisingly,	  after	  a	  couple	  of	  hours,	   the	  Cdc6-­‐null	  
cells	  are	  however	  able	   to	  proceed	  through	  mitosis,	  generating	  a	  new	  population	  of	  cells	  with	  0.5N	  
DNA	  content	  (Kelly	  et	  al.	  1993,	  Piatti	  et	  al.	  1995)	  (Fig.	  36).	  This	  reduction	  by	  half	  of	  the	  ploidy	  is	  due	  
to	  Cdc6-­‐null	  cells	  sustaining	  mitosis	  without	  replicating	  their	  DNA.	  The	  ability	  of	  Cdc6	  to	  restrain	  M-­‐
phase	   entry	   is	   independent	   of	   its	   function	   in	   the	   formation	   of	   the	   pre-­‐RCs	   and	   of	   checkpoint	  
activation.	   This	   conclusion	  was	   reached	   by	   using	   a	  mutant	   of	   Cdc6,	   Cdc6-­‐K114E,	   defective	   for	   the	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walker	  A	  box	  and	  unable	  to	  support	  the	  loading	  of	  MCM	  despite	  its	  binding	  to	  DNA.	  In	  Cdc6-­‐null	  cells,	  
the	   Cdc6-­‐K114E	   overexpression	   still	   inhibits	   the	   G2/M	   transition,	   as	   expected.	   In	   this	   context,	   the	  
further	  removal	  of	  Rad53	  (Chk2	  homologues)	  does	  not	  rescue	  the	  entry	  in	  M-­‐phase	  (Weinreich	  et	  al.	  
2001).	  Importantly,	  the	  expression	  of	  Cdc6-­‐K114E-­‐ΔN-­‐terminus,	  deleted	  for	  the	  N-­‐terminus	  of	  Cdc6,	  
is	  not	  longer	  able	  to	  block	  M-­‐phase	  entry	  (Weinreich	  et	  al.	  1999).	  This	  N-­‐terminus	  fragment	  of	  Cdc6	  
contains	   three	   sites	  of	  phosphorylation	   for	  Cdk1	  at	   T7,	   T23	  and	  S43	  and	   their	  mutation	   in	  Alanine	  
(Cdc6-­‐K114E-­‐T7A/T23A/S43A)	  make	  Cdc6	  unable	   to	  block	   cells	   in	  G2	   (Weinreich	   et	   al.	   2001).	   Since	  
Cdc6-­‐K114E-­‐T7A/T23A/S43A	  does	  not	   interact	  with	  Cdk1-­‐Cyclin	  B,	   these	  results	  nicely	  demonstrate	  
that	  Cdc6	  blocks	   the	  G2/M	  transition	  by	   interacting	  and	  directly	   inhibiting	  Cdk1	  activation	  and	  that	  
the	  mitotic	  Cyclins	  and	  the	  N-­‐Terminus	  of	  Cdc6	  are	  both	  fundamental	  for	  this	  process.	  This	  block	  of	  
the	   G2/M	   transition	   induced	   by	   the	   overexpression	   of	   Cdc6	   mutants	   unable	   to	   support	   DNA	  
replication	  is	  independent	  of	  the	  activation	  of	  checkpoint	  mechanisms	  (Fig.	  36).	  	  
On	  the	  other	  hand,	  in	  S.	  Pombe,	  the	  overexpression	  of	  wild-­‐type	  CDC18	  (Cdc6	  homolog)	  or	  mutants	  
CDC18	  that	  support	  DNA	  replication	  restricts	  the	  entry	  into	  M-­‐phase	  but	  also	  induces	  multiple	  round	  
of	  DNA	  replication,	  thus	  generating	  cells	  with	  DNA	  content	  higher	  than	  2N	  (Nishitani	  et	  al.	  1995).	  This	  
phenotype	  can	  be	  explained	   if	  overexpressed	  Cdc6	  allows	  multiple	  round	  of	   licensing	  of	   replicative	  
origins	   and	   if	   simultaneously	   the	   M-­‐phase	   entry	   is	   inhibited,	   escaping	   the	   reduction	   of	   the	   DNA	  
content	   by	   half.	   Several	   Cdc6	   mutants	   were	   then	   overexpressed	   in	   S.	   Pombe	   and	   their	   ability	   to	  
induce	   re-­‐replication	   and	   to	   block	   M-­‐phase	   entry	   was	   followed	   by	   monitoring	   DNA	   content	   and	  
analysing	   cellular	   morphology	   (Greenwood	   et	   al.	   1998).	   The	   overexpression	   of	   the	   N-­‐terminus	   of	  
Cdc6	   neither	   induce	   DNA	   re-­‐replication,	   nor	   support	   pre-­‐RC	   assembly,	   but	   blocks	   Cdk1	   activity	   as	  
seen	  by	  the	  elongation	  of	  the	  cell	  due	  to	  the	  absence	  of	  division	  (Greenwood	  et	  al.	  1998).	  This	  effect	  
is	   independent	  of	  checkpoint	  mechanisms	  as	  the	  presence	  of	  caffeine	  does	  not	  restore	  cell	  division	  
(Greenwood	   et	   al.	   1998).	   As	   mentioned	   before,	   the	   N-­‐terminus	   of	   Cdc6	   contains	   the	   three	   sites	  
essential	   for	  the	  binding	  to	  Cdk1	  (Weinreich	  et	  al.	  2001)	  that	  certainly	  directly	   inhibit	  Cdk1.	  On	  the	  
other	  hand,	  overexpressing	   the	  C-­‐terminus	  of	  Cdc6	   induces	  DNA	   re-­‐replication	  and	   inhibits	   the	  M-­‐
phase	  occurrence	   (Greenwood	   et	   al.	   1998).	   This	  mutant	   cannot	  directly	  bind	  and	   inhibit	   Cdk1	  and	  
blocks	  M-­‐phase	  entry	  by	  inducing	  the	  activation	  of	  a	  caffeine-­‐sensitive	  checkpoint	  (Greenwood	  et	  al.	  
1998)	  (Fig.	  36).	  	  
In	   summary,	   the	  absence	  of	  Cdc6	   in	  yeast	  blocks	  DNA	  replication	  and	  allows	   the	  cell	   to	  undergo	  a	  
reductional	  anaphase.	  Cdc6	  inhibits	  Cdk1	  through	  two	  independent	  pathways.	  The	  first	  one	  involves	  
the	  N-­‐terminus	  of	   the	  protein	   that	  directly	   interacts	  with	  Cdk1	  and	   inhibits	   its	  activity.	  The	  second	  
one	  is	  promoted	  by	  the	  C-­‐terminus	  of	  Cdc6	  and	  activates	  of	  a	  checkpoint	  mechanism	  that	  indirectly	  
restrains	   Cdk1	   activation,	   inhibiting	   the	   G2/M	   transition.	   However,	   the	   C-­‐terminus	   of	   Cdc6	   can	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support	   DNA	   replication	   and	   induces	   re-­‐replication	   when	   overexpressed,	   in	   S.	   Pombe.	   It	   will	   be	  
interesting	   to	   mutagenize	   the	   ATP-­‐binding	   site	   in	   this	   fragment	   (C-­‐terminus-­‐ΔATP)	   to	   determine	  
whether	  this	  fragment	  of	  Cdc6	  can	  still	  induce	  the	  activation	  of	  the	  checkpoint.	  If	  overexpressing	  C-­‐
terminus-­‐ΔATP	  does	  not	   induce	  checkpoint	  activation,	   it	  would	  strongly	  suggest	  that	  the	  activation	  
of	   the	   checkpoint	   induced	   by	   the	   C-­‐terminus	   of	   Cdc6	   relies	   on	   the	   process	   of	   re-­‐replication	   in	   S.	  
Pombe.	  	  
ii. Role	  of	  Cdc6	  in	  higher	  eukaryotes	  
The	  role	  of	  Cdc6	   in	  coordinating	  S-­‐phase	  with	  M-­‐phase	   is	  conserved	   in	  mammals.	  The	  depletion	  of	  
Cdc6	  from	  HeLa	  cells	  prevents	  DNA	  replication	  but	  these	  cells	  still	  proceed	  through	  M-­‐phase,	  without	  
activating	  a	  checkpoint	  mechanism	  (Lau	  et	  al.	  2006).	  The	  overexpression	  of	  human	  Cdc6	  also	  blocks	  
the	  entry	  in	  M-­‐phase	  in	  HeLa	  cells	  but,	  on	  the	  contrary	  to	  yeast,	  this	  inhibition	  cannot	  be	  rescued	  by	  
overexpressioning	   Cdk1-­‐Cyclin	   B	   (Clay-­‐Farrace	   et	   al.	   2003).	   This	   result	   suggests	   that	   the	   direct	  
interaction	  between	  Cdc6	  and	  Cdk1	  is	  not	  responsible	  for	  the	  arrest	  at	  the	  G2/M	  transition	  induced	  
by	  overexpressed	  Cdc6.	  However,	  the	  entry	  into	  M-­‐phase	  can	  be	  restored	  by	  overexpressing	  either	  a	  
constitutive	  active	   form	  of	  Cdk1,	  Cdk1	   (T14A/Y15A)-­‐Cyclin	  B,	  Cdc25B	  or	  Cdc25C	  (Clay-­‐Farrace	  et	  al.	  
2003).	  These	  experiments	   suggest	   that	   the	  cell	   cycle	  arrest	   is	   caused	  by	  a	  checkpoint	   cascade	   that	  
leads	   to	   the	   inactivation	   of	   Cdc25.	   Surprisingly,	   this	   checkpoint	   induced	   by	   human	   Cdc6	   is	   not	  
inhibited	  by	  Caffeine	  and	  M-­‐phase	  entry	  is	  restored	  using	  a	  selective	  inhibitor	  of	  Chk1,	  UCN-­‐01	  (Clay-­‐
Farrace	  et	  al.	  2003).	  This	  suggests	   that	  Cdc6	  would	   induce	  the	  activation	  of	  Chk1	   independently	  of	  
ATM	  and	  ATR	  activities.	  	  
In	  Xenopus	  interphasic	  extracts,	  Cdc6	  is	  released	  from	  the	  replicative	  origins	  after	  their	  licensing	  and	  
is	   again	   recruited	   onto	   the	   replication	   forks	   following	   their	   slicing	   a	   few	   hundred	   base	   pairs	   away	  
from	   the	   replicative	   origin	   (Oehlmann	   et	   al.	   2004).	   The	   binding	   of	   Cdc6	   to	   the	   replicative	   fork	  
depends	   on	   ORC	   proteins.	   This	   binding	   is	   required	   to	   induce	   the	   ATM/ATR-­‐dependent	  
phosphorylation	  of	  Chk1	  in	  response	  to	  stalled	  replicative	  forks	  caused	  by	  the	  addition	  of	  Aphidicolin	  
(Oehlmann	   et	   al.	   2004).	   This	   function	   of	   Cdc6	   in	   activating	   a	   checkpoint	   following	   replicative	  
damages	   and	   leading	   to	   the	   arrest	   of	   the	   cell	   in	   S-­‐phase	   is	   conserved	   in	   fission	   yeast.	   Upon	  
Hydroxyurea	   (HU)	   exposure,	   S.	   pombe	   cells	   get	   arrested	   in	   S-­‐phase.	   Under	   this	   condition,	   the	  
expression	   level	   of	   Cdc6	   as	   well	   as	   its	   binding	   to	   the	   chromatin	   are	   stabilized,	   allowing	   the	  
recruitment	  of	  ATR	  (Hermand	  et	  al.	  2007).	  The	  depletion	  of	  Cdc6	  promotes	  the	  release	  of	  ATR	  from	  
chromatin	  and	   the	  entry	   in	  aberrant	  mitosis	   (Hermand	   et	  al.	   2007).	   The	   interaction	  between	  Cdc6	  
and	  ATR	   and	   their	   involvement	   in	   the	   replicative	   checkpoint	  was	   confirmed	   in	   human	   cells	   and	   in	  
Xenopus	  using	  extracts	  (Yoshida	  et	  al.	  2010).	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In	   conclusion,	   the	   depletion	   of	   Cdc6	   in	  mammalian	   cells	   blocks	   DNA	   replication	   and	   promotes	  M-­‐
phase	  as	   in	  yeast.	  However,	  on	  the	  contrary	  to	  yeast,	   the	  overexpression	  of	  Cdc6	  does	  not	  directly	  
inhibit	   Cdk1	   activity	   but	   rather	   prevents	   Cdk1	   activation	   through	   a	   checkpoint	   mechanism.	   This	  
mechanism	  is	  certainly	  the	  physiologically	  one	  that	  surveys	  DNA	  replication	  in	  the	  presence	  of	  stalled	  
forks.	  Cdc6	  is	  unlikely	  to	  induce	  re-­‐replication	  as	  its	  overexpression	  is	  not	  sufficient	  for	  launching	  the	  
re-­‐replication	   and	   additional	   components	   must	   be	   switched-­‐off	   to	   promote	   the	   re-­‐replication	  
process	  (Siddiqui	  et	  al.	  2013).	  Therefore,	  Cdc6	  overexpression	  blocks	  entry	  in	  M-­‐phase	  by	  activating	  
the	  checkpoint	  pathway	  surveying	  the	  presence	  of	  stalled	  forks.	  	  
The	   direct	   effect	   of	   Cdc6	   on	   Cdk1	   seems	   to	   be	   conserved	   only	   in	   lower	   eukaryotes.	   However,	   an	  
effect	  of	  Cdc6	  on	  M-­‐phase	  entry	  has	  been	  recently	  reported	  in	  Xenopus	  cycling	  extracts	  (El	  Dika	  et	  al.	  
2014).	  In	  extracts	  treated	  with	  Norcantharidin,	  which	  decreases	  the	  level	  of	  Cdc6	  expression	  (Li	  et	  al.	  
2006),	   or	   supplemented	  with	   a	   blocking	   antibody	   against	   Cdc6,	   Cdk1	   activation	  was	   advanced	   (El	  
Dika	   et	   al.	   2014).	   Reversely,	   the	   addition	   of	   recombinant	   Cdc6	   delayed	   Cdk1	   activation	   that	   is	  
restored	   following	   the	   overexpression	   a	   non-­‐degradable	   form	   of	   Cyclin	   B.	   This	   suggests	   that	   in	  
Xenopus,	   Cdc6	   has	   the	   potential	   to	   directly	   inhibit	   Cdk1-­‐Cyclin	   B	   complexes	   during	   the	   first	  
embryonic	  cell	  cycle,	  as	  it	  does	  in	  yeast	  (El	  Dika	  et	  al.	  2014).	  
b. Cdc6	  and	  the	  progression	  through	  M-­‐phase	  
i. Cdc6	  and	  the	  spindle	  formation	  
While	  in	  yeast	  Cdc6	  is	  rapidly	  degraded	  after	  S-­‐phase,	  Cdc6	  is	  present	  in	  G2-­‐	  and	  S-­‐phases	  during	  the	  
mammalian	  cell	  cycle	  and	  its	  function	  is	  regulated	  by	  changes	  in	  its	  subcellular	  localization	  (Williams	  
et	  al.	  1997).	  Human	  Cdc6	  is	  nuclear	  in	  G1	  and	  is	  translocated	  to	  the	  cytoplasm	  at	  the	  beginning	  of	  S-­‐
phase	   via	   a	   Crm1-­‐dependent	   export	  mechanism	   (Petersen	   et	   al.	   1999)	   (Jiang	   et	   al.	   1999).	   In	   CHO	  
cells,	  overexpressed	  Cdc6	  localizes	  to	  the	  mitotic	  spindle	  (Illenye	  et	  al.	  2004).	  Human	  cells	  depleted	  
for	  Cdc6	  in	  S-­‐phase	  enter	  in	  mitosis,	  despite	  the	  lack	  of	  DNA	  synthesis,	  but	  the	  spindle	  is	  abnormally	  
formed	   leading	   to	   aberrant	   chromosomal	   congression	   (Lau	   et	   al.	   2006).	   Altogether,	   these	   results	  
suggest	  a	  role	  for	  Cdc6	  in	  the	  spindle	  formation.	  	  
This	  role	  is	  conserved	  in	  mouse	  and	  Xenopus	  oocytes	  (Anger	  et	  al.	  2005,	  Narasimhachar	  et	  al.	  2012).	  
As	  in	  Xenopus	  oocytes,	  Cdc6	  is	  not	  present	  in	  prophase-­‐arrested	  mouse	  oocytes.	  The	  protein	  is	  barely	  
detected	   at	   GVBD	   and	   accumulates	   starting	  MI	   to	   reach	   a	   significant	   level	   at	  MII	   (Lemaitre	   et	   al.	  
2002,	  Whitmire	  et	  al.	  2002,	  Lemaitre	  et	  al.	  2004,	  Anger	  et	  al.	  2005).	  In	  mouse	  oocytes,	  the	  selective	  
destruction	  of	  Cdc6	  mRNA	  by	   injecting	  dsRNA	  does	  not	  block	  meiosis	   resumption	  as	   seen	  by	  Cdk1	  
activation,	   chromosomes	   condensation	  and	  nuclear	   envelope	  breakdown	  but	   the	   spindle	  does	  not	  
form	  and	  the	  1st	  polar	  body	  is	  not	  extruded	  (Anger	  et	  al.	  2005).	  In	  Xenopus	  oocytes,	  a	  small	  amount	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of	   Cdc6	   starts	   to	   be	   detected	   shortly	   after	   GVBD	   by	   immunofluorescence.	   It	   localizes	   around	   the	  
spindle	  precursor	  that	  forms	  at	  the	  basis	  of	  the	  germinal	  vesicle	  and	  then	  to	  the	  spindle	  poles	  of	  both	  
MI	   and	  MII	   spindles	   (Narasimhachar	   et	   al.	   2012).	   The	   inhibition	  of	  Cdc6	  expression	  with	   antisense	  
oligonucleotides	  or	   its	   inhibition	  by	  injecting	  blocking	  antibodies	  strongly	  perturbs	  the	  formation	  of	  
the	   spindle	   as	   in	   mouse	   oocytes	   and	   promotes	   the	   appearance	   of	   microtubules	   monasters	  
(Narasimhachar	   et	   al.	   2012).	   Furthermore,	   the	   rotation	   of	   the	   spindle	   and	   its	   attachment	   to	   the	  
animal	  cortex	  are	  abolished.	  The	  precise	  role	  of	  Cdc6	  in	  the	  formation	  of	  the	  spindle	  remains	  elusive	  
but	  Cdc6	  could	  act	  as	  a	  structural	  protein	  independently	  of	  its	  role	  as	  a	  replicative	  factor.	  	  
ii. The	  control	  of	  the	  metaphase	  to	  anaphase	  transition	  
In	  budding	  yeast,	   the	  exit	   from	  M-­‐phase	   is	   controlled	  by	   the	  activation	  of	  APCCdc20	   that	   specifically	  
promotes	  the	  degradation	  of	  the	  securin,	  Pds1,	  and	  then	  by	  APCHct1/Cdh1	  that	  controls	  the	  proteolysis	  
of	  the	  mitotic	  Cyclins	  (Schwab	  et	  al.	  1997,	  Visintin	  et	  al.	  1997,	  Shirayama	  et	  al.	  1998).	  Interestingly,	  
cells	  missing	  Hct1/Cdh1	  are	  unable	  to	  degrade	  mitotic	  Cyclins	  at	  the	  onset	  of	  anaphase	  but	  still,	  the	  
activity	  of	  Cdk1	  decreases	  and	  the	  cells	  exit	  from	  mitosis	  with	  a	  moderate	  delay	  (Schwab	  et	  al.	  1997,	  
Calzada	   et	   al.	   2001).	   The	   mechanism	   controlling	   the	   exit	   from	   M-­‐phase	   independently	   of	   Cyclin	  
degradation	  relies	  on	  proteins	  that	  directly	   inhibit	  Cdk1	  activity	  (Schwab	  et	  al.	  1997).	  However,	  the	  
substitution	  at	  the	  end	  of	  mitosis	  of	  the	  encoding	  Cyclin	  B	  gene	  with	  a	  non-­‐degradable	  form	  of	  Cyclin	  
B	   (Cyclin	   B-­‐ΔDbox)	   block	   the	   cells	   in	   M-­‐phase	   (Wasch	   et	   al.	   2002).	   It	   was	   then	   proposed	   that	  
impairing	   the	  Hct1/Cdh1-­‐dependent	  degradation	  of	  Cyclin	  B	   is	  not	  sufficient	   to	  block	   the	  exit	   from	  
M-­‐phase	  because	  of	   the	  APCCdc20	   -­‐dependent	  degradation	  of	  Cyclin	  B	   through	   the	  D-­‐box.	  However,	  
the	  expression	  level	  of	  Cyclin	  B-­‐ΔDbox	  is	  much	  higher	  than	  the	  endogenous	  wild-­‐type	  Cyclins	  (Wasch	  
et	  al.	  2002)	  and	  could	   result	   in	  a	  non-­‐physiological	  hyperactivation	  of	  Cdk1	   insensitive	   to	   the	  Cdk1	  
direct	  inhibitors,	  thus	  causing	  the	  M-­‐phase	  arrest.	  These	  experiments	  shed	  new	  light	  on	  the	  M-­‐phase	  
control	  by	  direct	  Cdk1	  inhibitors.	  
Several	  direct	  inhibitors	  of	  Cdk1	  are	  known,	  as	  including	  Sic1	  (the	  yeast	  homolog	  of	  p27Cip1)	  and	  Cdc6.	  
Cdc6	  can	  inhibit	  Cdk1	  activity	  independently	  of	  Sic1.	  The	  Cdc6	  inhibitory	  effect	  toward	  Cdk1	  depends	  
on	  the	  first	  47	  residues	  of	  the	  N-­‐terminus	  of	  Cdc6	  since	  the	  expression	  of	  (Δ47)-­‐Cdc6	  (truncation	  of	  
these	  47	  residues)	  still	  supports	  DNA	  replication	  without	  inhibiting	  Cdk1	  activity	  (Calzada	  et	  al.	  2001).	  
Cell	  lines	  either	  expressing	  (Δ47)-­‐Cdc6	  instead	  of	  wild-­‐type	  Cdc6	  or	  depleted	  for	  Sic1	  (Δsic1)	  are	  able	  
to	   exit	   M-­‐phase	   normally	   as	   seen	   by	   the	   degradation	   of	   mitotic	   Cyclins	   and	   Cdk1	   inactivation	  
(Calzada	  et	  al.	  2001).	  These	  results	  prove	  that	  neither	  Cdc6	  nor	  Sic1	  are	  necessary	  for	  the	  metaphase	  
to	  anaphase	  transition.	  However,	  cells	  combining	  both	  mutations,	  (Δ47)-­‐Cdc6	  and	  Δsic1,	  are	  blocked	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with	  two	  nuclei	  containing	  extended	  mitotic	  spindles	  (Calzada	  et	  al.	  2001),	  arguing	  for	  a	  defect	  in	  late	  
anaphase.	  These	  results	  were	  challenged	  by	  another	  group	  that	  produced	  a	  viable	  Δ47-­‐Cdc6	  cell	  line	  
performing	   full	  mitosis	   (Archambault	   et	   al.	   2003).	   Therefore,	   whether	   the	   presence	   of	   CDK	   direct	  
inhibitors	   is	   required	   for	   the	   metaphase	   to	   anaphase	   transition	   in	   yeast	   remains	   controversial.	  
However,	  other	  evidence	  supports	  a	  role	  of	  Cdc6	  in	  this	  process.	  Yeast	  cells	  depleted	  for	  Hct1/Cdh1	  
together	  with	  Cdc6	  are	  neither	  able	  to	  degrade	  mitotic	  Cyclins	  nor	  to	  inhibit	  Cdk1	  activity	  (Calzada	  et	  
al.	  2001).	  Moreover,	  a	  moderated	  overexpression	  of	  either	  Cdc6	  or	  Sic1	  rescue	  M-­‐phase	  exit	  in	  Cyclin	  
B-­‐ΔDbox	  cell	  lines,	  which	  are	  blocked	  in	  M-­‐phase	  with	  a	  high	  level	  of	  non-­‐degradable	  mitotic	  Cyclins	  
(Wasch	   et	   al.	   2002)(Archambault	   et	   al.	   2003).	   Therefore,	   the	   ability	   of	   Cdc6	   in	   inhibiting	   Cdk1	   is	  
necessary	  for	  the	  exit	  from	  M-­‐phase	  when	  the	  degradation	  of	  mitotic	  Cyclins	  is	  prevented,	  such	  as	  in	  
ΔHct1/Cdh1	  cell	  lines	  or	  in	  Cyclin	  B-­‐ΔDbox	  cell	  lines.	  Under	  these	  conditions,	  Cdk1	  inhibitors,	  as	  Sic1	  
or	  Cdc6,	  can	   inhibit	  the	   large	  number	  of	  active	  and	  stable	  CDK-­‐Cyclin	  complexes	  and	  allow	  the	  exit	  
from	  M-­‐phase.	  
C. Cdc6	  in	  apoptosis	  
Apoptosis	  is	  an	  organized	  program	  leading	  to	  cell	  death	  in	  response	  of	  internal	  stress	  stimuli	  (intrinsic	  
pathway)	  or	  external	  receptors	  (extrinsic	  pathway).	  The	  intrinsic	  pathway	  involves	  the	  formation	  of	  
mitochondrial	  pores,	  which	  derive	  from	  the	  polymerization	  of	  Bax	  and	  Bak	  proteins	  and	  permeabilize	  
the	   outer	   membrane	   of	   the	   mitochondria.	   This	   promotes	   the	   release	   in	   the	   cytoplasm	   of	   the	  
Cytochrome	   C	   (CytC)	   that	   binds	   the	   protein	   Apaf-­‐1	   to	   form	   the	   heptameric	   complex	   called	  
apoptosome.	   The	   apoptosome	   recruits	   and	   activates	   Caspase-­‐9	   that	   in	   turn	   activates	   Caspase-­‐3,	  
responsible	   for	   the	   execution	   of	   the	   apoptotic	   program.	   Interestingly,	   the	   expression	   of	   Apaf-­‐1	   is	  
under	   the	   control	   of	   E2F	   transcription	   factor	   family	   that	   also	   regulates	   the	   expression	   of	   genes	  
necessary	  for	  the	  S-­‐phase	  execution.	  Among	  them	  is	  Cdc6.	  	  
When	   Cdc6	   is	   overexpressed	   in	   fibroblasts	   in	   which	   apoptosis	   is	   induced,	   Cdc6	   associates	   with	  
monomeric	  Cyt	  C-­‐Apaf-­‐1	  complexes,	  blocks	  the	  apoptosome	  and	  impairs	  the	  activation	  of	  Caspase-­‐9	  
(Niimi	   et	  al.	  2012).	  This	   function	  depends	  on	   the	  ATPase	  activity	  of	  Cdc6	  since	  a	  mutant	  unable	   to	  
hydrolyse	   ATP	   cannot	   bind	   CytC-­‐Apaf-­‐1	   (Niimi	   et	   al.	   2012).	   Therefore,	   endogenous	   Cdc6	   could	  
attenuate	  the	  apoptosis	  pathway	  in	  unstressed	  conditions	  (Fig.	  37).	  	  
However,	  inhibiting	  the	  topoisomerase	  with	  etoposide,	  a	  treatment	  activating	  the	  intrinsic	  apoptotic	  
pathway,	   induces	  the	  cleavage	  of	  Cdc6	  by	  Caspase-­‐3	   leading	  to	  the	  production	  of	  a	  fragment	  of	  49	  
kDa	  (p49-­‐tCdc6)	  (Yim	  et	  al.	  2003).	  This	  fragment	  localizes	  mainly	  in	  the	  nucleus	  and	  its	  expression	  not	  
only	   enhances	   apoptosis,	   when	   activated	   by	   etoposide,	   but	   also	   induces	   apoptosis	   in	   unstressed	  
HeLa	  cells	  (Yim	  et	  al.	  2003).	  On	  the	  contrary,	  the	  expression	  of	  a	  Cdc6	  mutant	  that	  cannot	  be	  cleaved	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reduces	  the	  efficiency	  of	  Cdc6	  in	  inducing	  apoptosis	  (Yim	  et	  al.	  2006).	  The	  p49-­‐tCdc6	  fragment	  acts	  as	  
a	  dominant	  negative	  mutant	  for	  the	  assembly	  of	  the	  pre-­‐RCs	  by	  interfering	  with	  the	  loading	  of	  MCM2-­‐
7	  on	  the	  chromatin	  (Yim	  et	  al.	  2006).	  As	  MCM2-­‐7	  cannot	  be	  recruited	  on	  chromatin,	  ATM	  is	  activated	  
and	  phosphorylates	  p53	  at	  S15	  causing	  the	  activation	  of	  a	  checkpoint	  that	  ends	  with	  the	  induction	  of	  
apoptosis	  (Yim	  et	  al.	  2006)	  (Fig.	  37).	  
Altogether,	  Cdc6	  appears	  as	  a	  modulator	  of	  apoptosis	  that	  represses	  this	  pathway	  under	  unstressed	  
conditions	   but	   acts	   as	   an	   enhancer	   of	   the	   ATM-­‐	   and	   p53-­‐dependent	   pathway	   when	   an	   apoptotic	  
signal	  is	  launched	  through	  its	  cleaved	  fragment.	  
D. Roles	  of	  Cdc6	  during	  the	  meiotic	  division	  
a. The	  binding	  of	  oocyte	  to	  sperm	  
At	  the	  time	  of	  ovulation,	  the	  oocyte	  is	  released	  from	  the	  ovary	  and	  simultaneously	  resumes	  meiosis.	  
In	   amphibian,	   the	  passage	   through	   the	  oviduct	   is	  necessary	   for	   the	  MII-­‐arrested	  oocyte	   to	  acquire	  
the	  ability	  to	  bind	  sperm.	  This	  process	  is	  mediated	  by	  a	  protease	  that	  is	  secreted	  by	  the	  oviduct	  and	  
modifies	  the	  glycoprotein	  gp43	  present	  in	  the	  coelomic	  egg	  envelop	  (CE).	  This	  protease	  converts	  the	  
CE	  into	  the	  sperm-­‐receptive	  vitelline	  envelope	  (VE)	  (Tian	  et	  al.	  1997a).	  Prophase-­‐arrested	  oocytes	  are	  
unable	  to	  bind	  sperm	  despite	  their	  passage	  through	  the	  oviduct	  (Tian	  et	  al.	  1997b).	  The	  injection	  in	  
prophase	  oocytes	  of	  the	  total	  fraction	  of	  polyadenylated	  mRNAs	  extracted	  from	  MII-­‐arrested	  oocyte	  
does	   not	   induce	  meiotic	  maturation	   but	   confers	   to	   the	   oocyte	   the	   ability	   to	   bind	   sperm	   after	   the	  
passage	   through	   the	   oviduct	   (Tian	   et	   al.	   1997b).	   This	   suggests	   that	   a	   protein	   synthesized	   during	  
meiotic	  maturation	   in	   response	   to	   the	   polyadenylation	  of	   its	  mRNA	   is	   required	   for	   the	   interaction	  
between	  sperm	  and	  oocytes.	  After	  screening	  hundreds	  of	  mRNAs,	   it	  was	   found	  that	  Cdc6	  mRNA	   is	  
able	  to	  confer	  sperm	  binding	  ability	  (Tian	  et	  al.	  1997b).	  This	  unexpected	  and	  surprising	  new	  role	  of	  
Cdc6	  has	  never	  been	  further	  explored	  since	  that	  time.	  	  
	  
b. The	  competence	  to	  replicate	  
As	  described	   in	   the	   introduction,	  oocytes	  arrested	   in	  prophase	   I	  and	  quiescent	  cells	  arrested	   in	  G0	  
have	  developed	  a	  common	  strategy	  to	  avoid	  unscheduled	  DNA	  replication	  during	  their	   long	   lasting	  
arrest.	  In	  both	  systems,	  the	  inability	  to	  replicate	  is	  due	  to	  the	  absence	  of	  the	  Cdc6	  protein	  (Stoeber	  et	  
al.	  1998,	  Cook	  et	  al.	  2002,	  Lemaitre	  et	  al.	  2002,	  Whitmire	  et	  al.	  2002,	  Lemaitre	  et	  al.	  2004,	  Duursma	  
et	  al.	  2005,	  Mailand	  et	  al.	  2005).	  When	  the	  cell	  re-­‐enters	  the	  cell	  cycle,	  either	  in	  G1	  for	  somatic	  cells	  
or	   in	   the	   1st	   meiotic	   division	   for	   female	   germ	   cells,	   the	   ability	   to	   replicate	   is	   restored	   by	   the	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accumulation	  of	  Cdc6	   (Stoeber	   et	   al.	   1998,	  Cook	   et	   al.	   2002,	   Lemaitre	   et	   al.	   2002,	  Whitmire	   et	   al.	  
2002,	  Lemaitre	  et	  al.	  2004,	  Duursma	  et	  al.	  2005,	  Mailand	  et	  al.	  2005).	   In	  Xenopus	  oocyte,	  the	  Cdc6	  
protein	   starts	   to	   accumulate	   45	   to	   60	  minutes	   after	   GVBD	   and	   renders	   the	   replicative	  machinery	  
functional.	  However,	  the	  oocyte	  progresses	  directly	  from	  the	  1st	   to	  the	  2nd	  meiotic	  division	  without	  
using	   this	   functional	   replicative	   machinery	   (See	   chapter:	   I-­‐B.e.iii.	   “The	   molecular	   control	   of	   DNA	  
replication”)	  
c. Working	   hypothesis:	   how	   to	   suppress	   the	   Cdc6-­‐	   dependent	  
synchronisation	   of	   S-­‐phase	   with	   mitosis	   during	   meiotic	  
maturation	  	  
During	  the	  mitotic	  cell	  cycle,	  an	  important	  role	  of	  Cdc6	  is	  to	  synchronize	  S-­‐phase	  with	  the	  entry	  into	  
mitosis,	  a	  process	  fundamental	  to	  maintain	  genome	  stability	  and	  the	  ploidy	  of	  somatic	  cells.	  During	  
meiosis,	  the	  ploidy	  must	  be	  reduced	  by	  half,	  what	  is	  achieved	  by	  the	  two	  successive	  divisions	  without	  
intervening	  S-­‐phase,	  each	  division	  being	  triggered	  by	  a	  wave	  of	  Cdk1	  activation.	  During	  this	  meiosis-­‐
specific	   critical	   period,	   Cdc6	   starts	   to	   be	   expressed	   and	   the	   replicative	   machinery	   becomes	  
functional.	  Still,	  replication	  has	  to	  be	  repressed	  and	  the	  negative	  regulation	  exerted	  by	  Cdc6	  on	  Cdk1	  
activation,	   if	   any,	  has	   to	  be	   suppressed	   to	  ensure	   the	  proper	  progression	   through	   the	   two	  meiotic	  
divisions.	  One	  way	  to	  avoid	  this	  inhibitory	  effect	  could	  be	  by	  controlling	  precisely	  the	  timing	  of	  Cdc6	  
accumulation	  during	  meiotic	  maturation.	  	  
Little	  is	  known	  regarding	  the	  regulation	  of	  Cdc6	  during	  meiotic	  maturation.	  Cdc6	  is	  not	  expressed	  in	  
prophase	  and	  the	  timing	  of	  its	  translation	  is	  unknown.	  Based	  on	  the	  polyadenylation	  of	  its	  mRNA,	  it	  
has	  been	  proposed	  that	  Cdc6	  could	  be	  synthesized	  around	  the	  time	  of	  GVBD.	  However,	  the	  protein	  
starts	   to	   accumulate	   45	   minutes	   after	   GVBD.	   The	   delay	   between	   the	   initiation	   of	   its	   supposed	  
translation	   and	   its	   accumulation,	   strongly	   suggests	   that	   Cdc6	   accumulation	   and	   turnover	   are	  









	   136	  
E. Results	  
a. Generation	  of	  molecular	  tools	  
We	   started	   this	   project	   by	   cloning	   Xenopus	   wild-­‐type	   Cdc6	   (WT-­‐Cdc6)	   to	   generate	   mRNA	   and	  
recombinant	   GST-­‐tagged	   proteins.	  We	   further	   generated	   by	  mutagenesis	   two	  mutants	   of	   Cdc6:	   a	  
non-­‐recognizable	  form	  of	  Cdc6	  by	  SCFCdc4	  by	  mutating	  the	  F	  box	  TPxxS	  into	  APxxS	  (APxxS-­‐Cdc6),	  and	  a	  
non-­‐phosphorylatable	   form	  of	  Cdc6	  by	  mutating	   the	  7	  putative	   SP	   sites	   into	   alanine	   (7A-­‐Cdc6).	   To	  
further	   analyse	   Cdc6	   in	   oocytes,	  we	  produced	  Cdc6	   antibodies	   using	  Xenopus	  WT-­‐Cdc6	   as	   antigen	  
(Fig.	  39).	  
b. Cdc6	   is	   stable	   in	   prophase	   and	   is	   degraded	   in	   a	   SCFCdc4-­‐
dependent-­‐manner	  in	  response	  to	  progesterone	  
By	   injecting	   prophase	   oocytes	  with	  mRNA	   encoding	  WT-­‐	   or	   APxxS-­‐Cdc6,	   I	   discovered	   that	   Cdc6	   is	  
expressed	   in	   prophase.	   However,	   progesterone	   leads	   to	   the	   disappearance	   of	   the	   WT	   protein	  
whereas	   the	   APxxS	   mutant	   is	   still	   expressed	   until	   the	   time	   of	   GVBD.	   Both	   proteins	   are	   then	   re-­‐
accumulated	   at	  GVBD	  until	  MII.	   These	   results	   suggest	   that	   the	   protein	   is	   degraded	   in	   response	   to	  
progesterone	   in	   a	   SCFCdc4-­‐dependent	   manner.	   The	   injection	   of	   recombinant	   WT-­‐	   and	   APxxS-­‐Cdc6	  
proteins	   confirmed	   this	   conclusion.	   To	   further	   characterize	   the	   degradation	   mechanism	   targeting	  
Cdc6,	   the	   activity	   of	   the	   proteasome	   as	   well	   as	   Cdk1	   activation	   were	   respectively	   inhibited	   using	  
MG132	   or	   p21Cip1.	   Under	   both	   conditions,	   the	   degradation	   of	   WT-­‐Cdc6	   normally	   triggered	   by	  
progesterone	   was	   abolished,	   arguing	   that	   progesterone	   activates	   a	   SCFCdc4-­‐dependent	   mechanism	  
that	   targets	   Cdc6	   to	   the	   proteasome	   and	   induces	   its	   degradation.	   This	   process	   depends	   on	   Cdk1	  
activation,	  explaining	  why	  it	  happens	  just	  before	  GVBD,	  precisely	  at	  the	  time	  when	  Cdk1	  activation	  is	  
initiated.	  
c. Ectopic	  Cdc6	  is	  turning-­‐over	  during	  the	  MI-­‐MII	  transition	  
Next,	  WT-­‐Cdc6	  and	  APxxS-­‐Cdc6	  were	  injected	  in	  oocytes	  at	  the	  time	  of	  GVBD,	  when	  the	  activation	  of	  
Cdk1	   is	  established.	  Both	  recombinant	  proteins	   remained	  detectable	  at	  a	  constant	   level	  during	   the	  
entire	  process	  of	  meiotic	  maturation:	  during	  the	  MI-­‐MII	  transition	  until	  the	  MII	  arrest.	  However,	  the	  
inhibition	  of	  protein	   synthesis	  with	  CHX	  at	  GVBD	   led	   to	   the	  disappearance	  of	  both	  proteins	  within	  
one	  hour.	  These	  results	  show	  that	  Cdc6	  is	  subjected	  to	  turn-­‐over	  during	  the	  MI-­‐MII	  transition,	  being	  
regulated	  by	   two	  opposite	  mechanisms:	  one	  promoting	   its	   stabilisation,	  which	  depends	  on	  protein	  
synthesis,	  and	  a	  second	  one	  leading	  to	  its	  degradation,	  which	  is	  independent	  of	  SCFCdc4.	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d. The	   accumulation	   of	   endogenous	   Cdc6	   is	   under	   the	   dual	  
control	  of	  Cdk1-­‐Cyclin	  B	  and	   the	  Mos/MAPK	  pathway	  during	  
the	  MI-­‐MII	  transition	  
Since	  the	  addition	  of	  CHX	  at	  GVBD	  leads	  to	  the	  inactivation	  of	  the	  Mos/MAPK	  pathway	  and	  prevents	  
the	   reactivation	   of	   Cdk1,	   we	   wondered	   whether	   these	   two	   kinase	   activities	   could	   play	   a	   role	   in	  
regulating	  Cdc6	  turnover.	  Both	  activities	  phosphorylate	  in	  vitro	  Cdc6	  at	  SP	  sites	  and	  the	  mutation	  of	  
these	  sites	  in	  alanine	  abolishes	  the	  phosphorylation	  of	  Cdc6	  induced	  by	  either	  active	  Cdk1	  or	  MAPK.	  
Furthermore,	  the	  7A	  mutant	  of	  Cdc6	  is	  still	  degraded	  when	  injected	  at	  GVBD	  in	  the	  presence	  of	  CHX	  
indicating	   that	   the	   phosphorylation	   of	   Cdc6	  might	   not	   be	   involved	   in	   the	   stabilization	   and	   in	   the	  
degradation	  of	  the	  protein	  post-­‐GVBD.	  	  
To	  decipher	   the	  effects	  of	  Cdk1	  and	  of	  MAPK	  on	  Cdc6	   turnover,	   the	   activity	  of	   either	  Cdk1	  or	   the	  
Mos/MAPK	  pathway	  were	   inhibited	   after	  GVBD	  using	   either	   antisense	   oligonucleotides	   specifically	  
directed	   against	   either	   Cyclin	   B	  mRNA	  or	  Mos-­‐morpholinos	   oligonucleotides.	   These	   treatments	   do	  
not	  block	  the	  1st	  wave	  of	  Cdk1	  activation	  and	  GVBD.	  However,	  oocytes	  are	  unable	  to	  reactivate	  Cdk1	  
in	   the	  presence	  of	  Cyclin	  B	  antisense	  whereas	   in	   the	  presence	  of	  Mos-­‐morpholinos,	   the	  activity	  of	  
Cdk1	  reincreases	  after	  meiosis	   I.	  The	  accumulation	  of	  endogenous	  Cdc6	  was	  monitored	  under	  each	  
condition.	   In	   control	   oocytes,	   the	   accumulation	   of	   Cdc6	   starts	   45	  minutes	   after	   GVBD.	   In	   Cyclin	   B	  
antisense-­‐injected	  oocytes,	  Cdk1	  is	  not	  reactivated	  and	  the	  accumulation	  of	  Cdc6	  is	  strongly	  delayed,	  
occurring	   only	   180	   minutes	   after	   GVBD,	   at	   the	   time	   of	   MAPK	   inactivation.	   In	   contrast,	   in	   Mos-­‐
morpholinos	  oocytes,	  Cdc6	  accumulation	   is	   advanced,	  being	  detected	   right	   after	  GVBD.	  Therefore,	  
during	  the	  MI-­‐MII	  transition,	  the	  accumulation	  of	  endogenous	  Cdc6	  is	  positively	  regulated	  by	  Cyclin	  B	  
accumulation	   or/and	   Cdk1	   re-­‐activation,	   whereas	   the	   Mos/MAPK	   pathway	   postpones	   the	  
appearance	  of	   Cdc6.	   To	   decipher	  whether	   the	  Cyclin	   B-­‐Cdk1	  dependent	   stabilization	  of	   Cdc6	   after	  
GVBD	  is	  caused	  by	  Cyclin	  B	  accumulation	  or	  by	  the	  catalytic	  activity	  of	  Cdk1,	  recombinant	  WT-­‐Cdc6	  
was	  injected	  at	  GVBD	  in	  oocytes	  treated	  with	  CHX	  together	  with	  trace-­‐amounts	  of	  a	  non-­‐degradable	  
form	  of	  Cyclin	  B.	  This	   low	  amount	  of	  Cyclin	  B	   is	  not	  high	  enough	  to	  reactivate	  Cdk1	   in	  CHX-­‐treated	  
oocytes.	  However,	  it	  abolishes	  the	  degradation	  of	  WT-­‐Cdc6	  in	  CHX-­‐treated	  oocytes.	  Therefore,	  Cdc6	  
is	   not	   stabilized	   by	   the	   catalytic	   activity	   of	   Cdk1	   after	  GVBD,	   but	   by	   the	   accumulation	   of	   Cyclin	   B.	  
Since	   both	   endogenous	   and	   ectopic	   Cdc6	   are	   able	   to	   interact	   with	   Cdk1-­‐Cyclin	   B	   complexes,	   this	  
further	  suggests	  that	  the	  direct	  interaction	  between	  Cdc6	  and	  Cyclin	  B	  is	  involved	  in	  this	  stabilization	  
mechanism,	  a	  process	  reminiscent	  of	  what	  happens	  the	  yeast	  system.	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e. Overexpressing	  Cdc6	  blocks	   Cdk1	   reactivation	  and	  drives	   the	  
oocyte	  into	  a	  replicative	  interphasic	  state	  after	  meiosis	  I	  
We	  then	  addressed	  the	  question	  of	  the	  consequences	  of	  the	  tight	  regulation	  of	  Cdc6	  accumulation	  
during	  meiotic	   maturation.	   Since	   Cdc6	   is	   a	   potent	   inhibitor	   of	   Cdk1	   in	   somatic	   cells	   as	   well	   as	   in	  
Xenopus	   extracts,	   this	   led	   us	   to	   hypothesize	   that	   deregulating	   the	   expression	   level	   of	   Cdc6	   could	  
affect	   the	   activity	   of	   Cdk1	   in	   our	  model	   system.	   In	   the	   experiments	   described	   previously,	   ectopic	  
Cdc6	  was	  expressed	  at	  a	  low	  concentration,	  0.05	  µM.	  When	  injected	  at	  this	  concentration	  either	  in	  
prophase	  or	  at	  GVBD,	  Cdc6	  affects	  neither	  entry	  into	  MI	  nor	  the	  reactivation	  of	  Cdk1	  at	  MII	  entry.	  We	  
then	  raised	  the	  amount	  of	  injected	  Cdc6	  to	  0.5	  µM,	  corresponding	  to	  the	  physiological	  concentration	  
of	  endogenous	  Cdc6	  at	  MII.	  Surprisingly,	  the	  injection	  of	  this	  higher	  amount	  of	  WT-­‐Cdc6	  delays	  GVBD	  
induction	  and	  decreases	  the	  level	  of	  Cdk1	  activity	  in	  response	  to	  progesterone.	  This	  inhibitory	  effect	  
over	  Cdk1	  activation	  is	  enhanced	  by	  the	  APxxS	  mutation	  that	  stabilizes	  Cdc6:	  almost	  all	  the	  oocytes	  
injected	  by	  this	  stable	  mutant	  are	  unable	  to	  activate	  Cdk1	  and	  to	  resume	  meiosis.	  We	  assume	  that	  
the	  APxxS-­‐Cdc6	  is	  more	  efficient	  because	  it	  is	  not	  degraded	  upon	  progesterone	  addition.	  Therefore,	  
Cdc6	  can	  inhibit	  Cdk1	  activation	  and	  entry	  into	  the	  1st	  meiotic	  division.	  Next,	  0.5	  µM	  of	  WT-­‐Cdc6	  was	  
injected	  at	  GVBD	  and	  the	  reactivation	  of	  Cdk1	  was	  followed	  up	  to	  4	  hours	  after	  GVBD.	  Injected	  WT-­‐
Cdc6	   remains	   stable	   after	   GVBD	   and	   abolishes	   the	   reactivation	   of	   Cdk1	   as	   well	   as	   the	   entry	   into	  
meiosis	  II.	  Under	  this	  condition,	  the	  oocytes	  replicate	  their	  DNA.	  Importantly,	  the	  inhibition	  of	  Cdk1	  
induced	  by	  Cdc6	  is	  still	  observed	  when	  DNA	  replication	  is	  blocked	  by	  aphidicolin.	  This	  indicates	  that	  
Cdc6	  directly	   inhibits	  Cdk1	  activation	  and	   that	   this	  process	   is	  not	  an	   indirect	  effect	  caused	  by	  DNA	  
replication.	  Conversely,	  the	  setting-­‐up	  of	  DNA	  replication	  directly	  depends	  on	  the	  inhibition	  of	  Cdk1	  
induced	  by	  Cdc6.	  
f. A	   new	   model	   for	   the	   regulation	   of	   Cdc6	   during	   the	   meiotic	  
divisions	  
Based	  on	  these	  results,	  we	  propose	  a	  model	  wherein	  the	  tight	  control	  of	  Cdc6	  accumulation	  is	  critical	  
to	  ensure	  the	  proper	  activation	  of	  Cdk1	  and	  thus,	  the	  succession	  of	  the	  two	  meiotic	  divisions	  with	  no	  
intervening	  S-­‐phase.	  
In	  this	  model,	  the	  translation	  of	  Cdc6	  is	  initiated	  at	  the	  time	  of	  the	  1st	  Cdk1	  activation.	  However,	  the	  
protein	  cannot	  accumulate	  because	  Cdk1	  activates	  a	  SCFCdc4-­‐dependent	  mechanism	  that	  targets	  Cdc6	  
for	  degradation	  to	  the	  proteasome.	  While	  this	  mechanism	  may	  not	  be	  physiologically	  involved	  during	  
meiosis	  resumption,	  it	  could	  be	  seen	  as	  a	  safeguard	  mechanism	  to	  ensure	  the	  absence	  of	  Cdc6	  at	  the	  
time	   of	   the	   1st	   activation	   of	   Cdk1	   that	   could	   otherwise	   perturb	  meiosis	   resumption.	   Starting	   from	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GVBD,	   Cdc6	   cannot	   accumulate	   at	   high	   levels	   because	   the	   Mos/MAPK	   pathway	   is	   activated,	  
promoting	   the	   degradation	   of	   the	   protein,	   and	   because	   Cyclin	   B,	   that	   stabilizes	   Cdc6,	   is	   rapidly	  
degraded	  once	  MI	  is	  completed.	  One	  hour	  after	  GVBD,	  Cyclin	  B	  starts	  to	  reaccumulate	  and	  stabilizes	  
Cdc6	   through	   a	   direct	   interaction.	   This	   stabilization	   mechanism	   overcomes	   the	   negative	   effect	  
exerted	  by	   the	  Mos/MAPK	  pathway	  on	  Cdc6	   turnover	   and	   allows	   the	  progressive	   accumulation	  of	  
Cdc6	  during	  the	  entry	  into	  MII	  and	  during	  the	  CSF	  arrest.	  This	  tight	  regulation	  controls	  the	  expression	  
level	  of	  Cdc6	  during	  the	  MI-­‐MII	  transition	  and	  prevents	  its	  ability	  to	  inhibit	  Cdk1	  activity,	  which	  would	  
lead	   to	   DNA	   replication.	   This	   process	   then	   indirectly	   inhibits	   the	   occurrence	   of	   DNA	   replication	  
between	   the	   two	  meiotic	   divisions	   but	   allows	   at	   the	   same	   time	   the	   accumulation	   of	   Cdc6	   that	   is	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F. Discussion	  
During	  the	  mitotic	  cell	  cycle,	  S-­‐	  and	  M-­‐phases	  are	  synchronized	  to	  ensure	  that	  the	  cell	  division	  does	  
not	  start	  before	  the	  completion	  of	  DNA	  replication.	   In	  proliferative	  cells,	  one	  way	  to	  arrest	  the	  cell	  
cycle	  before	  M-­‐phase	  is	  to	  inactivate	  or	  to	  remove	  pre-­‐RCs.	  When	  unsynchronized	  cells	  are	  treated	  
with	  aphidicolin,	  replication	  does	  not	  start	  and	  cells	  accumulate	  at	  the	  G1/S	  (Pedrali-­‐Noy	  et	  al.	  1980).	  
In	   yeast,	   the	   expression	   of	   a	   temperature-­‐sensitive	   mutant	   of	   ORC5	   inhibits	   DNA-­‐replication	   as	  
expected,	  but	  also	  blocks	  the	  cell	  cycle	  either	  at	  the	  G1/S	  transition	  or	  in	  early	  M-­‐phase	  (Dillin	  et	  al.	  
1998),	   whereas	   the	   expression	   of	   temperature-­‐sensitive	  mutants	   of	  Mcm2	   and	  Mcm3	   arrests	   the	  
cells	  before	  M-­‐phase	  (Yan	  et	  al.	  1991).	  These	  phenotypes	  imply	  that	  these	  proteins	  have	  additional	  
functions	  during	  the	  cell	  cycle	  than	  regulating	  DNA	  replication	  in	  S-­‐phase.	  Surprisingly,	  the	  depletion	  
of	   either	   Cdc6	   or	   Cdt1	   abolishes	   DNA	   replication	   in	   yeast,	   but	   the	   cells	   are	   still	   entering	   and	  
completing	  mitosis	  and,	  consequently,	  undergo	  a	  reductional	  anaphase	  (Hofmann	  et	  al.	  1994,	  Piatti	  
et	  al.	  1995).	  By	  directly	  or	  indirectly	  inhibiting	  Cdk1	  activation	  in	  this	  model	  system,	  Cdc6	  is	  therefore	  
able	  to	  synchronize	  S-­‐phase	  with	  M-­‐phase,	  avoiding	  the	  reduction	  of	  the	  ploidy	  and	  contributing	  to	  
maintain	  genome	  stability.	  	  
During	  meiosis,	   this	  synchronization	  must	  be	   lost	   to	  ensure	  the	  succession	  of	   two	  meiotic	  divisions	  
without	  an	  intervening	  S-­‐phase.	  This	  process	  is	  necessary	  to	  reduce	  by	  half	  the	  ploidy	  of	  the	  cell	  and	  
to	  generate	  fertilizable	  haploid	  gametes.	  In	  Xenopus	  oocytes,	  we	  show	  that	  Cdc6	  has	  the	  potential	  to	  
inhibit	   Cdk1	   activity	   by	   directly	   interacting	   with	   Cdk1-­‐Cyclin	   B	   complexes,	   independently	   of	   the	  
activation	  of	  ATM	  and	  ATR-­‐dependent	  checkpoints.	  This	  result	  strongly	  suggests	  that	  the	  function	  of	  
Cdc6	   as	   a	   synchronizer	   of	   S-­‐phase	   with	   cell	   division	   is	   conserved	   during	   meiotic	   maturation	   of	  
Xenopus	   oocytes,	   although	   this	   function	   is	   repressed.	   The	   tight	   control	   of	   the	   timing	   of	   Cdc6	  
accumulation	   in	   oocytes	   is	   used	   as	   a	   strategy	   to	   ensure	   the	   inhibition	   of	   DNA	   replication	  without	  
arresting	  the	  cell	  between	  the	  two	  meiotic	  divisions.	  
a. A	   tiny	   window	   between	   the	   initial	   activation	   of	   Cdk1	   and	  
GVBD	  to	  get	  rid	  out	  Cdc6	  
During	  the	  prophase	  arrest,	  the	  absence	  of	  Cdc6	  is	  sufficient	  to	  prevent	  the	  assembly	  of	  the	  pre-­‐RCs	  
(Lemaitre	  et	  al.	  2002,	  Whitmire	  et	  al.	  2002)	  (Fig.	  38).	  As	  the	  oocyte	  resumes	  meiosis,	  Cdc6	  mRNA	  are	  
polyadenylated	  downstream	  the	  1st	   activation	  of	  Cdk1,	   suggesting	   that	  Cdc6	   translation	   is	   initiated	  
around	   the	   time	  of	  GVBD	   (Lemaitre	   et	  al.	  2002).	  We	  confirmed	   this	  Cdk1-­‐dependent	   regulation	  by
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showing	   that	   the	   inhibition	   of	   the	   1st	   activation	   of	   Cdk1	   by	   p21Cip1	   injection	   prevents	   the	  
accumulation	   of	   endogenous	   Cdc6	   in	   response	   to	   progesterone.	   However,	   the	   protein	   cannot	  
accumulate	  because	  a	  degradation	  mechanism	   is	   simultaneously	  activated	  and	   targets	  Cdc6	   to	   the	  
proteasome	  for	  proteolysis.	  This	  degradation	  mechanism	  relies	  on	  the	  F-­‐box	  binding	  motif	  of	  Cdc6,	  
and	  thus	  certainly	  on	  the	  SCFCdc4	  system,	  and	  is	  activated	  in	  a	  Cdk1-­‐dependent	  manner.	  Whether	  this	  
SCFCdc4	   degradation	   mechanism	   has	   a	   physiological	   role	   and/or	   is	   necessary	   during	   meiosis	  
resumption	  is	  unknown.	  However,	  it	  is	  interesting	  to	  note	  that	  Cdc6	  is	  not	  the	  only	  regulator	  of	  Cdk1	  
that	   is	   degraded	   by	   this	   system.	   However	   SCF	   ubiquitination	   system	   was	   already	   reported	   to	   be	  
active	  during	  meiosis	  resumption	  since	  Erp1	  is	  degraded	  by	  SFCBtrcp	  when	  overexpressed	  in	  prophase	  
oocytes	  (Margottin-­‐Goguet	  et	  al.	  2003).	  When	  prophase	  oocytes	  are	   injected	  with	  high	  amounts	  of	  
WT-­‐Cdc6,	  they	  resume	  meiosis	  and	  activate	  Cdk1,	  but	  after	  a	  significant	  delay.	  Moreover,	  the	  same	  
amount	   of	   a	   stable	   form	   of	   Cdc6,	   which	   cannot	   be	   recognized	   by	   SCFCdc4,	   abolishes	   meiosis	  
resumption	  and	  Cdk1	  activation.	  This	  suggests	  that	  the	  SCFCdc4-­‐dependent	  degradation	  system	  could	  
act	  as	  a	  safeguard	  mechanism	  to	  eliminate	  right	  before	  GVBD	  any	  traces	  of	  Cdc6	  that	  could	  disturb	  
the	  full	  activation	  of	  Cdk1	  (Fig.	  38).	  One	  important	  issue	  regards	  the	  mechanism	  induced	  by	  Cdk1	  and	  
leading	   to	   Cdc6	   degradation.	   Is	   the	   Cdk1-­‐dependent	   phosphorylation	   of	   Cdc6	   required	   for	   its	  
recognition	  by	  SCFCdc4	  and	   its	  consecutive	  degradation,	  as	   in	  yeast	   (Drury	  et	  al.	  1997,	  Perkins	  et	  al.	  
2001)?	   Is	   Cdk1	   regulating	   directly	   the	   activity	   of	   SCFCdc4?	   The	   injection	   of	   the	   7A-­‐Cdc6	   mutant	   in	  
prophase	  will	  tell	  us	  whether	  the	  phosphorylation	  of	  Cdc6	  at	  SP	  sites	  is	  necessary	  for	  its	  degradation	  
in	  response	  to	  progesterone.	  
b. The	  Mos/MAPK	  pathway:	  a	  Godfather	   for	  Cdk1	  between	   the	  
two	  meiotic	  divisions	  
Once	   Cdk1	   is	   fully	   activated,	   it	   induces	   the	   breakdown	   of	   the	   nuclear	   envelope	   and	   DNA	  
condensation,	   two	   conditions	   incompatible	   with	   DNA	   replication	   in	   somatic	   cells.	   At	   GVBD,	   the	  
Mos/MAPK	  pathway	   is	   also	   activated.	  When	   the	  activation	  of	   this	  pathway	   is	   prevented	  with	  Mos	  
antisense	   oligonucleotides	   or	   U0126,	   the	   oocytes	   enter	   an	   interphasic	   state	   and	   replicate	   DNA	  
(Furuno	  et	  al.	  1994,	  Gross	  et	  al.	  2000,	  Dupre	  et	  al.	  2002).	  Therefore,	  the	  Mos/MAPK	  pathway	  plays	  a	  
pivotal	  role	  in	  inhibiting	  DNA	  replication	  after	  the	  1st	  meiotic	  division.	  	  
This	  kinase	  cascade	  (from	  Mos	  to	  p90Rsk)	  positively	  regulates	  the	  level	  of	  Cyclin	  B	  expression	  during	  
the	  MI-­‐MII	  transition	  in	  two	  manners:	  by	  attenuating	  its	  degradation	  and	  by	  promoting	  its	  synthesis	  
(Gross	  et	  al.	  2000,	  Dupre	  et	  al.	  2002).	  The	  Mos/MAPK	  pathway	  then	  contributes	  to	  Cdk1	  reactivation	  
by	  ensuring	  the	  fast	  reaccumulation	  of	  Cyclins	  B	  after	  the	  meiosis	  I,	  thus	  leading	  to	  entry	  into	  meiosis	  
II.	   The	   fact	   that	   recombinant	  Mos	   injected	   at	   GVBD	   is	   unable	   to	   prevent	   the	   occurrence	   of	   DNA	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replication	   in	   the	  presence	  of	   CHX	   strongly	   suggests	   that	   the	   ability	   of	   the	  Mos/MAPK	  pathway	   in	  
inhibiting	  DNA	  replication	  acts	  through	  the	  activity	  of	  Cdk1	  (Furuno	  et	  al.	  1994).	  	  
However,	   our	   results	   enlighten	   a	   new	   function	   of	   the	   Mos/MAPK	   pathway	   that	   postpones	   the	  
accumulation	   of	   Cdc6	   after	   GVBD.	   The	   inhibition	   of	   the	   Mos/MAPK	   pathway	   with	   either	   Mos	  
morpholino	   or	  U0126	   strongly	   advances	   Cdc6	   accumulation.	   Importantly,	   this	   new	   function	   of	   the	  
Mos/MAPK	   pathway	   is	   independent	   of	   the	   level	   of	   Cyclin	   B	   expression,	   as	   oocytes	   injected	   with	  
Cyclin	  B	  oligonucleotides	  cannot	  accumulate	  Cdc6	  unless	   the	  Mos/MAPK	  pathway	  gets	   inactivated.	  
Since	  the	  absence	  of	  Cdc6	  is	  sufficient	  to	  avoid	  DNA	  replication	  between	  the	  two	  meiotic	  divisions,	  
the	  Mos/MAPK	  pathway	  then	  can	  inhibit	  DNA	  replication	  on	  its	  own	  by	  delaying	  the	  accumulation	  of	  
endogenous	  Cdc6,	   independently	  of	   its	  effect	  over	  Cyclin	  B	  turnover	   (Fig.	   38).	  How	  the	  Mos/MAPK	  
controls	  Cdc6	  turnover	  and	  what	  are	  the	  mechanisms	  leading	  to	  the	  degradation	  of	  Cdc6	  during	  the	  
MI-­‐MII	  transition	  deserve	  further	  investigation.	  	  
In	   mitosis,	   APCCdh1	   is	   active	   at	   late	   anaphase	   and	   promotes	   the	   degradation	   of	   Cdc6.	   Cdh1	   is	  
expressed	   in	   both	   prophase-­‐	   and	   MII-­‐arrested	   oocytes	   (Zhou	   et	   al.	   2002,	   Papin	   et	   al.	   2004).	   In	  
Xenopus,	   since	   the	   inhibition	   of	   Cdh1	   expression	  with	   antisense	   oligonucleotides	   prevents	  meiosis	  
resumption	  induced	  by	  progesterone	  (Papin	  et	  al.	  2004),	  its	  involvement	  during	  the	  MI-­‐MII	  transition	  
is	  difficult	  to	  address.	   In	  yeast,	  a	  specific	   inhibitor	  of	  APCCdh1,	  called	  Acm1,	  has	  been	  identified.	  This	  
inhibitor	   acts	   as	   a	   pseudo-­‐substrate	   by	   preventing	   the	   interaction	   of	   Cdh1	   with	   its	   physiological	  
substrates	   (Martinez	  et	  al.	  2006,	  Martinez	  et	  al.	  2012).	  Acm1	  could	  be	  used	   in	  Xenopus	  oocytes	   to	  
inhibit	  the	  function	  of	  Cdh1	  after	  GVBD	  in	  order	  to	  determine	  whether	  this	  protein	  is	  involved	  or	  not	  
in	  Cdc6	  degradation	  during	  the	  MI-­‐MII	  transition.	  
The	  other	  form	  of	  APC/C,	  APCCdc20,	  is	  activated	  at	  the	  time	  of	  GVBD	  and	  its	  inhibition	  with	  antisense	  
oligonucleotides	   does	   not	   prevent	   the	  MI-­‐MII	   transition	   (Taieb	   et	   al.	   2001).	   Our	   preliminary	   data	  
indicates	   that	   the	   inhibition	   of	   Cdc20	   synthesis	   with	   antisense	   oligonucleotides	   advances	   the	  
accumulation	  of	  Cdc6	  compared	  to	  control	  oocytes.	  This	  suggests	  that	  the	  activity	  of	  APCCdc20	  could	  
regulate	   the	   level	  of	  Cdc6	  accumulation.	  Whether	   this	  mechanism	   is	  direct	  or	   is	  mediated	   through	  
Cyclin	  B	  accumulation	   remains	  an	   important	  question	   to	  elucidate.	   Interestingly,	   in	   yeast,	   the	   cells	  
can	  exit	   from	  M-­‐phase	   independently	  of	   the	  degradation	  of	  mitotic	  Cyclins	  due	   to	   the	  presence	  of	  
direct	  inhibitors	  of	  Cdk1	  such	  as	  Cdc6	  (See	  chapter:	  III-­‐,B.b.ii.	  “the	  control	  of	  metaphase	  to	  anaphase	  
transition”).	   Since	  oocytes	  accumulate	  Cdc6	   in	   advance	  when	   the	   synthesis	  of	  Cdc20	   is	  prevented,	  
Cdc6	   could	   counteract	   the	   absence	   of	   Cyclin	   B	   degradation	   during	   the	   exit	   from	  MI	   by	   inducing	   a	  
local	  inhibition	  of	  Cdk1.	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c. What	   roles	   for	   the	   interaction	  between	  Cdc6	  and	   the	  Cyclins	  
B	  ?	  
During	  the	  MI-­‐MII	  transition,	  the	  reaccumulation	  of	  Cyclin	  B	  promotes	  the	  reactivation	  of	  Cdk1,	  the	  
stabilization	   of	   Cdc6	   and	   the	   oocytes	   enter	   meiosis	   II.	   Furthermore,	   both	   endogenous	   and	  
recombinant	   Cdc6	   directly	   interact	   with	   Cdk1-­‐Cyclin	   B	   complexes.	   The	   activity	   of	   Cdk1,	   a	   potent	  
inhibitor	  of	  DNA	  replication	  in	  somatic	  cells,	  increases	  concomitantly	  with	  Cdc6	  because	  both	  events	  
rely	   on	   Cyclin	   B	   accumulation.	   Therefore,	   Cdc6	   starts	   to	   accumulate	   when	   Cdk1	   is	   not	   yet	   fully	  
reactivated.	   At	   that	   moment,	   the	   interaction	   between	   Cdc6,	   Cdk1	   and	   Cyclin	   B	   would	   therefore	  
support	   a	   double	   function:	   stabilizing	   Cdc6	   (that	   needs	   to	   be	   accumulated	   to	   support	   the	   future	  
embryonic	  cell	  cycles)	  and	  sequestering	  Cdc6	  to	  block	  its	  ability	  to	  form	  pre-­‐RC.	  This	  mechanism	  has	  
already	  been	  proposed	   in	  yeast,	   in	  which	   the	  binding	  of	  Cdc6	   to	   the	  mitotic	  Cyclins	  prevents	  Cdc6	  
from	  interacting	  with	  ORC	  proteins	  (Mimura	  et	  al.	  2004).	  	  
This	   mechanism	   of	   “Cdc6	   trapping”	   that	   both	   stabilizes	   Cdc6	   and	   blocks	   pre-­‐RCs	   formation	   is	  
reminiscent	   of	   Cdt1	   inhibition	   by	  Geminin.	   Geminin	  was	   shown	   to	   stabilize	   Cdt1	   by	   preventing	   its	  
ubiquitin-­‐dependent	   degradation	   in	   G2	   and	   during	   mitosis	   (Ballabeni	   et	   al.	   2004)	   and	   by	   further	  
inhibiting	   its	   ability	   to	   form	   pre-­‐RC	   (Ballabeni	   et	   al.	   2013).	   At	   the	   end	   of	   anaphase,	   APCCdc20	   is	  
activated,	  promotes	  the	  ubiquitination	  of	  Geminin	  that	  releases	  Cdt1.	  Cdt1	  then	  participates	   in	  the	  
licensing	   of	   replicative	   origins.	   This	   simplified	   model	   for	   Cdt1	   regulation	   by	   Geminin	   has	   been	  
challenged	  showing	  that	  Geminin	  binds	  Cdt1,	  but	  the	  effect	  of	  this	  interaction,	  in	  terms	  of	  promoting	  
or	  inhibiting	  pre-­‐RC	  formation,	  depends	  on	  the	  stoichiometric	  of	  Cdt1/Geminin	  complexes	  (Lutzmann	  
et	  al.	  2006).	  	  
In	  Xenopus	  oocytes,	  Cdt1	  and	  Geminin	  are	  already	  present	  in	  prophase	  and	  their	  levels	  of	  expression	  
increase	   significantly	   during	   meiotic	   maturation	   (Lemaitre	   et	   al.	   2002,	   Whitmire	   et	   al.	   2002,	  
Narasimhachar	  et	  al.	  2009).	  In	  this	  model	  system,	  Geminin	  stabilizes	  Cdt1	  as	  seen	  by	  the	  decrease	  in	  
the	  expression	  level	  of	  Cdt1	  following	  the	  inhibition	  of	  Geminin	  synthesis.	  However,	  Geminin	  is	  not	  
necessary	   to	   inhibit	  DNA	   replication	   in	  Xenopus	  oocytes,	   since	   its	  downregulation	  does	  not	   induce	  
unscheduled	   DNA	   replication	   (Narasimhachar	   et	   al.	   2009).	   Whether	   Geminin	   overexpression	   is	  
sufficient	   to	   inhibit	   DNA	   replication	   induced	   by	   CHX	   treatment	   after	   GVBD	   is	   not	   known.	   These	  
experiments	  suggest	  that	  Geminin,	  at	   its	  physiological	  concentration,	  may	  not	  be	  able	  to	  modulate	  
Cdt1	   ability	   to	   form	  pre-­‐RC	  during	  Xenopus	  meiotic	  maturation.	   The	   situation	  of	   the	  oocytes	   after	  
GVBD	  is	  therefore	  critical	  because	  there	  is	  no	  mechanism	  to	  restrict	  the	  pre-­‐RC	  assembly	  beside	  the	  
lack	   of	   Cdc6.	   Therefore,	   once	   Cdc6	   start	   to	   accumulate,	   the	   interaction	   between	   Cdc6,	   Cdk1	   and	  
Cyclin	  B	  could	  become	  an	  essential	  mechanism	  preventing	  DNA	  replication	  initiation	  (Fig.	  38).	  Upon	  
fertilization,	   the	   degradation	   of	   Cyclin	   B	   releases	   Cdc6	   that	   can	   in	   turn	   contribute	   to	   the	   pre-­‐RC	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formation.	   Cyclin	   B	   would	   therefore	   play	   two	   opposite	   roles	   on	   DNA	   replication	   during	   meiotic	  
maturation:	   preventing	   the	   origin	   licensing	   during	   the	  MI-­‐MII	   transition	   by	   sequestering	   Cdc6,	   but	  
allowing	  its	  accumulation	  that	   is	  necessary	  to	  support	  DNA	  replication	  after	  fertilization,	  during	  the	  
embryonic	  cell	  cycles.	  	  
	  
To	  better	  understand	  Cdc6	  stabilization	  by	  Cyclin	  B,	   it	  will	  be	  first	   important	  to	  determine	  whether	  
Cdc6	  interacts	  with	  Cdk1,	  with	  Cyclin	  B	  or	  both	  proteins	  by	  performing	  GST	  pull	  down	  experiments	  in	  
oocytes	  depleted	  from	  Cyclin	  B	  by	  antisense	  oligonucleotides.	   In	  yeast,	  Cdc6	  directly	   interacts	  with	  
the	  mitotic	  Cyclins	   (Mimura	   et	  al.	  2004).	  Recombinant	  Cdc6	   is	  degraded	  when	   injected	  at	  GVBD	   in	  
CHX-­‐treated	  oocytes	  but	   remains	   stable	  when	  oocytes	   are	   further	   injected	  with	   recombinant	  non-­‐
degradable	  Cyclin	  B.	  This	  strongly	  suggests	  that	  the	  interaction	  between	  Cdc6	  and	  Cyclin	  B	  is	  required	  
for	   Cdc6	   stabilization	   during	   the	   MI-­‐MII	   transition.	   However,	   when	   Cdc6	   is	   injected	   in	   prophase,	  
progesterone	  provokes	  the	  degradation	  of	  Cdc6	  despite	  the	  presence	  of	  pre-­‐MPF	  and	  the	  synthesis	  
of	  new	  Cyclin	  B	  molecules.	  This	  result	  suggests	  that	  the	  interaction	  between	  Cdc6	  and	  Cyclin	  B	  either	  
does	  not	  occur	   in	  ovo	   (GST-­‐Cdc6	   interacts	  with	  Cdk1-­‐Cyclin	  B	   in	  prophase	  extracts)	  or	   is	  unable	   to	  
protect	   Cdc6	   from	   degradation	   before	   GVBD.	   Therefore,	   the	   regulation	   of	   Cdc6	   stability	   may	   be	  
differentially	   regulated	   during	   the	   lag	   period	   separating	   hormonal	   stimulation	   and	   GVBD	   on	   one	  
hand,	   and	   the	   MI-­‐MII	   transition	   on	   the	   other	   hand.	   Several	   mechanisms	   can	   account	   for	   these	  
different	  regulations.	  
i. The	  phosphorylation	  status	  of	  Cdc6	  
At	  GVBD,	  both	  Cdk1-­‐Cyclin	  B	  and	  the	  Mos/MAPK	  pathway	  are	  activated.	  Cdk1	  and	  MAPK	  are	  able	  to	  
in	   vitro	   phosphorylate	   Cdc6	   and	   control	   the	   accumulation	  of	   the	   endogenous	  Cdc6	   in	   an	   opposite	  
manner.	   Whether	   the	   phosphorylation	   statute	   of	   Cdc6	   could	   control	   directly	   its	   turnover	   or	   its	  
interaction	   with	   Cyclin	   remains	   to	   be	   determined.	   The	   analysis	   of	   the	   Xenopus	   Cdc6	   sequence	  
indicates	  that	  Cdc6	  contains	  3	  consensus	  sites	  (S/T)Px(K/R)	  for	  Cdk1,	  2	  Px(S/T)P	  motifs	  for	  MAPK	  and	  
2	  others	  that	  can	  be	  potentially	  phosphorylated	  by	  both	  Cdk1	  and	  MAPK	  (Fig.	  39).	  	  
The	  mutation	  of	  all	  S	  within	  these	  SP	  sites	  into	  non-­‐phosphorylatable	  A	  residues	  (7A-­‐Cdc6)	  abolished	  
the	  phosphorylation	  of	  Cdc6	  by	  either	  Cdk1	  or	  MAPK.	  When	  injected	  at	  GVBD,	  the	  7A-­‐Cdc6	  mutant	  
behaves	  exactly	   the	   same	   than	  WT-­‐Cdc6,	   being	   stable	   in	   the	   absence	  of	  CHX	  and	  degraded	   in	   the	  
presence	  of	  CHX.	  Therefore,	  the	  direct	  phosphorylation	  of	  Cdc6	  at	  these	  7	  sites	  is	  unlikely	  involved	  in	  
the	   stabilization/destabilization	   of	   the	   protein.	   However,	   since	   the	   Cdk1-­‐	   and	   MAPK-­‐dependent	  
phosphorylations	  of	  Cdc6	  are	  expected	  to	  have	  opposite	  effects	  on	  Cdc6	  stability,	  the	  mutation	  into	  
alanine	   of	   serines	   within	   these	   SP	   sites	   is	   probably	   not	   the	   best	   approach	   to	   investigate	   their	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functions.	  Good	  tools	  to	  tackle	  this	  question	  would	  be	  to	  get	  Cdc6	  mutants,	  where	  phosphorylation	  
by	   one	   pathway	   is	   abolished	   while	   phosphorylation	   by	   the	   other	   one	   is	   preserved.	   I	   designed	   a	  
mutant	  in	  which	  all	  5	  predicted	  SP	  sites	  for	  Cdk1	  were	  suppressed	  without	  affecting	  the	  MAPK	  ones.	  
Unfortunately,	  this	  mutant	  was	  still	  weakly	  phosphorylated	  by	  Cdk1	  in	  our	  in	  vitro	  kinase	  assay.	  This	  
results	   suggests	   that	   the	   putative	   sites	   phosphorylated	   by	   MAPK	   can	   be	   also	   targeted	   by	   Cdk1.	  
Furthermore,	   since	   it	   is	  difficult	   to	  demonstrate	  whether	   these	  phosphorylations	  also	   take	  place	   in	  
vivo	  without	   specific	   anti-­‐phospho	  antibodies,	  we	  did	  not	   investigate	   further	   the	   regulation	  of	   this	  
particular	  mutant	  of	  Cdc6	  in	  the	  oocyte.	  	  
An	   interesting	  mechanism	  to	  control	   the	  stability	  and	   the	  ability	  of	  Cdc6	   to	  bind	  Cdk1-­‐Cyclin	  B	  has	  
been	   described	   in	   human	   cells.	   During	   mitosis,	   the	   phosphorylation	   of	   Cdc6	   at	   T37	   by	   Plk1	   was	  
shown	   to	   regulate	   the	   interaction	   between	   Cdc6	   and	   Cdk1-­‐Cyclin	   B,	   contributing	   to	   the	   Cdc6-­‐
mediated	   inhibition	   of	   Cdk1	   during	   the	   metaphase	   to	   anaphase	   transition	   (Yim	   et	   al.	   2010).	   In	  
Xenopus,	   Plx1,	   the	   homolog	   of	   Plk1,	   is	   activated	   at	   GVBD	   time	   and	   participates	   in	   the	   MPF	  
automplification	   loop.	   The	   timing	   of	   Plx1	   activation	   is	   compatible	   with	   the	   period	   when	   Cdc6	  
interacts	  with	   Cyclin	   B.	   However,	   human	   T37	   is	   not	   conserved	   in	  Xenopus	  Cdc6.	   Another	  minimal	  
consensus	   phosphorylation	   site	   for	   Plk1	   ((E/D)x(S/T)(L/M/F/W/V/A/C/I)	   (Nakajima	   et	   al.	   2003))	   is	  
located	   around	   S149	   in	  Xenopus	   Cdc6	   (Fig.	   39).	  Whether	   Plx1	  phosphorylates	   S149	  during	  meiotic	  
maturation	  is	  unknown	  but	  it	  would	  be	  interesting	  to	  test	  this	  hypothesis	  using	  purified	  Plx1	  in	  our	  in	  
vitro	  kinase	  assay.	  Moreover,	   it	  will	  be	  interesting	  to	  test	  the	  stability	  as	  well	  as	  the	  ability	  to	  block	  
Cdk1	  activation	  using	  a	  non	  phosphorylatable	  form	  of	  Cdc6	  (S149A-­‐Cdc6).	  
ii. The	  specific	  binding	  of	  Cdc6	  to	  different	  Cyclins	  B	  isoforms	  
Different	   Cyclin	   B	  members	   are	   expressed	   before	   and	   after	   GVBD.	   In	   prophase	   oocytes,	   the	  main	  
Cyclins	  correspond	  to	  Cyclin	  B2	  and	  B5	  isoforms	  and	  are	  associated	  with	  Cdk1	  to	  form	  the	  pre-­‐MPF.	  
In	  response	  to	  progesterone,	   the	  synthesis	  of	  Cyclin	  B1	  and	  B4	   is	   initiated	  (Hochegger	  et	  al.	  2001).	  
The	  suppression	  of	  the	  synthesis	  of	  all	  Cyclins	  B	  isoforms	  abolishes	  the	  accumulation	  of	  endogenous	  
Cdc6	   after	   GVBD	   until	   the	   inactivation	   of	   the	   Mos/MAPK	   pathway.	   It	   will	   be	   therefore	   very	  
interesting	   to	   study	   the	   accumulation	   of	   endogenous	   Cdc6	   in	   oocytes	   injected	   with	   antisense	  
targeting	  only	  one	   isoform	  of	  Cyclin	  B.	   If	   the	  elimination	  of	  B1	  and	  B4	   (GVBD	  Cyclins)	  delays	  Cdc6	  
accumulation	  while	  suppressing	  B2	  and	  B5	  (prophase	  Cyclins	  B)	  has	  not	  affect	  on	  Cdc6	  accumulation,	  
this	  would	   strongly	   suggest	   that	   only	  GVBD	   Cyclins	   are	   in	   vivo	   important	   for	   stabilizing	   Cdc6.	   This	  
result	   would	   also	   provide	   some	   relevance	   for	   the	   presence	   of	   different	   Cyclins	   B	   isoforms	   during	  
meiotic	  maturation.	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iii. Different	  status	  of	  Cdk1-­‐Cyclin	  B	  phosphorylation	  
At	   GVBD,	   it	   is	   known	   that	   the	   Cyclin	   B2	   sustains	   a	   shift	   up	   in	   its	   electrophoretic	   migration	   that	  
correlates	   with	   the	   activation	   of	   Cdk1.	   Whether	   the	   phosphorylation	   of	   Cyclin	   B	   can	   affect	   its	  
interaction	  with	  Cdc6	  could	  be	  explored.	  This	  hypothesis	  can	  be	  addressed	  by	  inactivating	  Cdk1	  right	  
after	   GVBD	   independently	   of	   Cyclin	   B	   degradation	   in	   order	   to	   generate	   some	   inactive	   pre-­‐MPF	  
molecules	  related	  to	  those	  present	  in	  prophase:	  Cyclin	  B	  associated	  with	  Cdk1	  that	  is	  phosphorylated	  
at	   T161,	   T14	   and	   Y15.	   The	   injection	   of	   p21Cip1	   at	   GVBD	   inhibits	   Cdk1	   and	   promotes	   its	  
rephosphorylation	   at	   Y15.	   Under	   this	   condition,	   the	   Cyclins	   B	   are	   not	   degraded	   but	   are	  
dephosphorylated	   (Frank-­‐Vaillant	   et	   al.	   2001).	   These	   Cdk1-­‐Cyclin	   B	   complexes	   are	   therefore	   very	  
similar	  to	  those	  present	  in	  prophase,	  despite	  the	  identity	  of	  the	  associated	  Cyclin	  B	  isoforms	  (B1,	  B2,	  
B4,	   B5).	   If	   the	   interaction	   between	   Cdc6	   and	   Cdk1-­‐Cyclins	   B,	   and	   therefore	   Cdc6	   stabilization,	  
depends	  on	  the	  phosphorylation	  status	  of	  the	  MPF,	  recombinant	  Cdc6	  should	  not	  be	  stable	  when	  co-­‐
injected	  with	  p21Cip1	  at	  GVBD.	  
iv. Localization	  of	  Cdc6	  and	  Cdk1-­‐Cyclin	  B	  complexes	  
Cyclin	   B2	   is	   pulled	   down	   together	   with	   GST-­‐Cdc6	   in	   prophase-­‐diluted	   extracts.	   This	   experiment	  
demonstrates	   that	   Cyclin	   B	   and	   ectopic	   Cdc6	   have	   the	   ability	   to	   interact	   but	   it	   does	   not	   allow	   to	  
address	   the	  potential	   regulation	   exerted	  by	   intracellular	   compartments	   since	   in	   these	   extracts	   the	  
intracellular	  organization	   is	   lost.	  My	  preliminary	  data	   indicate	   that	  ectopic	  Cdc6	   is	  mainly	   localized	  
within	  the	  nucleus	  in	  prophase	  while	  the	  pre-­‐MPF	  is	  known	  to	  be	  localized	  in	  both	  the	  nucleus	  and	  
the	   cytoplasm.	   It	   is	   therefore	   possible	   that	   due	   to	   these	   distinct	   localizations,	   only	   a	   part	   of	   Cdc6	  
interacts	  with	  Cyclin	  B.	   This	   different	   localization	  of	   Cdc6	   and	  Cdk1-­‐Cyclin	  B	   could	   account	   for	   the	  
degradation	  of	  ectopic	  Cdc6	  around	  the	  time	  of	  GVBD.	  The	  nuclear	  localization	  of	  Cdc6	  would	  protect	  
it	  from	  the	  degradation.	  At	  GVBD,	  Cdc6	  becomes	  entirely	  cytoplasmic	  and	  could	  be	  fully	  accessible	  to	  
the	   degradation	  mechanism.	   Therefore,	   one	   simple	   experiment	   to	   address	   this	   issue	  would	   be	   to	  
analyse	  the	  degradation	  of	  ectopic	  Cdc6	  in	  enucleated	  oocytes	  during	  meiosis	  resumption.	  
d. High	   molecular	   weight	   complexes	   containing	   both	   MPF	   and	  
Cdc6	  
Only	  50	  %	  of	  the	  Cyclin	  B	  is	  degraded	  at	  MI	  exit.	  Hence,	  a	  residual	  Cdk1	  activity	  persists	  during	  MI-­‐MII	  
transition.	   Cdk1	   activity	   is	   required	   for	   the	   polyadenylation	   of	   Erp1	   mRNA,	   which	   promotes	   its	  
translation,	   independently	   of	   the	   Mos/MAPK	   pathway	   (Tung	   et	   al.	   2007).	   Erp1	   is	   essential	   for	  
inhibiting	   APC/C	   and	   stabilizing	   newly	   synthesized	   Cyclin	   B,	   allowing	   entry	   into	   MII	   and	   then	   the	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arrest	  at	  that	  stage	  (Ohe	  et	  al.	  2007).	  From	  these	  observations,	  the	  presence	  of	  the	  residual	  activity	  
of	  Cdk1	  during	  MI-­‐MII	  transition	  is	  required	  to	  enter	  in	  MII,	  promoting	  Erp1	  translation	  (See	  chapter	  
I-­‐B.e.i.).	  The	  injection	  of	  0.5	  µM	  of	  WT-­‐Cdc6	  at	  GVBD	  induces	  full	  inactivation	  of	  Cdk1	  and	  the	  entry	  
in	  interphase.	  Hence,	  the	  absence	  of	  Cdc6	  at	  GVBD	  is	  important	  to	  ensure	  the	  entry	  in	  MII.	  
Following	   the	   activation	   of	   MII-­‐arrested	   oocytes,	   Erp1	   gets	   fully	   degraded	   within	   5	   minutes	   and	  
reaccumulates	   40	   minutes	   later	   (Schmidt	   et	   al.	   2005).	   On	   the	   contrary,	   the	   Mos/MAPK	   pathway	  
remains	  active	  for	  at	  least	  30	  minutes	  (Castro	  et	  al.	  2001b).	  Following	  Erp1	  degradation,	  the	  oocyte	  is	  
under	  a	  biochemical	  status	  similar	  to	  anaphase	  I:	  the	  Mos/MAPK	  pathway	  is	  active	  and	  the	  activation	  
of	   the	  APC/C	   leads	   to	  Cyclin	  B	  degradation.	  However,	   activated	  eggs	  do	  not	  perform	  an	  M-­‐	   to	  M-­‐
phase	   transition	   but	   enter	   in	   interphase.	   This	   discrepancy	   between	   the	   exit	   from	  MI	   and	   the	   exit	  
from	  MII	  can	  be	  due	  to	  the	  presence	  of	  the	  high	  levels	  of	  endogenous	  Cdc6	  present	  in	  MII-­‐arrested	  
oocytes,	  which	  allow	  the	  full	  inactivation	  of	  Cdk1.	  In	  order	  to	  assess	  the	  potential	  role	  of	  endogenous	  
Cdc6	  in	  contributing	  to	  the	  complete	  inactivation	  of	  Cdk1	  once	  the	  oocyte	  is	  released	  from	  the	  CSF	  
arrest,	   it	   will	   be	   interesting	   to	   study	   the	   kinetic	   of	   Cdk1	   inactivation	   in	   oocytes	   injected	   with	  
antisense	  oligonucleotides	  against	  Cdc6.	  	  
Moreover,	  our	  gel	  filtration	  experiments	  demonstrate	  that	  endogenous	  Cdc6	  is	  eluted	  together	  with	  
Cdk1-­‐Cyclin	  B	  complexes	  in	  high	  molecular	  weight	  fractions	  (H-­‐MPF).	  Besides	  H-­‐MPF,	  canonical	  Cyclin	  
B-­‐Cdk1	  dimers	   (L-­‐MPF)	  are	  also	   recovered	   in	  other	   fractions,	  as	  well	  as	  monomeric	  Cdk1.	  The	  high	  
molecular	  weight	  pool	  of	  MPF	  was	  previously	  described	  in	  prophase-­‐arrested	  oocytes	  (De	  Smedt	  et	  
al.	   2002),	   but	   its	   function	   has	   never	   been	   characterized.	   The	   formation	   of	   these	  MPF	   complexes	  
depends	  neither	  on	  Cdc6	  nor	  on	  the	  Mos/MAPK	  pathway	  since	  both	  Cdc6	  and	  Mos	  are	  not	  expressed	  
in	   prophase.	   Given	   the	   molecular	   weight	   of	   these	   complexes,	   they	   contain	   other	   molecules	   than	  
Cyclin	  B,	  Cdk1	  and	  Cdc6,	  but	  their	  components	  are	  not	  known.	  We	  showed	  that	  WT-­‐Cdc6	  injected	  at	  
GVBD	   interacts	   only	   with	   the	   H-­‐MPF.	   This	   pool	   of	   MPF	   could	   be	   an	   essential	   platform	   for	   the	  
reactivation	   of	   MPF	   during	   the	   MI-­‐MII	   transition.	   This	   exciting	   hypothesis	   can	   be	   investigated	   by	  
performing	  several	  experiments.	  Since	  only	  50	  %	  of	  Cyclin	  B	  is	  degraded	  during	  MI-­‐MII	  transition,	  we	  
could	  analyse	  the	  elution	  profile	  of	  the	  remaining	  Cyclin	  B	  by	  fractionating	  oocytes	  collected	  1	  hour	  
after	  GVBD	  on	  a	  gel	   filtration	  column.	   If	   the	  Cyclin	  B	  molecules	   included	   into	  H-­‐MPF	  correspond	  to	  
this	   stable	   pool,	  while	   the	   Cyclin	   B	   present	   in	   L-­‐MPF	   is	   degraded,	   it	  will	   be	   a	   good	   indication	   that	  
these	   two	   pools	   of	  MPF	   are	   differently	   regulated.	   Furthermore,	   it	   would	   suggest	   that	   the	   H-­‐MPF	  
could	   be	   specifically	   involved	   in	   keeping	   the	   residual	   level	   of	   Cdk1	   activity	   in	   MI-­‐MII	   and	   in	   the	  
reactivation	   of	   Cdk1	   for	   MII	   entry.	   This	   hypothesis	   as	   well	   as	   the	   physiological	   relevance	   of	   the	  
specific	  association	  of	  Cdc6	  with	  H-­‐MPF,	  but	  not	  with	  L-­‐MPF,	  deserves	  investigation.	  	  











Fine-­‐tuning	  of	  Cdc6	  accumulation	  by	  Cdk1	  and	  
MAP	  kinase	  is	  essential	  for	  the	  completion	  of	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During	  my	  Ph.D.,	   I	   investigated	   two	  main	   features	  of	   female	  meiosis:	   the	  prophase	   arrest	   and	   the	  
establishment	  of	  DNA	  replication	  competence.	  
These	  two	  peculiarities	  of	  the	  female	  meiosis	  are	  directly	  connected	  to	  the	  high	  sexual	  dimorphism	  
present	  in	  eukaryotic	  gametes.	  The	  female	  gamete,	  the	  oocyte,	  has	  to	  put	  aside	  many	  components	  
falling	   into	   two	   categories:	   energetic	  nutrients	   and	  embryonic	  determinants.	   The	   first	   ones	  will	   be	  
utilized	   by	   the	   embryo	   until	   its	   own	   genome	   is	   expressed,	   and	   its	   own	  metabolism	   as	   well	   as	   its	  
ability	  to	  feed	  itself	  are	  established.	  The	  second	  ones	  that	  are	  often	  localized	  in	  specific	  area	  of	  the	  
giant	  egg,	  will	  be	  inherited	  by	  embryonic	  cells	  and	  will	  orientate	  their	  fate	  and	  the	  organization	  of	  the	  
whole	   body.	   Hence	   these	   stored	   components	   corresponds	   to	   mRNA,	   proteins,	   lipids,	   glucids,	  
organelles,	   all	   of	   them	   required	   to	   sustain	   the	   first	   steps	   of	   the	   embryonic	   development	   until	   the	  
moment	   the	   new	   formed	   organism	   will	   be	   autonomous.	   From	   that	   necessity,	   female	   meiosis	   is	  
discontinuous	  and	  oocytes	  of	  all	  species	  of	  the	  animal	  kingdom	  arrest	  at	  prophase	  of	  the	  1st	  meiotic	  
division	  for	  a	   long	  time.	  Moreover,	  after	  prophase	  release,	  oocytes	   further	  arrest	  a	  second	  time	  to	  
generate	  a	   time	  window	   required	   to	   reach	  a	   significant	  probability	   to	  meet	   sperm	  and	  proceed	   to	  
fertilization.	  The	  arrest	  occurs	  at	  metaphase	  II	  in	  all	  vertebrates.	  
Both	  sperm	  and	  oocytes	  need	  to	  be	  haploid	  in	  order	  that	  fertilization	  restores	  a	  diploid	  genome	  that	  
guarantees	  a	  successful	   life	  cycle.	  While	   in	  both	  sexes	  DNA	  replication	  has	  to	  be	   inhibited	  between	  
the	   two	  meiotic	  divisions,	   the	  mechanisms	   to	  achieve	   this	  goal	  are	  different	   in	   females	  and	  males.	  
Sperm	  uses	  the	  simplest	  strategy	  to	  avoid	  DNA	  replication:	  it	  downregulates	  the	  expression	  of	  pre-­‐RC	  
components	   during	   the	   last	   steps	   of	   its	   terminal	   differentiation	   (Eward	   et	   al.	   2004).	   However,	  
oocytes	   cannot	   do	   the	   same	   because	   they	   need	   to	   accumulate	   for	   the	   future	   embryo	   enough	  
replicative	   components	   to	   ensure	   several	   rounds	   of	   embryonic	   divisions.	   By	   constituting	   this	  
maternal	  inheritance,	  the	  oocytes	  acquire	  themselves	  the	  competence	  to	  replicate.	  
These	  “female	  duties”	  unfortunately	  has	  some	  costs.	  Firstly,	  the	  quantity	  of	  energy	  invested	  for	  the	  
production	  of	  one	  gamete	  is	  much	  higher	  for	  females	  compared	  to	  males.	  Secondly,	  the	  long	  arrest	  
in	  prophase	  I,	  which	  in	  human	  lasts	  for	  years,	  is	  thought	  to	  at	  the	  origin	  of	  the	  decrease	  of	  the	  quality	  
of	  oocytes	  of	  elderly	  woman.	  Finally,	  the	  acquisition	  of	  DNA	  replication	  competence	  during	  meiosis,	  
which	   is	   necessary	   for	   the	   embryo,	   includes	   a	   risk	   for	   the	   oocyte	   meiosis.	   Therefore,	   oocytes	  
elaborated	   complex	   strategies	   to	   avoid	   the	   manifestation	   of	   that	   competence	   during	   meiotic	  
divisions.	  
Since	  both	  male	   and	   female	  meiotic	   divisions	   certainly	   evolved	   from	   the	  mitotic	   cycle,	  with	  which	  
they	  share	  many	  molecular	  players,	  it	  is	  therefore	  interesting	  to	  explore	  how	  the	  regulation	  of	  these	  
common	  actors	  has	  been	  adapted	  in	  each	  three	  systems	  in	  order	  to	  produce	  the	  specific	  outcomes	  of	  
each	  of	  them,	  mitotic	  cell	  cycle,	  female	  meiosis	  and	  male	  meiosis.	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My	   first	   Ph.D.	   project	   reveals	   the	   involvement	   of	   Arpp19	   during	   the	   prophase	   arrest	   of	   Xenopus	  
oocytes.	  We	  have	  shown	  that	  Arpp19	  is	  the	  long	  hidden	  substrate	  of	  PKA.	  Arpp19	  is	  phosphorylated	  
at	  S109,	  which	  is	  sufficient	  to	  arrest	  the	  oocytes	  in	  prophase.	  Moreover,	  S109	  dephosphorylation	  is	  
required	  for	  meiosis	  resumption.	  Surely,	  the	  natural	  continuation	  for	  this	  project	  is	  to	  elucidate	  how	  
Arpp19	   is	   blocking	   meiosis	   resumption	   in	   Xenopus	   oocytes,	   identifying	   which	   are	   its	   downstream	  
targets.	  This	  discovery	  was	  especially	  unexpected	  since	  Arpp19	  had	  been	  demonstrated	  a	  few	  years	  
ago	   to	   be	   required	   for	   M-­‐phase,	   including	   meiotic	   M-­‐phase.	   Hence,	   the	   small	   protein	   Arpp19	  
behaves	   as	   the	   yin	   and	   the	   yang	   of	   the	   G2/M	   transition.	   By	   virtue	   of	   the	   phosphorylation	   of	   two	  
serines,	  S67	  and	  S109,	  by	  two	  distinct	  kinases,	  Gwl	  and	  PKA,	  Arpp19	  is	  converted	  from	  an	  inhibitor	  
into	  an	  activator	  of	  M-­‐phase.	  If	  this	  role	  is	  conserved	  in	  the	  somatic	  cell	  cycle,	  this	  places	  Arpp19	  at	  a	  
critical	  position	  for	  regulating	  proliferation,	  and	  as	  a	  potential	  hot	  spot	  responsible	  for	  proliferation	  
disorders,	  such	  as	  cancer.	  
In	  all	  vertebrates	  the	  prophase	  arrest	  is	  maintained	  by	  high	  activity	  of	  PKA,	  suggesting	  that	  the	  role	  
of	   the	  PKA/Arpp19	  module	  should	  be	  conserved	   in	   this	  phylum,	  what	  deserves	   rapid	   investigation.	  
The	  powerful	  genetic	  tools	  available	  in	  model	  organisms	  such	  as	  mouse	  and	  zebrafish	  should	  provide	  
rapid	  insights	  about	  this	  question.	  
The	  release	  of	   the	  prophase	  block	  of	   invertebrate	  oocytes	   is	  ensured	  by	  a	  collection	  of	  various	  so-­‐
called	  "second	  messengers",	  such	  as	  Calcium,	  inositol-­‐3-­‐phosphate,	  etc.	  In	  some	  cases,	  as	  cnidarians	  
and	  ctenarians,	  cAMP	  and	  PKA	  are	  essential	  for	  maintaining	  the	  prophase	  arrest,	  but	  in	  an	  opposite	  
manner	   than	  what	   happens	   in	   vertebrates:	   prophase-­‐arrested	  oocytes	   contain	   low	   levels	   of	   cAMP	  
and	   low	  PKA	  activity.	  Both	  of	   them	  have	  to	  be	   increased	  for	   inducing	  the	  prophase	  release.	  A	  new	  
emerging	   animal	   model	   for	   developmental	   biology,	   the	   small	   jelly	   fish	   Clytia	   hemisphaerica,	   is	  
especially	  suited	  to	  study	  meiosis	  resumption	  and	  its	  control	  by	  cAMP	  and	  PKA	  (Takeda	  et	  al.	  2006,	  
Houliston	   et	   al.	   2010).	   In	   Clytia,	   the	   light/dark	   stimulus	   stimulates	   photoreceptors	   expressed	   in	  
somatic	  cells	  around	  the	  oocytes.	  These	  cells	  release	  a	  small	  peptide	  that	  reaches	  the	  oocytes,	  binds	  
membrane	   receptors	  and	   increases	   cAMP	   levels	  and	  PKA	  activity	   (Takeda	   et	  al.	   2006).	   It	  would	  be	  
interesting	  to	  determine	  if	  the	  PKA/Arpp19	  module	  mediates	  the	  cAMP-­‐induced	  meiotic	  maturation	  
in	  Clytia.	   If	   this	   is	   the	   case,	   the	   identification	  of	  Arpp19	  effectors	   in	   vertebrates	   and	   invertebrates	  
would	  be	  a	  great	  knowledge	  to	  understand	  how	  meiosis	  resumption	  can	  be	  regulated	  in	  an	  opposite	  
manner	  by	  the	  same	  cAMP/PKA/Arpp19	  module.	  	  
Finally,	   since	   the	   prophase	   arrest	   as	   many	   aspect	   of	   similarity	   with	   a	   mitotic	   G2/M	   arrest,	   it	   will	  
therefore	  interesting	  to	  investigate	  if	  the	  PKA/Arpp19	  module	  can	  play	  any	  role	  during	  this	  transition	  
in	   mitotic	   cells.	   Interestingly,	   cells	   activating	   a	   DNA	   damage	   checkpoint	   often	   arrest	   at	   the	   G2/M	  
transition	   and	   PKA	   site	   on	   Arpp19	   is	   also	   a	   potential	   consensus	   motif	   for	   checkpoint	   mediator	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kinases,	  Chk1/2.	  A	  potential	   role	  of	  Arpp19	   in	   these	  checkpoint	  mechanisms	  deserves	   surely	   to	  be	  
investigated.	  
In	   my	   second	   Ph.D.	   project,	   I	   investigated	   how	   is	   regulated	   the	   acquisition	   of	   DNA	   replication	  
competence	   in	  Xenopus	  oocytes.	  We	  discovered	  that	  Cdc6	  expression	   is	  tightly	  regulated	  during	  all	  
the	   process	   of	   meiosis	   maturation.	   This	   regulation	   is	   absolutely	   essential	   after	   MI,	   a	   highly	   risky	  
period	  where	   all	   components	   of	   the	   pre-­‐RC	  machinery	   are	   present	   and	   functional,	   and	  where	   the	  
oocyte	  has	  to	  avoid	  DNA	  replication.	  During	  the	  MI-­‐MII	  transition	  we	  have	  shown	  that	  endogenous	  
Cdc6	  is	  post-­‐translationally	  controlled	  by	  two	  opposite	  mechanisms.	  The	  Mos/MAPK	  pathway	  delays	  
Cdc6	   accumulation	  while	   it	   also	   facilitates	   the	   accumulation	   of	   Cyclin	   B,	   which	   is	   able	   to	   stabilize	  
Cdc6.	  The	  overall	  output	  of	  this	  opposite	  regulation	   is	   that	  Cdc6	  and	  Cyclin	  B	  are	  accumulated	   in	  a	  
synchronous	  manner.	  We	  have	  also	  shown	  that	  a	  fine	  tuning	  of	  the	  Cdc6	  dosage	  is	  essential	  for	  the	  
successful	   sequence	  of	   the	   two	  meiotic	  divisions	   since	   its	  ectopic	  expression	   in	  prophase	  or	   in	  MI,	  
alters	  Cdk1	  activity.	  
Interestingly,	   the	   regulation	   of	   Cdc6	   expression	   during	   meiosis	   resumption	   is	   well	   conserved	   in	  
mouse	  and	  Drosophila	  oocytes:	  in	  both	  species,	  Cdc6	  is	  not	  expressed	  in	  prophase	  oocytes,	  but	  the	  
protein	  starts	  to	  accumulate	  during	  MI-­‐MII	   transition,	  as	   in	  Xenopus	   (Lemaitre	  et	  al.	  2004).	   In	  both	  
mouse	  and	  Xenopus,	  and	  probably	  in	  all	  vertebrates,	  the	  Mos/MAPK	  pathway	  plays	  an	  important	  role	  
in	   the	   inhibition	   of	  DNA	   replication	   during	  meiotic	  maturation	   (Colledge	   et	   al.	   1994,	   Furuno	   et	   al.	  
1994,	  Hashimoto	  et	  al.	  1994a,	  Verlhac	  et	  al.	  1996a,	  Dupre	  et	  al.	  2002).	  Since	  we	  have	  shown	  that	  the	  
Mos/MAPK	  pathway	  kinase	  controls	  Cdc6	  accumulation,	  contributing	  both	  to	  the	  regulation	  of	  Cdk1	  
reactivation	  and	  to	  DNA	  replication	  repression,	  it	  will	  be	  interesting	  to	  evaluate	  if	  Cdc6	  regulation	  by	  
the	  Mos/MAPK	  pathway	  is	  conserved	  in	  the	  other	  species.	  If	  it	  is	  the	  case,	  it	  suggests	  that	  vertebrate	  
oocytes	   have	   developed	   two	   strategies	   to	   inhibit	   DNA	   replication	   during	   meiosis:	   ensuring	   the	  
absence	   of	   Cdc6	   in	   the	   first	   part	   of	  meiotic	  maturation	   (from	   the	   external	   stimulus	   to	  GVBD)	   and	  
using	   the	  Mos/MAPK	  pathway	  during	   the	   second	  part.	   Interestingly,	   in	  unicellular	  eukaryotes	  as	  S.	  
pombe,	  Cdc6	  is	  not	  expressed	  during	  meiosis	  and	  therefore	  the	  haploid	  spores	  produced	  by	  meiosis	  
are	  not	  competent	  to	  replicate	  DNA	  (Lemaitre	  et	  al.	  2004).	  Therefore	  yeast	  has	  adopted	  a	  strategy	  to	  
prevent	  DNA	  replication	  during	  meiosis	  similar	  to	  the	  one	  used	  by	  sperm	  or	  quiescent	  cells	  in	  higher	  
eukaryotes.	  In	  contrast	  to	  S.	  cerevisiae	  and	  higher	  eukaryotes,	  the	  overexpression	  of	  Cdc6	  during	  the	  
mitotic	   cell	   cycle	   of	   S.	   pombe	   induces	   DNA	   re-­‐replication,	   suggesting	   the	   absence	   of	   other	  
mechanisms	  to	  control	  this	  deleterious	  process	  (Nishitani	  et	  al.	  1995).	  	  
Besides	   its	   well-­‐established	   role	   in	   DNA	   replication,	   this	   PhD	   work	   reveals	   that	   in	   a	   physiological	  
situation,	   as	   Xenopus	   oocyte	   meiotic	   divisions,	   Cdc6	   has	   the	   potential	   to	   inhibit	   Cdk1	   by	   direct	  
binding	   to	  accumulating	  Cyclin	  B.	  While	   in	  yeast,	  Cdc6	  ability	   to	   regulate	  Cdk1	  both	   through	  direct	  
binding	  and	  by	  activating	  checkpoint	  mechanism	  is	  well	  established	  (Greenwood	  et	  al.	  1998),	  mainly	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the	  latter	  pathway	  has	  been	  characterized	  in	  higher	  eukaryotes	  (Oehlmann	  et	  al.	  2004,	  Yoshida	  et	  al.	  
2010).	  Recently,	  the	  role	  of	  Cdc6	  in	  modulating	  Cdk1	  activation	  was	  investigated	  in	  Xenopus	  extracts	  
(El	  Dika	   et	   al.	   2014)	   and	  during	   the	  metaphase	   to	   anaphase	   transition	   in	  mammal	   cells	   (Yim	   et	   al.	  
2010).	   Unfortunately,	   Cdc6	   plays	   many	   pleiotropic	   roles	   during	   mitosis,	   rendering	   difficult	   the	  
interpretation	   of	   the	   consequences	   of	   its	   ablation.	   Despite	   this	   difficulty,	   the	   identification	   of	   the	  
domains/sites	  in	  Cdc6	  protein	  that	  are	  involved	  in	  each	  of	  these	  processes	  are	  required	  to	  define	  the	  
importance	  of	  each	  of	  these	  roles	  during	  the	  cell	  cycle,	  and	  how	  they	  are	  coordinated.	  
Finally,	  the	  evidence	  that	  Cdc6	  binds	  directly	  and	  specifically	  to	  MPF	  contained	  into	  high	  molecular	  
weight	  complexes,	  but	  that	  it	  is	  able	  to	  inhibit	  the	  overall	  reactivation	  of	  MPF	  to	  drive	  the	  oocyte	  to	  
the	  2nd	  meiotic	  division	  opens	  the	  possibility	  of	  an	  unexpected	  role	  of	  these	  complexes	  in	  the	  control	  
of	   the	  meiotic	   divisions.	   It	   will	   be	   therefore	   important	   to	   evaluate	   if	   these	   high	  molecular	  weight	  
complexes	   are	   differentially	   regulated	   and	  play	   specific	   roles,	   compared	   to	   the	   canonical	   Cyclin	   B-­‐
Cdk1	  dimer	  during	  meiosis	  as	  well	  as	  mitosis.	  This	  observation	  questions	  again	  the	   identity	  of	  MPF	  
and	  re-­‐opens	   the	  Pandora	  box:	  what	   is	   the	  MPF?	   In	  conclusion,	   the	  major	   lesson	   learned	   from	  my	  
thesis	  work	  is	  that	  there	  is	  not	  end	  to	  questions.	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L’objectif	   de	   cette	   thèse	   a	   été	   de	   comprendre	   deux	   caractéristiques	   majeures	   des	   divisions	  
méiotiques	  chez	  la	  femelle:	  le	  blocage	  en	  prophase	  de	  1ère	  division	  méiotique	  qui	  permet	  à	  l’ovocyte	  
d’accumuler	   des	   réserves	   énergétiques	   et	   des	   déterminants	   nécessaires	   au	   développement	  
embryonnaire	  ;	  et	  l’absence	  de	  phase-­‐S	  entre	  les	  deux	  divisions	  méiotiques	  ce	  qui	  permet	  de	  former	  
des	  cellules	  haploïdes	  aptes	  à	  la	  fécondation.	  Pour	  cela,	  j’ai	  choisi	  comme	  modèle	  d’étude	  l’ovocyte	  
de	  Xénope	  qui	  permet	  de	  suivre	  ces	  processus	  in	  vitro	  en	  réponse	  à	  la	  progestérone.	  L’ovocyte	  subit	  
les	  deux	  divisions	  méiotiques	  grâce	  à	  l’activation	  du	  facteur	  universel	  de	  la	  division	  cellulaire,	  le	  MPF,	  
et	   se	  bloque	  en	  métaphase	  de	  2ème	  division	  méiotique	  dans	   l’attente	  d’être	   fécondé.	  Chez	   tous	   les	  
vertébrés,	  le	  1er	  arrêt	  en	  prophase	  dépend	  de	  l’activité	  de	  la	  protéine	  kinase	  dépendante	  de	  l’AMPc,	  
PKA,	  dont	  l’inactivation	  est	  nécessaire	  pour	  la	  reprise	  de	  la	  méiose.	  Le	  substrat	  de	  PKA	  dans	  l’ovocyte	  
était	  resté	  inconnu.	  Nous	  avons	  découvert	  que	  la	  protéine	  Arpp19,	  jusqu’alors	  connue	  pour	  son	  rôle	  
positif	   dans	   l’activation	   du	   MPF,	   est	   phosphorylée	   par	   PKA	   de	   cette	   phosphorylation	   bloque	  
l’activation	   du	   MPF	   nécessaire	   pour	   la	   levée	   du	   blocage	   en	   prophase.	   ARPP19	   possède	   donc	   un	  
double	  rôle,	   le	  1er	  exercé	  comme	  substrat	  de	  PKA	  et	  responsable	  de	   l’arrêt	  en	  prophase,	   le	  second	  
dans	   l’activation	  du	  MPF	   suite	   à	   un	   changement	  dans	   sa	   phosphorylation.	  Dans	  un	   second	   temps,	  
nous	   avons	   étudié	   la	   protéine	   Cdc6,	   un	   acteur	   majeur	   de	   la	   réplication	   de	   l’ADN.	   Absente	   en	  
prophase,	  Cdc6	  s’accumule	  entre	  les	  deux	  divisions	  méiotiques	  ce	  qui	  permet	  à	  l’ovocyte	  d’acquérir	  
la	  compétence	  à	   répliquer	   l’ADN.	  Cette	  compétence	  ne	  s’exprime	  pas	  ce	  qui	  permet	  de	  réduire	  de	  
moitié	  la	  ploïdie.	  Nous	  avons	  montré	  que	  Cdc6	  est	  un	  inhibiteur	  puissant	  du	  MPF	  capable	  de	  bloquer	  
les	   divisions	   méiotiques	   et	   d’induire	   la	   réplication	   de	   l’ADN.	   Pour	   éviter	   ces	   effets	   délétères	  
l’accumulation	   de	   Cdc6	   est	   strictement	   régulée	   lors	   des	   deux	   divisions	   méiotiques,	   ce	   qui	   est	  





The	  goal	  of	  my	  PhD	  project	  was	  to	  understand	  two	  main	  features	  of	  the	  female	  meiotic	  division:	  the	  
arrest	   in	   prophase	   of	   the	   1st	   meiotic	   division	   that	   allows	   the	   accumulation	   of	   nutrients	   and	  
determinants	  necessary	  for	  the	  embryonic	  cell	  cycles;	  and	  the	  absence	  of	  S-­‐phase	  between	  the	  two	  
meiotic	  divisions	  in	  order	  to	  produce	  haploid	  gametes.	  For	  this	  purpose,	  I	  studied	  Xenopus	  oocytes,	  a	  
powerful	  model	  system	  that	  allows	  the	  biochemical	  analysis	  of	  these	  two	  processes	  in	  vitro.	  In	  ovary,	  
oocytes	   are	   arrested	   in	   prophase	   I	   and	   resume	  meiosis	   in	   response	   to	   progesterone.	   The	   oocytes	  
then	   proceed	   through	   the	   1st	   and	   the	   2nd	  meiotic	   divisions	   and	   halt	   at	  metaphase	   II,	   awaiting	   for	  
fertilization.	   These	   two	   consecutive	   divisions	   are	   controlled	   by	   two	  waves	   of	   Cdk1	   activation,	   the	  
universal	   factor	   responsible	   for	   the	   entry	   into	  mitosis.	   I	   analysed	   the	  mechanisms	   responsible	   for	  
arresting	   the	  oocyte	   in	   prophase	   I.	   In	   all	   vertebrates,	   this	   arrest	   depends	  on	   a	   high	   activity	   of	   the	  
cAMP-­‐dependent	   protein	   kinase,	   PKA,	   whose	   downregulation	   is	   required	   for	   the	   release	   of	   the	  
prophase	   block.	   The	   substrate	   of	   PKA	   had	   never	   been	   identified	   up	   to	   date.	   I	   discovered	   that	   the	  
small	  protein	  Arpp19,	  already	  known	  for	  positively	  regulating	  entry	  into	  M-­‐phase,	  is	  phosphorylated	  
by	   PKA	   in	   prophase	   I	   and	   is	   dephosphorylated	   upon	   progesterone	   addition,	   an	   event	   required	   for	  
Cdk1	   activation.	   Hence,	   Arpp19	   has	   a	   dual	   function,	   responsible	   of	   the	   prophase	   arrest	   as	   a	   PKA	  
substrate,	  and	  then	  converted	   into	  an	  activator	  of	  Cdk1	  by	  changes	  of	   its	  phosphorylation	  pattern.	  
The	  second	  part	  of	  my	  thesis	  has	  been	  dedicated	  to	  understanding	  the	  role	  and	  the	  regulation	  of	  the	  
Cdc6	  protein	  during	  meiotic	  divisions.	  This	  protein	  is	  essential	  for	  DNA	  replication	  in	  somatic	  cells.	  It	  
is	  accumulated	  between	  the	  two	  oocyte	  meiotic	  divisions	  and	  restores	  the	  competence	  to	  replicate	  
DNA	   in	   oocyte.	   However,	   this	   competence	   is	   repressed	   before	   fertilization,	   allowing	   formation	   of	  
haploid	  cells.	  I	  found	  that	  the	  accumulation	  of	  Cdc6	  is	  tightly	  controlled	  during	  meiotic	  maturation	  by	  
the	  Cyclin	  B	  accumulation	  and	  the	  Mos/MAPK	  pathway.	  I	  further	  demonstrated	  that	  Cdc6	  is	  a	  strong	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inhibitor	   of	   Cdk1	   in	   Xenopus	   oocytes	   and	   that	   the	   timely	   accumulation	   of	   Cdc6	   is	   required	   to	  
coordinate	  the	  two	  meiotic	  divisions	  with	  no	  intercaling	  S-­‐phase.	  
